participant_id,GUID,visit_name,visit_month,sample_type,test_name,test_value,test_units
BF-1045,PDEZ044TE4,M0,0,Plasma,14-3-3 protein beta/alpha,20989.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,14-3-3 protein epsilon,788.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,14-3-3 protein family,6006,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,14-3-3 protein sigma,1066.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,14-3-3 protein theta,1249,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,14-3-3 protein zeta/delta,157378.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1412.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",521.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,348,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,293.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1431.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1419,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",3844.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",706.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,877.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,40S ribosomal protein S3,496.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,40S ribosomal protein S3a,644.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,40S ribosomal protein S7,815.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,40S ribosomal protein SA,1346.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",7057.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",15281.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,72 kDa type IV collagenase,6612.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Abelson tyrosine-protein kinase 2,2044.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,212.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,17497.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Activated Protein C,817.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Activin receptor type-1B,274.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Adapter molecule crk,4739.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Adenylate kinase isoenzyme 1,33457.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Adenylosuccinate lyase,1925.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Adhesion G protein-coupled receptor E2,1183,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Adhesion G-protein coupled receptor G5,722.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Adiponectin,2748.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2982.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,500.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,355.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,180.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,358.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,815.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,6505.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Adrenomedullin,2282.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",472.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Afamin,27032.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,5659.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Aggrecan core protein,484.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Agouti-related protein,1555.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,AH receptor-interacting protein,6365,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alanine aminotransferase 1,3230.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],3211.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Allograft inflammatory factor 1,3064.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",5009,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-1-antichymotrypsin,216946,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-1-antichymotrypsin complex,6932.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-1-antitrypsin,1261.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-2-antiplasmin,2030.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-2-HS-glycoprotein,1911.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-2-macroglobulin,10892.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,792.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-enolase,51433.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,alpha-Fetoprotein,805.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-L-iduronidase,1037.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-soluble NSF attachment protein,8154.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Alpha-synuclein,12610.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Aminoacylase-1,4691.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Amphiregulin,3634.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Amphoterin-induced protein 2,1273.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),410,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),3506.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Amyloid beta A4 protein,18247.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiogenin,3498.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiopoietin-1,492.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",2241.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiopoietin-2,147.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiopoietin-4,599.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiopoietin-related protein 3,508.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiopoietin-related protein 4,5201.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiostatin,20284.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiotensin-converting enzyme 2,514.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Angiotensinogen,6453.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ankyrin-2,908.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Annexin A1,3997,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Annexin A2,4383.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Annexin A5,2717.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Annexin A6,4710.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Anterior gradient protein 2 homolog,890.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Antileukoproteinase,35939,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Antithrombin-III,105397,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein A-I,18175.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein B,18263.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein D,6591.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein E,67520.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein E (isoform E2),242939.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein E (isoform E3),257527.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein E (isoform E4),240080,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein L1,31293.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apolipoprotein M,11226.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Apoptosis regulator Bcl-2,1421.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Appetite-regulating hormone,905.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Arginase-1,1163.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,245.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Artemin,468.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Arylsulfatase A,1027.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Arylsulfatase B,1205.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Asialoglycoprotein receptor 1,1143.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",2700.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,3152.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",1577.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",3564.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Atrial natriuretic factor,835.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,506.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Aurora kinase A,1026.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Aurora kinase B,870.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Azurocidin,290.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bactericidal permeability-increasing protein,927.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,299.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,693.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,127.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Basal Cell Adhesion Molecule,2091,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Basigin,498,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,B-cell lymphoma 6 protein,1673,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,B-cell receptor CD22,929.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bcl2-associated agonist of cell death,10267.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bcl-2-like protein 1,1325.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bcl-2-like protein 2,635.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bcl-2-related protein A1,818.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,BDNF/NT-3 growth factors receptor,981.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Beta-2-microglobulin,2349.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,beta-adrenergic receptor kinase 1,7886.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Beta-Ala-His dipeptidase,5884.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Betacellulin,601.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Beta-endorphin,5154.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,beta-nerve growth factor,449.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,BH3-interacting domain death agonist,1300.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Biglycan,1375,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,BMP-binding endothelial regulator protein,474,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bone morphogenetic protein 10,1433.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bone morphogenetic protein 1,3500.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bone morphogenetic protein 6,13807.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bone morphogenetic protein 7,509.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,1094.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bone morphogenetic protein receptor type-2,543,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Bone sialoprotein 2,5749.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Brain-derived neurotrophic factor,747.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Brain natriuretic peptide 32,472.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Brain-specific serine protease 4,2526.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1666.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Brevican core protein,1666.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Brother of CDO,917.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C3a anaphylatoxin,591.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C3a anaphylatoxin des Arginine,164474.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C5a anaphylatoxin,12707.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cadherin-12,924.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cadherin-15,4504.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cadherin-1,62910.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cadherin-2,1943.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cadherin-3,35870.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cadherin-5,12898.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cadherin-6,570.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcineurin,1974.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcineurin subunit B type 1,9432.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",978.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,477.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,5006.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,3071.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,656.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,1943.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,5148.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calcium-dependent phospholipase A2,338.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calpain I,54345,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calpastatin,6387.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Calreticulin,2178.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,912.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,cAMP-regulated phosphoprotein 19,3007.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1496.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbohydrate sulfotransferase 15,5948.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbohydrate sulfotransferase 2,348.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbohydrate sulfotransferase 6,395.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase 1,28445.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase 13,1471.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase 2,224.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase 3,10490.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase 4,2692.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase 6,13677.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase 7,602.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase 9,2878.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carbonic anhydrase-related protein 10,801.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carboxypeptidase B2,13547.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Carboxypeptidase E,1620.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cardiotrophin-1,688.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,289,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,9102.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Casein kinase II subunit alpha,484,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Caspase-10,3799.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Caspase-2,349.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Caspase-3,6270.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Catalase,19365.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin B,1907.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin D,616,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin E,798.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin F,2401.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin G,1137.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin H,470.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin L2,960.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin S,1007.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cathepsin Z,6786.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,33932.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CCAAT/enhancer-binding protein beta,822.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 1,2890,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 13,453.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 14,5740.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 15,4091,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 16,37721.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 17,1162.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 18,6027.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 19,359.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 20,129.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 2,1114.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 21,25948.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 22,1108.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 23,2979.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 24,385.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 25,1652.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 26,1198,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 27,1086.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 28,6864.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 3,798.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 3-like 1,1725.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 4-like,447.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 5,31992.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 7,472.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-C motif chemokine 8,219.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD109 antigen,2931.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD166 antigen,13888.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD177 antigen,592.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD209 antigen,1353.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD226 antigen,821.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD27 antigen,7490.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD40 ligand,366.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD48 antigen,626.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD59 glycoprotein,2477.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD5 antigen-like,4477.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD63 antigen,474.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD70 antigen,256.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD83 antigen,315.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CD97 antigen,2202.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cell adhesion molecule 1,1701.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cell adhesion molecule 3,1253.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5507.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,917.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cellular tumor antigen p53,1117.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cerebral dopamine neurotrophic factor,4404.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",8101.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",976.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",15589,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Chitinase-3-like protein 1,34359.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Chitotriosidase-1,1751.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Chloride intracellular channel protein 1,5298.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Choline/ethanolamine kinase,2849.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Chordin-like protein 1,3001.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Chorionic somatomammotropin hormone,2120.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Chromobox protein homolog 5,462.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Chromogranin-A,9221.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Chymase,603.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ciliary neurotrophic factor,235.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,7693.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ck-beta-8-1,60403.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Clusterin,1164,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,CMRF35-like molecule 6,4007.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coactosin-like protein,1940.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coagulation factor IX,12829.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coagulation factor IXab,9000.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coagulation Factor V,63987.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coagulation factor VII,862.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coagulation Factor X,5138.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coagulation factor Xa,4167.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coagulation Factor XI,1856.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cofilin-1,8094.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Coiled-coil domain-containing protein 80,2195.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Collagen alpha-1(VIII) chain,662,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Collagen alpha-1(XXIII) chain,292.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Collagenase 3,541.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Collectin-11,10457.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Collectin-12,2111.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,COMM domain-containing protein 7,1777.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C1q subcomponent,43256.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C1r subcomponent,3159.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C2,3250.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C3,63598.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C3b,20579.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Complement C3b, inactivated",9790.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C3d fragment,9516.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C4,95234.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C4b,186.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C5,8418.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement C5b-C6 complex,589.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4667.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement component C1q receptor,9630.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement component C6,75644.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement component C7,1524.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement component C8,3365.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement component C9,76206.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement decay-accelerating factor,17977.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement factor B,23416.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement factor D,1288.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement factor H,57329.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement factor H-related protein 5,1413.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Complement factor I,39290.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Connective tissue-activating peptide III,14618.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Connective tissue growth factor,1493.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Contactin-1,260,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Contactin-2,818.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Contactin-4,3524.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Contactin-5,636.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Copine-1,4650.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Corticosteroid-binding globulin,734.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Corticotropin,381.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-reactive protein,49796.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Creatine kinase B-type,674,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Creatine kinase M-type,1084.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,630.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cryptic protein,2197.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-type lectin domain family 1 member B,11739,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-type lectin domain family 4 member K,202.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-type lectin domain family 4 member M,46748,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-type lectin domain family 7 member A,857.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-type mannose receptor 2,2704.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-X-C motif chemokine 10,2297,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-X-C motif chemokine 11,1660.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-X-C motif chemokine 13,4498.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-X-C motif chemokine 16,14084.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-X-C motif chemokine 5,535.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-X-C motif chemokine 6,1686.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,C-X-C motif chemokine 9,445.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,831.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,591,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1525.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1722.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,2372.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cystatin-C,2916.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cystatin-D,14908.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cystatin-F,739.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cystatin-M,10237.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cystatin-S,149.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cystatin-SA,20754.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cystatin-SN,2284,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cysteine and glycine-rich protein 3,4291.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cysteine-rich secretory protein 3,246.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,2787.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytochrome c,1568.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytochrome P450 3A4,18769,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytokine receptor common subunit gamma,3710,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,498.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytokine receptor-like factor 2,1432.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytoplasmic protein NCK1,3955.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,325.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytoskeleton-associated protein 2,14155,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytosolic non-specific dipeptidase,1553.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,796.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,92.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,dCTP pyrophosphatase 1,7666.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,D-dimer,13925.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Death-associated protein kinase 2,2729.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Decorin,2929,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Delta-like protein 1,2521.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Delta-like protein 4,491.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dermatopontin,5451.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Desert hedgehog protein N-product,644.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Desmocollin-2,3908.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Desmocollin-3,316.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Desmoglein-1,2810.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Diablo homolog, mitochondrial",4595.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dickkopf-like protein 1,3335,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dickkopf-related protein 1,20562.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dickkopf-related protein 3,6513.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dickkopf-related protein 4,6534.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dipeptidyl peptidase 1,663.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dipeptidyl peptidase 2,1656.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Discoidin domain-containing receptor 2,1750.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,453.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,2333.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,DnaJ homolog subfamily B member 1,543.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,DNA repair protein RAD51 homolog 1,2906.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,DNA topoisomerase 1,546.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Down syndrome cell adhesion molecule,1031.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Drebrin-like protein,3529.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2552.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,475.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2611.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,2408.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,55837.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dual specificity protein phosphatase 3,1638.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2635.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dynactin subunit 2,1541.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",328.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Dynein light chain roadblock-type 1,1442.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,509.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,642.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,212.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,1159.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,554.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Ectodysplasin-A, secreted form",1651,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1682.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1416.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,4095,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,3569.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1507,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Elafin,28729.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Elongation factor 1-beta,760,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Endoglin,1036.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,48288.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Endoplasmic reticulum resident protein 29,6314.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Endostatin,59747.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Endothelial cell-selective adhesion molecule,5145.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Endothelial cell-specific molecule 1,1358.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,2864.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Endothelin-converting enzyme 1,9695,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Enteropeptidase,233.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Eotaxin,8048,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin-A2,1308.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin-A3,2151.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin-A4,2127.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin-A5,3217.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin-B1,2030.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin-B2,13946.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin-B3,952.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin type-A receptor 10,410.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin type-A receptor 1,5496.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin type-A receptor 2,2651.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin type-A receptor 3,149.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin type-A receptor 5,601.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin type-B receptor 2,14276.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin type-B receptor 4,3887.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ephrin type-B receptor 6,1802.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Epidermal growth factor,805.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Epidermal growth factor receptor,25471.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,513.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Epidermal growth factor receptor variant III,243.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Epiregulin,651.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,316.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Erythropoietin,1299.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Erythropoietin receptor,381.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,E-selectin,31811.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,2119.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Estrogen receptor,904.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Eukaryotic initiation factor 4A-III,627,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,270,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,2118.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Eukaryotic translation initiation factor 4H,2485.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Eukaryotic translation initiation factor 5,1402.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,34874.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Extracellular matrix protein 1,12553.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],685.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,FACT complex subunit SSRP1,412.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Fatty acid-binding protein, epidermal",935.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Fatty acid-binding protein, heart",20901.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Fatty acid-binding protein, liver",2731.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fc receptor-like protein 3,396.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ferritin,9901.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fetuin-B,5224.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibrinogen,141108.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibrinogen gamma chain,61523.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 10,1048,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 1,208.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 12,208.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 16,2976.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 17,250.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 18,273.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 19,8632.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 20,351.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 2,1036.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 23,656.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 4,232.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 5,628.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 6,437.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 7,2145.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 8 isoform A,421.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 8 isoform B,864.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor 9,518.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor receptor 1,675.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor receptor 2,234.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor receptor 3,1221.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibroblast growth factor receptor 4,838.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibronectin,5530.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibronectin Fragment 3,1215.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fibronectin Fragment 4,44180,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ficolin-1,1463.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ficolin-2,1721.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ficolin-3,1063.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,513.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Focal adhesion kinase 1,268,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Follicle stimulating hormone,610.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Follistatin,1029.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Follistatin-related protein 1,31881.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Follistatin-related protein 3,8579.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,8025.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fractalkine,3959.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Fructose-bisphosphate aldolase A,74836,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,G2/mitotic-specific cyclin-B1,540,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,442.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galectin-10,577.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galectin-2,406.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galectin-3,21905.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galectin-3-binding protein,826.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galectin-4,649,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galectin-7,617.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galectin-8,380.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Galectin-9,1319.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Gamma-enolase,18762.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Gastrin-releasing peptide,323,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,GDNF family receptor alpha-1,1201.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,GDNF family receptor alpha-2,7038.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,GDNF family receptor alpha-3,1130.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Gelsolin,832.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glia-derived nexin,1148.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glial cell line-derived neurotrophic factor,426.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glial fibrillary acidic protein,505.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glucagon,1247.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glucocorticoid receptor,83.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glucokinase regulatory protein,633.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glucose-6-phosphate isomerase,17467.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glutamate carboxypeptidase 2,298.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glutathione S-transferase A3,194.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glutathione S-transferase P,4416.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,80574.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",840.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,17931.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,3574.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glypican-2,250.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glypican-3,1011.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glypican-5,662.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Glypican-6,1946.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"gp41 C34 peptide, HIV",916.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Granulins,21043.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Granulocyte colony-stimulating factor,1599.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,829.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,257.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Granulysin,1720.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Granzyme A,2405.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Granzyme B,235.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Granzyme H,247.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,GRB2-related adapter protein 2,588.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Gremlin-1,565.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Gro-beta/gamma,788.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Group 10 secretory phospholipase A2,629.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Group IIE secretory phospholipase A2,275.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth arrest-specific protein 1,839.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth/differentiation factor 11,1068.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth/differentiation factor 11/8,880.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth/differentiation factor 15,1721.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth/differentiation factor 2,2196.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth/differentiation factor 5,1370.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth/differentiation factor 8,5524.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth/differentiation factor 9,432.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth factor receptor-bound protein 2,25604.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth hormone receptor,1221.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Growth-regulated alpha protein,4386.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,GTPase KRas,1269.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,GTP-binding nuclear protein Ran,5688.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Haptoglobin,26913,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heat shock 70 kDa protein 1A,8349,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heat shock cognate 71 kDa protein,1738.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heat shock protein beta-1,7718.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,8258.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heat shock protein HSP 90-beta,40794.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heme oxygenase 2,515.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,HemK methyltransferase family member 2,3076.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hemoglobin,2606.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hemojuvelin,1095.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hemopexin,1491.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2751.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heparin-binding EGF-like growth factor,370.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heparin cofactor 2,2875.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hepatitis A virus cellular receptor 2,8996.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hepatocyte growth factor,1785.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hepatocyte growth factor activator,2536.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hepatocyte growth factor-like protein,7635.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hepatocyte growth factor receptor,8590.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,773.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hepcidin,6462.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,HERV-H LTR-associating protein 2,949.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1886.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,246.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2842.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3011.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hexokinase-1,1401.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hexokinase-2,552.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",367.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",404.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,565.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,High affinity nerve growth factor receptor,4022.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,High mobility group protein B1,6312.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histidine-rich glycoprotein,4998.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,1318.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone acetyltransferase KAT6A,1642.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,274,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone deacetylase 8,2320.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone H1.2,1040.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone H2A type 3,642.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone H2A.z,1865.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone H2B type 2-E,13576,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone H3.1,1227.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,412.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Homeobox protein NANOG,176.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Homeodomain-interacting protein kinase 3,478.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hsp90 co-chaperone Cdc37,478.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Human Chorionic Gonadotropin,2060.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,1004.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,465.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,ICOS ligand,1173.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Iduronate 2-sulfatase,2110,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Immunoglobulin A,2369.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Immunoglobulin alpha Fc receptor,237.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Immunoglobulin D,6254.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Immunoglobulin E,435.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Immunoglobulin G,172807.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Immunoglobulin M,5627.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,5342.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Importin subunit alpha-1,257.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Importin subunit beta-1,3891.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,835.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Inducible T-cell costimulator,679.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Inhibin beta A chain,2052.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,601.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Inhibitor of growth protein 1,16577.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Inorganic pyrophosphatase,15871.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1531.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2582.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin,164.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-degrading enzyme,2213.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor 1 receptor,6580.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor-binding protein 1,1033,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor-binding protein 2,1195,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor-binding protein 3,1320.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor-binding protein 4,6292.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor-binding protein 5,2757.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor-binding protein 6,1115,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor-binding protein 7,57836,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin-like growth factor I,1176.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Insulin receptor,7494.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Integrin alpha-I: beta-1 complex,950.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,1468.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Integrin alpha-V: beta-5 complex,557.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,32526.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Intercellular adhesion molecule 1,3515.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Intercellular adhesion molecule 2,1516.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Intercellular adhesion molecule 3,684,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Intercellular adhesion molecule 5,930.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon alpha-10,290.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon alpha-2,171.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon alpha-7,280.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon alpha/beta receptor 1,1118,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon beta,629.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon gamma,543.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon gamma receptor 1,384.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon gamma receptor 2,456.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon lambda-1,333.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon lambda-2,231.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interferon regulatory factor 1,1298.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-10,539.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1573.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-10 receptor subunit beta,1209.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-11,322.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-12,230.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,550.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,691.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-13,682.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,2344.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-15 receptor subunit alpha,938.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-16,333.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-17A,367.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-17B,159.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-17D,387.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-17F,871.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-17 receptor A,665.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-17 receptor B,1307.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-17 receptor C,1004.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-17 receptor D,550.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-18-binding protein,12982.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-18 receptor 1,10855.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-18 receptor accessory protein,297.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-19,4844.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-1 alpha,551.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-1 beta,2522.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-1 Receptor accessory protein,30256.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-1 receptor antagonist protein,3298.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-1 receptor-like 1,4694.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-1 receptor-like 2,880,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-1 receptor type 1,6363.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-1 receptor type 2,9704.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-20,339.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-20 receptor subunit alpha,247.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-2,1141.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-22,1256.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,1879.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,1783,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-23,1060.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-23 receptor,4326.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-24,376.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-25,310.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-27,602.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-27 receptor subunit alpha,1719.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-2 receptor subunit alpha,1134.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-3,1700.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-34,845.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-36 alpha,628.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-36 beta,476.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-37,2367.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-3 receptor subunit alpha,1211.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-4,506.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-4 receptor subunit alpha,218.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-5,462.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-5 receptor subunit alpha,1606.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-6,304.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-6 receptor subunit alpha,21920,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-6 receptor subunit beta,7002.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-7,201,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-7 receptor subunit alpha,397.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-8,780.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interleukin-9,230.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Interstitial collagenase,951.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Junctional adhesion molecule B,10794.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Junctional adhesion molecule C,5555.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Junctional adhesion molecule-like,418.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-11,1075.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-12,8394.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-13,1929.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-14,10107.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-4,376.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-5,188.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-6,3588.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-7,1792.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallikrein-8,2698.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kallistatin,45142.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kelch-like ECH-associated protein 1,425.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Keratin, type I cytoskeletal 18",902.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1554.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,298,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,2606.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,394.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kinesin-like protein KIF23,1127.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kininogen-1,32132.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kin of IRRE-like protein 3,302.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kremen protein 2,3756.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kunitz-type protease inhibitor 1,4653.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kunitz-type protease inhibitor 2,1352.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Kynureninase,753.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lactadherin,1005.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lactoperoxidase,476.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lactotransferrin,48052,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lamin-B1,712.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Laminin,2006.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1438.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Layilin,1621.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Legumain,2918.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leptin,5182,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leptin receptor,1987.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leucine carboxyl methyltransferase 1,1971.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,5623,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2764.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,138.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,242.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1106,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,21001.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,2603.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leukemia inhibitory factor receptor,3838,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,5354.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,8151.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leukocyte surface antigen CD47,1007.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Leukotriene A-4 hydrolase,1046.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,244,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Limbic system-associated membrane protein,1445.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lipopolysaccharide-binding protein,84842.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lithostathine-1-alpha,550.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,L-lactate dehydrogenase B chain,1242.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,5714.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,98.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,772.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1469.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Low-density lipoprotein receptor,190.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,48044.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",1132.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,1730.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,6388,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,L-Selectin,3628.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lumican,1472,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Luteinizing hormone,748.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,1042.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,297.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lymphocyte activation gene 3 protein,6872.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lymphocyte antigen 86,4596.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lymphotactin,396.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lymphotoxin alpha1:beta2,108.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lymphotoxin alpha2:beta1,2227.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lymphotoxin-alpha,643.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lysosomal protective protein,9167.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lysosome membrane protein 2,447.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Lysozyme C,99956,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Macrophage-capping protein,1148.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Macrophage colony-stimulating factor 1,1919.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,155.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Macrophage mannose receptor 1,6251.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Macrophage metalloelastase,912.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Macrophage migration inhibitory factor,1109.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Macrophage scavenger receptor types I and II,1027.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Macrophage-stimulating protein receptor,659.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",24765.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mammaglobin-B,8096.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mannan-binding lectin serine protease 1,4783.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mannose-binding protein C,14342.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,MAP kinase-activated protein kinase 2,11039.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,MAP kinase-activated protein kinase 3,1451.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,MAP kinase-activated protein kinase 5,551.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,15063.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Matrilin-2,9768,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Matrilin-3,585.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Matrilysin,2767.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,293.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Matrix metalloproteinase-14,1103.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Matrix metalloproteinase-16,854.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Matrix metalloproteinase-17,966.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Matrix metalloproteinase-9,15429.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,75381.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,1300,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Melanoma-derived growth regulatory protein,4409.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Membrane frizzled-related protein,1956.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,1128,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mesothelin,379.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Metalloproteinase inhibitor 1,83.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Metalloproteinase inhibitor 2,393.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Metalloproteinase inhibitor 3,1098.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Methionine aminopeptidase 1,1666.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Methionine aminopeptidase 2,34498.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Methyl-CpG-binding domain protein 4,453.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,MHC class I polypeptide-related sequence A,233,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,MHC class I polypeptide-related sequence B,1536.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Microtubule-associated protein tau,351.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Midkine,24040.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitochondrial glutamate carrier 2,1014,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,703.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase 1,10645.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase 11,787,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase 12,782.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase 13,443.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase 14,2502.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase 3,30799.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase 8,1327.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase 9,1069,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,1642.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Moesin,800.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mothers against decapentaplegic homolog 2,15075.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mothers against decapentaplegic homolog 3,15608.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Mucin-1,1287.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Muellerian-inhibiting factor,9987.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Myc proto-oncogene protein,390.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Myeloblastin,5737.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Myeloid cell surface antigen CD33,3858.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Myeloperoxidase,13372.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Myoglobin,2506.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Myosin-binding protein C, slow-type",5143.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,N-acetyl-D-glucosamine kinase,922.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,2057.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,7237.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,6107.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NADPH--cytochrome P450 reductase,2385.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,4817,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,2834.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,335.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,641.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Natural killer cell receptor 2B4,161.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Netrin-1,562.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Netrin-4,879.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Netrin receptor UNC5C,4621.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Netrin receptor UNC5D,6439.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",17946.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neural cell adhesion molecule L1,433.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,10705.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neuregulin-1,175.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neuregulin-4,819.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neurexin-1-beta,776.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neurexin-3-beta,1159.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neurexophilin-1,5100.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1118.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neurogenic locus notch homolog protein 1,21571,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neurogenic locus notch homolog protein 2,648.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neurogenic locus notch homolog protein 3,649.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Neuroligin-4, X-linked",666.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neuronal cell adhesion molecule,16497.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neuronal growth regulator 1,5122.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neuropilin-1,1786.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neurotrophin-3,186.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neurotrophin-4,280.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neutral ceramidase,5819.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neutrophil-activating peptide 2,4767.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neutrophil collagenase,1831,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neutrophil elastase,390.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,25106,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,698.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Nidogen-1,5689.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Nidogen-2,2813.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NKG2D ligand 1,829.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NKG2D ligand 2,303.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NKG2D ligand 3,832.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NKG2-D type II integral membrane protein,544.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Noggin,1757.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Non-histone chromosomal protein HMG-14,953.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,1722,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NSFL1 cofactor p47,303.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NT-3 growth factor receptor,3682.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,N-terminal pro-BNP,6792.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,561.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Nucleoside diphosphate kinase A,2899.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Nucleoside diphosphate kinase B,21218.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,NudC domain-containing protein 3,263,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,OCIA domain-containing protein 1,914.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Olfactomedin-4,203.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Oncostatin-M,2167.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,3401.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Osteocalcin,1634.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Osteomodulin,8518.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Osteopontin,3032.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,OX-2 membrane glycoprotein,2288.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,2269,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pancreatic hormone,3002,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pappalysin-1,14857.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Parathyroid hormone,3519.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Parathyroid hormone-related protein,850.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peptide YY,1645.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peptidoglycan recognition protein 1,790.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,120855.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,6399.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,15901.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,1098.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",10347.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Periostin,6421.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peroxiredoxin-1,3020.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",435.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peroxiredoxin-6,707.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,395.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Persephin,259.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",4422.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pescadillo homolog,271.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,6960.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",533.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2673.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Phosphoglucomutase-1,568.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Phosphoglycerate kinase 1,2244.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Phosphoglycerate mutase 1,2033,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Phospholipase A2,722.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Phospholipase A2, membrane associated",2512.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pigment epithelium-derived factor,57481.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,PIK3CA/PIK3R1,541.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,PILR alpha-associated neural protein,5969.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,234.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,310,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Placenta growth factor,301.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Plasma kallikrein,25410.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Plasma protease C1 inhibitor,7990.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Plasma serine protease inhibitor,95868.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Plasmin,882.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Plasminogen,3469.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Plasminogen activator inhibitor 1,958.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet-activating factor acetylhydrolase,1416.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,6561.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet-derived growth factor C,350.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet-derived growth factor receptor alpha,915,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet-derived growth factor receptor beta,2516.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet-derived growth factor subunit A,10114.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet-derived growth factor subunit B,26709.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet endothelial cell adhesion molecule,1156.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet factor 4,22237.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet glycoprotein 4,7971.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,1431.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet glycoprotein VI,12921.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Platelet receptor Gi24,508,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pleiotrophin,1867.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Plexin-B2,4903,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Plexin-C1,681.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Polymeric immunoglobulin receptor,2830.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,PolyUbiquitin K48-linked,2417.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,PolyUbiquitin K63-linked,4352.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Prefoldin subunit 5,375.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Programmed cell death 1 ligand 1,721.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Programmed cell death 1 ligand 2,3493.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Prokineticin-1,196.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Prolactin,696.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Prolactin receptor,1225.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proliferating cell nuclear antigen,201.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proliferation-associated protein 2G4,2243.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Prolyl endopeptidase FAP,819.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pro-opiomelanocortin,742,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Properdin,98930.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,1316.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,628.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Prostaglandin G/H synthase 2,465.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Prostate-specific antigen,19493.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proteasome activator complex subunit 1,1331.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proteasome activator complex subunit 3,340.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proteasome subunit alpha type-1,685.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proteasome subunit alpha type-2,562.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proteasome subunit alpha type-6,991.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein 4.1,9081.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein amnionless,214.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein deglycase DJ-1,503.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein disulfide-isomerase,232,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein disulfide-isomerase A3,4053.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein E7_HPV16,970,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein E7_HPV18,2296.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein FAM107A,333.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein FAM107B,1626.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein FAM3B,909.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein FAM3D,6889.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,163,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein jagged-1,574.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein jagged-2,351.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein kinase C alpha type,43140.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),12310.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein kinase C delta type,3760.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein kinase C gamma type,500.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein kinase C iota type,2718.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein kinase C theta type,3199.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein kinase C zeta type,935.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein lin-7 homolog B,435,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein NOV homolog,647.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein Rev_HV2BE,174.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein S100-A12,772.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein S100-A4,1642.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein S100-A6,2956.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein S100-A7,237.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein S100-A9,3548.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein SET,634,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein-tyrosine kinase 6,302.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein Wnt-7a,260.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Protein Z-dependent protease inhibitor,6535.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Prothrombin,138368.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,920.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,55303.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Proto-oncogene vav,9898.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,P-selectin,18681.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pulmonary surfactant-associated protein D,4367.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pyridoxal kinase,251.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pyridoxal phosphate phosphatase,4116.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1771.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Pyruvate kinase PKM,54064.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Quinone oxidoreductase-like protein 1,3854.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Rab GDP dissociation inhibitor beta,23885.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,5611,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,14250.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ras GTPase-activating protein 1,798.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,34861.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,6831.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,5606.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,402.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,303.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,175.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Regenerating islet-derived protein 4,1783.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Relaxin receptor 1,434.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Renin,688.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Repulsive guidance molecule A,19499.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Resistin,1391.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Reticulon-4 receptor,2176.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Retinoblastoma-associated protein,1494.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Retinoic acid receptor responder protein 2,2558,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Retinol-binding protein 4,345.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,RGM domain family member B,2605.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ribonuclease H1,145,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,576.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,230.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ribosome maturation protein SBDS,15174.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,RNA-binding protein 39,403.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Roundabout homolog 2,2497.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Roundabout homolog 3,380.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,R-spondin-2,461.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,R-spondin-3,2104.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,R-spondin-4,310.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Scavenger receptor class F member 1,8141.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Scavenger receptor class F member 2,264.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2347.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sclerostin,58456.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Secreted and transmembrane protein 1,1454.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Secreted frizzled-related protein 1,4048.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Secreted frizzled-related protein 3,3420.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Secretin,195.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Seizure 6-like protein 2,1459.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Semaphorin-3A,2229,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Semaphorin-3E,1859.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Semaphorin-5A,4894.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Semaphorin-6A,7367.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Semaphorin-6B,1982.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine protease 27,7433,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",4048.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase 16,2158.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase 17B,4494.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase Chk1,784.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase Chk2,205.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1435.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,1355.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,24430,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,656.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase pim-1,889.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase PLK1,235.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1372.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase TBK1,266.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serine/threonine-protein kinase WNK3,995.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serotransferrin,183506.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serum albumin,10064.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serum amyloid A-1 protein,322.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serum amyloid P-component,48269.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Serum paraoxonase/arylesterase 1,186.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sex hormone-binding globulin,2645.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,S-formylglutathione hydrolase,2694.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SH2 domain-containing protein 1A,5093.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SHC-transforming protein 1,9333.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,26211.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,207.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1172.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,22518.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sialoadhesin,180.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,10613.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Signal transducer and activator of transcription 3,1603.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Signal transducer and activator of transcription 6,481.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SLAM family member 5,5288.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SLAM family member 6,356.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SLAM family member 7,32926.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SLIT and NTRK-like protein 1,1626.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SLIT and NTRK-like protein 5,1619.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,1903.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Small nuclear ribonucleoprotein F,2883.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Small ubiquitin-related modifier 3,2691.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Somatostatin-28,1205.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Somatotropin,242.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sonic hedgehog protein,843.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sorting nexin-4,13092.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SPARC,16688.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SPARC-like protein 1,12385.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,4004.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",179,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,S-phase kinase-associated protein 1,10629.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sphingosine kinase 1,14967.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Sphingosine kinase 2,583.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Spondin-1,2273.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Stabilin-2,926.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Stanniocalcin-1,2649.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Stem cell growth factor-alpha,1854.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Stem Cell Growth Factor-beta,875.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Stress-induced-phosphoprotein 1,9234.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Stromal cell-derived factor 1,5954.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Stromelysin-1,1270.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Stromelysin-2,660.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,SUMO-conjugating enzyme UBC9,1982.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Superoxide dismutase [Cu-Zn],1224.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",45516.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Synaptosomal-associated protein 25,1330.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Syntaxin-1A,349.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,7687.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,TATA-box-binding protein,442.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,T-cell surface glycoprotein CD4,378.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tenascin,15042.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,527,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Testican-1,2739.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Testican-2,953.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,TGF-beta receptor type-2,1937,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thioredoxin domain-containing protein 12,2576.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thrombin,1033.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thrombopoietin,227.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thrombopoietin Receptor,200.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thrombospondin-1,1837.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thrombospondin-2,11240.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thrombospondin-4,737.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thymic stromal lymphopoietin,406,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Thymidine kinase, cytosolic",543.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thymidylate synthase,342.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thyroglobulin,373.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thyroid peroxidase,1895.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thyroid Stimulating Hormone,922.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Thyroxine-binding globulin,39242.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tissue Factor,1057.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tissue factor pathway inhibitor,63265.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tissue-type plasminogen activator,705.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,T-lymphocyte activation antigen CD80,641.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,T-lymphocyte activation antigen CD86,642.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,1010.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Toll-like receptor 2,433.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Toll-like receptor 4,291.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4617.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transcription factor AP-1,3429.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,2116.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transforming growth factor beta-1,2914.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transforming growth factor beta-2,269.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transforming growth factor beta-3,471.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,48521.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transforming growth factor beta receptor type 3,36806.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transgelin-2,30524.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transketolase,49061.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Translationally-controlled tumor protein,15735.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Transmembrane glycoprotein NMB,5611,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Trefoil factor 1,3408.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Trefoil factor 2,8370.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Trefoil factor 3,11915.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Triosephosphate isomerase,10125.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tropomyosin alpha-1 chain,844.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tropomyosin alpha-4 chain,87464.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tropomyosin beta chain,2551.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Troponin I, cardiac muscle",548.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Troponin I, fast skeletal muscle",19511,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Troponin T, cardiac muscle",8239.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Trypsin-1,7518.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Trypsin-2,3223.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Trypsin-3,3354,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tryptase beta-2,1359.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tryptase gamma,252.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor-associated calcium signal transducer 2,406.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor,529.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,1372.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,761.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,570.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,1126.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,512.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,737.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,712.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,311.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",433.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,1656.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,409.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1529.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,416,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,881.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1519.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,17048.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,170.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,1130.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2799.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,540.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,7842.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,644.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,961.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,3263.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,1945.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,14645.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,8350.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,791.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,8036.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,923.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,2334,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,629.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,1033.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,335.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,1093.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase ABL1,186,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase BTK,10458.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase CSK,11912.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase Fer,1982.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase Fgr,278.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase Fyn,2932.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase HCK,198.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase JAK2,119687,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase Lck,584.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase Lyn,5473.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",26467.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",8654.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,580,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase Tec,3721.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,669.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase Yes,1159,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,16860.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,8468.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,2486.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,375.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,9676.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,7025.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin,1600.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",3973.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,883.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1523.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,4744.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,1830.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,6898.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin-fold modifier 1,3256.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,18190.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Ubiquitin-like protein ISG15,1507.2,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,UMP-CMP kinase,6066.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Urokinase plasminogen activator surface receptor,8103.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Urokinase-type plasminogen activator,2239.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,30719.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vascular cell adhesion protein 1,15995.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vascular endothelial growth factor A,10580.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",701.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vascular endothelial growth factor C,1365,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vascular endothelial growth factor D,497.1,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vascular endothelial growth factor receptor 2,8960.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vascular endothelial growth factor receptor 3,6158.9,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vasoactive Intestinal Peptide,374,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vesicular integral-membrane protein VIP36,12700.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vitamin K-dependent protein C,1410.8,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vitamin K-dependent protein S,4479.7,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Vitronectin,69486.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,von Willebrand factor,5782.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,403,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",1360.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7366.4,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,6339.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,1010.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Wnt inhibitory factor 1,3040.5,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,Xaa-Pro aminopeptidase 1,4272.6,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,822.3,RFU
BF-1045,PDEZ044TE4,M0,0,Plasma,X-ray repair cross-complementing protein 6,215.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,18988.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,14-3-3 protein epsilon,815.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,14-3-3 protein family,3906.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,14-3-3 protein sigma,855.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,14-3-3 protein theta,1335.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,179783.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1381.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",528.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,339.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,286.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1449.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1233.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",5179.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",653.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,1029.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,40S ribosomal protein S3,499.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,40S ribosomal protein S3a,632.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,40S ribosomal protein S7,899,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,40S ribosomal protein SA,1378.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",9108.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",15916.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,72 kDa type IV collagenase,7505.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,2129.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,178,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,17845.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Activated Protein C,777.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Activin receptor type-1B,267.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Adapter molecule crk,5465.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,45881.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Adenylosuccinate lyase,2816.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,1408.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,653.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Adiponectin,2651.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,3481.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,441.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,332.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,172.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,350.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,791.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,5882.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Adrenomedullin,1976.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",459.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Afamin,21960.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,4545.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Aggrecan core protein,468.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Agouti-related protein,1629.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,AH receptor-interacting protein,6867.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alanine aminotransferase 1,3515.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],3219.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Allograft inflammatory factor 1,2856.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",6973.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,313777.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,6428.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-1-antitrypsin,1064.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-2-antiplasmin,1962.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1484.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-2-macroglobulin,11850.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,688.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-enolase,43110,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,alpha-Fetoprotein,819.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-L-iduronidase,984,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,8653.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Alpha-synuclein,13220.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Aminoacylase-1,3653.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Amphiregulin,3524.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Amphoterin-induced protein 2,1610,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),356.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),3895.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Amyloid beta A4 protein,19746.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiogenin,3387.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiopoietin-1,534.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",2120.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiopoietin-2,132.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiopoietin-4,534.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiopoietin-related protein 3,480.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiopoietin-related protein 4,6369.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiostatin,19749.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,545.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Angiotensinogen,5397.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ankyrin-2,924,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Annexin A1,5568.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Annexin A2,5767.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Annexin A5,2989.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Annexin A6,4726.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,934,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Antileukoproteinase,38679.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Antithrombin-III,117790.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein A-I,16668.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein B,20624.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein D,5822.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein E,48345.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),295016.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),280301.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),292006.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein L1,32374.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apolipoprotein M,13047,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,1456,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Appetite-regulating hormone,925,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Arginase-1,1169.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,301.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Artemin,505.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Arylsulfatase A,1082.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Arylsulfatase B,1205.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1161.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",3110.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,3440.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",2237.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",2882.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Atrial natriuretic factor,804.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,558.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Aurora kinase A,945.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Aurora kinase B,799.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Azurocidin,299.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,1355.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,304,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,626.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,116.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,2374.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Basigin,418.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,1668.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,B-cell receptor CD22,910.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,11035.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bcl-2-like protein 1,1109.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bcl-2-like protein 2,650.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bcl-2-related protein A1,854.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,952.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Beta-2-microglobulin,2494.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,7175.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,5816.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Betacellulin,574.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Beta-endorphin,5234.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,beta-nerve growth factor,476.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,BH3-interacting domain death agonist,1355.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Biglycan,1786.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,455,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1280.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bone morphogenetic protein 1,3540.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bone morphogenetic protein 6,17738.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bone morphogenetic protein 7,509.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,969.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,545.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Bone sialoprotein 2,6751.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,699.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Brain natriuretic peptide 32,426.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Brain-specific serine protease 4,2719.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1887.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Brevican core protein,1655.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Brother of CDO,1053.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C3a anaphylatoxin,1374.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,191459.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C5a anaphylatoxin,16697.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cadherin-12,781.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cadherin-15,5578.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cadherin-1,70255.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cadherin-2,1961.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cadherin-3,30914.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cadherin-5,13149.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cadherin-6,506.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcineurin,1804.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcineurin subunit B type 1,8539.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",842.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,408.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,5438.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2869.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,701.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,2351.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,6650.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,311.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calpain I,51413.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calpastatin,6111.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Calreticulin,2151.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,802.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,2342.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1373.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,5899.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,383.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,400.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase 13,1232.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase 1,49219.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase 2,225,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase 3,10469,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase 4,2461,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase 6,13021.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase 7,636.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase 9,2987.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,699.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carboxypeptidase B2,12019.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Carboxypeptidase E,1621.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cardiotrophin-1,662.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,12184.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,349.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Casein kinase II subunit alpha,502.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Caspase-10,4175.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Caspase-2,360.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Caspase-3,7216,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Catalase,29149.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin B,1852.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin D,709.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin E,800,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin F,2519.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin G,1157.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin H,494.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin L2,871.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin S,1229.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cathepsin Z,6691,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,39277,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,920.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 1,2707.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 13,460.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 14,6260.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 15,5002.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 16,39458.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 17,1092,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 18,4877.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 19,373.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 20,125.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 21,26537.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 2,1370.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 22,938.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 23,3372.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 24,366.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 25,1638.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 26,1520.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 27,958.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 28,7860.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 3,664.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,1626.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 4-like,600.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 5,39597.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 7,577.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-C motif chemokine 8,208.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD109 antigen,2792.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD166 antigen,14625.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD177 antigen,611.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD209 antigen,1369.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD226 antigen,844.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD27 antigen,7213.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD40 ligand,367.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD48 antigen,691.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD59 glycoprotein,2580.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD5 antigen-like,3894,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD63 antigen,469.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD70 antigen,253,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD83 antigen,319.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CD97 antigen,2014.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cell adhesion molecule 1,1623.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cell adhesion molecule 3,1341.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,4839.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,873.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cellular tumor antigen p53,1073.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,5251.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",7031.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1109.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",13104.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Chitinase-3-like protein 1,45015.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Chitotriosidase-1,1521,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,4041.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Choline/ethanolamine kinase,2702.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Chordin-like protein 1,2602.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,2798.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Chromobox protein homolog 5,426.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Chromogranin-A,9186.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Chymase,519.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ciliary neurotrophic factor,204.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,8461.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ck-beta-8-1,83658.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Clusterin,1022.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,CMRF35-like molecule 6,4317.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coactosin-like protein,2073,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coagulation factor IX,12628,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coagulation factor IXab,9025.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coagulation Factor V,74931.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coagulation factor VII,808.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coagulation Factor X,4980.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coagulation factor Xa,4071.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coagulation Factor XI,1859.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cofilin-1,7964.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,1888.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,691.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,273.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Collagenase 3,541.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Collectin-11,9757.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Collectin-12,2052.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,COMM domain-containing protein 7,1914.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C1q subcomponent,39190.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C1r subcomponent,1998.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C2,2879.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C3,59913.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C3b,15215,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Complement C3b, inactivated",7282.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C3d fragment,9597,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C4,118960.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C4b,141,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C5,7661.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement C5b-C6 complex,573.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4818.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement component C1q receptor,9745.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement component C6,78950.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement component C7,1141.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement component C8,3099.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement component C9,106339.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement decay-accelerating factor,17567.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement factor B,29119.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement factor D,993.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement factor H,62408.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement factor H-related protein 5,1275,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Complement factor I,42941.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Connective tissue-activating peptide III,10958.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Connective tissue growth factor,1556.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Contactin-1,240.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Contactin-2,648.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Contactin-4,3373.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Contactin-5,585.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Copine-1,4159.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Corticosteroid-binding globulin,760.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Corticotropin,382.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-reactive protein,125643.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Creatine kinase B-type,647.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Creatine kinase M-type,922.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,636.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cryptic protein,2047.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,11719.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,187.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,66040.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,788.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-type mannose receptor 2,2535.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-X-C motif chemokine 10,5859.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-X-C motif chemokine 11,4085.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-X-C motif chemokine 13,5552.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-X-C motif chemokine 16,15852.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-X-C motif chemokine 5,528.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-X-C motif chemokine 6,1536.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,C-X-C motif chemokine 9,644.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,698.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,605.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1404.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1564.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,2526.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cystatin-C,2914.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cystatin-D,9929.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cystatin-F,683.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cystatin-M,10276.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cystatin-S,142.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cystatin-SA,13539.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cystatin-SN,1213.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,5110.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,242.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,2763.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytochrome c,1898.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytochrome P450 3A4,16696.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,3783.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,500.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,1402.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,4221.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,297.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,15724.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,1241.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,773.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,94.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,8761.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,D-dimer,13453.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Death-associated protein kinase 2,2732.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Decorin,3583.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Delta-like protein 1,3044.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Delta-like protein 4,476.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dermatopontin,4666.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Desert hedgehog protein N-product,663,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Desmocollin-2,4199.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Desmocollin-3,329,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Desmoglein-1,2570.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",5526.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dickkopf-like protein 1,3175.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dickkopf-related protein 1,20618.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dickkopf-related protein 3,7029.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dickkopf-related protein 4,5679.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,612.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,1546.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1735.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,442.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,2707.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,593.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,2432.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,DNA topoisomerase 1,585.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,1112.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Drebrin-like protein,2908.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2670.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,435.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2318.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,2784.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,69190.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,1376.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,3060.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dynactin subunit 2,1795.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",319.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,1281.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,795.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,808.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,197.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,1202.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,496.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",1539.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1613.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1233,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3678.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,3944.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1379.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Elafin,30202.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Elongation factor 1-beta,689.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Endoglin,1203.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,69362.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,6644,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Endostatin,71545.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,4649.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,1345.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,3427.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,10098.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Enteropeptidase,208.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Eotaxin,8308.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin-A2,1371.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin-A3,2073.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin-A4,2271.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin-A5,3198.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin-B1,1933.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin-B2,17476.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin-B3,936,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin type-A receptor 10,379.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin type-A receptor 1,6869.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin type-A receptor 2,3103.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin type-A receptor 3,165.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin type-A receptor 5,641.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin type-B receptor 2,17665.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin type-B receptor 4,3441.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ephrin type-B receptor 6,1762.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Epidermal growth factor,766.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Epidermal growth factor receptor,30198.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,534.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,225.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Epiregulin,612,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,323.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Erythropoietin,1386.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Erythropoietin receptor,382.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,E-selectin,36362.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,1945.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Estrogen receptor,973.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,690.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,241.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,1949.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,2598.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,1613.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,43778.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Extracellular matrix protein 1,10321.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],1290.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,FACT complex subunit SSRP1,429.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",1168.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",26926.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",2931.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fc receptor-like protein 3,375.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ferritin,14774,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fetuin-B,5060.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibrinogen,168780,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibrinogen gamma chain,60122.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 10,1042,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 12,214.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 1,221.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 16,3006,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 17,221.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 18,283.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 19,5424.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 20,316,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 2,1340.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 23,685.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 4,203.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 5,604.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 6,442.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 7,2297.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,468.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,801.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor 9,489.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,814.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,222.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,1192,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,1003,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibronectin,2819.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibronectin Fragment 3,840.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fibronectin Fragment 4,42239.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ficolin-1,1505.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ficolin-2,1658.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ficolin-3,544.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,495.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Focal adhesion kinase 1,296.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Follicle stimulating hormone,644.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Follistatin,953.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Follistatin-related protein 1,33776.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Follistatin-related protein 3,9015.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,10314.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fractalkine,3208.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,93064.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,481,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,400.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galectin-10,527.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galectin-2,393,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galectin-3,23937.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galectin-3-binding protein,895.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galectin-4,676.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galectin-7,626.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galectin-8,428.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Galectin-9,1626.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Gamma-enolase,20303.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Gastrin-releasing peptide,323.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,GDNF family receptor alpha-1,1159.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,GDNF family receptor alpha-2,6926.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,GDNF family receptor alpha-3,1157.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Gelsolin,738.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glia-derived nexin,988.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,411.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glial fibrillary acidic protein,510.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glucagon,1093.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glucocorticoid receptor,81.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glucokinase regulatory protein,582.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,16828.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,300.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glutathione S-transferase A3,184.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glutathione S-transferase P,4700.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,118093.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1168.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,14018.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,2894.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glypican-2,245.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glypican-3,1068.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glypican-5,650,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Glypican-6,1993.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",1027.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Granulins,23924.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1859.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,1202.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,275.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Granulysin,1635.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Granzyme A,2505.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Granzyme B,253.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Granzyme H,226.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,GRB2-related adapter protein 2,558.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Gremlin-1,513.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Gro-beta/gamma,756.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,583,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,268,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth arrest-specific protein 1,774,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth/differentiation factor 11,1032,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,856.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth/differentiation factor 15,1546.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth/differentiation factor 2,2191.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth/differentiation factor 5,1918.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth/differentiation factor 8,5834.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth/differentiation factor 9,367.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,24381.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth hormone receptor,946.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Growth-regulated alpha protein,5828.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,GTPase KRas,1275.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,7380,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Haptoglobin,30551.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,8247.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,1780,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heat shock protein beta-1,5452,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,6986.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,43952.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heme oxygenase 2,438.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,HemK methyltransferase family member 2,2856.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hemoglobin,3889.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hemojuvelin,1115.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hemopexin,1580,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2583.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,328.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heparin cofactor 2,2846.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,9731.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hepatocyte growth factor,2159.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hepatocyte growth factor activator,2147.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,6504.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,8493.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,787.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hepcidin,14612.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,946.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1743.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,271.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2551.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,2957.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hexokinase-1,1487.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hexokinase-2,641.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",375.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",397.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,512.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,4860.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,High mobility group protein B1,5801.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histidine-rich glycoprotein,4710.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,1444.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1649.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,272.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone deacetylase 8,2101.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone H1.2,954.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone H2A type 3,727.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone H2A.z,1947.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone H2B type 2-E,15685,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone H3.1,1355.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,389.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Homeobox protein NANOG,152.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,446.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,429.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,2517.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,1013.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,496.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,ICOS ligand,1309.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Iduronate 2-sulfatase,2356,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Immunoglobulin A,2072.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,233.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Immunoglobulin D,6571.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Immunoglobulin E,520.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Immunoglobulin G,208836.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Immunoglobulin M,5037.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,5497.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Importin subunit alpha-1,257.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Importin subunit beta-1,4359,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,933.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Inducible T-cell costimulator,710.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Inhibin beta A chain,2175.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,637.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Inhibitor of growth protein 1,18401.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Inorganic pyrophosphatase,27846,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1841.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2612.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin,133.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-degrading enzyme,2443,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,7773.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,1672.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,1681.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,1235.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,7403.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,2421.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,921.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,62573.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin-like growth factor I,825.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Insulin receptor,8159.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,1351.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,1800.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,473.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,38325,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,4027.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,1678.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,606.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,860.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon alpha-10,326.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon alpha-2,156.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon alpha-7,272.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,1111.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon beta,665.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon gamma,620.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon gamma receptor 1,398.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon gamma receptor 2,452,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon lambda-1,356.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon lambda-2,203.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interferon regulatory factor 1,1456.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-10,513.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1536.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,1102.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-11,280.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-12,223.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,493.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,751.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-13,691.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,2464.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,956.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-16,333.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-17A,367.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-17B,154.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-17D,340.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-17F,981.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-17 receptor A,698.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-17 receptor B,1234.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-17 receptor C,1095.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-17 receptor D,545,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-18-binding protein,15904.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-18 receptor 1,12488.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,279.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-19,5787.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-1 alpha,528.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-1 beta,2847.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,30126.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,6808.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,5471.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,867.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,7037.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,9917.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-20,333.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,234.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-2,1324.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-22,1553.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,1841.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,2187,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-23,1236.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-23 receptor,4624.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-24,348.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-25,308.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-27,671.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,1881.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,1314.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-3,1687.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-34,775,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-36 alpha,788.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-36 beta,453.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-37,2175.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,1371.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-4,512.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,233.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-5,442.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,1643.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-6,321.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,17215.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,6460,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-7,205.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,350,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-8,810.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interleukin-9,232.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Interstitial collagenase,977.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Junctional adhesion molecule B,10774.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Junctional adhesion molecule C,5700.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Junctional adhesion molecule-like,429.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-11,1187.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-12,6472.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-13,1761.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-14,9238.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-4,336.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-5,177.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-6,3426.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-7,1526.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallikrein-8,2762.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kallistatin,35750.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,457.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",1027.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,2349.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,262,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,2744.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,363.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kinesin-like protein KIF23,1183.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kininogen-1,26312.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,306.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kremen protein 2,3563.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,4174.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,1281.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Kynureninase,714.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lactadherin,1074.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lactoperoxidase,565.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lactotransferrin,51059.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lamin-B1,706.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Laminin,2259.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1507.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Layilin,1510.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Legumain,3146.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leptin,4676.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leptin receptor,2127,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,1999.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,5627.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2475.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,146.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,248.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1085.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,23085.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,3394.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,4490.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,5282.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,9242.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,865.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,1028.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,257.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Limbic system-associated membrane protein,1433.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,120994,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lithostathine-1-alpha,836.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,1439.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,5568.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,93,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,784.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1290.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Low-density lipoprotein receptor,274.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,48270.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",1194.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,1843.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,7645,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,L-Selectin,3245.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lumican,1366.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Luteinizing hormone,678.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,1130.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,240.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,10230.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lymphocyte antigen 86,4373.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lymphotactin,351.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,90.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,2057.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lymphotoxin-alpha,576.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lysosomal protective protein,7228,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lysosome membrane protein 2,399.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Lysozyme C,136741.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Macrophage-capping protein,1047.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,2180.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,155.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Macrophage mannose receptor 1,7469.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Macrophage metalloelastase,947.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,1086,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,1110.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,523.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",28914.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mammaglobin-B,8746.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,4906.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mannose-binding protein C,16347.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,7866.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,1183.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,588.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,11914.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Matrilin-2,8229.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Matrilin-3,539.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Matrilysin,2747.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,281.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Matrix metalloproteinase-14,1168.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Matrix metalloproteinase-16,801.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Matrix metalloproteinase-17,1019.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Matrix metalloproteinase-9,34984.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,91541.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,1226.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,4103,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Membrane frizzled-related protein,2079.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,1105.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mesothelin,379.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,100.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,478.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,988.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Methionine aminopeptidase 1,1579,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Methionine aminopeptidase 2,37429.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,449.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,228.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,1734.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Microtubule-associated protein tau,360.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Midkine,32157.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,901.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,675.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,854.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,746.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,481.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,2113.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,9660.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,27611.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,1259.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,1160.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,2092.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Moesin,1031.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,15890.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,19614.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Mucin-1,1327.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Muellerian-inhibiting factor,11327.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Myc proto-oncogene protein,369.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Myeloblastin,7616.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,3734.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Myeloperoxidase,14915.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Myoglobin,2406.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",5886.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,1071.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,2039,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,5781.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,6841.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,2491.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,5941,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,3276.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,303.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,663.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,164.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Netrin-1,444.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Netrin-4,1033.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Netrin receptor UNC5C,4967.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Netrin receptor UNC5D,7086.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",19842.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,425.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,9824.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neuregulin-1,180.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neuregulin-4,895.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neurexin-1-beta,704.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neurexin-3-beta,1207.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neurexophilin-1,4556.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1067.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,25237.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,696.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,835.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",671.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,15007.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neuronal growth regulator 1,4357.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neuropilin-1,2139.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neurotrophin-3,163.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neurotrophin-4,269.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neutral ceramidase,5413.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,4133.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neutrophil collagenase,3096.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neutrophil elastase,402.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,29534.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,506.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Nidogen-1,5926.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Nidogen-2,2598.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NKG2D ligand 1,841.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NKG2D ligand 2,325.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NKG2D ligand 3,823.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,517.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Noggin,1953.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,830.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,1992.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NSFL1 cofactor p47,336.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NT-3 growth factor receptor,3672.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,N-terminal pro-BNP,9548.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,510.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,3044.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,21131.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,NudC domain-containing protein 3,259.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,OCIA domain-containing protein 1,978.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Olfactomedin-4,181.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Oncostatin-M,1989.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,3320.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Osteocalcin,1665.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Osteomodulin,7185.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Osteopontin,3643,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,2437.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,3761.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pancreatic hormone,2449.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pappalysin-1,16776.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Parathyroid hormone,4675.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Parathyroid hormone-related protein,809.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peptide YY,1731.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,812.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,154092.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,6432.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,12828.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,942.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",8063.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Periostin,6646.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peroxiredoxin-1,3730.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",445,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peroxiredoxin-6,1006.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,485,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Persephin,245.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",4477.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pescadillo homolog,238.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,7789.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",494,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2312,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Phosphoglucomutase-1,605.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,2743.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,494.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Phospholipase A2,814.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",2478.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pigment epithelium-derived factor,57940.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,PIK3CA/PIK3R1,482.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,PILR alpha-associated neural protein,5369.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,249.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,291.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Placenta growth factor,300.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Plasma kallikrein,21890.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,6577.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Plasma serine protease inhibitor,95053.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Plasmin,823.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Plasminogen,3258.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,782.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,1121.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,7094.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet-derived growth factor C,349.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,851.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,2433.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,10784.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,25282.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,1125,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet factor 4,18117.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet glycoprotein 4,8753.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,1319.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet glycoprotein VI,10052.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Platelet receptor Gi24,496,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pleiotrophin,1683,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Plexin-B2,5420.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Plexin-C1,678.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,3167.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,3328.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,4394.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Prefoldin subunit 5,395.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,803.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,3856.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Prokineticin-1,187.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Prolactin,553.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Prolactin receptor,1304.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,207.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,2399.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,722.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pro-opiomelanocortin,705.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Properdin,106340.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,1499.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,786.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,422.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Prostate-specific antigen,22091.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,1534.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,295.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,722.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,571.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,955.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein 4.1,13578.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein amnionless,203.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein deglycase DJ-1,362.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein disulfide-isomerase,252.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,3479.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein E7_HPV16,884.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein E7_HPV18,2223.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein FAM107A,322.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein FAM107B,1942.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein FAM3B,785.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein FAM3D,5858,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,187.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein jagged-1,545.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein jagged-2,350.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein kinase C alpha type,41602.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),10866.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein kinase C delta type,4234.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein kinase C gamma type,516.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein kinase C iota type,3652,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein kinase C theta type,2916.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein kinase C zeta type,799.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein lin-7 homolog B,434.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein NOV homolog,611.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein Rev_HV2BE,164.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein S100-A12,851.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein S100-A4,1822.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein S100-A6,4346.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein S100-A7,236.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein S100-A9,4909.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein SET,530.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,312,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein Wnt-7a,261.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,7408.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Prothrombin,177816.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,809.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,63518.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Proto-oncogene vav,12918.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,P-selectin,17523.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,4231.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pyridoxal kinase,250.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,4343.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1879.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Pyruvate kinase PKM,46422.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,2927.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,24059.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,4069.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,11341.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,948.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,29928.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,6147.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,4064.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,441.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,281.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,161.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,1364.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Relaxin receptor 1,410,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Renin,617.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Repulsive guidance molecule A,22727.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Resistin,1205.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Reticulon-4 receptor,2186.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1636.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,2923.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Retinol-binding protein 4,255.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,RGM domain family member B,2613.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ribonuclease H1,153.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,649,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,251,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,13527.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,RNA-binding protein 39,363.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Roundabout homolog 2,2799.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Roundabout homolog 3,370.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,R-spondin-2,559,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,R-spondin-3,2165.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,R-spondin-4,309.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Scavenger receptor class F member 1,8550.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Scavenger receptor class F member 2,254.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2271.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sclerostin,64554.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,1534.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,4470.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,3156.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Secretin,196.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Seizure 6-like protein 2,1569.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Semaphorin-3A,2296.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Semaphorin-3E,2029.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Semaphorin-5A,5620.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Semaphorin-6A,8622,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Semaphorin-6B,2611.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine protease 27,8410.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",4076.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,2119.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,4716.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,699.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,207.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,1320.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,1058.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,15378.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,567.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,802.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,198.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1389.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,240.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,1668.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serotransferrin,243096.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serum albumin,8453.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serum amyloid A-1 protein,1062,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serum amyloid P-component,53852.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,169,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sex hormone-binding globulin,2930.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,S-formylglutathione hydrolase,3167.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,10031.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SHC-transforming protein 1,12451.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,36889.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,182,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1224.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,28156.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sialoadhesin,190.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,11974.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,1526.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,517,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SLAM family member 5,5013.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SLAM family member 6,365.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SLAM family member 7,38171.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1556.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,1555.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,2282.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,3242.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,2873.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Somatostatin-28,1166.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Somatotropin,250.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sonic hedgehog protein,885.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sorting nexin-4,12619.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SPARC,20264.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SPARC-like protein 1,14677.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,4253.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",148.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,12358,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sphingosine kinase 1,13080.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Sphingosine kinase 2,556.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Spondin-1,1838.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Stabilin-2,809.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Stanniocalcin-1,2642.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Stem cell growth factor-alpha,1701.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,833.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,10139.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Stromal cell-derived factor 1,5644.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Stromelysin-1,1921.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Stromelysin-2,743.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,2078.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],1249.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",51761,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,1385,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Syntaxin-1A,292.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,7184.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,TATA-box-binding protein,454.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,363.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tenascin,15881.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,606.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Testican-1,2876.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Testican-2,1033.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,TGF-beta receptor type-2,1990.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,2616.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thrombin,681.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thrombopoietin,235.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thrombopoietin Receptor,183,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thrombospondin-1,2015.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thrombospondin-2,12663.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thrombospondin-4,771.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,402.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",535.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thymidylate synthase,399.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thyroglobulin,360.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thyroid peroxidase,1887,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,883.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Thyroxine-binding globulin,38670.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tissue Factor,1083.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,79112.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tissue-type plasminogen activator,470.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,631.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,671.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,1212.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Toll-like receptor 2,423.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Toll-like receptor 4,292.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4886.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transcription factor AP-1,12596.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,2192.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transforming growth factor beta-1,2741.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transforming growth factor beta-2,267.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transforming growth factor beta-3,483.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,51688.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,41261.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transgelin-2,37669.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transketolase,54972.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Translationally-controlled tumor protein,14872.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,5363,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Trefoil factor 1,4615.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Trefoil factor 2,9420.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Trefoil factor 3,13868.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Triosephosphate isomerase,9473.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,920,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,99216.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tropomyosin beta chain,2234.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",505.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",21273.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",8259.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Trypsin-1,6748.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Trypsin-2,2476.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Trypsin-3,3147,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tryptase beta-2,1552,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tryptase gamma,226,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,373.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor,606.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,1702.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,778.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,584.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,1332.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,522.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,770.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,657.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,314.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",473.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,1503,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,414,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1235.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,407.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,905,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1878.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,15682.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,175.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,1144.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,2309.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,584,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,7404.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,697.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,963.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,3403.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,2141.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,19813.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,8801.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,925.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,6312.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,957.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,2435.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,636.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,933.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,349.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,901.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,146.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,7629.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,8879,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,2771.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,371.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,6280,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,194.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,145312.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,641.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,5803.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",36961.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",8273.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,520.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,3224.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,658.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,1019.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,13842.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,7125.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,2680.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,327.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,4466.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,7308.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin,1373.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",4163.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1077.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1392.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,5745.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,1820.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,7449,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,3491.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,18286.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,2044.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,UMP-CMP kinase,6613.1,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,10352.3,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,2072.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,32438.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,16842.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vascular endothelial growth factor A,12785.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",785,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vascular endothelial growth factor C,1508.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vascular endothelial growth factor D,452.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,8759.5,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,6623.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,381.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,12780,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vitamin K-dependent protein C,1415.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vitamin K-dependent protein S,3970.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Vitronectin,91523.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,von Willebrand factor,4702,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,396.4,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",1387.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7102.7,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,4968.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,1109.2,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Wnt inhibitory factor 1,2916.6,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,3684.9,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,865.8,RFU
BF-1045,PDEZ044TE4,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,212.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,14-3-3 protein beta/alpha,123631.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,14-3-3 protein epsilon,806.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,14-3-3 protein family,32947.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,14-3-3 protein sigma,1505.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,14-3-3 protein theta,3675.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,14-3-3 protein zeta/delta,292247.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],3126.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",534,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,612.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,414.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,294.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,7805,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",9445.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",1638.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,6908.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,40S ribosomal protein S3,4836.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,40S ribosomal protein S3a,2870.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,40S ribosomal protein S7,6897.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,40S ribosomal protein SA,1678.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",53125,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",90490.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,72 kDa type IV collagenase,5176.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Abelson tyrosine-protein kinase 2,2148.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,246.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,12467.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Activated Protein C,850.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Activin receptor type-1B,803.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Adapter molecule crk,20558.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Adenylate kinase isoenzyme 1,98570.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Adenylosuccinate lyase,2544.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Adhesion G protein-coupled receptor E2,689.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Adhesion G-protein coupled receptor G5,714.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Adiponectin,1181,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2198.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,412,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,664.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,129.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,348,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,480.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,3867.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Adrenomedullin,3214.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",370.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Afamin,31642.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,33083,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Aggrecan core protein,599.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Agouti-related protein,1090.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,AH receptor-interacting protein,16442.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alanine aminotransferase 1,7879.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],16562.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Allograft inflammatory factor 1,8624.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",3914,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-1-antichymotrypsin,296020,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-1-antichymotrypsin complex,10726.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-1-antitrypsin,2062.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-2-antiplasmin,1879.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-2-HS-glycoprotein,1867.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-2-macroglobulin,4459.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,1706.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-enolase,181805.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,alpha-Fetoprotein,985.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-L-iduronidase,2184.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-soluble NSF attachment protein,38090.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Alpha-synuclein,16109.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Aminoacylase-1,6817.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Amphiregulin,13565.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Amphoterin-induced protein 2,2056.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),543.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),23081.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Amyloid beta A4 protein,83365.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiogenin,2804.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiopoietin-1,2255.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",1722,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiopoietin-2,112.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiopoietin-4,832.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiopoietin-related protein 3,522.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiopoietin-related protein 4,6598.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiostatin,14084,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiotensin-converting enzyme 2,873.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Angiotensinogen,5039,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ankyrin-2,475,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Annexin A1,27191.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Annexin A2,29744.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Annexin A5,851.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Annexin A6,15231.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Anterior gradient protein 2 homolog,991.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Antileukoproteinase,18961.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Antithrombin-III,131372.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein A-I,17637,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein B,5560.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein D,4543.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein E,50791.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein E (isoform E2),291125.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein E (isoform E3),235191.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein E (isoform E4),273565.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein L1,44455.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apolipoprotein M,6621,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Apoptosis regulator Bcl-2,3574.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Appetite-regulating hormone,854.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Arginase-1,758.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,292.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Artemin,453.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Arylsulfatase A,1321.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Arylsulfatase B,1072.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Asialoglycoprotein receptor 1,998.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",2877.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,12758.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",6036.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",8571.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Atrial natriuretic factor,930.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,1574,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Aurora kinase A,1143.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Aurora kinase B,596.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Azurocidin,691.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bactericidal permeability-increasing protein,2640.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,251.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,523.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,95.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Basal Cell Adhesion Molecule,939,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Basigin,714.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,B-cell lymphoma 6 protein,1259.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,B-cell receptor CD22,1136.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bcl2-associated agonist of cell death,39492.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bcl-2-like protein 1,2073,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bcl-2-like protein 2,666.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bcl-2-related protein A1,1990.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,BDNF/NT-3 growth factors receptor,694.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Beta-2-microglobulin,1402.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,beta-adrenergic receptor kinase 1,34018.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Beta-Ala-His dipeptidase,8904.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Betacellulin,827.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Beta-endorphin,625.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,beta-nerve growth factor,333.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,BH3-interacting domain death agonist,3124.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Biglycan,1808.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,BMP-binding endothelial regulator protein,552.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bone morphogenetic protein 10,940.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bone morphogenetic protein 1,2686.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bone morphogenetic protein 6,8737.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bone morphogenetic protein 7,649.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,457.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bone morphogenetic protein receptor type-2,510.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Bone sialoprotein 2,3251.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Brain-derived neurotrophic factor,1634.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Brain natriuretic peptide 32,460,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Brain-specific serine protease 4,787.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1790.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Brevican core protein,1153.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Brother of CDO,781.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C3a anaphylatoxin,413.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C3a anaphylatoxin des Arginine,187561.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C5a anaphylatoxin,8661.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cadherin-12,1759.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cadherin-1,53944.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cadherin-15,5891.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cadherin-2,1492.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cadherin-3,21949.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cadherin-5,5658.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cadherin-6,652.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcineurin,9478.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcineurin subunit B type 1,16354,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",1539.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,1858.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,8033.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1994.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,3513,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,10871,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,33382.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calcium-dependent phospholipase A2,512,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calpain I,179534.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calpastatin,6241.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Calreticulin,2073.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,1832.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,cAMP-regulated phosphoprotein 19,11597.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1384.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbohydrate sulfotransferase 15,3637,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbohydrate sulfotransferase 2,499.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbohydrate sulfotransferase 6,240.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase 1,18239.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase 13,5852.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase 2,241,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase 3,1944.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase 4,1313.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase 6,6015.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase 7,274.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase 9,1124.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carbonic anhydrase-related protein 10,514,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carboxypeptidase B2,12632.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Carboxypeptidase E,1532,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cardiotrophin-1,605.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,1057.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,39515,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Casein kinase II subunit alpha,962.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Caspase-10,6199.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Caspase-2,382.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Caspase-3,40484.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Catalase,34008.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin B,2931.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin D,972.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin E,399.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin F,2594.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin G,1227.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin H,470.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin L2,826.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin S,873.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cathepsin Z,3827,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,34603.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CCAAT/enhancer-binding protein beta,1610.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 1,1853.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 13,1463.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 14,4222.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 15,2378.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 16,26769.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 17,3109.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 18,9163,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 19,219.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 20,347.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 21,19536.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 22,1081.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 23,2031.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 24,324.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 25,685.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 26,1689,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 27,1211.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 2,715.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 28,10270.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 3,945.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 3-like 1,1334.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 4-like,355.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 5,117384.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 7,703.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-C motif chemokine 8,185.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD109 antigen,1978.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD166 antigen,9052.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD177 antigen,796.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD209 antigen,906.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD226 antigen,1043.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD27 antigen,3533.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD40 ligand,710.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD48 antigen,580.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD59 glycoprotein,1305.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD5 antigen-like,3497.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD63 antigen,1031.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD70 antigen,229.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD83 antigen,222.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CD97 antigen,1409.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cell adhesion molecule 1,994.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cell adhesion molecule 3,1551,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5310.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,760.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cellular tumor antigen p53,1430.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cerebral dopamine neurotrophic factor,2888.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",17523.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1996.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",58919.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Chitinase-3-like protein 1,10217,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Chitotriosidase-1,1744.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Chloride intracellular channel protein 1,37015,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Choline/ethanolamine kinase,6966.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Chordin-like protein 1,1419.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Chorionic somatomammotropin hormone,6822.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Chromobox protein homolog 5,354.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Chromogranin-A,4199.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Chymase,2438.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ciliary neurotrophic factor,147,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,3841.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ck-beta-8-1,29367.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Clusterin,1835,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,CMRF35-like molecule 6,3185.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coactosin-like protein,2872.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coagulation factor IX,12951.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coagulation factor IXab,9265.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coagulation Factor V,44253.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coagulation factor VII,748.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coagulation Factor X,5998.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coagulation factor Xa,4976.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coagulation Factor XI,1751.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cofilin-1,13344.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Coiled-coil domain-containing protein 80,2190,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Collagen alpha-1(VIII) chain,670.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Collagen alpha-1(XXIII) chain,832.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Collagenase 3,639,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Collectin-11,7447,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Collectin-12,1086.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,COMM domain-containing protein 7,4359.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C1q subcomponent,36104.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C1r subcomponent,2278.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C2,2564.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C3,69150.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C3b,9350.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Complement C3b, inactivated",7457,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C3d fragment,10248.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C4,145899.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C4b,199.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C5,7679.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement C5b-C6 complex,557.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",6548.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement component C1q receptor,6287.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement component C6,80372.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement component C7,1214.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement component C8,1903.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement component C9,69414.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement decay-accelerating factor,13720.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement factor B,30259.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement factor D,1039.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement factor H,62146.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement factor H-related protein 5,2522,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Complement factor I,42024.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Connective tissue-activating peptide III,136137,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Connective tissue growth factor,4440,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Contactin-1,391.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Contactin-2,531.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Contactin-4,2629.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Contactin-5,430.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Copine-1,26890.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Corticosteroid-binding globulin,855.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Corticotropin,457.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-reactive protein,28586.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Creatine kinase B-type,497.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Creatine kinase M-type,546.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,412.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cryptic protein,5993.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-type lectin domain family 1 member B,46485.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-type lectin domain family 4 member K,148.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-type lectin domain family 4 member M,51858.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-type lectin domain family 7 member A,1116.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-type mannose receptor 2,2067.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-X-C motif chemokine 10,1593.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-X-C motif chemokine 11,8942.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-X-C motif chemokine 13,1436.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-X-C motif chemokine 16,8839.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-X-C motif chemokine 5,798.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-X-C motif chemokine 6,2829.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,C-X-C motif chemokine 9,330.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,1109.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,254.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1002.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,3949.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,2699.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cystatin-C,1740.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cystatin-D,5117.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cystatin-F,663.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cystatin-M,6953.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cystatin-S,119.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cystatin-SA,6560.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cystatin-SN,657.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cysteine and glycine-rich protein 3,7596.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cysteine-rich secretory protein 3,392.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,2010.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytochrome c,1977.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytochrome P450 3A4,61985.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytokine receptor common subunit gamma,13974.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,365.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytokine receptor-like factor 2,2692.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytoplasmic protein NCK1,3451.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,415.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytoskeleton-associated protein 2,12430.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytosolic non-specific dipeptidase,2014.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,2014.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,56.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,dCTP pyrophosphatase 1,9056.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,D-dimer,12990.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Death-associated protein kinase 2,4854.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Decorin,3817.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Delta-like protein 1,1578.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Delta-like protein 4,490.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dermatopontin,2695.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Desert hedgehog protein N-product,2015.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Desmocollin-2,1965.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Desmocollin-3,278.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Desmoglein-1,2680,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Diablo homolog, mitochondrial",4088.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dickkopf-like protein 1,7107.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dickkopf-related protein 1,52717.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dickkopf-related protein 3,4383.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dickkopf-related protein 4,13215.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dipeptidyl peptidase 1,386.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dipeptidyl peptidase 2,2359.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Discoidin domain-containing receptor 2,1735.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,483.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,980.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,DnaJ homolog subfamily B member 1,2731.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,DNA repair protein RAD51 homolog 1,1694.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,DNA topoisomerase 1,6076.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Down syndrome cell adhesion molecule,782.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Drebrin-like protein,10122.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",9754.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,455,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1810.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,5189.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,36733.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dual specificity protein phosphatase 3,10354.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2685.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dynactin subunit 2,1402.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",441.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Dynein light chain roadblock-type 1,11512.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,1413.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,4892.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,250.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,1129.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,329.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Ectodysplasin-A, secreted form",1028.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1504.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1432.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,5176.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,3703.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1545.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Elafin,12497.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Elongation factor 1-beta,2089,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Endoglin,827.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,97014.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Endoplasmic reticulum resident protein 29,6731.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Endostatin,44093.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Endothelial cell-selective adhesion molecule,6287.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Endothelial cell-specific molecule 1,925.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,4065.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Endothelin-converting enzyme 1,13507.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Enteropeptidase,176.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Eotaxin,3260.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin-A2,740.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin-A3,1293.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin-A4,925.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin-A5,1299.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin-B1,3565,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin-B2,5831.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin-B3,1054.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin type-A receptor 10,300.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin type-A receptor 1,3937.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin type-A receptor 2,1200.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin type-A receptor 3,107,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin type-A receptor 5,518.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin type-B receptor 2,7016.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin type-B receptor 4,8800.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ephrin type-B receptor 6,1297.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Epidermal growth factor,2645.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Epidermal growth factor receptor,22457.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,1558.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Epidermal growth factor receptor variant III,249.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Epiregulin,1476.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,440.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Erythropoietin,805.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Erythropoietin receptor,576.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,E-selectin,25872.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,4202,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Estrogen receptor,1224,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Eukaryotic initiation factor 4A-III,1587.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,422.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,17298.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Eukaryotic translation initiation factor 4H,26277,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Eukaryotic translation initiation factor 5,2813.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,66169.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Extracellular matrix protein 1,14766.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],447.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,FACT complex subunit SSRP1,2556.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Fatty acid-binding protein, epidermal",718.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Fatty acid-binding protein, heart",13908.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Fatty acid-binding protein, liver",1830.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fc receptor-like protein 3,347.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ferritin,14809.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fetuin-B,2902.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibrinogen,165255,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibrinogen gamma chain,61132.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 10,274.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 1,134.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 12,265.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 16,10183.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 17,189.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 18,197.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 19,1521.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 20,330.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 2,2450.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 23,377.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 4,347.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 5,532.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 6,1161.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 7,4952.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 8 isoform A,1227.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 8 isoform B,1000,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor 9,388,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor receptor 1,551.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor receptor 2,224.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor receptor 3,832.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibroblast growth factor receptor 4,1511.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibronectin,8091.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibronectin Fragment 3,1683.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fibronectin Fragment 4,37778,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ficolin-1,1841.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ficolin-2,1083.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ficolin-3,3383.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,391.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Focal adhesion kinase 1,340.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Follicle stimulating hormone,424.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Follistatin,1771.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Follistatin-related protein 1,25567.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Follistatin-related protein 3,3560.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,3433.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fractalkine,1560.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Fructose-bisphosphate aldolase A,204996,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,G2/mitotic-specific cyclin-B1,526.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,329.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galectin-10,494.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galectin-2,554,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galectin-3,18159.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galectin-3-binding protein,775.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galectin-4,1011.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galectin-7,1511.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galectin-8,377.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Galectin-9,1137.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Gamma-enolase,40805.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Gastrin-releasing peptide,281,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,GDNF family receptor alpha-1,671,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,GDNF family receptor alpha-2,5083.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,GDNF family receptor alpha-3,1027.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Gelsolin,989.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glia-derived nexin,3049.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glial cell line-derived neurotrophic factor,383.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glial fibrillary acidic protein,814.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glucagon,1292.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glucocorticoid receptor,202,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glucokinase regulatory protein,503.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glucose-6-phosphate isomerase,63036.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glutamate carboxypeptidase 2,418.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glutathione S-transferase A3,182.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glutathione S-transferase P,6293.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,332732.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",972.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,56353.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,12691.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glypican-2,192.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glypican-3,441.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glypican-5,1022.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Glypican-6,2707.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"gp41 C34 peptide, HIV",637.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Granulins,19172.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Granulocyte colony-stimulating factor,878.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,1093.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,340.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Granulysin,7670.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Granzyme A,2857.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Granzyme B,1382.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Granzyme H,251.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,GRB2-related adapter protein 2,427.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Gremlin-1,699,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Gro-beta/gamma,3610,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Group 10 secretory phospholipase A2,533.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Group IIE secretory phospholipase A2,235.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth arrest-specific protein 1,601.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth/differentiation factor 11,647,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth/differentiation factor 11/8,1069.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth/differentiation factor 15,1142.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth/differentiation factor 2,1209.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth/differentiation factor 5,2177.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth/differentiation factor 8,2688.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth/differentiation factor 9,601.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth factor receptor-bound protein 2,95873.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth hormone receptor,1022,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Growth-regulated alpha protein,22380.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,GTPase KRas,787.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,GTP-binding nuclear protein Ran,21010.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Haptoglobin,54145.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heat shock 70 kDa protein 1A,5279.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heat shock cognate 71 kDa protein,4995.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heat shock protein beta-1,14741.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,43412.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heat shock protein HSP 90-beta,140755.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heme oxygenase 2,659.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,HemK methyltransferase family member 2,14628.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hemoglobin,2526.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hemojuvelin,1135,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hemopexin,913.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2141.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heparin-binding EGF-like growth factor,559.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heparin cofactor 2,3875.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hepatitis A virus cellular receptor 2,5945.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hepatocyte growth factor,1413.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hepatocyte growth factor activator,2225.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hepatocyte growth factor-like protein,889,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hepatocyte growth factor receptor,5583.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,1957.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hepcidin,10725.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,HERV-H LTR-associating protein 2,1319.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,9962.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,172.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,4130.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,46999.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hexokinase-1,1427,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hexokinase-2,2212.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",496.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",247.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,360.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,High affinity nerve growth factor receptor,4363.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,High mobility group protein B1,45918.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histidine-rich glycoprotein,2412.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,4178.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone acetyltransferase KAT6A,1673.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,666.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone deacetylase 8,3570.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone H1.2,39608.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone H2A type 3,8915.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone H2A.z,7567.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone H2B type 2-E,53029.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone H3.1,2620.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,510.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Homeobox protein NANOG,123.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Homeodomain-interacting protein kinase 3,383.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hsp90 co-chaperone Cdc37,985,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Human Chorionic Gonadotropin,465.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,893.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,445.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,ICOS ligand,9265.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Iduronate 2-sulfatase,2769.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Immunoglobulin A,4670.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Immunoglobulin alpha Fc receptor,200.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Immunoglobulin D,7391.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Immunoglobulin E,3452.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Immunoglobulin G,173509.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Immunoglobulin M,1584.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,3062.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Importin subunit alpha-1,205.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Importin subunit beta-1,21419.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1076.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Inducible T-cell costimulator,1644.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Inhibin beta A chain,2488.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,469.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Inhibitor of growth protein 1,68146.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Inorganic pyrophosphatase,51896.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,4571.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,6456.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin,127.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-degrading enzyme,3771.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor 1 receptor,3395.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor-binding protein 1,339,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor-binding protein 2,389.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor-binding protein 3,1749.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor-binding protein 4,4802.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor-binding protein 5,2027,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor-binding protein 6,640.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor-binding protein 7,33867.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin-like growth factor I,2134.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Insulin receptor,5350,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Integrin alpha-I: beta-1 complex,6966.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,2737.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Integrin alpha-V: beta-5 complex,784.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,35440.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Intercellular adhesion molecule 1,2926.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Intercellular adhesion molecule 2,3874.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Intercellular adhesion molecule 3,690.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Intercellular adhesion molecule 5,613,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon alpha-10,242.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon alpha-2,137.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon alpha-7,202.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon alpha/beta receptor 1,1137.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon beta,471.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon gamma,506.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon gamma receptor 1,232.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon gamma receptor 2,377.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon lambda-1,728.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon lambda-2,164.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interferon regulatory factor 1,2407.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-10,154.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1387.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-10 receptor subunit beta,1006.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-11,419.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-12,261.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,430.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,833.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-13,782.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,1250.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-15 receptor subunit alpha,894.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-16,652.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-17A,360.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-17B,142.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-17D,246,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-17F,456.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-17 receptor A,892.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-17 receptor B,656.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-17 receptor C,582.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-17 receptor D,362.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-18-binding protein,4680.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-18 receptor 1,5755.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-18 receptor accessory protein,363.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-19,4043.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-1 alpha,1569.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-1 beta,2801.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-1 Receptor accessory protein,21006.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-1 receptor antagonist protein,3656.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-1 receptor-like 1,4263,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-1 receptor-like 2,799.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-1 receptor type 1,4246.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-1 receptor type 2,9403.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-20,331.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-20 receptor subunit alpha,266.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-2,1317.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-22,1406.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,1158.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,1077.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-23,760.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-23 receptor,5415.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-24,297.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-25,211.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-27,628.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-27 receptor subunit alpha,1057.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-2 receptor subunit alpha,1275.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-3,1641.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-34,458.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-36 alpha,673,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-36 beta,418.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-37,1968.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-3 receptor subunit alpha,4028.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-4,798.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-4 receptor subunit alpha,137.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-5,202.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-5 receptor subunit alpha,955.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-6,615.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-6 receptor subunit alpha,8866.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-6 receptor subunit beta,4387.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-7,138,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-7 receptor subunit alpha,325.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-8,895.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interleukin-9,228.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Interstitial collagenase,9491.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Junctional adhesion molecule B,10500.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Junctional adhesion molecule C,18212.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Junctional adhesion molecule-like,518.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-11,1053.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-12,4092,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-13,1064.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-14,13816.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-4,328.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-5,123.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-6,2091.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-7,1298.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallikrein-8,1801.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kallistatin,31017.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kelch-like ECH-associated protein 1,420.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Keratin, type I cytoskeletal 18",1795.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,4710.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,268.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,536.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,356.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kinesin-like protein KIF23,3491,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kininogen-1,28260.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kin of IRRE-like protein 3,330.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kremen protein 2,9956.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kunitz-type protease inhibitor 1,2325.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kunitz-type protease inhibitor 2,2084,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Kynureninase,1295.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lactadherin,317.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lactoperoxidase,430.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lactotransferrin,53509.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lamin-B1,1202.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Laminin,3144.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1141.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Layilin,1071.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Legumain,5306,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leptin,3032.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leptin receptor,995.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leucine carboxyl methyltransferase 1,2464.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,3612.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,3616.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,84.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,150.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,2676.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,8485.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,2585.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leukemia inhibitory factor receptor,2454.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3369.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,6094.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leukocyte surface antigen CD47,2171.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Leukotriene A-4 hydrolase,808.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,184.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Limbic system-associated membrane protein,921.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lipopolysaccharide-binding protein,69513.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lithostathine-1-alpha,273.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,L-lactate dehydrogenase B chain,4730.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,2918,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,78.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,1415,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1447.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Low-density lipoprotein receptor,124.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,35684,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",1305.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,1830,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,8867.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,L-Selectin,4024,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lumican,1115.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Luteinizing hormone,2778.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,1089.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,460.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lymphocyte activation gene 3 protein,4204.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lymphocyte antigen 86,9873.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lymphotactin,331.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lymphotoxin alpha1:beta2,77.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lymphotoxin alpha2:beta1,1550.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lymphotoxin-alpha,651.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lysosomal protective protein,13503.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lysosome membrane protein 2,374.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Lysozyme C,84710.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Macrophage-capping protein,873.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Macrophage colony-stimulating factor 1,1487.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,230.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Macrophage mannose receptor 1,7164.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Macrophage metalloelastase,438.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Macrophage migration inhibitory factor,3983,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Macrophage scavenger receptor types I and II,1150.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Macrophage-stimulating protein receptor,492.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",93948.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mammaglobin-B,16756.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mannan-binding lectin serine protease 1,4060.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mannose-binding protein C,7507.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,MAP kinase-activated protein kinase 2,29227.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,MAP kinase-activated protein kinase 3,7019.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,MAP kinase-activated protein kinase 5,1118.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,9850.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Matrilin-2,5435.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Matrilin-3,437.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Matrilysin,1431.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,229.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Matrix metalloproteinase-14,698.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Matrix metalloproteinase-16,1043,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Matrix metalloproteinase-17,1089.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Matrix metalloproteinase-9,13708.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,58669.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,471.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Melanoma-derived growth regulatory protein,1812.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Membrane frizzled-related protein,4316.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,1268.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mesothelin,705.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Metalloproteinase inhibitor 1,86.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Metalloproteinase inhibitor 2,399.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Metalloproteinase inhibitor 3,5211.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Methionine aminopeptidase 1,12283,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Methionine aminopeptidase 2,92993.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Methyl-CpG-binding domain protein 4,630.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,MHC class I polypeptide-related sequence A,174.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,MHC class I polypeptide-related sequence B,573.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Microtubule-associated protein tau,187.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Midkine,35911.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitochondrial glutamate carrier 2,816.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,648.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase 11,420.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase 12,2027.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase 1,37481.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase 13,863.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase 14,11260,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase 3,105807.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase 8,5711,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase 9,545.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,8060.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Moesin,4173,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mothers against decapentaplegic homolog 2,73946.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mothers against decapentaplegic homolog 3,44424.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Mucin-1,788.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Muellerian-inhibiting factor,7872.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Myc proto-oncogene protein,407,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Myeloblastin,3351.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Myeloid cell surface antigen CD33,2082.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Myeloperoxidase,15717.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Myoglobin,871.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Myosin-binding protein C, slow-type",1105.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,N-acetyl-D-glucosamine kinase,2939.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,3334.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,7131.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,22382.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NADPH--cytochrome P450 reductase,3244.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,12728.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,1419.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,310.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,417.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Natural killer cell receptor 2B4,220.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Netrin-1,356.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Netrin-4,946.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Netrin receptor UNC5C,2521.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Netrin receptor UNC5D,2144.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",7836.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neural cell adhesion molecule L1,331,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,7111.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neuregulin-1,129.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neuregulin-4,837.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neurexin-1-beta,429.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neurexin-3-beta,515.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neurexophilin-1,7797.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,951.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neurogenic locus notch homolog protein 1,15851.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neurogenic locus notch homolog protein 2,462.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neurogenic locus notch homolog protein 3,482.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Neuroligin-4, X-linked",546.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neuronal cell adhesion molecule,5930.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neuronal growth regulator 1,2320.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neuropilin-1,2204.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neurotrophin-3,172,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neurotrophin-4,163.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neutral ceramidase,1798.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neutrophil-activating peptide 2,43695.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neutrophil collagenase,2317.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neutrophil elastase,453.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,14602.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,471.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Nidogen-1,4776.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Nidogen-2,3501.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NKG2D ligand 1,453.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NKG2D ligand 2,286,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NKG2D ligand 3,2129.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NKG2-D type II integral membrane protein,727.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Noggin,4212.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Non-histone chromosomal protein HMG-14,4635.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,7724.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NSFL1 cofactor p47,1369.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NT-3 growth factor receptor,2525.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,N-terminal pro-BNP,1355.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,653.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Nucleoside diphosphate kinase A,2451,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Nucleoside diphosphate kinase B,70925.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,NudC domain-containing protein 3,602.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,OCIA domain-containing protein 1,1131.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Olfactomedin-4,197.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Oncostatin-M,1574.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,6248.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Osteocalcin,2935.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Osteomodulin,5216.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Osteopontin,2073.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,OX-2 membrane glycoprotein,1991.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,1904.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pancreatic hormone,1173.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pappalysin-1,9758.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Parathyroid hormone,2277.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Parathyroid hormone-related protein,726.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peptide YY,1537.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peptidoglycan recognition protein 1,427.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,285607.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,3667.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,74148.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,3732.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",79552.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Periostin,2313.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peroxiredoxin-1,10054.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",422.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peroxiredoxin-6,2201.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,272.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Persephin,365.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",4293.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pescadillo homolog,580.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,28705.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",797.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2377.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Phosphoglucomutase-1,443,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Phosphoglycerate kinase 1,8874.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Phosphoglycerate mutase 1,11537,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Phospholipase A2,547,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Phospholipase A2, membrane associated",1590.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pigment epithelium-derived factor,46299.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,PIK3CA/PIK3R1,937.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,PILR alpha-associated neural protein,2479.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,215.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,167.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Placenta growth factor,252.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Plasma kallikrein,21788.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Plasma protease C1 inhibitor,6502.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Plasma serine protease inhibitor,74854.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Plasmin,737.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Plasminogen,3642.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Plasminogen activator inhibitor 1,4185.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet-activating factor acetylhydrolase,1308.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,14704.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet-derived growth factor C,320,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet-derived growth factor receptor alpha,977.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet-derived growth factor receptor beta,2067.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet-derived growth factor subunit A,39989.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet-derived growth factor subunit B,109502.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet endothelial cell adhesion molecule,1033.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet factor 4,217509.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet glycoprotein 4,9303.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,2053.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet glycoprotein VI,44331.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Platelet receptor Gi24,963.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pleiotrophin,1546.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Plexin-B2,3097.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Plexin-C1,590.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Polymeric immunoglobulin receptor,2546.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,PolyUbiquitin K48-linked,2668.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,PolyUbiquitin K63-linked,4611.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Prefoldin subunit 5,361.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Programmed cell death 1 ligand 1,625.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Programmed cell death 1 ligand 2,4953.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Prokineticin-1,429.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Prolactin,1343,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Prolactin receptor,1051.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proliferating cell nuclear antigen,190.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proliferation-associated protein 2G4,10977.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Prolyl endopeptidase FAP,561.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pro-opiomelanocortin,433.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Properdin,143917.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,1208.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,586.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Prostaglandin G/H synthase 2,1926.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Prostate-specific antigen,1747.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proteasome activator complex subunit 1,5372.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proteasome activator complex subunit 3,292.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proteasome subunit alpha type-1,922.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proteasome subunit alpha type-2,798.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proteasome subunit alpha type-6,3078.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein 4.1,46987.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein amnionless,114.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein deglycase DJ-1,393.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein disulfide-isomerase,174.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein disulfide-isomerase A3,16865.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein E7_HPV16,360.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein E7_HPV18,1713.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein FAM107A,228.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein FAM107B,2665.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein FAM3B,692.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein FAM3D,2700.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,212.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein jagged-1,438.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein jagged-2,269.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein kinase C alpha type,146177.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),61764.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein kinase C delta type,15456.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein kinase C gamma type,551.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein kinase C iota type,9239.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein kinase C theta type,13160.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein kinase C zeta type,2117.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein lin-7 homolog B,539.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein NOV homolog,839.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein Rev_HV2BE,128.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein S100-A12,1053.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein S100-A4,2872,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein S100-A6,7960.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein S100-A7,273.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein S100-A9,9150.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein SET,859.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein-tyrosine kinase 6,230.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein Wnt-7a,175.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Protein Z-dependent protease inhibitor,2168,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Prothrombin,180525.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,775.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,123442.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Proto-oncogene vav,70533.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,P-selectin,46459.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pulmonary surfactant-associated protein D,131953.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pyridoxal kinase,511.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pyridoxal phosphate phosphatase,15994.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",2193.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Pyruvate kinase PKM,222354.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Quinone oxidoreductase-like protein 1,2451.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Rab GDP dissociation inhibitor beta,77016,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,28554.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,44560.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ras GTPase-activating protein 1,1893.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,136309.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,19197.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,13441.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,464.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,255.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,127,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Regenerating islet-derived protein 4,962,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Relaxin receptor 1,533.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Renin,1260.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Repulsive guidance molecule A,18718.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Resistin,965.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Reticulon-4 receptor,1291,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Retinoblastoma-associated protein,1578.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Retinoic acid receptor responder protein 2,2353,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Retinol-binding protein 4,306.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,RGM domain family member B,1400.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ribonuclease H1,465.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,2722.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,680.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ribosome maturation protein SBDS,51107.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,RNA-binding protein 39,861.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Roundabout homolog 2,2156.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Roundabout homolog 3,349.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,R-spondin-2,810.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,R-spondin-3,975,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,R-spondin-4,262.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Scavenger receptor class F member 1,21397.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Scavenger receptor class F member 2,306.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2797.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sclerostin,11594.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Secreted and transmembrane protein 1,1442.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Secreted frizzled-related protein 1,3502.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Secreted frizzled-related protein 3,2920.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Secretin,192.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Seizure 6-like protein 2,4368.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Semaphorin-3A,2237.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Semaphorin-3E,1145.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Semaphorin-5A,3094,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Semaphorin-6A,5044.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Semaphorin-6B,2026.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine protease 27,7922.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",10319.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase 16,2026.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase 17B,16063.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase Chk1,630.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase Chk2,187.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1850.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,888.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,36904.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,815.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase pim-1,845.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase PLK1,158.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1946.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase TBK1,359.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serine/threonine-protein kinase WNK3,6131.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serotransferrin,234080.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serum albumin,10192.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serum amyloid A-1 protein,650,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serum amyloid P-component,40177.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Serum paraoxonase/arylesterase 1,264.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sex hormone-binding globulin,1106.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,S-formylglutathione hydrolase,2234.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SH2 domain-containing protein 1A,8935.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SHC-transforming protein 1,45200.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,8432.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,141.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1248.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,10440.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sialoadhesin,112,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,41745.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Signal transducer and activator of transcription 3,12698.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Signal transducer and activator of transcription 6,1878.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SLAM family member 5,10425.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SLAM family member 6,319.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SLAM family member 7,25119.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SLIT and NTRK-like protein 1,2053.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SLIT and NTRK-like protein 5,885,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,11383.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Small nuclear ribonucleoprotein F,2646.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Small ubiquitin-related modifier 3,16034.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Somatostatin-28,1436.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Somatotropin,218.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sonic hedgehog protein,537.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sorting nexin-4,56932.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SPARC,84946.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SPARC-like protein 1,7628.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,2903.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",173.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,S-phase kinase-associated protein 1,11307.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sphingosine kinase 1,56576,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Sphingosine kinase 2,575.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Spondin-1,1064.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Stabilin-2,772.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Stanniocalcin-1,1530.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Stem cell growth factor-alpha,3147.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Stem Cell Growth Factor-beta,1262.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Stress-induced-phosphoprotein 1,44298.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Stromal cell-derived factor 1,6163,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Stromelysin-1,643.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Stromelysin-2,535.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,SUMO-conjugating enzyme UBC9,13120.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Superoxide dismutase [Cu-Zn],3204.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",40325,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Synaptosomal-associated protein 25,1328.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Syntaxin-1A,371.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,5532.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,TATA-box-binding protein,1366.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,T-cell surface glycoprotein CD4,416.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tenascin,10260.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,406.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Testican-1,10214.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Testican-2,711.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,TGF-beta receptor type-2,1006.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thioredoxin domain-containing protein 12,3411.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thrombin,737.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thrombopoietin,686.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thrombopoietin Receptor,210.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thrombospondin-1,21811.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thrombospondin-2,6757.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thrombospondin-4,444.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thymic stromal lymphopoietin,806.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Thymidine kinase, cytosolic",432.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thymidylate synthase,305.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thyroglobulin,298.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thyroid peroxidase,2053.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thyroid Stimulating Hormone,472.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Thyroxine-binding globulin,33212.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tissue Factor,781.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tissue factor pathway inhibitor,60985.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tissue-type plasminogen activator,652.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,T-lymphocyte activation antigen CD80,475.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,T-lymphocyte activation antigen CD86,584.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,1300.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Toll-like receptor 2,479.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Toll-like receptor 4,232.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,2962,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transcription factor AP-1,9780.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,2829.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transforming growth factor beta-1,2149,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transforming growth factor beta-2,291.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transforming growth factor beta-3,346.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,19541.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transforming growth factor beta receptor type 3,19129.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transgelin-2,19968.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transketolase,182199.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Translationally-controlled tumor protein,85002.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Transmembrane glycoprotein NMB,3453.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Trefoil factor 1,1521.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Trefoil factor 2,4869.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Trefoil factor 3,5692.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Triosephosphate isomerase,53123.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tropomyosin alpha-1 chain,924.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tropomyosin alpha-4 chain,274075.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tropomyosin beta chain,1221.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Troponin I, cardiac muscle",374.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Troponin I, fast skeletal muscle",2605.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Troponin T, cardiac muscle",3939.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Trypsin-1,6204.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Trypsin-2,1967.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Trypsin-3,298.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tryptase beta-2,2713.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tryptase gamma,298.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor-associated calcium signal transducer 2,671.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor,351.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,821.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,337.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,537,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,1047.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,757.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,832,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,561.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,310.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",448.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,1521.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,335.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1344,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,421.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,982.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1948.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,9241.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,176.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,969.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,3399.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,472.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,4448.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,560.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,707.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,1038.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,1124.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,9063.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,4765.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,950.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,3520.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,557.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,1219.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,497.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,816.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,285.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,4385.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase ABL1,121.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase BTK,72750.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase CSK,72622.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase Fer,15726.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase Fgr,1726.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase Fyn,45591.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase HCK,130.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase JAK2,91307.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase Lck,693.9,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase Lyn,46348.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",132848.1,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",5862.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,352.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase Tec,15534.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,310.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase Yes,2414.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,9698.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,11530.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,27726.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,294.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,29126.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,2703.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",18367.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin,3940.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1769.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,4886,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,6943,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,5910.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,38071,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin-fold modifier 1,16275.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,47619.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Ubiquitin-like protein ISG15,4496.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,UMP-CMP kinase,6669.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Urokinase plasminogen activator surface receptor,4711.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Urokinase-type plasminogen activator,969.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,127843.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vascular cell adhesion protein 1,10670.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vascular endothelial growth factor A,9126.6,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",957.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vascular endothelial growth factor C,3475.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vascular endothelial growth factor D,289.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vascular endothelial growth factor receptor 2,6563.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vascular endothelial growth factor receptor 3,5805.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vasoactive Intestinal Peptide,840.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vesicular integral-membrane protein VIP36,16480.8,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vitamin K-dependent protein C,2279.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vitamin K-dependent protein S,4404.2,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Vitronectin,24961.7,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,von Willebrand factor,9526.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,325.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",565.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2613.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,8214.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,1242.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Wnt inhibitory factor 1,1903.5,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,Xaa-Pro aminopeptidase 1,18962.3,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,955.4,RFU
BF-1051,PDYA912JPR,M0,0,Plasma,X-ray repair cross-complementing protein 6,722.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,160348.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,14-3-3 protein epsilon,1035,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,14-3-3 protein family,34973.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,14-3-3 protein sigma,1348.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,14-3-3 protein theta,3518.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,328131.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],3443.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",500.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,707.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,534.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,296.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,10424.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",10447,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",1640.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,8651.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,40S ribosomal protein S3,4021.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,40S ribosomal protein S3a,2737.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,40S ribosomal protein S7,9131.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,40S ribosomal protein SA,1990.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",87152.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",102928.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,72 kDa type IV collagenase,5408.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1774.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,271,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,9843.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Activated Protein C,864.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Activin receptor type-1B,770.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Adapter molecule crk,36175.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,102708.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Adenylosuccinate lyase,12711.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,603.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,687.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Adiponectin,1161.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2482.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,413.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,605.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,127.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,330.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,458.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,4171.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Adrenomedullin,3804.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",404.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Afamin,31530.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,35366.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Aggrecan core protein,629.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Agouti-related protein,1354.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,AH receptor-interacting protein,23427.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alanine aminotransferase 1,11250.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],17224.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Allograft inflammatory factor 1,8842.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",3792.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,319838.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,9672.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-1-antitrypsin,1752.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-2-antiplasmin,1807.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1722.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-2-macroglobulin,5224.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,1690,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-enolase,234179,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,alpha-Fetoprotein,998,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-L-iduronidase,2389.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,39158.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Alpha-synuclein,16307.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Aminoacylase-1,7906.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Amphiregulin,13896.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Amphoterin-induced protein 2,2378.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),523.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),30368.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Amyloid beta A4 protein,99847,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiogenin,2704.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiopoietin-1,2705.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",1771.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiopoietin-2,101,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiopoietin-4,824.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiopoietin-related protein 3,498.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiopoietin-related protein 4,4491.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiostatin,13662.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,873.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Angiotensinogen,4393.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ankyrin-2,452,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Annexin A1,34319.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Annexin A2,39340.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Annexin A5,882.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Annexin A6,16696.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,847.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Antileukoproteinase,18772,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Antithrombin-III,139137.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein A-I,13427.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein B,3723.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein D,4705,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein E,50525.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),322202.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),251220.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),310319.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein L1,44881.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apolipoprotein M,7041.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,3505.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Appetite-regulating hormone,921,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Arginase-1,856.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,334.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Artemin,441.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Arylsulfatase A,1515.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Arylsulfatase B,1107.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1225.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",4040.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,15249.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",4313.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",13026.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Atrial natriuretic factor,915.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,1799.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Aurora kinase A,1072.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Aurora kinase B,528.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Azurocidin,683.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,2096.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,227,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,444.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,89.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1015,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Basigin,627.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,1468.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,B-cell receptor CD22,1106.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,42674.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bcl-2-like protein 1,2522.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bcl-2-like protein 2,698.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bcl-2-related protein A1,2078.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,718.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Beta-2-microglobulin,1457,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,41322.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,7005.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Betacellulin,778.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Beta-endorphin,628.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,beta-nerve growth factor,331.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,BH3-interacting domain death agonist,4148.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Biglycan,2435.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,550.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1152.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bone morphogenetic protein 1,2472.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bone morphogenetic protein 6,8811.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bone morphogenetic protein 7,745.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,341.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,441.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Bone sialoprotein 2,3158.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,1762.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Brain natriuretic peptide 32,456,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Brain-specific serine protease 4,789,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1515.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Brevican core protein,1109,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Brother of CDO,898.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C3a anaphylatoxin,460,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,223425.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C5a anaphylatoxin,7649.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cadherin-12,1728.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cadherin-15,4606.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cadherin-1,62930.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cadherin-2,1487.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cadherin-3,21428.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cadherin-5,5879.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cadherin-6,638.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcineurin,9435.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcineurin subunit B type 1,15133.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",1567.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,1923.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,7977.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1894.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,4532.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,12992.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,38844.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,503.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calpain I,211527.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calpastatin,6719.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Calreticulin,2031.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,4637.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,9574.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1491.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,4048.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,496.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,241.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase 1,12027.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase 13,11710.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase 2,221.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase 3,1771.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase 4,1285.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase 6,5732.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase 7,269.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase 9,938.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,459.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carboxypeptidase B2,11432.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Carboxypeptidase E,1447.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cardiotrophin-1,675.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,1700.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,45596.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Casein kinase II subunit alpha,1039,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Caspase-10,6908.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Caspase-2,380.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Caspase-3,72194.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Catalase,30731.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin B,3321.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin D,900.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin E,394.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin F,3032.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin G,1136.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin H,592.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin L2,848.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin S,800.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cathepsin Z,3731.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,34098.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,1761.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 1,1817.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 13,1508,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 14,4709.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 15,2932.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 16,26940.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 17,3943,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 18,9297.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 19,233.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 20,360.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 21,19620.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 22,1143.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 23,1975.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 24,306.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 25,813.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 26,1294,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 2,626.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 27,1268,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 28,9938.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 3,932.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,1371.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 4-like,470.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 5,146271.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 7,914.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-C motif chemokine 8,203.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD109 antigen,2414.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD166 antigen,9312.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD177 antigen,843.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD209 antigen,956.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD226 antigen,1139.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD27 antigen,8111.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD40 ligand,719.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD48 antigen,562.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD59 glycoprotein,1378,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD5 antigen-like,3353.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD63 antigen,986.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD70 antigen,216.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD83 antigen,234.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CD97 antigen,1235.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cell adhesion molecule 1,1242.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cell adhesion molecule 3,1522.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5141.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,801.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cellular tumor antigen p53,1443.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,2798.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",16569.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",2161.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",80326,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Chitinase-3-like protein 1,10184.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Chitotriosidase-1,1634,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,36551.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Choline/ethanolamine kinase,7442.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Chordin-like protein 1,1412.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,9245,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Chromobox protein homolog 5,355.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Chromogranin-A,4122.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Chymase,2425,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ciliary neurotrophic factor,147.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,4167.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ck-beta-8-1,29236.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Clusterin,1772.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,CMRF35-like molecule 6,3054,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coactosin-like protein,4090.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coagulation factor IX,12182.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coagulation factor IXab,8736.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coagulation Factor V,35723.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coagulation factor VII,625.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coagulation Factor X,5167.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coagulation factor Xa,4554.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coagulation Factor XI,1662.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cofilin-1,13402.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,2085.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,692.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,914.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Collagenase 3,633.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Collectin-11,6675.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Collectin-12,1126.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,COMM domain-containing protein 7,6910.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C1q subcomponent,32922.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C1r subcomponent,1534.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C2,2451.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C3,66313.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C3b,7789.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Complement C3b, inactivated",8933.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C3d fragment,10222,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C4,157252.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C4b,255.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C5,7595.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement C5b-C6 complex,559.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",7102.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement component C1q receptor,6504.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement component C6,84311.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement component C7,1108.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement component C8,1836.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement component C9,79024.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement decay-accelerating factor,12968.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement factor B,30147.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement factor D,987.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement factor H,64926.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement factor H-related protein 5,2324.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Complement factor I,40559.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Connective tissue-activating peptide III,132840.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Connective tissue growth factor,4791.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Contactin-1,376.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Contactin-2,502.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Contactin-4,2716.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Contactin-5,444,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Copine-1,28163.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Corticosteroid-binding globulin,815.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Corticotropin,447.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-reactive protein,23659.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Creatine kinase B-type,489.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Creatine kinase M-type,627.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,664,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cryptic protein,7282.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,49045.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,143.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,60005,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,1074.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-type mannose receptor 2,2016.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-X-C motif chemokine 10,1706.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-X-C motif chemokine 11,10574,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-X-C motif chemokine 13,1413.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-X-C motif chemokine 16,9260.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-X-C motif chemokine 5,837.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-X-C motif chemokine 6,2654.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,C-X-C motif chemokine 9,372.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,1094.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,231.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,961.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,3955.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,2581.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cystatin-C,1720.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cystatin-D,4834.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cystatin-F,666.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cystatin-M,7424.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cystatin-S,118.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cystatin-SA,7896.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cystatin-SN,716.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,9419.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,390.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,2200.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytochrome c,2050.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytochrome P450 3A4,68812.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,14816.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,366.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,2667.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,3520.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,404.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,16845.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,1871.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,1942.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,54.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,11586.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,D-dimer,13399.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Death-associated protein kinase 2,5777.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Decorin,4014.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Delta-like protein 1,1640.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Delta-like protein 4,532.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dermatopontin,2946.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Desert hedgehog protein N-product,2123.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Desmocollin-2,2402,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Desmocollin-3,276.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Desmoglein-1,2551,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",5034.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dickkopf-like protein 1,6384.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dickkopf-related protein 1,61595.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dickkopf-related protein 3,4053.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dickkopf-related protein 4,13628.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,415.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,2443.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1721.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,473.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1006.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,3724.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,1543.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,DNA topoisomerase 1,6777.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,791,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Drebrin-like protein,10486.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",9637.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,495.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1801.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,6272.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,40781.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,14696.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2050.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dynactin subunit 2,1432.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",432.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,14923.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,1318.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,5933.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,280,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,1113.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,350.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",1010.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1488.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1405,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,4154.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,3231.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1370.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Elafin,12147.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Elongation factor 1-beta,2075.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Endoglin,1115.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,122181.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,7245.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Endostatin,47571.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,6903.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,985.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,4022.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,13458.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Enteropeptidase,172.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Eotaxin,4674.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin-A2,703.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin-A3,1134,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin-A4,912,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin-A5,1584,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin-B1,3906.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin-B2,8439.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin-B3,1080,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin type-A receptor 10,279,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin type-A receptor 1,6325.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin type-A receptor 2,1397.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin type-A receptor 3,108.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin type-A receptor 5,643.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin type-B receptor 2,7128.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin type-B receptor 4,7637.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ephrin type-B receptor 6,1187.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Epidermal growth factor,2085.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Epidermal growth factor receptor,23499.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,2332.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,250.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Epiregulin,1652.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,498.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Erythropoietin,938.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Erythropoietin receptor,557,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,E-selectin,25234.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,4391.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Estrogen receptor,1142.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,1583.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,431.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,29688.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,53116.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,3222.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,81438.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Extracellular matrix protein 1,14524.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],418,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,FACT complex subunit SSRP1,2668.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",908,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",17600.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",3069.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fc receptor-like protein 3,355.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ferritin,18441.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fetuin-B,2589.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibrinogen,181519.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibrinogen gamma chain,64173.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 10,248.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 1,123.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 12,292.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 16,10525.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 17,181.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 18,194.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 19,3007.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 20,329.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 2,2924.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 23,361.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 4,347.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 5,500.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 6,1151.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 7,5130.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,1221.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,953.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor 9,352.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,533.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,230.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,790.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,1285.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibronectin,5301.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibronectin Fragment 3,1234,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fibronectin Fragment 4,38418.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ficolin-1,2057.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ficolin-2,931.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ficolin-3,249.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,356.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Focal adhesion kinase 1,333.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Follicle stimulating hormone,415.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Follistatin,1710.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Follistatin-related protein 1,25364.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Follistatin-related protein 3,3735,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,4870.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fractalkine,1569.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,224586.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,493.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,381.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galectin-10,463.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galectin-2,591.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galectin-3,16182.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galectin-3-binding protein,796.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galectin-4,1016.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galectin-7,1608.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galectin-8,389.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Galectin-9,1086.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Gamma-enolase,74528.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Gastrin-releasing peptide,269.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,GDNF family receptor alpha-1,703.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,GDNF family receptor alpha-2,5030.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,GDNF family receptor alpha-3,841.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Gelsolin,1151.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glia-derived nexin,3256.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,352.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glial fibrillary acidic protein,790.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glucagon,2185.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glucocorticoid receptor,217.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glucokinase regulatory protein,481.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,80044.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,414.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glutathione S-transferase A3,169.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glutathione S-transferase P,8035.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,354560.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1885.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,64800.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,10613.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glypican-2,190.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glypican-3,405.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glypican-5,1001.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Glypican-6,3173.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",598.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Granulins,19626.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1007.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,941.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,435.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Granulysin,8326,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Granzyme A,2778.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Granzyme B,1366.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Granzyme H,229,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,GRB2-related adapter protein 2,397.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Gremlin-1,618.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Gro-beta/gamma,3815.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,575.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,252.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth arrest-specific protein 1,604.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth/differentiation factor 11,639.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,1138.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth/differentiation factor 15,1166.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth/differentiation factor 2,1311.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth/differentiation factor 5,2440.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth/differentiation factor 8,2435.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth/differentiation factor 9,695.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,150404.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth hormone receptor,1052.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Growth-regulated alpha protein,22506.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,GTPase KRas,728.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,25101.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Haptoglobin,56298.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,5591.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,5091.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heat shock protein beta-1,16323.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,47023.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,158156.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heme oxygenase 2,698.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,HemK methyltransferase family member 2,15013.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hemoglobin,1511.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hemojuvelin,1022.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hemopexin,894.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2261.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,520.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heparin cofactor 2,3681.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,6229.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hepatocyte growth factor,1310.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hepatocyte growth factor activator,2050.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,839.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,6103.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,1630.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hepcidin,10976.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,1654.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,9523.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,171.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,4977.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,47572.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hexokinase-1,1159.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hexokinase-2,2475,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",488.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",243,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,354.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,3884.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,High mobility group protein B1,40335.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histidine-rich glycoprotein,5089.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,4650.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1324,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,721.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone deacetylase 8,3671.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone H1.2,45349.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone H2A type 3,14682.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone H2A.z,8592,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone H2B type 2-E,70779.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone H3.1,3953.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,481.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Homeobox protein NANOG,120.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,415.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,1057,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,455.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,1001,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,419.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,ICOS ligand,12586.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Iduronate 2-sulfatase,3640.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Immunoglobulin A,4540,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,172.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Immunoglobulin D,7358.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Immunoglobulin E,3222.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Immunoglobulin G,182046.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Immunoglobulin M,1519.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2864,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Importin subunit alpha-1,203.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Importin subunit beta-1,38397.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1121.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Inducible T-cell costimulator,1597.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Inhibin beta A chain,2869.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,522.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Inhibitor of growth protein 1,65037.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Inorganic pyrophosphatase,74179.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,6818.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,7332.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin,143.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-degrading enzyme,4057,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,3371.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,626.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,479.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,1874.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,5196.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,2119.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,592.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,34538.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin-like growth factor I,1992.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Insulin receptor,5735.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,8093.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,2628.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,788.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,37691.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,2981,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,4246.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,694.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,622.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon alpha-10,250.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon alpha-2,157.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon alpha-7,194.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,1282,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon beta,474.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon gamma,589,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon gamma receptor 1,272.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon gamma receptor 2,382.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon lambda-1,740.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon lambda-2,173.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interferon regulatory factor 1,2234.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-10,146.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1497.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,985.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-11,429,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-12,245.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,424.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,868.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-13,805,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,1264.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,906.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-16,619.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-17A,366.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-17B,141,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-17D,218.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-17F,441.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-17 receptor A,880.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-17 receptor B,692.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-17 receptor C,609.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-17 receptor D,338.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-18-binding protein,4365.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-18 receptor 1,5414.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,369.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-19,4002.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-1 alpha,1602.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-1 beta,2259.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,22597.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,4337,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,4242.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,804.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,5093.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,9303.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-20,337.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,269.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-2,1793.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-22,1415.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,1100.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,1332.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-23,874.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-23 receptor,5375.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-24,330,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-25,210.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-27,643.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,1065.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,1075.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-3,1571.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-34,450.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-36 alpha,1375.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-36 beta,406.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-37,1804.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,4022.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-4,805.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,133,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-5,189.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,1051.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-6,677.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,8932,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,4280.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-7,149.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,316.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-8,817.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interleukin-9,253.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Interstitial collagenase,10345,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Junctional adhesion molecule B,10400.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Junctional adhesion molecule C,19420.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Junctional adhesion molecule-like,508.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-11,1220.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-12,3880.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-13,1126.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-14,12930.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-4,314.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-5,130.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-6,2024.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-7,1294.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallikrein-8,2352,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kallistatin,29254.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,456.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",1765.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,3573.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,265.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,535.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,350.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kinesin-like protein KIF23,3529.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kininogen-1,24628.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,338.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kremen protein 2,9945.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,2505.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,1988.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Kynureninase,1274.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lactadherin,337.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lactoperoxidase,454.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lactotransferrin,48233.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lamin-B1,1195.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Laminin,3234.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1164.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Layilin,1092.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Legumain,4857.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leptin,2675,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leptin receptor,1046,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,2961.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,4050.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,3905.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,81.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,142.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,2533.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,8737.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,4276.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,2274.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3444.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,6138.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,2171.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,827.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,180.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Limbic system-associated membrane protein,924.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,65688.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lithostathine-1-alpha,261.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,4389.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,3093.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,65,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,1366.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1424.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Low-density lipoprotein receptor,114.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,34531.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",1629.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,2039.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,10626.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,L-Selectin,4098.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lumican,1237.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Luteinizing hormone,2718.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,1186.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,413.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,6093.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lymphocyte antigen 86,10485.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lymphotactin,347.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,85.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,1432.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lymphotoxin-alpha,517.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lysosomal protective protein,14204.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lysosome membrane protein 2,359,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Lysozyme C,94784.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Macrophage-capping protein,947.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1252.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,190.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Macrophage mannose receptor 1,8580,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Macrophage metalloelastase,499.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,3812,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,1021.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,463.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",98825.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mammaglobin-B,19046.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,3725.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mannose-binding protein C,8032.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,32226.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,6936.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,1114.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,9510.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Matrilin-2,5741.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Matrilin-3,434.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Matrilysin,1502.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,219,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Matrix metalloproteinase-14,567.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Matrix metalloproteinase-16,1012.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Matrix metalloproteinase-17,880.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Matrix metalloproteinase-9,5248.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,61839.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,436.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,1915.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Membrane frizzled-related protein,4282.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,1228.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mesothelin,710.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,86.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,393.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,4873.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Methionine aminopeptidase 1,10501.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Methionine aminopeptidase 2,102925.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,642.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,195.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,647.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Microtubule-associated protein tau,189.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Midkine,36680.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,767.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,680.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,420.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,2755,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,37054.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,955.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,11637.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,125087.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,5942.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,576,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,9208.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Moesin,4974.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,82902.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,47448,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Mucin-1,770.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Muellerian-inhibiting factor,8446.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Myc proto-oncogene protein,423.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Myeloblastin,3347.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,1979.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Myeloperoxidase,16287.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Myoglobin,908.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",1064,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,3021,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,3535.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,8394.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,22766,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,4942.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,18290.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,1580.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,335.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,432.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,219.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Netrin-1,336.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Netrin-4,923.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Netrin receptor UNC5C,2795.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Netrin receptor UNC5D,1810.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",7856.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,312.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,7318.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neuregulin-1,160.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neuregulin-4,761,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neurexin-1-beta,387.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neurexin-3-beta,529.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neurexophilin-1,7428.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1048,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,16653.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,532.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,449.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",571.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,4111,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neuronal growth regulator 1,2238.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neuropilin-1,2717.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neurotrophin-3,164.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neurotrophin-4,153.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neutral ceramidase,1622.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,40882,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neutrophil collagenase,2784.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neutrophil elastase,463.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,15047.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,531.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Nidogen-1,4725.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Nidogen-2,3553.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NKG2D ligand 1,457.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NKG2D ligand 2,291.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NKG2D ligand 3,2108.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,696.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Noggin,4432.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,4774.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,8304.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NSFL1 cofactor p47,2975.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NT-3 growth factor receptor,3274.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,N-terminal pro-BNP,1754.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,575.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,2661.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,91538.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,NudC domain-containing protein 3,908.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,OCIA domain-containing protein 1,1130.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Olfactomedin-4,201.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Oncostatin-M,1422.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,5819.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Osteocalcin,3010.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Osteomodulin,5955.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Osteopontin,3584.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,1980.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,1420.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pancreatic hormone,2581.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pappalysin-1,10704,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Parathyroid hormone,2548.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Parathyroid hormone-related protein,754.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peptide YY,1689.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,309.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,331251.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,2967.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,82489,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,4508.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",133497.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Periostin,2169.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peroxiredoxin-1,10301.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",469.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peroxiredoxin-6,2194,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,245.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Persephin,372.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3725.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pescadillo homolog,537.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,27980.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1275.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",3061.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Phosphoglucomutase-1,483.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,11756.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,5684.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Phospholipase A2,683.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",1536.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pigment epithelium-derived factor,43286.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,PIK3CA/PIK3R1,1379.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,PILR alpha-associated neural protein,1706.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,220.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,158.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Placenta growth factor,258.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Plasma kallikrein,20837.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,6479.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Plasma serine protease inhibitor,74619.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Plasmin,726.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Plasminogen,3354,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,4383.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,1144.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,15750.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet-derived growth factor C,314.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,1155.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,2321.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,45112.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,126961.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,1004,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet factor 4,254522.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet glycoprotein 4,10082.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,2173.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet glycoprotein VI,45400,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Platelet receptor Gi24,849.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pleiotrophin,1534.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Plexin-B2,3045.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Plexin-C1,580.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,2566.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,2681.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,5304.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Prefoldin subunit 5,491,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,718.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,4989.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Prokineticin-1,433.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Prolactin,1681.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Prolactin receptor,1118.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,194.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,10843.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,558.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pro-opiomelanocortin,596.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Properdin,142871.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,1606.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,685.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,1808.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Prostate-specific antigen,1795.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,6242,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,296.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,949,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,830.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,3159.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein 4.1,39516,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein amnionless,105.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein deglycase DJ-1,482.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein disulfide-isomerase,164.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,16480.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein E7_HPV16,313.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein E7_HPV18,1518.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein FAM107A,211.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein FAM107B,3507.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein FAM3B,869.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein FAM3D,4449.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,406.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein jagged-1,458.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein jagged-2,267.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein kinase C alpha type,183021.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),67314.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein kinase C delta type,19369.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein kinase C gamma type,517.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein kinase C iota type,9066.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein kinase C theta type,13484.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein kinase C zeta type,2299.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein lin-7 homolog B,573,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein NOV homolog,854.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein Rev_HV2BE,125,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein S100-A12,1035.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein S100-A4,2858,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein S100-A6,7962.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein S100-A7,304.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein S100-A9,11425.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein SET,822,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,236.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein Wnt-7a,169.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,2299.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Prothrombin,206874.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,761.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,138549.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Proto-oncogene vav,87793.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,P-selectin,49329.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,132268.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pyridoxal kinase,838.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,17331.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",2656.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Pyruvate kinase PKM,225718.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,2374.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,84667.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,32320.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,53025.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,2398.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,154555.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,23492.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,13166.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,437.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,258.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,129.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,1181.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Relaxin receptor 1,448.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Renin,1067.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Repulsive guidance molecule A,18380,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Resistin,929.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Reticulon-4 receptor,1180.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1378.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,1955.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Retinol-binding protein 4,258.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,RGM domain family member B,1398.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ribonuclease H1,462.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,4831.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,683.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,51847.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,RNA-binding protein 39,1081.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Roundabout homolog 2,2246.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Roundabout homolog 3,309.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,R-spondin-2,642.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,R-spondin-3,1038,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,R-spondin-4,282.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Scavenger receptor class F member 1,21986.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Scavenger receptor class F member 2,304,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2895.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sclerostin,10926,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,1609.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,4089.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,2809.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Secretin,193.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Seizure 6-like protein 2,4690,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Semaphorin-3A,2084.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Semaphorin-3E,1064.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Semaphorin-5A,3056.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Semaphorin-6A,7370,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Semaphorin-6B,2758.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine protease 27,6720.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",14292.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,1950.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,14816.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,562.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,170.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,1768.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,765.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,33606.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,780.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,753.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,158.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1864.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,383.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,6673.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serotransferrin,281781.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serum albumin,9490.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serum amyloid A-1 protein,434.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serum amyloid P-component,38910.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,252.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sex hormone-binding globulin,1312.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,S-formylglutathione hydrolase,2800.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,6218.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SHC-transforming protein 1,55924.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,8372.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,139.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1234.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,10849.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sialoadhesin,108.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,41781.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,12944.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,1848.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SLAM family member 5,15814.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SLAM family member 6,301.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SLAM family member 7,25207.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1905,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,1189.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,18954.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,3000.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,15261.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Somatostatin-28,1415.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Somatotropin,217.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sonic hedgehog protein,788.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sorting nexin-4,65132.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SPARC,100846.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SPARC-like protein 1,7100.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,2801.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",169.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,11452.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sphingosine kinase 1,70385.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Sphingosine kinase 2,595.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Spondin-1,1173,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Stabilin-2,743.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Stanniocalcin-1,1862.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Stem cell growth factor-alpha,3512,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,1372.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,46097.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Stromal cell-derived factor 1,6851.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Stromelysin-1,1909,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Stromelysin-2,575.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,12493.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],3275,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",43249.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,1160.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Syntaxin-1A,375.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,5224.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,TATA-box-binding protein,1378.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,415.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tenascin,11046.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,465,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Testican-1,12796.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Testican-2,670.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,TGF-beta receptor type-2,804.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,3796.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thrombin,879.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thrombopoietin,756,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thrombopoietin Receptor,217,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thrombospondin-1,22830.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thrombospondin-2,5782.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thrombospondin-4,409.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,820.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",447.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thymidylate synthase,299.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thyroglobulin,301.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thyroid peroxidase,1950.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,559.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Thyroxine-binding globulin,35090.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tissue Factor,925.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,60994.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tissue-type plasminogen activator,569.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,470,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,683.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,2342.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Toll-like receptor 2,560.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Toll-like receptor 4,246.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,2833.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transcription factor AP-1,7075,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,2410.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transforming growth factor beta-1,2144.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transforming growth factor beta-2,339.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transforming growth factor beta-3,365.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,20099.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,19697.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transgelin-2,21533.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transketolase,194288.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Translationally-controlled tumor protein,88201.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,3364.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Trefoil factor 1,2121.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Trefoil factor 2,5977.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Trefoil factor 3,6253.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Triosephosphate isomerase,54756.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,888.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,310581,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tropomyosin beta chain,1204.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",354.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",2849.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",3172.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Trypsin-1,5940.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Trypsin-2,2365.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Trypsin-3,296.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tryptase beta-2,2630.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tryptase gamma,307.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,629.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor,330.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,782.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,305.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,591.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,1237.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,875.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,882,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,573.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,317.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",546.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,1682.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,334,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1266.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,404.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,913.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1454.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,8674.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,178.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,879.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,3519.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,425.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,4534.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,607.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,721.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,1099.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,1094.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,9300.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,4770.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,781.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,3467.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,508.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,1076.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,476.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,861.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,283.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,5783.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,125.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,85194.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,82975.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,17981.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,2092.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,61609.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,122.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,107837.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,641.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,66029.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",167694.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",6264.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,372.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,18486,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,294.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,2657.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,8576.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,12132.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,38122.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,291.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,39880.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,3114.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",16824.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin,3635.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1794.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,5022.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,7535.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,6052.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,37519.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,29240.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,59452.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,5697.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,UMP-CMP kinase,5611.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,4971.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,1017.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,137591.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,11296,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vascular endothelial growth factor A,9365.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",1029.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vascular endothelial growth factor C,3568.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vascular endothelial growth factor D,292.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,6685.8,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,5999.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,842,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,17345.7,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vitamin K-dependent protein C,2238.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vitamin K-dependent protein S,3997.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Vitronectin,28959.9,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,von Willebrand factor,6518.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,316.1,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",537.6,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2598.3,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,7749.4,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,1319.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Wnt inhibitory factor 1,2127,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,31959.2,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,961.5,RFU
BF-1051,PDYA912JPR,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,923,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,14-3-3 protein beta/alpha,139951.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,14-3-3 protein epsilon,830.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,14-3-3 protein family,33294.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,14-3-3 protein sigma,1264.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,14-3-3 protein theta,3345.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,14-3-3 protein zeta/delta,323516.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],3081,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",661.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,390.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,406.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,314.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,10631.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",11051.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",392,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,8363.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,40S ribosomal protein S3,1678.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,40S ribosomal protein S3a,1218.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,40S ribosomal protein S7,2156.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,40S ribosomal protein SA,1706.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",50845.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",96327.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,72 kDa type IV collagenase,5045.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Abelson tyrosine-protein kinase 2,1616.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,234.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,7984.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Activated Protein C,924.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Activin receptor type-1B,279.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Adapter molecule crk,21448.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Adenylate kinase isoenzyme 1,83670.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Adenylosuccinate lyase,2185.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Adhesion G protein-coupled receptor E2,588.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Adhesion G-protein coupled receptor G5,796.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Adiponectin,1522.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2678.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,450.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,676,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,145.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,349.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,501.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,348.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Adrenomedullin,3450.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",273,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Afamin,34732.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,27702.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Aggrecan core protein,730,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Agouti-related protein,944.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,AH receptor-interacting protein,17986.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alanine aminotransferase 1,8874,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],17254.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Allograft inflammatory factor 1,6729.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",5024.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-1-antichymotrypsin,301343.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-1-antichymotrypsin complex,5775.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-1-antitrypsin,1842.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-2-antiplasmin,1711.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-2-HS-glycoprotein,1903.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-2-macroglobulin,6997.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,1746.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-enolase,206901.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,alpha-Fetoprotein,1009.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-L-iduronidase,2334.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-soluble NSF attachment protein,47553.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Alpha-synuclein,13589.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Aminoacylase-1,4998.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Amphiregulin,14163.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Amphoterin-induced protein 2,1604.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),544.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),31642,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Amyloid beta A4 protein,109802.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiogenin,2910.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiopoietin-1,3820.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",1558.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiopoietin-2,114.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiopoietin-4,922.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiopoietin-related protein 3,589.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiopoietin-related protein 4,4931.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiostatin,14217.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiotensin-converting enzyme 2,920.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Angiotensinogen,4517.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ankyrin-2,496.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Annexin A1,27010.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Annexin A2,9492.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Annexin A5,663.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Annexin A6,17695,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Anterior gradient protein 2 homolog,826.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Antileukoproteinase,23342.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Antithrombin-III,120768.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein A-I,18222.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein B,4209.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein D,4410.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein E,66624.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein E (isoform E2),336732.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein E (isoform E3),259420.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein E (isoform E4),341943.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein L1,38565.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apolipoprotein M,4681.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Apoptosis regulator Bcl-2,3759,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Appetite-regulating hormone,1044,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Arginase-1,994.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,278.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Artemin,465.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Arylsulfatase A,1952,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Arylsulfatase B,1180.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Asialoglycoprotein receptor 1,943,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",3577.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,14082.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",2419.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",18597.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Atrial natriuretic factor,974.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,1817.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Aurora kinase A,907.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Aurora kinase B,1460.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Azurocidin,748.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bactericidal permeability-increasing protein,1756.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,250.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,494.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,117,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Basal Cell Adhesion Molecule,1048.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Basigin,609.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,B-cell lymphoma 6 protein,1421.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,B-cell receptor CD22,1099.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bcl2-associated agonist of cell death,43056.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bcl-2-like protein 1,2232.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bcl-2-like protein 2,801.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bcl-2-related protein A1,1960.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,BDNF/NT-3 growth factors receptor,633.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Beta-2-microglobulin,1633.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,beta-adrenergic receptor kinase 1,38451.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Beta-Ala-His dipeptidase,5523.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Betacellulin,875.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Beta-endorphin,442.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,beta-nerve growth factor,403.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,BH3-interacting domain death agonist,3828.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Biglycan,1747.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,BMP-binding endothelial regulator protein,534.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bone morphogenetic protein 10,1157.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bone morphogenetic protein 1,2790.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bone morphogenetic protein 6,7763.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bone morphogenetic protein 7,592.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,407.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bone morphogenetic protein receptor type-2,410.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Bone sialoprotein 2,2287.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Brain-derived neurotrophic factor,2170.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Brain natriuretic peptide 32,551.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Brain-specific serine protease 4,815.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1379.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Brevican core protein,1262.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Brother of CDO,514.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C3a anaphylatoxin,382,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C3a anaphylatoxin des Arginine,205803.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C5a anaphylatoxin,7320.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cadherin-12,1684.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cadherin-1,46402.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cadherin-15,4037.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cadherin-2,2316.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cadherin-3,23408.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cadherin-5,8289.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cadherin-6,549,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcineurin,10214.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcineurin subunit B type 1,12234.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",1660.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,2035.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,9721.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2056.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,5443.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,16522.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,54290.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calcium-dependent phospholipase A2,558,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calpain I,187226.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calpastatin,5254.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Calreticulin,2121.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,2282.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,cAMP-regulated phosphoprotein 19,9434.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1280.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbohydrate sulfotransferase 15,3681.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbohydrate sulfotransferase 2,414.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbohydrate sulfotransferase 6,252,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase 13,7619.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase 1,9749,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase 2,243.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase 3,1146.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase 4,41598.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase 6,5074.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase 7,292.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase 9,1042.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carbonic anhydrase-related protein 10,496,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carboxypeptidase B2,10855.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Carboxypeptidase E,1196.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cardiotrophin-1,610.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,37451.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,859.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Casein kinase II subunit alpha,1013.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Caspase-10,6687.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Caspase-2,444.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Caspase-3,37599.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Catalase,27406.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin B,2223.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin D,1038.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin E,419.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin F,2626.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin G,1104.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin H,520.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin L2,676.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin S,703.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cathepsin Z,3920.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,26761.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CCAAT/enhancer-binding protein beta,1204.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 1,1696.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 13,626.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 14,3595.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 15,2421.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 16,31757.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 17,5063.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 18,4567.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 19,315.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 20,190,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 21,19012.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 22,1692.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 23,2309,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 24,366.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 25,1144.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 26,1238.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 27,1339.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 28,13350.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 2,900.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 3,806.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 3-like 1,1018.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 4-like,642.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 5,140075.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 7,808.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-C motif chemokine 8,207.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD109 antigen,1621.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD166 antigen,10430.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD177 antigen,245,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD209 antigen,1116.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD226 antigen,1136.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD27 antigen,7503.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD40 ligand,968.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD48 antigen,506,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD59 glycoprotein,1267.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD5 antigen-like,1430.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD63 antigen,865,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD70 antigen,248,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD83 antigen,257.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CD97 antigen,1157.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cell adhesion molecule 1,1057.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cell adhesion molecule 3,1465.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,3881.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,999.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cellular tumor antigen p53,1431.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cerebral dopamine neurotrophic factor,2780.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",13906,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",2412.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",68362.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Chitinase-3-like protein 1,5824.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Chitotriosidase-1,1491.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Chloride intracellular channel protein 1,31993.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Choline/ethanolamine kinase,6385.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Chordin-like protein 1,1402,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Chorionic somatomammotropin hormone,12169.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Chromobox protein homolog 5,348,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Chromogranin-A,37248.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Chymase,1093.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ciliary neurotrophic factor,169.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,3798.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ck-beta-8-1,31014.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Clusterin,1624.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,CMRF35-like molecule 6,3413.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coactosin-like protein,2840.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coagulation factor IX,12842.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coagulation factor IXab,9463,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coagulation Factor V,58306.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coagulation factor VII,689.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coagulation Factor X,5102.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coagulation factor Xa,4264.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coagulation Factor XI,1484.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cofilin-1,14117.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Coiled-coil domain-containing protein 80,1835.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Collagen alpha-1(VIII) chain,673.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Collagen alpha-1(XXIII) chain,898.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Collagenase 3,496.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Collectin-11,14208.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Collectin-12,1211.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,COMM domain-containing protein 7,6203,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C1q subcomponent,35712.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C1r subcomponent,1628.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C2,2719.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C3,65881,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C3b,4254.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Complement C3b, inactivated",6477.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C3d fragment,7199,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C4,127446.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C4b,116.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C5,6459.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement C5b-C6 complex,444.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",6780.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement component C1q receptor,7526.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement component C6,57984.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement component C7,1037,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement component C8,3498.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement component C9,70383.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement decay-accelerating factor,10617.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement factor B,28029,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement factor D,907.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement factor H,62829.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement factor H-related protein 5,2355.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Complement factor I,40283.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Connective tissue-activating peptide III,155358,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Connective tissue growth factor,4973.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Contactin-1,372.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Contactin-2,562.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Contactin-4,2661.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Contactin-5,506.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Copine-1,26124.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Corticosteroid-binding globulin,851.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Corticotropin,548.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-reactive protein,19081.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Creatine kinase B-type,536.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Creatine kinase M-type,425.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,321.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cryptic protein,5475,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-type lectin domain family 1 member B,58969.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-type lectin domain family 4 member K,166.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-type lectin domain family 4 member M,52563.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-type lectin domain family 7 member A,982.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-type mannose receptor 2,2035.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-X-C motif chemokine 10,1813.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-X-C motif chemokine 11,3126.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-X-C motif chemokine 13,2136.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-X-C motif chemokine 16,9328.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-X-C motif chemokine 5,546.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-X-C motif chemokine 6,2380.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,C-X-C motif chemokine 9,322.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,1672.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,270.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1089.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,3670.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,1190.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cystatin-C,2263.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cystatin-D,3626.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cystatin-F,909.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cystatin-M,7528.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cystatin-S,137.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cystatin-SA,18082.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cystatin-SN,1742,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cysteine and glycine-rich protein 3,9484.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cysteine-rich secretory protein 3,290.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,2385.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytochrome c,2265.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytochrome P450 3A4,64014.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytokine receptor common subunit gamma,15474.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,370.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytokine receptor-like factor 2,2656.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytoplasmic protein NCK1,3227.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,455.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytoskeleton-associated protein 2,15374.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytosolic non-specific dipeptidase,1982.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,7938.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,72.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,dCTP pyrophosphatase 1,6043.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,D-dimer,13839.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Death-associated protein kinase 2,7421.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Decorin,4254.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Delta-like protein 1,1676.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Delta-like protein 4,540.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dermatopontin,3344.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Desert hedgehog protein N-product,2196.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Desmocollin-2,1682.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Desmocollin-3,283.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Desmoglein-1,2545.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Diablo homolog, mitochondrial",3413.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dickkopf-like protein 1,4881.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dickkopf-related protein 1,62218.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dickkopf-related protein 3,4231.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dickkopf-related protein 4,14603.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dipeptidyl peptidase 1,467.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dipeptidyl peptidase 2,2687.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Discoidin domain-containing receptor 2,1723.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,545.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,928.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,DnaJ homolog subfamily B member 1,2929.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,DNA repair protein RAD51 homolog 1,1424.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,DNA topoisomerase 1,577.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Down syndrome cell adhesion molecule,777.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Drebrin-like protein,9724,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",12213.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,534.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2242.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,5452.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,40078,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dual specificity protein phosphatase 3,8810.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2108,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dynactin subunit 2,1387.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",324.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Dynein light chain roadblock-type 1,8459.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,820.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,4867.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,301.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,1050.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,433.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Ectodysplasin-A, secreted form",1032.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1519.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1396,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3501.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2613.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1625.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Elafin,7938.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Elongation factor 1-beta,2079.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Endoglin,728,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,17434.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Endoplasmic reticulum resident protein 29,6381.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Endostatin,61170.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Endothelial cell-selective adhesion molecule,7506,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Endothelial cell-specific molecule 1,893.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,3601,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Endothelin-converting enzyme 1,11022.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Enteropeptidase,220.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Eotaxin,6584.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin-A2,799.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin-A3,1260.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin-A4,946.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin-A5,1641.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin-B1,3481.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin-B2,5983.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin-B3,1284.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin type-A receptor 10,363.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin type-A receptor 1,5157.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin type-A receptor 2,1227.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin type-A receptor 3,111,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin type-A receptor 5,470.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin type-B receptor 2,8872.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin type-B receptor 4,6189.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ephrin type-B receptor 6,1396.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Epidermal growth factor,4234.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Epidermal growth factor receptor,20774.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,1787.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Epidermal growth factor receptor variant III,266.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Epiregulin,1564,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,514.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Erythropoietin,703.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Erythropoietin receptor,628.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,E-selectin,12243,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,1760.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Estrogen receptor,1043.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Eukaryotic initiation factor 4A-III,861.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,514.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,20167.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Eukaryotic translation initiation factor 4H,26432.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Eukaryotic translation initiation factor 5,3402.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,73025.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Extracellular matrix protein 1,16945.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],652.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,FACT complex subunit SSRP1,448,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Fatty acid-binding protein, epidermal",849.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Fatty acid-binding protein, heart",18702.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Fatty acid-binding protein, liver",2408.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fc receptor-like protein 3,404.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ferritin,31102.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fetuin-B,5458.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibrinogen,183623.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibrinogen gamma chain,65800.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 10,307.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 1,146.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 12,189.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 16,11662.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 17,197.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 18,320.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 19,6625.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 20,437.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 23,373.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 2,6238.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 4,392,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 5,535.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 6,1236,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 7,5560.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 8 isoform A,1358.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 8 isoform B,1129.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor 9,496.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor receptor 1,550.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor receptor 2,215.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor receptor 3,796.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibroblast growth factor receptor 4,1036,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibronectin,13406.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibronectin Fragment 3,2311.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fibronectin Fragment 4,51673.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ficolin-1,1569.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ficolin-2,1305.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ficolin-3,207.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,454.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Focal adhesion kinase 1,380.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Follicle stimulating hormone,932.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Follistatin,1559.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Follistatin-related protein 1,27971.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Follistatin-related protein 3,4869.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,15255.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fractalkine,1718.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Fructose-bisphosphate aldolase A,211726.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,G2/mitotic-specific cyclin-B1,418.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,359.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galectin-10,509.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galectin-2,687.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galectin-3,13315.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galectin-3-binding protein,603.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galectin-4,1126.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galectin-7,1704.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galectin-8,389.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Galectin-9,1428,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Gamma-enolase,38841.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Gastrin-releasing peptide,340.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,GDNF family receptor alpha-1,638.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,GDNF family receptor alpha-2,4562.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,GDNF family receptor alpha-3,1321.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Gelsolin,965.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glia-derived nexin,2835.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glial cell line-derived neurotrophic factor,308.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glial fibrillary acidic protein,496.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glucagon,1968.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glucocorticoid receptor,282.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glucokinase regulatory protein,510.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glucose-6-phosphate isomerase,66929.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glutamate carboxypeptidase 2,306,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glutathione S-transferase A3,143.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glutathione S-transferase P,5105.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,366692.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",822.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,57133.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,9793.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glypican-2,201.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glypican-3,517.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glypican-5,1244.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Glypican-6,2946.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"gp41 C34 peptide, HIV",556.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Granulins,18357.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Granulocyte colony-stimulating factor,1008.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,1269.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,410.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Granulysin,1658.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Granzyme A,1329,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Granzyme B,198.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Granzyme H,231.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,GRB2-related adapter protein 2,437,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Gremlin-1,680.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Gro-beta/gamma,4340.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Group 10 secretory phospholipase A2,616.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Group IIE secretory phospholipase A2,297.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth arrest-specific protein 1,539.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth/differentiation factor 11,695.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth/differentiation factor 11/8,1291.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth/differentiation factor 15,1369.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth/differentiation factor 2,1380.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth/differentiation factor 5,2288.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth/differentiation factor 8,2616.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth/differentiation factor 9,671.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth factor receptor-bound protein 2,118340.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth hormone receptor,1059.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Growth-regulated alpha protein,10081.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,GTPase KRas,1100.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,GTP-binding nuclear protein Ran,17373.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Haptoglobin,29435.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heat shock 70 kDa protein 1A,5886.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heat shock cognate 71 kDa protein,4030.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heat shock protein beta-1,13567.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,48164.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heat shock protein HSP 90-beta,153364.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heme oxygenase 2,726.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,HemK methyltransferase family member 2,15411.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hemoglobin,1878.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hemojuvelin,1171.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hemopexin,1502.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2033.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heparin-binding EGF-like growth factor,619.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heparin cofactor 2,3411.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hepatitis A virus cellular receptor 2,8247.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hepatocyte growth factor,1449.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hepatocyte growth factor activator,3749,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hepatocyte growth factor-like protein,7995.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hepatocyte growth factor receptor,5701.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,937.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hepcidin,16465.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,HERV-H LTR-associating protein 2,1138.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,4130.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,208.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,4373.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,9630.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hexokinase-1,1122.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hexokinase-2,889.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",459.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",276.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,545.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,High affinity nerve growth factor receptor,4661,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,High mobility group protein B1,10581.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histidine-rich glycoprotein,5135.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,4347.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone acetyltransferase KAT6A,1667.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,657.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone deacetylase 8,3344,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone H1.2,2105,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone H2A type 3,1459.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone H2A.z,2142.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone H2B type 2-E,16876.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone H3.1,2097.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,352,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Homeobox protein NANOG,144.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Homeodomain-interacting protein kinase 3,539,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hsp90 co-chaperone Cdc37,947.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Human Chorionic Gonadotropin,611.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,1036,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,616.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,ICOS ligand,7291.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Iduronate 2-sulfatase,2431.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Immunoglobulin A,2133.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Immunoglobulin alpha Fc receptor,202.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Immunoglobulin D,1254.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Immunoglobulin E,1859.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Immunoglobulin G,177171.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Immunoglobulin M,1654.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2435,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Importin subunit alpha-1,190,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Importin subunit beta-1,26393.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,696.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Inducible T-cell costimulator,1022.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Inhibin beta A chain,3370.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,606.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Inhibitor of growth protein 1,67922.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Inorganic pyrophosphatase,55413.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,3833.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,6160.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin,155,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-degrading enzyme,3609.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor 1 receptor,3141,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor-binding protein 1,588.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor-binding protein 2,406.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor-binding protein 3,1639,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor-binding protein 4,5984,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor-binding protein 5,1810.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor-binding protein 6,718.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor-binding protein 7,40166.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin-like growth factor I,1943,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Insulin receptor,3396.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Integrin alpha-I: beta-1 complex,7570.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,3596.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Integrin alpha-V: beta-5 complex,928.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,42601.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Intercellular adhesion molecule 1,3920.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Intercellular adhesion molecule 2,1906,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Intercellular adhesion molecule 3,801.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Intercellular adhesion molecule 5,340.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon alpha-10,255.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon alpha-2,132.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon alpha-7,192.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon alpha/beta receptor 1,944.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon beta,433.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon gamma,647.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon gamma receptor 1,289.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon gamma receptor 2,457.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon lambda-1,787.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon lambda-2,188.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interferon regulatory factor 1,1971.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-10,163,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1421.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-10 receptor subunit beta,1006.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-11,471.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-12,303.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,499.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,2149.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-13,879.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,1142.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-15 receptor subunit alpha,755.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-16,904.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-17A,445.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-17B,122.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-17D,243.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-17F,586.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-17 receptor A,900.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-17 receptor B,738.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-17 receptor C,654.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-17 receptor D,377.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-18-binding protein,3775.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-18 receptor 1,6333,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-18 receptor accessory protein,458.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-19,5053.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-1 alpha,812,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-1 beta,2947.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-1 Receptor accessory protein,28008.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-1 receptor antagonist protein,3808.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-1 receptor-like 1,2187.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-1 receptor-like 2,826.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-1 receptor type 1,3802.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-1 receptor type 2,6213,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-20,378.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-20 receptor subunit alpha,313.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-2,1527.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-22,1266.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,1083.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,993.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-23,1062.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-23 receptor,5829,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-24,338.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-25,248.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-27,619.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-27 receptor subunit alpha,1026.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-2 receptor subunit alpha,1091.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-3,1663.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-34,651.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-36 alpha,474.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-36 beta,454.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-37,1561.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-3 receptor subunit alpha,4549.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-4,838.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-4 receptor subunit alpha,259.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-5,188.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-5 receptor subunit alpha,1215.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-6,717,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-6 receptor subunit alpha,12133.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-6 receptor subunit beta,4024.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-7,195.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-7 receptor subunit alpha,280.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-8,813.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interleukin-9,395.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Interstitial collagenase,3467.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Junctional adhesion molecule B,10676.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Junctional adhesion molecule C,21359.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Junctional adhesion molecule-like,515,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-11,1159.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-12,3056.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-13,864.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-14,10673.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-4,369.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-5,133.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-6,1894.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-7,1054.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallikrein-8,1932.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kallistatin,38137.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kelch-like ECH-associated protein 1,406.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Keratin, type I cytoskeletal 18",1880.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,3171.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,297.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,620.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,395.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kinesin-like protein KIF23,3810.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kininogen-1,26894.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kin of IRRE-like protein 3,361.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kremen protein 2,9913.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kunitz-type protease inhibitor 1,2328.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kunitz-type protease inhibitor 2,1946.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Kynureninase,1403.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lactadherin,347.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lactoperoxidase,740.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lactotransferrin,34807.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lamin-B1,1696.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Laminin,4315.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,923.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Layilin,2716.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Legumain,4014.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leptin,10085.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leptin receptor,1447.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leucine carboxyl methyltransferase 1,2684.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,3502.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,3171.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,97.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,186.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,2911.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,8526.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,1873.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leukemia inhibitory factor receptor,1883.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3671.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,9440.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leukocyte surface antigen CD47,2268.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Leukotriene A-4 hydrolase,711.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,189.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Limbic system-associated membrane protein,979.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lipopolysaccharide-binding protein,64279,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lithostathine-1-alpha,229.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,L-lactate dehydrogenase B chain,4503.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,2826.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,1216.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,925.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1521.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Low-density lipoprotein receptor,127.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,37345.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",1388.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,1867,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,9171.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,L-Selectin,3502.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lumican,911.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Luteinizing hormone,3216.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,1048.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,326.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lymphocyte activation gene 3 protein,3649.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lymphocyte antigen 86,8975.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lymphotactin,388.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lymphotoxin alpha1:beta2,91.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lymphotoxin alpha2:beta1,1611.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lymphotoxin-alpha,540.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lysosomal protective protein,18374.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lysosome membrane protein 2,465.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Lysozyme C,83075.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Macrophage-capping protein,778.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Macrophage colony-stimulating factor 1,1793.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,154.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Macrophage mannose receptor 1,7119.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Macrophage metalloelastase,471.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Macrophage migration inhibitory factor,3486.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Macrophage scavenger receptor types I and II,991.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Macrophage-stimulating protein receptor,729.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",83042.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mammaglobin-B,16707.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mannan-binding lectin serine protease 1,3326,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mannose-binding protein C,7858,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,MAP kinase-activated protein kinase 2,27839.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,MAP kinase-activated protein kinase 3,7625,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,MAP kinase-activated protein kinase 5,1082.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,8386.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Matrilin-2,5510.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Matrilin-3,454.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Matrilysin,1455,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,240.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Matrix metalloproteinase-14,947.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Matrix metalloproteinase-16,605.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Matrix metalloproteinase-17,930.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Matrix metalloproteinase-9,10647.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,64438,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,459.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Melanoma-derived growth regulatory protein,2673,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Membrane frizzled-related protein,4352,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,1223.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mesothelin,764.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Metalloproteinase inhibitor 1,109.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Metalloproteinase inhibitor 2,418.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Metalloproteinase inhibitor 3,7038.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Methionine aminopeptidase 1,10621.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Methionine aminopeptidase 2,95508,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Methyl-CpG-binding domain protein 4,710.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,MHC class I polypeptide-related sequence A,132.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,MHC class I polypeptide-related sequence B,625.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Microtubule-associated protein tau,211.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Midkine,45935.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitochondrial glutamate carrier 2,815.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,850,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase 11,447.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase 12,2366.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase 13,451.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase 14,11589.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase 1,41517.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase 3,86201.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase 8,5627.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase 9,576.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,9915.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Moesin,5711.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mothers against decapentaplegic homolog 2,86510.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mothers against decapentaplegic homolog 3,47166,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Mucin-1,849.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Muellerian-inhibiting factor,8212.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Myc proto-oncogene protein,501.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Myeloblastin,2011.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Myeloid cell surface antigen CD33,1478.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Myeloperoxidase,11458.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Myoglobin,974.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Myosin-binding protein C, slow-type",1087.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,N-acetyl-D-glucosamine kinase,3463.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,1849.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,3289.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,12235.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NADPH--cytochrome P450 reductase,6618.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,14422.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,1540.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,373.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,469.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Natural killer cell receptor 2B4,249.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Netrin-1,436.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Netrin-4,869.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Netrin receptor UNC5C,2617.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Netrin receptor UNC5D,2532.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",8264.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neural cell adhesion molecule L1,260.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,7302.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neuregulin-1,156.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neuregulin-4,607.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neurexin-1-beta,410.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neurexin-3-beta,550,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neurexophilin-1,8564.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1042.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neurogenic locus notch homolog protein 1,16396.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neurogenic locus notch homolog protein 2,463.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neurogenic locus notch homolog protein 3,569.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Neuroligin-4, X-linked",556.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neuronal cell adhesion molecule,4766.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neuronal growth regulator 1,2692.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neuropilin-1,2170.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neurotrophin-3,201.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neurotrophin-4,180.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neutral ceramidase,2705.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neutrophil-activating peptide 2,46447.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neutrophil collagenase,1329.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neutrophil elastase,488.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,10604,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,1147.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Nidogen-1,7332.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Nidogen-2,4399.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NKG2D ligand 1,432.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NKG2D ligand 2,319.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NKG2D ligand 3,2381.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NKG2-D type II integral membrane protein,980.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Noggin,5371.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Non-histone chromosomal protein HMG-14,751.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,4802.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NSFL1 cofactor p47,1636.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NT-3 growth factor receptor,2922.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,N-terminal pro-BNP,4820.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,644.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Nucleoside diphosphate kinase A,2652.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Nucleoside diphosphate kinase B,74159.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,NudC domain-containing protein 3,840.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,OCIA domain-containing protein 1,1031.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Olfactomedin-4,212.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Oncostatin-M,1226.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,4587.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Osteocalcin,3350.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Osteomodulin,2720.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Osteopontin,2149,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,OX-2 membrane glycoprotein,1806,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,1154.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pancreatic hormone,1510.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pappalysin-1,10606,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Parathyroid hormone,2500,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Parathyroid hormone-related protein,681.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peptide YY,1446.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peptidoglycan recognition protein 1,644.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,305826.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,3371,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,91935.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,3524.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",83061.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Periostin,2078.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peroxiredoxin-1,10136.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",465.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peroxiredoxin-6,2020.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,255.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Persephin,260.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3205.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pescadillo homolog,379.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,25259.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",927.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2858.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Phosphoglucomutase-1,482.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Phosphoglycerate kinase 1,9735.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Phosphoglycerate mutase 1,13803.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Phospholipase A2,535.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Phospholipase A2, membrane associated",1753.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pigment epithelium-derived factor,52199.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,PIK3CA/PIK3R1,1198.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,PILR alpha-associated neural protein,2230.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,233.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,185.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Placenta growth factor,293.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Plasma kallikrein,21643.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Plasma protease C1 inhibitor,5943.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Plasma serine protease inhibitor,92234.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Plasmin,840.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Plasminogen,3507.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Plasminogen activator inhibitor 1,5319.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet-activating factor acetylhydrolase,1123.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,13731.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet-derived growth factor C,303.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet-derived growth factor receptor alpha,996.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet-derived growth factor receptor beta,4788.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet-derived growth factor subunit A,45622.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet-derived growth factor subunit B,133454.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet endothelial cell adhesion molecule,1008.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet factor 4,278974.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet glycoprotein 4,8010.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,2148.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet glycoprotein VI,63850.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Platelet receptor Gi24,928.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pleiotrophin,1578.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Plexin-B2,3666,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Plexin-C1,1726.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Polymeric immunoglobulin receptor,2318.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,PolyUbiquitin K48-linked,2350.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,PolyUbiquitin K63-linked,4658.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Prefoldin subunit 5,323.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Programmed cell death 1 ligand 1,1205,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Programmed cell death 1 ligand 2,5610.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Prokineticin-1,196.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Prolactin,974.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Prolactin receptor,1048.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proliferating cell nuclear antigen,245.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proliferation-associated protein 2G4,10398.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Prolyl endopeptidase FAP,537.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pro-opiomelanocortin,426.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Properdin,124669.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,1296.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,800.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Prostaglandin G/H synthase 2,579,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Prostate-specific antigen,2029.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proteasome activator complex subunit 1,4499.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proteasome activator complex subunit 3,352.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proteasome subunit alpha type-1,940.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proteasome subunit alpha type-2,481,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proteasome subunit alpha type-6,3480.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein 4.1,35072,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein amnionless,128.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein deglycase DJ-1,790.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein disulfide-isomerase,184.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein disulfide-isomerase A3,16925.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein E7_HPV16,358.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein E7_HPV18,1396.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein FAM107A,383.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein FAM107B,2970.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein FAM3B,624.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein FAM3D,2806.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,109,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein jagged-1,383.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein jagged-2,334.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein kinase C alpha type,165367.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),71111.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein kinase C delta type,21930.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein kinase C gamma type,512.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein kinase C iota type,11262,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein kinase C theta type,15573.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein kinase C zeta type,1986.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein lin-7 homolog B,512.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein NOV homolog,837.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein Rev_HV2BE,158.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein S100-A12,901.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein S100-A4,2308.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein S100-A6,6930.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein S100-A7,213.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein S100-A9,3449.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein SET,740,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein-tyrosine kinase 6,296.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein Wnt-7a,214.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Protein Z-dependent protease inhibitor,4557,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Prothrombin,217279.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,691.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,146977.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Proto-oncogene vav,96350.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,P-selectin,56497.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pulmonary surfactant-associated protein D,19273.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pyridoxal kinase,642.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pyridoxal phosphate phosphatase,19008.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",3282.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Pyruvate kinase PKM,246664.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Quinone oxidoreductase-like protein 1,2503.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Rab GDP dissociation inhibitor beta,75911.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,34154.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,54122.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ras GTPase-activating protein 1,1835.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,144885.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,21123,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,11157.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,432.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,246.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,155.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Regenerating islet-derived protein 4,908.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Relaxin receptor 1,477.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Renin,1066.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Repulsive guidance molecule A,17835.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Resistin,804.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Reticulon-4 receptor,1619.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Retinoblastoma-associated protein,1338.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Retinoic acid receptor responder protein 2,3329.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Retinol-binding protein 4,261.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,RGM domain family member B,1538.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ribonuclease H1,259.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,3235,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,744.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ribosome maturation protein SBDS,70885,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,RNA-binding protein 39,1062.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Roundabout homolog 2,2332.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Roundabout homolog 3,368.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,R-spondin-2,871.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,R-spondin-3,1303.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,R-spondin-4,262.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Scavenger receptor class F member 1,21508.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Scavenger receptor class F member 2,320.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2143.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sclerostin,12667.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Secreted and transmembrane protein 1,1282.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Secreted frizzled-related protein 1,4974.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Secreted frizzled-related protein 3,2784.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Secretin,234.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Seizure 6-like protein 2,4962.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Semaphorin-3A,2480.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Semaphorin-3E,2218.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Semaphorin-5A,19589.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Semaphorin-6A,5166.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Semaphorin-6B,1973.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine protease 27,5912.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",9621.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase 16,1530.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase 17B,5530.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase Chk1,544.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase Chk2,207.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1610.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,880.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,36249,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,801,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase pim-1,789.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase PLK1,223.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1893.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase TBK1,450,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serine/threonine-protein kinase WNK3,6552.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serotransferrin,242193.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serum albumin,7628.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serum amyloid A-1 protein,177.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serum amyloid P-component,40341,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Serum paraoxonase/arylesterase 1,238.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sex hormone-binding globulin,3579.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,S-formylglutathione hydrolase,2751.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SH2 domain-containing protein 1A,8030.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SHC-transforming protein 1,63582.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,9478,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,164,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1200.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,6937.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sialoadhesin,129.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,43713.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Signal transducer and activator of transcription 3,14617.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Signal transducer and activator of transcription 6,2057.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SLAM family member 5,11068.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SLAM family member 6,286,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SLAM family member 7,22605.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SLIT and NTRK-like protein 1,1931.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SLIT and NTRK-like protein 5,1034.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,12916.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Small nuclear ribonucleoprotein F,2517.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Small ubiquitin-related modifier 3,13949.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Somatostatin-28,1216.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Somatotropin,290.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sonic hedgehog protein,644.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sorting nexin-4,56912.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SPARC,91201.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SPARC-like protein 1,7872.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,2921.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",157.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,S-phase kinase-associated protein 1,12327.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sphingosine kinase 1,67837.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Sphingosine kinase 2,603.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Spondin-1,1384.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Stabilin-2,727,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Stanniocalcin-1,1625.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Stem cell growth factor-alpha,3829.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Stem Cell Growth Factor-beta,1470.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Stress-induced-phosphoprotein 1,44960,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Stromal cell-derived factor 1,5199.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Stromelysin-1,661.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Stromelysin-2,536.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,SUMO-conjugating enzyme UBC9,10303.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Superoxide dismutase [Cu-Zn],3219.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",41223.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Synaptosomal-associated protein 25,991.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Syntaxin-1A,310.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,6363.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,TATA-box-binding protein,428.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,T-cell surface glycoprotein CD4,483.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tenascin,8219.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,1845.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Testican-1,9440.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Testican-2,726.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,TGF-beta receptor type-2,918.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thioredoxin domain-containing protein 12,3165.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thrombin,669.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thrombopoietin,239.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thrombopoietin Receptor,302,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thrombospondin-1,26276.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thrombospondin-2,4367.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thrombospondin-4,400.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thymic stromal lymphopoietin,876.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Thymidine kinase, cytosolic",363.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thymidylate synthase,300.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thyroglobulin,525,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thyroid peroxidase,1638.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thyroid Stimulating Hormone,392.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Thyroxine-binding globulin,40298.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tissue Factor,898.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tissue factor pathway inhibitor,65400.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tissue-type plasminogen activator,687.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,T-lymphocyte activation antigen CD80,469.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,T-lymphocyte activation antigen CD86,606.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,988.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Toll-like receptor 2,465.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Toll-like receptor 4,234.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,2142,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transcription factor AP-1,6449,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,2322.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transforming growth factor beta-1,3111.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transforming growth factor beta-2,506.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transforming growth factor beta-3,422.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,28938.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transforming growth factor beta receptor type 3,23044.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transgelin-2,20107.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transketolase,180313.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Translationally-controlled tumor protein,78452.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Transmembrane glycoprotein NMB,2840.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Trefoil factor 1,3097.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Trefoil factor 2,5524.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Trefoil factor 3,8439.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Triosephosphate isomerase,50549.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tropomyosin alpha-1 chain,863.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tropomyosin alpha-4 chain,295606.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tropomyosin beta chain,2199.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Troponin I, cardiac muscle",353,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Troponin I, fast skeletal muscle",2014.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Troponin T, cardiac muscle",2747.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Trypsin-1,6309.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Trypsin-2,2675.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Trypsin-3,411.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tryptase beta-2,3714.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tryptase gamma,174,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor-associated calcium signal transducer 2,647.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor,424.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,585.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,356.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,699.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,1061.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,891.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,1256.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,583.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,362.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",428,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,1624,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,336.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1380.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,489.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,831.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1569.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,8443.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,191,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,860.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2915.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,461.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,4607.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,529.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,847.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,1336.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,1178.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,8841.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,5583.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,807.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,3254.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,561.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,1028.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,547.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,891,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,341,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,3053.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase ABL1,140.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase BTK,83741.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase CSK,76155,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase Fer,23298.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase Fgr,2009.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase Fyn,64625.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase HCK,153.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase JAK2,107032.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase Lck,455.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase Lyn,56097.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",161333.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",5452.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,475.6,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase Tec,23444.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,377.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase Yes,2397.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,6600.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,27199.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,14328.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,302.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,19770.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,832.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",13523.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin,3181.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,2414.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,5381.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,7642.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,6823.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,34940,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin-fold modifier 1,17069.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,55828.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Ubiquitin-like protein ISG15,5755,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,UMP-CMP kinase,5150.1,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Urokinase plasminogen activator surface receptor,4734.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Urokinase-type plasminogen activator,935.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,160738.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vascular cell adhesion protein 1,9218.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vascular endothelial growth factor A,10162.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",1339.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vascular endothelial growth factor C,3711,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vascular endothelial growth factor D,340.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vascular endothelial growth factor receptor 2,6272.9,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vascular endothelial growth factor receptor 3,3600.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vasoactive Intestinal Peptide,912.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vesicular integral-membrane protein VIP36,16559.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vitamin K-dependent protein C,2217.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vitamin K-dependent protein S,4298.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Vitronectin,55266.3,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,von Willebrand factor,12725,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,585.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",552.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",3095.8,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,6284.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,1214.2,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Wnt inhibitory factor 1,2046.5,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,Xaa-Pro aminopeptidase 1,17531.4,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,956.7,RFU
BF-1052,PDYV290XFK,M0,0,Plasma,X-ray repair cross-complementing protein 6,337.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,128014.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,14-3-3 protein epsilon,869.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,14-3-3 protein family,32969,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,14-3-3 protein sigma,1456.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,14-3-3 protein theta,3297.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,293238.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],3461.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",612.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,423.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,481.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,290.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,11851.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",13476.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",367.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,8010.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,40S ribosomal protein S3,3031.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,40S ribosomal protein S3a,1776.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,40S ribosomal protein S7,4088.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,40S ribosomal protein SA,1900.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",58842.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",98916.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,72 kDa type IV collagenase,4682.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1581.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,253.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,9622.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Activated Protein C,903.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Activin receptor type-1B,334.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Adapter molecule crk,25879.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,80764.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Adenylosuccinate lyase,9248.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,486.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,793.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Adiponectin,1510.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2487,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,411,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,664.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,130.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,333.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,469.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,320.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Adrenomedullin,3761.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",295.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Afamin,31289.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,29150.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Aggrecan core protein,724.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Agouti-related protein,948,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,AH receptor-interacting protein,20921.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alanine aminotransferase 1,11781.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],17021.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Allograft inflammatory factor 1,7928,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",5724.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,273211.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,10503.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-1-antitrypsin,2171,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-2-antiplasmin,1653.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1948.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-2-macroglobulin,7534.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,1881.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-enolase,191809,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,alpha-Fetoprotein,1119.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-L-iduronidase,2544.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,45503.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Alpha-synuclein,15838.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Aminoacylase-1,5404,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Amphiregulin,14225.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Amphoterin-induced protein 2,1673.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),528.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),29097.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Amyloid beta A4 protein,98695,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiogenin,3189.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiopoietin-1,3779.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",1568.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiopoietin-2,104.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiopoietin-4,889.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiopoietin-related protein 3,553.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiopoietin-related protein 4,4353.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiostatin,14027.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,911.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Angiotensinogen,4765.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ankyrin-2,468.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Annexin A1,30213.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Annexin A2,15485.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Annexin A5,699.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Annexin A6,17499.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,828.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Antileukoproteinase,22447.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Antithrombin-III,110845.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein A-I,16544.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein B,3486.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein D,3887.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein E,45737.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),311819.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),192553.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),273565.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein L1,38306,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apolipoprotein M,4459.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,3844.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Appetite-regulating hormone,1006.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Arginase-1,1036.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,293.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Artemin,419.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Arylsulfatase A,2168.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Arylsulfatase B,1202.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1001.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",4321.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,14854,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",3239.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",20572.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Atrial natriuretic factor,963.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,1886.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Aurora kinase A,892.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Aurora kinase B,1263.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Azurocidin,821.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,5853.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,247.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,442.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,109.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1046.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Basigin,676.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,1408.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,B-cell receptor CD22,1090.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,41530.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bcl-2-like protein 1,2475.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bcl-2-like protein 2,874.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bcl-2-related protein A1,2036.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,593.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Beta-2-microglobulin,1912.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,39719.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,5208.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Betacellulin,829.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Beta-endorphin,399.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,beta-nerve growth factor,365.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,BH3-interacting domain death agonist,4475.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Biglycan,2144,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,536.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1188.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bone morphogenetic protein 1,2701.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bone morphogenetic protein 6,6761.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bone morphogenetic protein 7,664.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,366.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,395.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Bone sialoprotein 2,2084.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,2136.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Brain natriuretic peptide 32,533.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Brain-specific serine protease 4,798.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1375.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Brevican core protein,1192.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Brother of CDO,516.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C3a anaphylatoxin,523,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,203742.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C5a anaphylatoxin,7419.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cadherin-12,1840.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cadherin-1,45091.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cadherin-15,3914.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cadherin-2,2244.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cadherin-3,23015.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cadherin-5,8235.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cadherin-6,549.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcineurin,10603.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcineurin subunit B type 1,12959.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",1713.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,2112.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,9358.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2032.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,5960.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,15127.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,43874.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,538.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calpain I,171539.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calpastatin,5672,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Calreticulin,2043.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,3193.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,9313,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1533.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,3262.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,457.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,248.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase 1,11149.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase 13,9040.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase 2,221.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase 3,1199.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase 4,33046.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase 6,4913.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase 7,277.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase 9,1020.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,455.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carboxypeptidase B2,10501.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Carboxypeptidase E,1128.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cardiotrophin-1,609.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,1118.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,41143.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Casein kinase II subunit alpha,1110.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Caspase-10,6934.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Caspase-2,429.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Caspase-3,45871.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Catalase,27327.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin B,2350.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin D,1026.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin E,432.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin F,2741.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin G,1201.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin H,579.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin L2,690.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin S,652.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cathepsin Z,3940.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,24937.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,1559.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 1,1549.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 13,745.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 14,3690.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 15,2950,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 16,29736.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 17,5710.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 18,4704.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 19,302.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 20,192.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 21,17585.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 22,1894.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 23,2096.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 24,333,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 25,952.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 26,1321.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 27,1331.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 28,14679.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 2,829.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 3,798.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,1011.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 4-like,799.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 5,143955.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 7,832.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-C motif chemokine 8,202.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD109 antigen,1727.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD166 antigen,9567.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD177 antigen,250.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD209 antigen,1024.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD226 antigen,1115.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD27 antigen,7608.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD40 ligand,1053.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD48 antigen,484.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD59 glycoprotein,1365.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD5 antigen-like,1467.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD63 antigen,899,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD70 antigen,248,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD83 antigen,264.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CD97 antigen,1100.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cell adhesion molecule 1,1089.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cell adhesion molecule 3,1431.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,3739.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,913.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cellular tumor antigen p53,1539.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,2821.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",14559.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",2411.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",74058.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Chitinase-3-like protein 1,4852.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Chitotriosidase-1,1681.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,33746.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Choline/ethanolamine kinase,6749.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Chordin-like protein 1,1366.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,11430.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Chromobox protein homolog 5,327.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Chromogranin-A,24894.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Chymase,1229.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ciliary neurotrophic factor,151.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,3581.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ck-beta-8-1,26471.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Clusterin,1813.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,CMRF35-like molecule 6,3044.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coactosin-like protein,3406.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coagulation factor IX,12927.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coagulation factor IXab,9512.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coagulation Factor V,49682.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coagulation factor VII,645.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coagulation Factor X,5349.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coagulation factor Xa,4503.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coagulation Factor XI,1578.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cofilin-1,11837.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,1815.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,638.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,929.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Collagenase 3,519.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Collectin-11,11410,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Collectin-12,1162.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,COMM domain-containing protein 7,6771.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C1q subcomponent,38116.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C1r subcomponent,1774.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C2,2940.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C3,68319.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C3b,6350,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Complement C3b, inactivated",10320.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C3d fragment,8536.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C4,127957.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C4b,218.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C5,6378,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement C5b-C6 complex,441.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",7129.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement component C1q receptor,6975.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement component C6,56439.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement component C7,1021.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement component C8,3019.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement component C9,70932,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement decay-accelerating factor,9951.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement factor B,28510.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement factor D,918.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement factor H,61208.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement factor H-related protein 5,2517.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Complement factor I,39481.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Connective tissue-activating peptide III,165814.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Connective tissue growth factor,5027.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Contactin-1,387.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Contactin-2,532.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Contactin-4,2428,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Contactin-5,483.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Copine-1,27841.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Corticosteroid-binding globulin,836.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Corticotropin,533.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-reactive protein,18547.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Creatine kinase B-type,545,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Creatine kinase M-type,420.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,395.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cryptic protein,6474.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,50874.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,144.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,52019.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,985.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-type mannose receptor 2,2001.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-X-C motif chemokine 10,1810.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-X-C motif chemokine 11,3182.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-X-C motif chemokine 13,2135.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-X-C motif chemokine 16,7944.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-X-C motif chemokine 5,554,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-X-C motif chemokine 6,2537.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,C-X-C motif chemokine 9,309.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,1577.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,251.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,997,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,3744.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,1610.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cystatin-C,2515.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cystatin-D,2522.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cystatin-F,1017.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cystatin-M,7869.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cystatin-S,144.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cystatin-SA,11700.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cystatin-SN,1119.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,10299.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,297.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,2158.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytochrome c,2246.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytochrome P450 3A4,63867.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,16240.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,346.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,2799.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,3395.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,438.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,16188.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,2106.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,7053.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,64.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,7542.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,D-dimer,13991.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Death-associated protein kinase 2,7495,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Decorin,4371.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Delta-like protein 1,1611.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Delta-like protein 4,532,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dermatopontin,3603.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Desert hedgehog protein N-product,2259.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Desmocollin-2,1803.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Desmocollin-3,285.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Desmoglein-1,2383.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",3687.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dickkopf-like protein 1,5268.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dickkopf-related protein 1,59897.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dickkopf-related protein 3,4110.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dickkopf-related protein 4,16003.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,442.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,2858.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1712.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,532.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,928.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,3528.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,1323.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,DNA topoisomerase 1,2245.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,763.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Drebrin-like protein,10638.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",12577.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,561,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2303.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,6133.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,35882.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,9543.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2046.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dynactin subunit 2,1388.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",334.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,8494.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,929.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,5111.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,302.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,1039.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,420.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",983.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1490.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1368.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3262.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2840.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1862.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Elafin,10587.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Elongation factor 1-beta,2308.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Endoglin,753.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,19661.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,6561.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Endostatin,55572.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,8556.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,901.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,3731.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,10851.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Enteropeptidase,196.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Eotaxin,6039.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin-A2,793.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin-A3,1146.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin-A4,957.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin-A5,1689.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin-B1,3593.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin-B2,6814.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin-B3,1238.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin type-A receptor 10,349.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin type-A receptor 1,6314.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin type-A receptor 2,1330.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin type-A receptor 3,109.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin type-A receptor 5,538.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin type-B receptor 2,7939.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin type-B receptor 4,6917.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ephrin type-B receptor 6,1366,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Epidermal growth factor,2801.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Epidermal growth factor receptor,19042.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,1905.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,255.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Epiregulin,1693.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,517.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Erythropoietin,631.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Erythropoietin receptor,605.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,E-selectin,11458.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,3283.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Estrogen receptor,1109.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,1022,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,502.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,26170.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,38291.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,4085.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,66028.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Extracellular matrix protein 1,16412,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],636.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,FACT complex subunit SSRP1,1011.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",949.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",24830.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",2593.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fc receptor-like protein 3,378.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ferritin,28125.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fetuin-B,5481.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibrinogen,175653.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibrinogen gamma chain,63976.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 10,288.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 1,142.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 12,179.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 16,11046.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 17,185.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 18,286.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 19,3013.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 20,410.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 23,360.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 2,6646.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 4,372.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 5,559.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 6,1271.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 7,5402.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,1387,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,1051.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor 9,457.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,563.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,213.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,766.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,1034.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibronectin,11466.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibronectin Fragment 3,1994.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fibronectin Fragment 4,42556.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ficolin-1,1608,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ficolin-2,1287.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ficolin-3,209.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,442.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Focal adhesion kinase 1,366.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Follicle stimulating hormone,817.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Follistatin,1646.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Follistatin-related protein 1,27413.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Follistatin-related protein 3,4560.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,4743.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fractalkine,1648.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,187468.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,420.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,347.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galectin-10,515.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galectin-2,677.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galectin-3,14948.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galectin-3-binding protein,572.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galectin-4,1071.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galectin-7,1805.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galectin-8,354.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Galectin-9,1230.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Gamma-enolase,53060.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Gastrin-releasing peptide,317.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,GDNF family receptor alpha-1,658.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,GDNF family receptor alpha-2,4355.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,GDNF family receptor alpha-3,1203.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Gelsolin,1077,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glia-derived nexin,2915.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,298.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glial fibrillary acidic protein,475.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glucagon,1310.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glucocorticoid receptor,268.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glucokinase regulatory protein,506.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,67939.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,297.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glutathione S-transferase A3,136,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glutathione S-transferase P,5725.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,311257.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1150.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,55694.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,10415.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glypican-2,194,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glypican-3,480.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glypican-5,1119.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Glypican-6,3289.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",552.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Granulins,16691.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1035.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,1077.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,467,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Granulysin,1986,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Granzyme A,1307.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Granzyme B,310.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Granzyme H,232.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,GRB2-related adapter protein 2,410.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Gremlin-1,692.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Gro-beta/gamma,4482.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,600,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,277.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth arrest-specific protein 1,531.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth/differentiation factor 11,686,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,1229.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth/differentiation factor 15,1159,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth/differentiation factor 2,1375.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth/differentiation factor 5,2340.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth/differentiation factor 8,1987.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth/differentiation factor 9,687.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,119104.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth hormone receptor,1060.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Growth-regulated alpha protein,10396.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,GTPase KRas,1030.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,21782.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Haptoglobin,30145,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,5849,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,4898.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heat shock protein beta-1,12518.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,50662.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,156749.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heme oxygenase 2,749.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,HemK methyltransferase family member 2,15800.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hemoglobin,1683.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hemojuvelin,1170,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hemopexin,1606.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,1850.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,591.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heparin cofactor 2,3494.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,7486.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hepatocyte growth factor,1400.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hepatocyte growth factor activator,3573.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,7431.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,5256.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,1224.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hepcidin,10119.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,1376.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,5582.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,193,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,4998.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,19686.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hexokinase-1,1104.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hexokinase-2,1705.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",456.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",283.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,497.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,4462.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,High mobility group protein B1,19138.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histidine-rich glycoprotein,5290.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,4517.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1577.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,706.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone deacetylase 8,3469.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone H1.2,24535.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone H2A type 3,5885.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone H2A.z,5173.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone H2B type 2-E,42739.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone H3.1,3084.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,390.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Homeobox protein NANOG,129,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,519.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,1105.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,526.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,931.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,580.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,ICOS ligand,16722.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Iduronate 2-sulfatase,2850,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Immunoglobulin A,2155.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,200.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Immunoglobulin D,1246.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Immunoglobulin E,1709.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Immunoglobulin G,164500.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Immunoglobulin M,1599.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2178.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Importin subunit alpha-1,185.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Importin subunit beta-1,31345.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,803.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Inducible T-cell costimulator,1061.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Inhibin beta A chain,3494.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,607.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Inhibitor of growth protein 1,58651.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Inorganic pyrophosphatase,65840.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,5770.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,7264.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin,115.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-degrading enzyme,3460.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,3011.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,649.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,383.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,1773.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,6896.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,1960.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,723.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,38546,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin-like growth factor I,2172.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Insulin receptor,3415.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,7597.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,3736.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,903.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,41707.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,3859.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,2670.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,761.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,311.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon alpha-10,247.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon alpha-2,145.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon alpha-7,189,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,1004.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon beta,433.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon gamma,616.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon gamma receptor 1,277.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon gamma receptor 2,427.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon lambda-1,793.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon lambda-2,186.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interferon regulatory factor 1,1821.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-10,152.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1506.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,984.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-11,475.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-12,288.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,456.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,1964.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-13,882.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,1123.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,776.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-16,916.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-17A,440.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-17B,117.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-17D,246.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-17F,598.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-17 receptor A,882.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-17 receptor B,714.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-17 receptor C,635.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-17 receptor D,344.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-18-binding protein,3291.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-18 receptor 1,5713.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,424.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-19,4767,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-1 alpha,792.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-1 beta,2673.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,26001.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,4369.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,1892.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,808,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,3778.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,5817.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-20,357.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,280.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-2,1652.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-22,1336.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,1108.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,986.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-23,1081.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-23 receptor,5949.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-24,337.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-25,238.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-27,617.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,996.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,1080.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-3,1585.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-34,562.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-36 alpha,923.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-36 beta,451.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-37,1493.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,4382.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-4,850,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,242.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-5,168.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,1226.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-6,744.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,10403.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,3786.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-7,174.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,279,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-8,768.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interleukin-9,403.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Interstitial collagenase,3754.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Junctional adhesion molecule B,10615.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Junctional adhesion molecule C,20962.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Junctional adhesion molecule-like,442,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-11,1212.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-12,2720.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-13,895.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-14,10717.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-4,371.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-5,120.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-6,1747.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-7,1042.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallikrein-8,2074.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kallistatin,35992.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,438,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",1940.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,4163.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,294.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,619.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,406.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kinesin-like protein KIF23,3888.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kininogen-1,26525.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,362.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kremen protein 2,9759.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,2125.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,2076.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Kynureninase,1502.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lactadherin,289.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lactoperoxidase,623.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lactotransferrin,48549.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lamin-B1,1561.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Laminin,4576.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,894.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Layilin,2398.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Legumain,4321.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leptin,10363.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leptin receptor,1317.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,2893,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,3051.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,3390.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,86.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,166.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,2988.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,7840.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,2362.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,1605.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3371.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,8327.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,2272.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,700.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,169,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Limbic system-associated membrane protein,929.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,61616,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lithostathine-1-alpha,273.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,4880.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,2752.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,1118.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,876.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1448.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Low-density lipoprotein receptor,121.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,34205.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",1388.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,1938.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,9713.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,L-Selectin,3381.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lumican,874,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Luteinizing hormone,2998.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,1027.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,361.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,3435.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lymphocyte antigen 86,9362.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lymphotactin,350.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,84.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,1468.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lymphotoxin-alpha,568.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lysosomal protective protein,19705.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lysosome membrane protein 2,445.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Lysozyme C,79696.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Macrophage-capping protein,901.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1833.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,160,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Macrophage mannose receptor 1,6684.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Macrophage metalloelastase,521.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,3654.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,962.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,649.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",77326.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mammaglobin-B,19155.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,3156.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mannose-binding protein C,7564,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,29951.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,8230.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,1095.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,8257.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Matrilin-2,4977.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Matrilin-3,433.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Matrilysin,1481.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,238.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Matrix metalloproteinase-14,714.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Matrix metalloproteinase-16,630.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Matrix metalloproteinase-17,899.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Matrix metalloproteinase-9,10080.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,58130.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,458.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,2379.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Membrane frizzled-related protein,4437.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,1266.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mesothelin,795.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,118,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,405.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,7791,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Methionine aminopeptidase 1,7419.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Methionine aminopeptidase 2,89909.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,720.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,127.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,600.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Microtubule-associated protein tau,210.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Midkine,39030.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,797.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,813,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,391.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,2566.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,541.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,39758.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,12419.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,83339.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,6225.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,608.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,9287.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Moesin,5631.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,82220.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,46803.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Mucin-1,836.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Muellerian-inhibiting factor,7899.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Myc proto-oncogene protein,480.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Myeloblastin,3034.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,1312.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Myeloperoxidase,17223.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Myoglobin,1287.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",860.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,3497.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,1954.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,4308.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,16236.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,6911.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,15761.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,1718.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,382.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,459.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,247.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Netrin-1,362.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Netrin-4,926.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Netrin receptor UNC5C,2412.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Netrin receptor UNC5D,2224.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",7696.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,261.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,6989.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neuregulin-1,156.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neuregulin-4,592.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neurexin-1-beta,389,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neurexin-3-beta,480.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neurexophilin-1,8757.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1110.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,14952.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,438.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,583.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",527.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,3852.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neuronal growth regulator 1,2597.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neuropilin-1,2407.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neurotrophin-3,183,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neurotrophin-4,159.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neutral ceramidase,2367.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,53390.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neutrophil collagenase,3128.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neutrophil elastase,502.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,16390,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,1084.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Nidogen-1,7487.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Nidogen-2,4339.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NKG2D ligand 1,434.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NKG2D ligand 2,318.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NKG2D ligand 3,2339.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,979.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Noggin,5353.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,2555.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,6092.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NSFL1 cofactor p47,2037.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NT-3 growth factor receptor,3161.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,N-terminal pro-BNP,3977.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,592.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,2631.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,72947.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,NudC domain-containing protein 3,912.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,OCIA domain-containing protein 1,1089.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Olfactomedin-4,212.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Oncostatin-M,1146.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,4945,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Osteocalcin,3440.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Osteomodulin,2215.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Osteopontin,2444.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,1784.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,2213.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pancreatic hormone,1318.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pappalysin-1,9369.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Parathyroid hormone,2758.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Parathyroid hormone-related protein,696.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peptide YY,1455.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,662.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,278619.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,3140.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,95684.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,4305.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",97806.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Periostin,2007.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peroxiredoxin-1,10905,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",425.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peroxiredoxin-6,2728.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,250.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Persephin,264.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3185.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pescadillo homolog,414.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,26825.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1138.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",3140,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Phosphoglucomutase-1,497.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,8799.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,7492.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Phospholipase A2,534.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",1522.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pigment epithelium-derived factor,50879.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,PIK3CA/PIK3R1,1383.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,PILR alpha-associated neural protein,2143.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,237.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,168.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Placenta growth factor,285.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Plasma kallikrein,20757.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,5749.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Plasma serine protease inhibitor,87772.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Plasmin,825.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Plasminogen,3665.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,5576.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,1173.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,14152,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet-derived growth factor C,294.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,977.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,4790.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,45533.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,127125.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,1002.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet factor 4,259860.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet glycoprotein 4,8935.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,2038.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet glycoprotein VI,65358,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Platelet receptor Gi24,1117.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pleiotrophin,1481.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Plexin-B2,3312.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Plexin-C1,1473.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,2140.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,2011.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,4818.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Prefoldin subunit 5,397.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,1132.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,6250.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Prokineticin-1,189,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Prolactin,1099.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Prolactin receptor,1064.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,229.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,11754.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,543.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pro-opiomelanocortin,496,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Properdin,120018.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,1363.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,811.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,1044.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Prostate-specific antigen,1946.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,5846.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,341.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,961.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,550.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,3555.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein 4.1,35244.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein amnionless,112.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein deglycase DJ-1,1109.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein disulfide-isomerase,168.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,17641,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein E7_HPV16,345.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein E7_HPV18,1314.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein FAM107A,337.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein FAM107B,3063.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein FAM3B,523,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein FAM3D,2434.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,115.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein jagged-1,351.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein jagged-2,306,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein kinase C alpha type,159308.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),68893.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein kinase C delta type,19067,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein kinase C gamma type,513.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein kinase C iota type,11022.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein kinase C theta type,15742.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein kinase C zeta type,2175.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein lin-7 homolog B,520.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein NOV homolog,852.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein Rev_HV2BE,128.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein S100-A12,1371,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein S100-A4,2300.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein S100-A6,7457.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein S100-A7,213.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein S100-A9,10268.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein SET,781.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,289.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein Wnt-7a,197.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,4267.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Prothrombin,195618.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,651.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,128570.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Proto-oncogene vav,83307.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,P-selectin,62364.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,57979.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pyridoxal kinase,742.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,18498,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",3552,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Pyruvate kinase PKM,206683.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,1978.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,72019,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,35805.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,53331.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,2263.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,148477.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,21699.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,14690.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,385.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,220.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,135.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,847.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Relaxin receptor 1,445.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Renin,948.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Repulsive guidance molecule A,17308.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Resistin,892.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Reticulon-4 receptor,1473.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1328.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,3430.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Retinol-binding protein 4,275.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,RGM domain family member B,1484.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ribonuclease H1,306.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,4033.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,741.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,63229.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,RNA-binding protein 39,1049,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Roundabout homolog 2,2196.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Roundabout homolog 3,340,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,R-spondin-2,917.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,R-spondin-3,1320.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,R-spondin-4,274.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Scavenger receptor class F member 1,20152.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Scavenger receptor class F member 2,315,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,1913.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sclerostin,10808.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,1361,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,4920.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,2483,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Secretin,235.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Seizure 6-like protein 2,4978.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Semaphorin-3A,2482.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Semaphorin-3E,1915,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Semaphorin-5A,21551.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Semaphorin-6A,5934.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Semaphorin-6B,2154.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine protease 27,5513.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",11175.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,1464.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,7654.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,515,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,203.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,1687.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,832.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,43976.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,781.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,763.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,219.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1860.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,420.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,6123.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serotransferrin,239936.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serum albumin,7335,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serum amyloid A-1 protein,166.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serum amyloid P-component,39128.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,224.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sex hormone-binding globulin,3609.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,S-formylglutathione hydrolase,3501.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,7286.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SHC-transforming protein 1,57705.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,8541.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,142.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1095.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,6014.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sialoadhesin,131,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,37228,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,13937.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,2021.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SLAM family member 5,11677.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SLAM family member 6,277.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SLAM family member 7,19803.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1933.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,1106.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,15658.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,2738.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,14981,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Somatostatin-28,1218.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Somatotropin,267.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sonic hedgehog protein,537.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sorting nexin-4,54252.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SPARC,86511.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SPARC-like protein 1,7410.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,2922,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",151.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,11923.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sphingosine kinase 1,64834.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Sphingosine kinase 2,603.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Spondin-1,1252.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Stabilin-2,701.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Stanniocalcin-1,1562.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Stem cell growth factor-alpha,3595.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,1361.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,45845.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Stromal cell-derived factor 1,5216.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Stromelysin-1,598.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Stromelysin-2,528.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,11344.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],3315.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",39211.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,979.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Syntaxin-1A,306,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,5548.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,TATA-box-binding protein,639.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,475.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tenascin,7514.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,1965,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Testican-1,12969.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Testican-2,678.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,TGF-beta receptor type-2,854.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,3159.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thrombin,662.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thrombopoietin,273.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thrombopoietin Receptor,325.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thrombospondin-1,30052.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thrombospondin-2,4666.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thrombospondin-4,465,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,902.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",331,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thymidylate synthase,286.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thyroglobulin,488.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thyroid peroxidase,1643.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,457.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Thyroxine-binding globulin,40381.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tissue Factor,826.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,59029.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tissue-type plasminogen activator,754.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,444.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,588.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,1238.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Toll-like receptor 2,484.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Toll-like receptor 4,236.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,2185.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transcription factor AP-1,9535.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,2385,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transforming growth factor beta-1,2991.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transforming growth factor beta-2,450.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transforming growth factor beta-3,384.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,29310.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,20067.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transgelin-2,22186.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transketolase,162655.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Translationally-controlled tumor protein,80706.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,2536.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Trefoil factor 1,2416.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Trefoil factor 2,5791.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Trefoil factor 3,8455,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Triosephosphate isomerase,47844.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,812.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,256250.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tropomyosin beta chain,1938.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",332.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",1815.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",2686.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Trypsin-1,5365.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Trypsin-2,2506.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Trypsin-3,377.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tryptase beta-2,3705.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tryptase gamma,158.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,617.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor,405.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,530.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,314.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,733.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,1206.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,957.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,1240,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,545.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,379.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",414.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,1546.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,297.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1414.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,473,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,785.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1592.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,7776.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,182.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,854.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,2792.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,432.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,4472.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,573.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,785.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,1353.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,1184.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,8812.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,5069.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,802.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,2921.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,535.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,1102.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,508.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,838,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,314.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,3072.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,141,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,81985.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,72080,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,20447.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,2521.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,72482,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,141.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,95034.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,456.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,53530.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",146323.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",5020.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,434.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,23012,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,345.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,2921.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,6429.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,31873.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,13691.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,295.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,27107.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,808.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",14984.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin,3563.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,2145.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,5602.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,6919.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,6671,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,34842.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,20670.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,52982.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,5312.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,UMP-CMP kinase,4869.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,4520.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,926.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,143769.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,8804.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vascular endothelial growth factor A,9958.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",1556.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vascular endothelial growth factor C,3986.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vascular endothelial growth factor D,340.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,5681.3,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,3418.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,948.6,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,17784.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vitamin K-dependent protein C,2369.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vitamin K-dependent protein S,4934.9,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Vitronectin,49916,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,von Willebrand factor,9539.8,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,545.4,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",471.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2947.2,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,8327,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,1309.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Wnt inhibitory factor 1,1946.5,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,23974.7,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,976.1,RFU
BF-1052,PDYV290XFK,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,461.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,14-3-3 protein beta/alpha,38685.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,14-3-3 protein epsilon,978.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,14-3-3 protein family,8083.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,14-3-3 protein sigma,592.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,14-3-3 protein theta,1408.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,14-3-3 protein zeta/delta,245959.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1269.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",467.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,330.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,502.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,290.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1788.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",4855.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",573.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,1409.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,40S ribosomal protein S3,598.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,40S ribosomal protein S3a,731.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,40S ribosomal protein S7,14667.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,40S ribosomal protein SA,1591.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",25168.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",24781.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,72 kDa type IV collagenase,7247,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Abelson tyrosine-protein kinase 2,1533.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,172.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,3341.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Activated Protein C,806.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Activin receptor type-1B,255.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Adapter molecule crk,16831.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Adenylate kinase isoenzyme 1,32317.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Adenylosuccinate lyase,3064,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Adhesion G protein-coupled receptor E2,725.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Adhesion G-protein coupled receptor G5,635.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Adiponectin,4474.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,3169.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,417.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,326.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,158.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,376.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,545.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,11025.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Adrenomedullin,2252.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",374.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Afamin,30419.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,7390.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Aggrecan core protein,577.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Agouti-related protein,2207.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,AH receptor-interacting protein,9002.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alanine aminotransferase 1,3179.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],6285,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Allograft inflammatory factor 1,2756.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",7855.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-1-antichymotrypsin,286656.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-1-antichymotrypsin complex,6586.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-1-antitrypsin,958.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-2-antiplasmin,1627.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-2-HS-glycoprotein,1739.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-2-macroglobulin,12163.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,685.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-enolase,83951.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,alpha-Fetoprotein,702.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-L-iduronidase,1613.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-soluble NSF attachment protein,9881.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Alpha-synuclein,21557.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Aminoacylase-1,2318.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Amphiregulin,5483.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Amphoterin-induced protein 2,2485.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),318.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),9149.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Amyloid beta A4 protein,39623.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiogenin,4261.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiopoietin-1,878.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",2461,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiopoietin-2,138.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiopoietin-4,557.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiopoietin-related protein 3,441.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiopoietin-related protein 4,4578.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiostatin,20035.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiotensin-converting enzyme 2,538.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Angiotensinogen,5744.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ankyrin-2,463.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Annexin A1,10792.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Annexin A2,10889.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Annexin A5,1014.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Annexin A6,21420.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Anterior gradient protein 2 homolog,795,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Antileukoproteinase,38761.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Antithrombin-III,117232.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein A-I,14075.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein B,8858.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein D,4675.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein E,39867.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein E (isoform E2),296119.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein E (isoform E3),234629.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein E (isoform E4),255384.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein L1,32960.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apolipoprotein M,13175.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Apoptosis regulator Bcl-2,1708,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Appetite-regulating hormone,1180.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Arginase-1,1101.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,302.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Artemin,404.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Arylsulfatase A,1335.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Arylsulfatase B,875.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Asialoglycoprotein receptor 1,1312.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",3610.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,7297.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",1880.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",6490.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Atrial natriuretic factor,707.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,733.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Aurora kinase A,1054.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Aurora kinase B,649.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Azurocidin,367.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bactericidal permeability-increasing protein,1903.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,203.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,552.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,91.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Basal Cell Adhesion Molecule,1661.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Basigin,304.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,B-cell lymphoma 6 protein,1568.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,B-cell receptor CD22,846,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bcl2-associated agonist of cell death,16276.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bcl-2-like protein 1,1714.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bcl-2-like protein 2,714.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bcl-2-related protein A1,894,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,BDNF/NT-3 growth factors receptor,990.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Beta-2-microglobulin,2178.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,beta-adrenergic receptor kinase 1,13601.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Beta-Ala-His dipeptidase,4631.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Betacellulin,534,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Beta-endorphin,854.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,beta-nerve growth factor,497.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,BH3-interacting domain death agonist,2146.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Biglycan,2490.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,BMP-binding endothelial regulator protein,397.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bone morphogenetic protein 10,1271.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bone morphogenetic protein 1,3213.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bone morphogenetic protein 6,17806.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bone morphogenetic protein 7,726.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,774.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bone morphogenetic protein receptor type-2,414.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Bone sialoprotein 2,5204.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Brain-derived neurotrophic factor,2113.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Brain natriuretic peptide 32,528.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Brain-specific serine protease 4,2059.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1339.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Brevican core protein,1745.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Brother of CDO,1283.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C3a anaphylatoxin,622.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C3a anaphylatoxin des Arginine,172425.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C5a anaphylatoxin,6258.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cadherin-12,884.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cadherin-15,4214.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cadherin-1,74197.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cadherin-2,1556.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cadherin-3,22583.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cadherin-5,11228.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cadherin-6,489.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcineurin,2645.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcineurin subunit B type 1,6946.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",975.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,522.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,3979.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1814.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,902.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,2170.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,6968.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calcium-dependent phospholipase A2,326,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calpain I,84661.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calpastatin,8184.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Calreticulin,1968.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,2489.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,cAMP-regulated phosphoprotein 19,5754.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1462.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbohydrate sulfotransferase 15,5892.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbohydrate sulfotransferase 2,289.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbohydrate sulfotransferase 6,259,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase 1,13946.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase 13,5590.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase 2,258.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase 3,2806.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase 4,2378.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase 6,9344.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase 7,294.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase 9,1116.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carbonic anhydrase-related protein 10,634.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carboxypeptidase B2,11709.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Carboxypeptidase E,1737.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cardiotrophin-1,657.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,13258.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,549.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Casein kinase II subunit alpha,496,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Caspase-10,3581.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Caspase-2,308.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Caspase-3,27886.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Catalase,14213.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin B,2062.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin D,759.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin E,495.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin F,3384.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin G,923.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin H,1075.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin L2,1294.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin S,907,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cathepsin Z,4211.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,31293,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CCAAT/enhancer-binding protein beta,899.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 1,2330.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 13,393.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 14,6783,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 15,3782.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 16,37226,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 17,2482,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 18,6925.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 19,415.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 20,120.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 21,32785,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 22,1570.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 23,3389,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 24,290.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 25,1413,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 26,978.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 27,1287.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 2,875.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 28,9365.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 3,728.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 3-like 1,1671,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 4-like,541.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 5,102882,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 7,1077.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-C motif chemokine 8,227.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD109 antigen,4856.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD166 antigen,15022.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD177 antigen,722,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD209 antigen,1351.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD226 antigen,789,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD27 antigen,7537.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD40 ligand,452.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD48 antigen,576.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD59 glycoprotein,1804.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD5 antigen-like,2139,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD63 antigen,422.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD70 antigen,289.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD83 antigen,297.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CD97 antigen,1825,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cell adhesion molecule 1,2465.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cell adhesion molecule 3,1502.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5872.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,919.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cellular tumor antigen p53,881.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cerebral dopamine neurotrophic factor,4492.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",6606.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",831.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",43023.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Chitinase-3-like protein 1,12757.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Chitotriosidase-1,3175.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Chloride intracellular channel protein 1,8270.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Choline/ethanolamine kinase,2297.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Chordin-like protein 1,3016.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Chorionic somatomammotropin hormone,3536.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Chromobox protein homolog 5,404.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Chromogranin-A,30176.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Chymase,603.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ciliary neurotrophic factor,201.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,9126.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ck-beta-8-1,80523.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Clusterin,1200.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,CMRF35-like molecule 6,3557.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coactosin-like protein,3215.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coagulation factor IX,11977.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coagulation factor IXab,8733.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coagulation Factor V,53815.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coagulation factor VII,566.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coagulation Factor X,4994.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coagulation factor Xa,4279.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coagulation Factor XI,1637.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cofilin-1,17109.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Coiled-coil domain-containing protein 80,2847.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Collagen alpha-1(VIII) chain,840.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Collagen alpha-1(XXIII) chain,365.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Collagenase 3,565.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Collectin-11,5876.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Collectin-12,1767.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,COMM domain-containing protein 7,2535.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C1q subcomponent,39013.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C1r subcomponent,951.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C2,2933.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C3,82864.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C3b,13358,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Complement C3b, inactivated",9464.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C3d fragment,8633.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C4,143739.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C4b,124.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C5,7121.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement C5b-C6 complex,487.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4458.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement component C1q receptor,10854.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement component C6,87316.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement component C7,1376.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement component C8,2463.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement component C9,75486.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement decay-accelerating factor,17983.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement factor B,18603,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement factor D,1152.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement factor H,54480.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement factor H-related protein 5,1164,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Complement factor I,39782.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Connective tissue-activating peptide III,49795.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Connective tissue growth factor,2178.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Contactin-1,317.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Contactin-2,1305.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Contactin-4,3943.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Contactin-5,535.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Copine-1,7698.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Corticosteroid-binding globulin,615.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Corticotropin,364.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-reactive protein,34846.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Creatine kinase B-type,1012.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Creatine kinase M-type,951.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,713.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cryptic protein,2280.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-type lectin domain family 1 member B,27857,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-type lectin domain family 4 member K,172,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-type lectin domain family 4 member M,53040,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-type lectin domain family 7 member A,639,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-type mannose receptor 2,3084.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-X-C motif chemokine 10,2530.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-X-C motif chemokine 11,4490.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-X-C motif chemokine 13,7114.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-X-C motif chemokine 16,11381.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-X-C motif chemokine 5,636.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-X-C motif chemokine 6,3201.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,C-X-C motif chemokine 9,602.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,698.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,280.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1215.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,2132.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,2210,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cystatin-C,2790.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cystatin-D,3318.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cystatin-F,870.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cystatin-M,11344.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cystatin-S,211.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cystatin-SA,15184.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cystatin-SN,937.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cysteine and glycine-rich protein 3,3564.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cysteine-rich secretory protein 3,295.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,2285.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytochrome c,2744,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytochrome P450 3A4,29518.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytokine receptor common subunit gamma,5905.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,402.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytokine receptor-like factor 2,1605.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytoplasmic protein NCK1,1417.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,301.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytoskeleton-associated protein 2,17096.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytosolic non-specific dipeptidase,1464.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,1376.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,80,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,dCTP pyrophosphatase 1,16959.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,D-dimer,14423,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Death-associated protein kinase 2,3203.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Decorin,4015.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Delta-like protein 1,2396.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Delta-like protein 4,567.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dermatopontin,4351.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Desert hedgehog protein N-product,920.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Desmocollin-2,3050.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Desmocollin-3,297.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Desmoglein-1,3155.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Diablo homolog, mitochondrial",4270.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dickkopf-like protein 1,2446.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dickkopf-related protein 1,40229,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dickkopf-related protein 3,5528.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dickkopf-related protein 4,9271.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dipeptidyl peptidase 1,516.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dipeptidyl peptidase 2,1122.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Discoidin domain-containing receptor 2,1607.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,424.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1345.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,DnaJ homolog subfamily B member 1,749.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,DNA repair protein RAD51 homolog 1,2563.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,DNA topoisomerase 1,517.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Down syndrome cell adhesion molecule,935.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Drebrin-like protein,4387.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2262.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,430.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2014.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,3222.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,65760.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dual specificity protein phosphatase 3,6162.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2080.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dynactin subunit 2,1303.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",275.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Dynein light chain roadblock-type 1,4237,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,696.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,1862,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,202,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,1152.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,388.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Ectodysplasin-A, secreted form",1734,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1595.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1173.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3022.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,4071.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1751.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Elafin,24728.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Elongation factor 1-beta,876.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Endoglin,1721.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,106408.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Endoplasmic reticulum resident protein 29,5769.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Endostatin,76833.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Endothelial cell-selective adhesion molecule,4022.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Endothelial cell-specific molecule 1,1367.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,3949.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Endothelin-converting enzyme 1,19625.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Enteropeptidase,165.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Eotaxin,10921.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin-A2,991.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin-A3,2265.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin-A4,1937.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin-A5,3931.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin-B1,2200.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin-B2,17141.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin-B3,780.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin type-A receptor 10,389.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin type-A receptor 1,11077.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin type-A receptor 2,3471.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin type-A receptor 3,130,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin type-A receptor 5,633.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin type-B receptor 2,21253.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin type-B receptor 4,2669.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ephrin type-B receptor 6,1711.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Epidermal growth factor,1235.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Epidermal growth factor receptor,22908.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,555.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Epidermal growth factor receptor variant III,189.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Epiregulin,1088.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,342.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Erythropoietin,1091.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Erythropoietin receptor,384.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,E-selectin,26966.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,1823.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Estrogen receptor,720.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Eukaryotic initiation factor 4A-III,491.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,280.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,7040.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Eukaryotic translation initiation factor 4H,12226,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Eukaryotic translation initiation factor 5,1781.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,65338.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Extracellular matrix protein 1,16364,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],646,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,FACT complex subunit SSRP1,413,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Fatty acid-binding protein, epidermal",1014.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Fatty acid-binding protein, heart",18214,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Fatty acid-binding protein, liver",3994.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fc receptor-like protein 3,422.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ferritin,24972.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fetuin-B,2722.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibrinogen,185026.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibrinogen gamma chain,64821.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 10,190.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 1,168.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 12,174.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 16,4525,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 17,205.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 18,254.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 19,18053.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 20,445.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 2,1925.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 23,396.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 4,211.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 5,641.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 6,517.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 7,2813.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 8 isoform A,605.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 8 isoform B,701,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor 9,529.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor receptor 1,733.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor receptor 2,213.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor receptor 3,711.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibroblast growth factor receptor 4,726.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibronectin,8410.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibronectin Fragment 3,1866.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fibronectin Fragment 4,54663.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ficolin-1,2154,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ficolin-2,1315.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ficolin-3,228,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,418.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Focal adhesion kinase 1,273.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Follicle stimulating hormone,628.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Follistatin,910,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Follistatin-related protein 1,36419.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Follistatin-related protein 3,7474.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,3677.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fractalkine,3343.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Fructose-bisphosphate aldolase A,107895.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,G2/mitotic-specific cyclin-B1,371.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,385,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galectin-10,1225.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galectin-2,435.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galectin-3,24356.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galectin-3-binding protein,675.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galectin-4,758,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galectin-7,679.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galectin-8,420.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Galectin-9,1765.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Gamma-enolase,52273.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Gastrin-releasing peptide,288.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,GDNF family receptor alpha-1,1421.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,GDNF family receptor alpha-2,5200.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,GDNF family receptor alpha-3,810.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Gelsolin,914.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glia-derived nexin,1241.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glial cell line-derived neurotrophic factor,354,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glial fibrillary acidic protein,608.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glucagon,3614.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glucocorticoid receptor,86.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glucokinase regulatory protein,432.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glucose-6-phosphate isomerase,37392.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glutamate carboxypeptidase 2,361.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glutathione S-transferase A3,191.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glutathione S-transferase P,9570,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,148158.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1198,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,29065.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,6599.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glypican-2,179.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glypican-3,1039.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glypican-5,1080.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Glypican-6,1701.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"gp41 C34 peptide, HIV",917,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Granulins,24007,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Granulocyte colony-stimulating factor,1397.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,756,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,262.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Granulysin,2090.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Granzyme A,3178.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Granzyme B,202.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Granzyme H,229.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,GRB2-related adapter protein 2,447.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Gremlin-1,395.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Gro-beta/gamma,1565.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Group 10 secretory phospholipase A2,573.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Group IIE secretory phospholipase A2,246,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth arrest-specific protein 1,626.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth/differentiation factor 11,822,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth/differentiation factor 11/8,988.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth/differentiation factor 15,1475.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth/differentiation factor 2,2792.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth/differentiation factor 5,1682.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth/differentiation factor 8,4449.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth/differentiation factor 9,621.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth factor receptor-bound protein 2,74358.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth hormone receptor,852.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Growth-regulated alpha protein,5168.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,GTPase KRas,1420.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,GTP-binding nuclear protein Ran,14274.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Haptoglobin,65280.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heat shock 70 kDa protein 1A,8858.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heat shock cognate 71 kDa protein,1897.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heat shock protein beta-1,24550.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,11170.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heat shock protein HSP 90-beta,58814.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heme oxygenase 2,402,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,HemK methyltransferase family member 2,4049.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hemoglobin,1598.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hemojuvelin,948.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hemopexin,2153,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2509.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heparin-binding EGF-like growth factor,340.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heparin cofactor 2,3677.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hepatitis A virus cellular receptor 2,11270.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hepatocyte growth factor,1470.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hepatocyte growth factor activator,4128.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hepatocyte growth factor-like protein,3626.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hepatocyte growth factor receptor,8871.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,743.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hepcidin,25948.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,HERV-H LTR-associating protein 2,1259.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,2114.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,412.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2874.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3887.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hexokinase-1,1273.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hexokinase-2,909.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",356,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",346.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,269.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,High affinity nerve growth factor receptor,2884.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,High mobility group protein B1,8504.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histidine-rich glycoprotein,5135.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,2401.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone acetyltransferase KAT6A,1293.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,330,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone deacetylase 8,2806.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone H1.2,3223.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone H2A type 3,700.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone H2A.z,1634.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone H2B type 2-E,16459.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone H3.1,1721.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,300.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Homeobox protein NANOG,147.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Homeodomain-interacting protein kinase 3,399.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hsp90 co-chaperone Cdc37,545.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Human Chorionic Gonadotropin,1874.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,828.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,573,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,ICOS ligand,2689.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Iduronate 2-sulfatase,3785,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Immunoglobulin A,5159.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Immunoglobulin alpha Fc receptor,171.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Immunoglobulin D,2446.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Immunoglobulin E,145.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Immunoglobulin G,229384.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Immunoglobulin M,2733.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,6450.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Importin subunit alpha-1,255.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Importin subunit beta-1,11475.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1494.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Inducible T-cell costimulator,638.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Inhibin beta A chain,5235.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,764.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Inhibitor of growth protein 1,33245.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Inorganic pyrophosphatase,50785.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,3002.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2470.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin,142.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-degrading enzyme,3006.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor 1 receptor,6209.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor-binding protein 1,1062.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor-binding protein 2,854.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor-binding protein 3,1182.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor-binding protein 4,5766.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor-binding protein 5,2028.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor-binding protein 6,782.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor-binding protein 7,51282.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin-like growth factor I,944.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Insulin receptor,10020.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Integrin alpha-I: beta-1 complex,887.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,2473.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Integrin alpha-V: beta-5 complex,732.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,41421.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Intercellular adhesion molecule 1,3679.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Intercellular adhesion molecule 2,1742.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Intercellular adhesion molecule 3,559.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Intercellular adhesion molecule 5,814.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon alpha-10,298.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon alpha-2,133.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon alpha-7,224.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon alpha/beta receptor 1,1686.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon beta,678,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon gamma,780.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon gamma receptor 1,460.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon gamma receptor 2,725.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon lambda-1,408,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon lambda-2,140.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interferon regulatory factor 1,1686.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-10,182.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1093.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-10 receptor subunit beta,1235.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-11,302.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-12,344.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,478.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,736.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-13,644.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,2276.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-15 receptor subunit alpha,986.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-16,338.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-17A,333.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-17B,165,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-17D,222.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-17F,669.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-17 receptor A,547.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-17 receptor B,3106.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-17 receptor C,901.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-17 receptor D,493.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-18-binding protein,11330.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-18 receptor 1,8326.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-18 receptor accessory protein,290.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-19,4736.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-1 alpha,618,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-1 beta,2000,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-1 Receptor accessory protein,44855.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-1 receptor antagonist protein,5018.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-1 receptor-like 1,2499,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-1 receptor-like 2,965.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-1 receptor type 1,10798.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-1 receptor type 2,9446.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-20,324.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-20 receptor subunit alpha,236,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-22,1000.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-2,2461.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,722.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,2900.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-23,2206,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-23 receptor,3085.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-24,207.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-25,271.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-27,621.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-27 receptor subunit alpha,1240.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-2 receptor subunit alpha,1006.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-3,1276.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-34,713.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-36 alpha,958.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-36 beta,418.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-37,1944.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-3 receptor subunit alpha,1834.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-4,597.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-4 receptor subunit alpha,211.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-5,261.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-5 receptor subunit alpha,1463.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-6,330.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-6 receptor subunit alpha,12578.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-6 receptor subunit beta,6369.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-7,155.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-7 receptor subunit alpha,310.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-8,819.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interleukin-9,253.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Interstitial collagenase,2828.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Junctional adhesion molecule B,9443.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Junctional adhesion molecule C,8516.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Junctional adhesion molecule-like,437.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-11,958.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-12,4968.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-13,1191.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-14,7833.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-4,305.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-5,153.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-6,2802.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-7,1438.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallikrein-8,3565,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kallistatin,37929.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kelch-like ECH-associated protein 1,491.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Keratin, type I cytoskeletal 18",1005.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1718.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,243.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,428.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,309.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kinesin-like protein KIF23,1774.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kininogen-1,23979.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kin of IRRE-like protein 3,297.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kremen protein 2,4810.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kunitz-type protease inhibitor 1,6379.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kunitz-type protease inhibitor 2,1492.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Kynureninase,941.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lactadherin,1066.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lactoperoxidase,637.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lactotransferrin,48847.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lamin-B1,824.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Laminin,3383.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1638.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Layilin,1449.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Legumain,2258,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leptin,3163,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leptin receptor,2130.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leucine carboxyl methyltransferase 1,2085,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,6366.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,1971,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,103.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,187.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1263.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,21374.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,5599.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leukemia inhibitory factor receptor,4243.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3551.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,11106.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leukocyte surface antigen CD47,1393.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Leukotriene A-4 hydrolase,1108.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,206.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Limbic system-associated membrane protein,1624.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lipopolysaccharide-binding protein,102966,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lithostathine-1-alpha,539.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,L-lactate dehydrogenase B chain,1656.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,4601.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,49.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,906.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1344.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Low-density lipoprotein receptor,142.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,38349.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",2482.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,2435.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,14824.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,L-Selectin,4642.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lumican,1598.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Luteinizing hormone,792.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,1378.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,287.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lymphocyte activation gene 3 protein,9169.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lymphocyte antigen 86,4388.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lymphotactin,319.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lymphotoxin alpha1:beta2,136,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lymphotoxin alpha2:beta1,2453.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lymphotoxin-alpha,423,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lysosomal protective protein,9459.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lysosome membrane protein 2,373.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Lysozyme C,104931.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Macrophage-capping protein,1605.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Macrophage colony-stimulating factor 1,1288.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,172.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Macrophage mannose receptor 1,10221,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Macrophage metalloelastase,2338,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Macrophage migration inhibitory factor,2017.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Macrophage scavenger receptor types I and II,926.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Macrophage-stimulating protein receptor,466.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",32308.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mammaglobin-B,8944.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mannan-binding lectin serine protease 1,4491.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mannose-binding protein C,10248.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,MAP kinase-activated protein kinase 2,18077.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,MAP kinase-activated protein kinase 3,2054.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,MAP kinase-activated protein kinase 5,530.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,14902.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Matrilin-2,11365.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Matrilin-3,479.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Matrilysin,2610.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,221.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Matrix metalloproteinase-14,855.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Matrix metalloproteinase-16,610.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Matrix metalloproteinase-17,748.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Matrix metalloproteinase-9,10623.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,68650.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,318.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Melanoma-derived growth regulatory protein,3758.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Membrane frizzled-related protein,2162.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,935.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mesothelin,385.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Metalloproteinase inhibitor 1,79.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Metalloproteinase inhibitor 2,426,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Metalloproteinase inhibitor 3,1778.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Methionine aminopeptidase 1,3162.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Methionine aminopeptidase 2,54050.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Methyl-CpG-binding domain protein 4,455.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,MHC class I polypeptide-related sequence A,302.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,MHC class I polypeptide-related sequence B,847.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Microtubule-associated protein tau,194.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Midkine,38884,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitochondrial glutamate carrier 2,836,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,534.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase 1,15607.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase 11,999.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase 12,1245.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase 13,471.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase 14,3462.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase 3,62741.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase 8,3103.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase 9,1118.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,1826.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Moesin,1191.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mothers against decapentaplegic homolog 2,28925,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mothers against decapentaplegic homolog 3,27321.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Mucin-1,1093,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Muellerian-inhibiting factor,9836.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Myc proto-oncogene protein,458.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Myeloblastin,4155.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Myeloid cell surface antigen CD33,1578.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Myeloperoxidase,15307.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Myoglobin,1745.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Myosin-binding protein C, slow-type",2821.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,N-acetyl-D-glucosamine kinase,1421.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,2587.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,4272.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,9638,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NADPH--cytochrome P450 reductase,2775.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,5733.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,2864.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,299.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,526.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Natural killer cell receptor 2B4,193.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Netrin-1,524.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Netrin-4,929.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Netrin receptor UNC5C,3800.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Netrin receptor UNC5D,5299.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",13403,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neural cell adhesion molecule L1,399.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,11140.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neuregulin-1,144.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neuregulin-4,663.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neurexin-1-beta,700.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neurexin-3-beta,832.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neurexophilin-1,4961.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1168.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neurogenic locus notch homolog protein 1,23060.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neurogenic locus notch homolog protein 2,660.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neurogenic locus notch homolog protein 3,785.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Neuroligin-4, X-linked",694.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neuronal cell adhesion molecule,17294.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neuronal growth regulator 1,4865.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neuropilin-1,3288.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neurotrophin-3,279.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neurotrophin-4,182.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neutral ceramidase,2915.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neutrophil-activating peptide 2,16406.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neutrophil collagenase,3236.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neutrophil elastase,377.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,26141.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,801.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Nidogen-1,6238.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Nidogen-2,3012.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NKG2D ligand 1,361.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NKG2D ligand 2,308.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NKG2D ligand 3,1140.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NKG2-D type II integral membrane protein,1005,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Noggin,4246.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Non-histone chromosomal protein HMG-14,819.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,1923.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NSFL1 cofactor p47,652.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NT-3 growth factor receptor,6956.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,N-terminal pro-BNP,20776.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,504.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Nucleoside diphosphate kinase A,598.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Nucleoside diphosphate kinase B,51408.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,NudC domain-containing protein 3,380.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,OCIA domain-containing protein 1,824.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Olfactomedin-4,161.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Oncostatin-M,1761.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,2579.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Osteocalcin,1136.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Osteomodulin,8972.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Osteopontin,9658.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,OX-2 membrane glycoprotein,2606.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,2139.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pancreatic hormone,3586.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pappalysin-1,21072.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Parathyroid hormone,3614.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Parathyroid hormone-related protein,934.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peptide YY,2016.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peptidoglycan recognition protein 1,660.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,191963,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,2893.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,22155.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,3558.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",30701.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Periostin,5835,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peroxiredoxin-1,3127.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",437.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peroxiredoxin-6,904.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,209.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Persephin,226,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",4194.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pescadillo homolog,241.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,9082.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",767.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2148.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Phosphoglucomutase-1,505.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Phosphoglycerate kinase 1,6006.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Phosphoglycerate mutase 1,790.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Phospholipase A2,2794.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Phospholipase A2, membrane associated",3853.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pigment epithelium-derived factor,52019.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,PIK3CA/PIK3R1,766.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,PILR alpha-associated neural protein,5085.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,314.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,209.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Placenta growth factor,290.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Plasma kallikrein,19790.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Plasma protease C1 inhibitor,7541.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Plasma serine protease inhibitor,92461.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Plasmin,666.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Plasminogen,3877.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Plasminogen activator inhibitor 1,1343.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet-activating factor acetylhydrolase,920.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,8660.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet-derived growth factor C,348.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet-derived growth factor receptor alpha,1518.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet-derived growth factor receptor beta,6677.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet-derived growth factor subunit A,30592.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet-derived growth factor subunit B,77132.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet endothelial cell adhesion molecule,978.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet factor 4,93003.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet glycoprotein 4,12090.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,1437.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet glycoprotein VI,24805,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Platelet receptor Gi24,458.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pleiotrophin,1913.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Plexin-B2,4215.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Plexin-C1,652.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Polymeric immunoglobulin receptor,1908.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,PolyUbiquitin K48-linked,1360.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,PolyUbiquitin K63-linked,4527,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Prefoldin subunit 5,397.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Programmed cell death 1 ligand 1,967.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Programmed cell death 1 ligand 2,5101.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Prokineticin-1,178,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Prolactin,543.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Prolactin receptor,1267,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proliferating cell nuclear antigen,192.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proliferation-associated protein 2G4,3507.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Prolyl endopeptidase FAP,692.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pro-opiomelanocortin,583.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Properdin,116125.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,2101.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,755.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Prostaglandin G/H synthase 2,482.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Prostate-specific antigen,7371.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proteasome activator complex subunit 1,1526.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proteasome activator complex subunit 3,286.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proteasome subunit alpha type-1,7026.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proteasome subunit alpha type-2,628.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proteasome subunit alpha type-6,1358.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein 4.1,9593.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein amnionless,122.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein deglycase DJ-1,390.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein disulfide-isomerase,204.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein disulfide-isomerase A3,4145.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein E7_HPV16,390.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein E7_HPV18,1847.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein FAM107A,292.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein FAM107B,2518.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein FAM3B,980.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein FAM3D,7707.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,6309.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein jagged-1,495.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein jagged-2,283.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein kinase C alpha type,113257.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),20856.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein kinase C delta type,5659.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein kinase C gamma type,445.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein kinase C iota type,3450.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein kinase C theta type,6172.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein kinase C zeta type,833.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein lin-7 homolog B,450.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein NOV homolog,648,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein Rev_HV2BE,155.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein S100-A12,785.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein S100-A4,2240.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein S100-A6,2829.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein S100-A7,220.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein S100-A9,7305.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein SET,548.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein-tyrosine kinase 6,205.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein Wnt-7a,198.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Protein Z-dependent protease inhibitor,4095.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Prothrombin,160745.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,723.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,94535.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Proto-oncogene vav,13788.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,P-selectin,24666.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pulmonary surfactant-associated protein D,9192.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pyridoxal kinase,500.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pyridoxal phosphate phosphatase,6727.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1299.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Pyruvate kinase PKM,72368.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Quinone oxidoreductase-like protein 1,1834,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Rab GDP dissociation inhibitor beta,28365,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,10083,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,30905.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ras GTPase-activating protein 1,1406.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,54951.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,12826.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,7195.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,411.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,262.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,150.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Regenerating islet-derived protein 4,2789.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Relaxin receptor 1,374.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Renin,356.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Repulsive guidance molecule A,20177.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Resistin,1280,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Reticulon-4 receptor,1440.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Retinoblastoma-associated protein,1241.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Retinoic acid receptor responder protein 2,2376.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Retinol-binding protein 4,246.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,RGM domain family member B,2184,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ribonuclease H1,147.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,1041.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,314.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ribosome maturation protein SBDS,36040.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,RNA-binding protein 39,317.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Roundabout homolog 2,2878.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Roundabout homolog 3,320.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,R-spondin-2,391.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,R-spondin-3,1809.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,R-spondin-4,469.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Scavenger receptor class F member 1,9067.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Scavenger receptor class F member 2,243.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,3164.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sclerostin,48473.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Secreted and transmembrane protein 1,1084,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Secreted frizzled-related protein 1,6667,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Secreted frizzled-related protein 3,3893,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Secretin,212.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Seizure 6-like protein 2,2138.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Semaphorin-3A,1592.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Semaphorin-3E,3383.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Semaphorin-5A,7210.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Semaphorin-6A,13943.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Semaphorin-6B,4619.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine protease 27,6098,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",6019.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase 16,1934.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase 17B,4807.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase Chk1,531.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase Chk2,158.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1143.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,1032.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,20354.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,549,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase pim-1,801,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase PLK1,158.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1505.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase TBK1,264,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serine/threonine-protein kinase WNK3,872.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serotransferrin,242613.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serum albumin,8521.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serum amyloid A-1 protein,180.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serum amyloid P-component,34249.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Serum paraoxonase/arylesterase 1,191,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sex hormone-binding globulin,4106.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,S-formylglutathione hydrolase,3614.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SH2 domain-containing protein 1A,3269.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SHC-transforming protein 1,16494.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,20938,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,158.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1448.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,34147.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sialoadhesin,163.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,21046.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Signal transducer and activator of transcription 3,4023.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Signal transducer and activator of transcription 6,1036.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SLAM family member 5,11811.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SLAM family member 6,430.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SLAM family member 7,68251.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SLIT and NTRK-like protein 1,1383.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SLIT and NTRK-like protein 5,2512.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,5156.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Small nuclear ribonucleoprotein F,2902.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Small ubiquitin-related modifier 3,5517.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Somatostatin-28,1774.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Somatotropin,262.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sonic hedgehog protein,1149.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sorting nexin-4,21311.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SPARC,38300.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SPARC-like protein 1,11268.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,3569,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",135.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,S-phase kinase-associated protein 1,5968.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sphingosine kinase 1,20130.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Sphingosine kinase 2,514.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Spondin-1,2462.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Stabilin-2,757.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Stanniocalcin-1,1656.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Stem cell growth factor-alpha,3284.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Stem Cell Growth Factor-beta,1278.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Stress-induced-phosphoprotein 1,10775.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Stromal cell-derived factor 1,7763.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Stromelysin-1,3208.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Stromelysin-2,830.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,SUMO-conjugating enzyme UBC9,3586,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Superoxide dismutase [Cu-Zn],1469.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",49747.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Synaptosomal-associated protein 25,1441.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Syntaxin-1A,280.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,7355.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,TATA-box-binding protein,437.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,T-cell surface glycoprotein CD4,341.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tenascin,30417.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,710.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Testican-1,3295.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Testican-2,805.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,TGF-beta receptor type-2,838.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thioredoxin domain-containing protein 12,3034,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thrombin,881.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thrombopoietin,190.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thrombopoietin Receptor,189.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thrombospondin-1,6646.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thrombospondin-2,10612.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thrombospondin-4,544.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thymic stromal lymphopoietin,467.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Thymidine kinase, cytosolic",511.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thymidylate synthase,478.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thyroglobulin,324.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thyroid peroxidase,1544.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thyroid Stimulating Hormone,1134,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Thyroxine-binding globulin,46678.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tissue Factor,1322.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tissue factor pathway inhibitor,61839.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tissue-type plasminogen activator,514.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,T-lymphocyte activation antigen CD80,555.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,T-lymphocyte activation antigen CD86,1130,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,2914.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Toll-like receptor 2,524.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Toll-like receptor 4,272.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4741,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transcription factor AP-1,3721.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,1879.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transforming growth factor beta-1,1390.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transforming growth factor beta-2,203.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transforming growth factor beta-3,414.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,46088.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transforming growth factor beta receptor type 3,29285.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transgelin-2,8819.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transketolase,78108.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Translationally-controlled tumor protein,28635.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Transmembrane glycoprotein NMB,5678.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Trefoil factor 1,8156.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Trefoil factor 2,12336.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Trefoil factor 3,12306.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Triosephosphate isomerase,15160.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tropomyosin alpha-1 chain,1071.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tropomyosin alpha-4 chain,151404,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tropomyosin beta chain,1953.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Troponin I, cardiac muscle",497.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Troponin I, fast skeletal muscle",6235.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Troponin T, cardiac muscle",3559.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Trypsin-1,7015.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Trypsin-2,2458.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Trypsin-3,345.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tryptase beta-2,930.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tryptase gamma,223.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor-associated calcium signal transducer 2,426.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor,519.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,5781.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,456.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,767,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,1398.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,562.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,861.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,680.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,286.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",538.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,2573.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,369.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1369.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,345,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,1090,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1306.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,13906.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,192.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,957.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2457.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,529.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,9735.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,791,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,1018.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,2590.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,1160.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,10981.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,8701,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,842.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,5569.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,794.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,1737.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,713.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,1059.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,397.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,2328.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase ABL1,137.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase BTK,21388.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase CSK,18959.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase Fer,3805.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase Fgr,444.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase Fyn,4306.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase HCK,169.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase JAK2,127565.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase Lck,306.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase Lyn,8505,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",46153.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",6453.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,518.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase Tec,6605.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,625.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase Yes,1453.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,12523.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,13320,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,2218.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,281.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,11764.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,6799.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin,1413.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",4070.5,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,938.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1891.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,4485.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,2431.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,10389.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin-fold modifier 1,10917.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,41485.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Ubiquitin-like protein ISG15,2838.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,UMP-CMP kinase,4796.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Urokinase plasminogen activator surface receptor,11324.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Urokinase-type plasminogen activator,1663,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,51860.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vascular cell adhesion protein 1,14104.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vascular endothelial growth factor A,12923.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",716.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vascular endothelial growth factor C,1830.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vascular endothelial growth factor D,481.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vascular endothelial growth factor receptor 2,6526.2,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vascular endothelial growth factor receptor 3,7757.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vasoactive Intestinal Peptide,434.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vesicular integral-membrane protein VIP36,9148.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vitamin K-dependent protein C,1332.1,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vitamin K-dependent protein S,4432.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Vitronectin,30326.3,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,von Willebrand factor,15304,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,303.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",990.8,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7352.6,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,2727.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,1051.7,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Wnt inhibitory factor 1,3496.4,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,Xaa-Pro aminopeptidase 1,14576.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,1093.9,RFU
BF-1083,PDHC631ZTT,M0,0,Plasma,X-ray repair cross-complementing protein 6,260.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,36641.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,14-3-3 protein epsilon,901.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,14-3-3 protein family,7660.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,14-3-3 protein sigma,644.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,14-3-3 protein theta,1258.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,240293.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1314.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",477.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,342.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,485.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,296.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,2058.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",5155.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",578.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,1320.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,40S ribosomal protein S3,623,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,40S ribosomal protein S3a,698.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,40S ribosomal protein S7,13143.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,40S ribosomal protein SA,1653.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",24721.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",25733.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,72 kDa type IV collagenase,6901.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1631.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,201.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,3750,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Activated Protein C,860.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Activin receptor type-1B,257.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Adapter molecule crk,14698.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,31186.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Adenylosuccinate lyase,3189.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,778,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,667.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Adiponectin,4243.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2994.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,405.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,335.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,165,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,384.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,552.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,9274,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Adrenomedullin,2004.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",379.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Afamin,28864.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,6963.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Aggrecan core protein,529.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Agouti-related protein,2321.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,AH receptor-interacting protein,9214.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alanine aminotransferase 1,3420.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],5977.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Allograft inflammatory factor 1,2973.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",8273.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,267124.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,4245.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-1-antitrypsin,1019.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-2-antiplasmin,1835.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1771,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-2-macroglobulin,12084.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,676.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-enolase,77756.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,alpha-Fetoprotein,728.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-L-iduronidase,1270.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,8737.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Alpha-synuclein,19975.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Aminoacylase-1,2350.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Amphiregulin,4925,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Amphoterin-induced protein 2,2163.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),334.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),8631.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Amyloid beta A4 protein,44632,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiogenin,4995.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiopoietin-1,989.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",2423.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiopoietin-2,145.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiopoietin-4,567.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiopoietin-related protein 3,460.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiopoietin-related protein 4,4737.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiostatin,20126.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,551.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Angiotensinogen,5257.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ankyrin-2,476.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Annexin A1,6913.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Annexin A2,9758.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Annexin A5,1012.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Annexin A6,28555.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,808.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Antileukoproteinase,38080.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Antithrombin-III,120521.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein A-I,14608.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein B,8772.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein D,4641.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein E,42294.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),259318.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),230628,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),253745.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein L1,31159.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apolipoprotein M,12431.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,1608.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Appetite-regulating hormone,1110.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Arginase-1,1067,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,321.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Artemin,425.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Arylsulfatase A,1347.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Arylsulfatase B,872.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1243.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",3458.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,5904.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",1737,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",5864.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Atrial natriuretic factor,750,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,697.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Aurora kinase A,1084.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Aurora kinase B,690.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Azurocidin,327.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,894.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,202.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,585.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,102.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1599.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Basigin,328.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,1560.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,B-cell receptor CD22,902.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,15402,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bcl-2-like protein 1,1590,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bcl-2-like protein 2,692.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bcl-2-related protein A1,880.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,968.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Beta-2-microglobulin,2253.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,11729.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,4921.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Betacellulin,536.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Beta-endorphin,873.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,beta-nerve growth factor,483.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,BH3-interacting domain death agonist,1925.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Biglycan,2503.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,413.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1183.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bone morphogenetic protein 1,2877,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bone morphogenetic protein 6,17087,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bone morphogenetic protein 7,681.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,699,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,454.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Bone sialoprotein 2,5074.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,2340.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Brain natriuretic peptide 32,460.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Brain-specific serine protease 4,1960.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1438,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Brevican core protein,1633.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Brother of CDO,1313.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C3a anaphylatoxin,2197.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,151586.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C5a anaphylatoxin,8048,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cadherin-12,888.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cadherin-15,4288.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cadherin-1,75512.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cadherin-2,1686.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cadherin-3,23489.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cadherin-5,10480.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cadherin-6,516.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcineurin,2583.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcineurin subunit B type 1,7442.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",966.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,504.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,4025.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1976,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,936.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,2367,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,7518.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,324.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calpain I,84941.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calpastatin,8331.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Calreticulin,2120.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,1945.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,5419.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1672.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,5350.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,313.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,265.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase 1,15013.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase 13,4657.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase 2,267.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase 3,2996.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase 4,2187.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase 6,8260.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase 7,302.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase 9,1251.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,631.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carboxypeptidase B2,11318.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Carboxypeptidase E,1754.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cardiotrophin-1,683.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,13579.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,549.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Casein kinase II subunit alpha,510.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Caspase-10,3604,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Caspase-2,317.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Caspase-3,23635.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Catalase,14920.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin B,2074.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin D,786.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin E,486.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin F,3058.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin G,809.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin H,994.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin L2,1280.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin S,934.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cathepsin Z,4655.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,31009,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,855.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 1,2343.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 13,408.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 14,8081.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 15,4797.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 16,36014.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 17,2512.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 18,6823.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 19,410.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 20,133.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 21,32540.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 22,1728.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 23,3479,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 24,315.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 25,1247.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 26,999.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 27,1300.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 28,9930.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 2,909,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 3,744.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,1707.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 4-like,528.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 5,104154.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 7,1058.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-C motif chemokine 8,232.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD109 antigen,4372.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD166 antigen,15024.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD177 antigen,702,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD209 antigen,1327.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD226 antigen,777.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD27 antigen,6934.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD40 ligand,476.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD48 antigen,576.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD59 glycoprotein,2282.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD5 antigen-like,1936,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD63 antigen,438.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD70 antigen,276.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD83 antigen,312.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CD97 antigen,1805.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cell adhesion molecule 1,2257.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cell adhesion molecule 3,1504.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5518.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,884.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cellular tumor antigen p53,909.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,4638,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",6612,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",864.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",33432.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Chitinase-3-like protein 1,7936.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Chitotriosidase-1,3255.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,8237.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Choline/ethanolamine kinase,2503.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Chordin-like protein 1,3020.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,3247.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Chromobox protein homolog 5,415.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Chromogranin-A,25977.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Chymase,621,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ciliary neurotrophic factor,190.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,8092.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ck-beta-8-1,84029.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Clusterin,1174.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,CMRF35-like molecule 6,4011.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coactosin-like protein,3105.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coagulation factor IX,12089.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coagulation factor IXab,8446.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coagulation Factor V,54143.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coagulation factor VII,687.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coagulation Factor X,5416.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coagulation factor Xa,4341,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coagulation Factor XI,1657.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cofilin-1,15323.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,2623.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,859.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,379.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Collagenase 3,604.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Collectin-11,5992.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Collectin-12,1624.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,COMM domain-containing protein 7,2477,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C1q subcomponent,42969.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C1r subcomponent,1484.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C2,2801.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C3,139257.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C3b,15921.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Complement C3b, inactivated",8368.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C3d fragment,8260.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C4,128236.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C4b,208.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C5,6837.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement C5b-C6 complex,497.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4568.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement component C1q receptor,10223.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement component C6,77432.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement component C7,1347,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement component C8,2567.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement component C9,76009.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement decay-accelerating factor,18404.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement factor B,18647.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement factor D,1200.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement factor H,51355.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement factor H-related protein 5,1143.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Complement factor I,38599.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Connective tissue-activating peptide III,45910.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Connective tissue growth factor,2083.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Contactin-1,374.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Contactin-2,1069.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Contactin-4,3866.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Contactin-5,531.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Copine-1,7150.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Corticosteroid-binding globulin,646.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Corticotropin,401.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-reactive protein,40052,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Creatine kinase B-type,1068.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Creatine kinase M-type,768.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,442.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cryptic protein,2106.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,26998.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,162.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,52403.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,680.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-type mannose receptor 2,2964.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-X-C motif chemokine 10,2528,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-X-C motif chemokine 11,4617.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-X-C motif chemokine 13,6372.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-X-C motif chemokine 16,11032.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-X-C motif chemokine 5,642.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-X-C motif chemokine 6,3322.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,C-X-C motif chemokine 9,640.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,726.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,298.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1250.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1981.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,2050.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cystatin-C,2993.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cystatin-D,3170,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cystatin-F,875.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cystatin-M,12394.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cystatin-S,225.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cystatin-SA,13407.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cystatin-SN,901.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,3148.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,300.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,2171.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytochrome c,2771.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytochrome P450 3A4,28232.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,5374.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,410.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,1634.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,1337.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,302.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,16150.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,1409.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,1333.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,87.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,14654.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,D-dimer,13686.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Death-associated protein kinase 2,2965.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Decorin,4033.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Delta-like protein 1,2488.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Delta-like protein 4,561.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dermatopontin,5263.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Desert hedgehog protein N-product,889.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Desmocollin-2,3321.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Desmocollin-3,288.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Desmoglein-1,3064.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",4309.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dickkopf-like protein 1,2855.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dickkopf-related protein 1,42023.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dickkopf-related protein 3,5533.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dickkopf-related protein 4,8683.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,542.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,1217.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1640.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,435,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1292.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,751.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,2691.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,DNA topoisomerase 1,487.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,915.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Drebrin-like protein,4189.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2357.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,417.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1986.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,2555.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,70050.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,5208.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2173.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dynactin subunit 2,1517.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",278.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,3757.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,625.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,1583.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,207.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,1120.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,395.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",1653,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1595.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1183.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3221.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,3769,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1612.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Elafin,24764.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Elongation factor 1-beta,871.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Endoglin,1655.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,103761.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,5789.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Endostatin,80102.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,4003.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,1444.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,3766.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,18674.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Enteropeptidase,186.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Eotaxin,9230.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin-A2,1045.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin-A3,2012.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin-A4,1995.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin-A5,3721.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin-B1,2151.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin-B2,17289.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin-B3,830.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin type-A receptor 10,402.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin type-A receptor 1,12394.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin type-A receptor 2,3494.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin type-A receptor 3,136.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin type-A receptor 5,617.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin type-B receptor 2,19577.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin type-B receptor 4,2872.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ephrin type-B receptor 6,1744.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Epidermal growth factor,1378,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Epidermal growth factor receptor,23474,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,549.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,190.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Epiregulin,1051.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,332.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Erythropoietin,1196.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Erythropoietin receptor,378.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,E-selectin,26294.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,1642.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Estrogen receptor,756.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,456.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,292.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,6445.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,11175.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,1789.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,61427.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Extracellular matrix protein 1,15797.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],1122.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,FACT complex subunit SSRP1,437,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",914.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",18861.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",4560.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fc receptor-like protein 3,412.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ferritin,27226.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fetuin-B,2799.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibrinogen,153024.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibrinogen gamma chain,63568,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 10,199.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 1,175,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 12,187.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 16,3967.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 17,207.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 18,253.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 19,14189.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 20,429.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 2,1661.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 23,422.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 4,207.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 5,674,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 6,504.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 7,2505.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,537.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,748,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor 9,514.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,866.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,216,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,775.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,730.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibronectin,10001.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibronectin Fragment 3,2151.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fibronectin Fragment 4,59235.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ficolin-1,2159.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ficolin-2,1511.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ficolin-3,278.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,463.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Focal adhesion kinase 1,281.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Follicle stimulating hormone,610.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Follistatin,866,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Follistatin-related protein 1,35873.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Follistatin-related protein 3,7349.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,2584.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fractalkine,3565.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,111646.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,381.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,338.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galectin-10,1251.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galectin-2,461.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galectin-3,28762.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galectin-3-binding protein,696.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galectin-4,735.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galectin-7,700.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galectin-8,450.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Galectin-9,1700.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Gamma-enolase,45364.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Gastrin-releasing peptide,311,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,GDNF family receptor alpha-1,1363.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,GDNF family receptor alpha-2,5156.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,GDNF family receptor alpha-3,812.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Gelsolin,833,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glia-derived nexin,1316.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,354.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glial fibrillary acidic protein,612.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glucagon,2288.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glucocorticoid receptor,91.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glucokinase regulatory protein,457.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,34218.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,327.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glutathione S-transferase A3,205.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glutathione S-transferase P,8825,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,163139.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1087.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,27672.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,6588.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glypican-2,181.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glypican-3,944.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glypican-5,1059,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Glypican-6,1772.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",999.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Granulins,24755.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1491.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,725.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,272.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Granulysin,1979.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Granzyme A,3236.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Granzyme B,204,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Granzyme H,234.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,GRB2-related adapter protein 2,481.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Gremlin-1,380.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Gro-beta/gamma,1548.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,544.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,246.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth arrest-specific protein 1,670.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth/differentiation factor 11,831.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,857.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth/differentiation factor 15,1591.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth/differentiation factor 2,2508.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth/differentiation factor 5,1489.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth/differentiation factor 8,3959.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth/differentiation factor 9,604.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,67728.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth hormone receptor,831.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Growth-regulated alpha protein,5249.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,GTPase KRas,1365.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,13452.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Haptoglobin,60988.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,9513.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,1882.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heat shock protein beta-1,19610.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,10357,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,59611.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heme oxygenase 2,409.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,HemK methyltransferase family member 2,3829,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hemoglobin,1771.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hemojuvelin,991.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hemopexin,2197.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2471.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,323.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heparin cofactor 2,3867.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,11063.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hepatocyte growth factor,1472.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hepatocyte growth factor activator,4073.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,3688.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,8969.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,780.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hepcidin,25904.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,1159.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,2152.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,382.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2668.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3856.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hexokinase-1,1309,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hexokinase-2,787.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",361.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",371.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,269.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,3181.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,High mobility group protein B1,8277.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histidine-rich glycoprotein,4696.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,2307.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1347.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,317.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone deacetylase 8,2616.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone H1.2,1747.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone H2A type 3,712.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone H2A.z,1849.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone H2B type 2-E,16925.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone H3.1,1549.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,299.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Homeobox protein NANOG,146.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,407.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,524.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,2067.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,778.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,595.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,ICOS ligand,2401.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Iduronate 2-sulfatase,3489.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Immunoglobulin A,5272.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,173.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Immunoglobulin D,2469.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Immunoglobulin E,145.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Immunoglobulin G,226186.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Immunoglobulin M,2856.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,5955.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Importin subunit alpha-1,248.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Importin subunit beta-1,10524.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1462.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Inducible T-cell costimulator,633.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Inhibin beta A chain,4292.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,763.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Inhibitor of growth protein 1,29816.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Inorganic pyrophosphatase,44117.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,2747.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2448.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin,125.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-degrading enzyme,2782.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,5874,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,1481.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,1164.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,1141.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,5883.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,2270.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,847.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,51919.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin-like growth factor I,946.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Insulin receptor,9551.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,1036.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,2324.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,775.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,41398.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,3676.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,1833.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,585.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,781,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon alpha-10,300.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon alpha-2,127.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon alpha-7,230,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,1642.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon beta,698.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon gamma,720.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon gamma receptor 1,448,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon gamma receptor 2,705.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon lambda-1,388.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon lambda-2,147.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interferon regulatory factor 1,1512.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-10,182,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1218.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,1250.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-11,277.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-12,368.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,489.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,754,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-13,674.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,2338.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,986.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-16,340.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-17A,337.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-17B,166.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-17D,224.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-17F,672.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-17 receptor A,519.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-17 receptor B,3213.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-17 receptor C,905.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-17 receptor D,481.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-18-binding protein,10998.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-18 receptor 1,8549.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,286.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-19,4700,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-1 alpha,639.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-1 beta,2368.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,46433,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,4856.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,2334.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,877.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,10054,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,9605.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-20,321.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,253,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-2,2361.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-22,935.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,731.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,2727.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-23,2095,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-23 receptor,2928.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-24,202.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-25,278.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-27,625.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,1295.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,1040,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-3,1337.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-34,706,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-36 alpha,1275.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-36 beta,431.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-37,2103.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,1646.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-4,592.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,214.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-5,265.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,1384.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-6,341.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,12363.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,6347.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-7,152,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,323.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-8,845.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interleukin-9,236.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Interstitial collagenase,3022.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Junctional adhesion molecule B,9736.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Junctional adhesion molecule C,7797.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Junctional adhesion molecule-like,425.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-11,945.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-12,5268.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-13,1180,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-14,8037.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-4,301.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-5,170.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-6,2747,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-7,1430.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallikrein-8,3481.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kallistatin,36234.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,460,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",1056.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1689.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,254.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,434.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,315.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kinesin-like protein KIF23,1629.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kininogen-1,20772.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,297.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kremen protein 2,4543.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,5888.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,1681.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Kynureninase,931.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lactadherin,967.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lactoperoxidase,596,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lactotransferrin,38781.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lamin-B1,766,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Laminin,3678.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1618.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Layilin,1471.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Legumain,2526.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leptin,3194.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leptin receptor,2135.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,1935.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,5766.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,1965.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,103.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,191.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1264.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,20379.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,5553.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,3981.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3525.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,10439.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,1297.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,1125.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,207.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Limbic system-associated membrane protein,1611.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,102878.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lithostathine-1-alpha,757.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,1752.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,4838.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,49.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,928.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1195.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Low-density lipoprotein receptor,160.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,43551.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",2226.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,2366.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,13444.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,L-Selectin,4405.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lumican,1622.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Luteinizing hormone,782,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,1331.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,255.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,9429.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lymphocyte antigen 86,4308.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lymphotactin,330.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,124,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,2541,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lymphotoxin-alpha,431.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lysosomal protective protein,8547.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lysosome membrane protein 2,391.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Lysozyme C,107655.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Macrophage-capping protein,1705.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1353.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,185.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Macrophage mannose receptor 1,9082.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Macrophage metalloelastase,2374.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,2148.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,994.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,494.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",31076.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mammaglobin-B,9512.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,4916.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mannose-binding protein C,10147.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,15197.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,1718.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,561.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,15173,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Matrilin-2,10615.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Matrilin-3,491,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Matrilysin,2850,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,224.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Matrix metalloproteinase-14,844.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Matrix metalloproteinase-16,658.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Matrix metalloproteinase-17,819.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Matrix metalloproteinase-9,8654.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,71470.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,346.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,3775.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Membrane frizzled-related protein,2137.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,998.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mesothelin,369.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,88.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,505.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,1749.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Methionine aminopeptidase 1,3139.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Methionine aminopeptidase 2,54057,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,445.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,274.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,815.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Microtubule-associated protein tau,200.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Midkine,43454.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,890.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,549.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,1033.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,15157.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,1102.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,484.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,3189.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,58472.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,2609.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,1061.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,1899.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Moesin,1328.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,24462.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,22416.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Mucin-1,1125.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Muellerian-inhibiting factor,9624.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Myc proto-oncogene protein,477.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Myeloblastin,3889,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,1417.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Myeloperoxidase,13816.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Myoglobin,2278.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",2300.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,1343.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,2548.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,3874.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,8928.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,2758.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,5507.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,2709.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,298.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,530.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,186.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Netrin-1,478.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Netrin-4,922.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Netrin receptor UNC5C,3745,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Netrin receptor UNC5D,5271.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",13347.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,407,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,11065.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neuregulin-1,144.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neuregulin-4,685.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neurexin-1-beta,686.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neurexin-3-beta,813.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neurexophilin-1,5477.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1199,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,22063.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,735.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,1056.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",691.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,14930.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neuronal growth regulator 1,4632.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neuropilin-1,3570.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neurotrophin-3,254.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neurotrophin-4,184.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neutral ceramidase,2810.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,15128,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neutrophil collagenase,2112,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neutrophil elastase,402.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,23352.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,633.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Nidogen-1,6226.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Nidogen-2,3109.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NKG2D ligand 1,376,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NKG2D ligand 2,303.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NKG2D ligand 3,1134.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,968.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Noggin,4434.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,813.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,2199.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NSFL1 cofactor p47,616.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NT-3 growth factor receptor,5920.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,N-terminal pro-BNP,13301.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,515.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,568.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,44503,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,NudC domain-containing protein 3,367.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,OCIA domain-containing protein 1,937.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Olfactomedin-4,165.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Oncostatin-M,1877.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,2757.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Osteocalcin,1145.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Osteomodulin,8192.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Osteopontin,9333,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,2643.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,1391.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pancreatic hormone,2987.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pappalysin-1,21030.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Parathyroid hormone,4070.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Parathyroid hormone-related protein,876.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peptide YY,1753.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,597.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,216985.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,3115,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,20397.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,3210.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",28435.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Periostin,5492.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peroxiredoxin-1,3361.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",472,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peroxiredoxin-6,1135.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,207.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Persephin,233.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",4211.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pescadillo homolog,246.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,9218.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",745.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2181.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Phosphoglucomutase-1,523.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,4308.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,1339.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Phospholipase A2,2861.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",3614.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pigment epithelium-derived factor,49427.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,PIK3CA/PIK3R1,677.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,PILR alpha-associated neural protein,5120.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,335.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,203.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Placenta growth factor,297.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Plasma kallikrein,18517.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,7299.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Plasma serine protease inhibitor,92050.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Plasmin,695.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Plasminogen,3560.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,1320.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,947.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,8713.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet-derived growth factor C,366,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,1427,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,6146,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,33000.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,85101.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,989.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet factor 4,96830.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet glycoprotein 4,11273.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,1354.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet glycoprotein VI,21350.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Platelet receptor Gi24,443.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pleiotrophin,2129.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Plexin-B2,4152.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Plexin-C1,620.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,1644.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,1463.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,4284.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Prefoldin subunit 5,371.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,936.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,4641.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Prokineticin-1,184.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Prolactin,628.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Prolactin receptor,1415.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,193.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,2935.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,673.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pro-opiomelanocortin,714.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Properdin,106433.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,1945.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,786.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,449,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Prostate-specific antigen,7219.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,1722.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,291.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,6867,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,662.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,1263.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein 4.1,9991.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein amnionless,126.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein deglycase DJ-1,417.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein disulfide-isomerase,192.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,4376.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein E7_HPV16,399.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein E7_HPV18,1993.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein FAM107A,289.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein FAM107B,2384.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein FAM3B,909,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein FAM3D,7013.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,5637.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein jagged-1,479.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein jagged-2,293.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein kinase C alpha type,99370.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),17083.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein kinase C delta type,3800.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein kinase C gamma type,460.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein kinase C iota type,2864.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein kinase C theta type,5009.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein kinase C zeta type,835.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein lin-7 homolog B,438.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein NOV homolog,653,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein Rev_HV2BE,150.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein S100-A12,675.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein S100-A4,2235.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein S100-A6,2801.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein S100-A7,219.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein S100-A9,4628.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein SET,521.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,233,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein Wnt-7a,215.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,4111.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Prothrombin,158553.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,675.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,94087.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Proto-oncogene vav,13415.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,P-selectin,24092.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,8167.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pyridoxal kinase,540.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,5926.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1392.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Pyruvate kinase PKM,72906.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,2030.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,26165.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,8231.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,25547.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,1336.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,53158.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,11872.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,8148.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,426.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,242.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,150.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,2459.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Relaxin receptor 1,377.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Renin,328.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Repulsive guidance molecule A,19966.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Resistin,1324.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Reticulon-4 receptor,1524.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1306.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,2933.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Retinol-binding protein 4,256.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,RGM domain family member B,2201.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ribonuclease H1,146.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,1091.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,290.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,32238.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,RNA-binding protein 39,316,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Roundabout homolog 2,2778,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Roundabout homolog 3,339.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,R-spondin-2,395.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,R-spondin-3,1828.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,R-spondin-4,459.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Scavenger receptor class F member 1,8912.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Scavenger receptor class F member 2,239.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,3022.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sclerostin,44327.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,1059.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,6609.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,3693.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Secretin,209,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Seizure 6-like protein 2,1957.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Semaphorin-3A,1814.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Semaphorin-3E,3376.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Semaphorin-5A,6593.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Semaphorin-6A,12630.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Semaphorin-6B,4665.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine protease 27,6616.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",5920.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,2016.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,4664.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,515,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,163.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,1187.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,1121.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,33880,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,561.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,819.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,166.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1495.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,257.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,914.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serotransferrin,225765.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serum albumin,9034.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serum amyloid A-1 protein,186,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serum amyloid P-component,33302.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,198,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sex hormone-binding globulin,4179.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,S-formylglutathione hydrolase,3818.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,4477.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SHC-transforming protein 1,15440.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,19557.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,150,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1371.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,31324.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sialoadhesin,161.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,18974.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,3623.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,959.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SLAM family member 5,11485.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SLAM family member 6,398.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SLAM family member 7,66195.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1399.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,2255.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,4665.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,2815,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,5559.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Somatostatin-28,1659.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Somatotropin,270,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sonic hedgehog protein,922.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sorting nexin-4,20343.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SPARC,37325.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SPARC-like protein 1,10939.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,3695.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",140.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,5776.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sphingosine kinase 1,18378.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Sphingosine kinase 2,550.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Spondin-1,2254.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Stabilin-2,715.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Stanniocalcin-1,1663.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Stem cell growth factor-alpha,3233.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,1344.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,11588.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Stromal cell-derived factor 1,7561.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Stromelysin-1,910.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Stromelysin-2,831.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,3556.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],1453.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",47798.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,1487.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Syntaxin-1A,284,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,7257.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,TATA-box-binding protein,453.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,359,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tenascin,29919.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,695.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Testican-1,3277.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Testican-2,850.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,TGF-beta receptor type-2,882.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,3022.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thrombin,942.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thrombopoietin,194.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thrombopoietin Receptor,186.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thrombospondin-1,7390.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thrombospondin-2,11144.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thrombospondin-4,636.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,453.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",522.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thymidylate synthase,474.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thyroglobulin,319.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thyroid peroxidase,1608.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,1376.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Thyroxine-binding globulin,44047.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tissue Factor,1429.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,64511.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tissue-type plasminogen activator,567,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,569.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,1078,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,2534.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Toll-like receptor 2,503.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Toll-like receptor 4,293.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4641.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transcription factor AP-1,5025,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,1874,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transforming growth factor beta-1,1512.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transforming growth factor beta-2,205.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transforming growth factor beta-3,441.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,48277.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,28947.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transgelin-2,8165.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transketolase,71618.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Translationally-controlled tumor protein,26898.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,5365.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Trefoil factor 1,7742.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Trefoil factor 2,11972.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Trefoil factor 3,13014,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Triosephosphate isomerase,14185,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,1106.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,155311.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tropomyosin beta chain,2091.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",479.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",5744.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",3813.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Trypsin-1,6916.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Trypsin-2,2312.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Trypsin-3,354.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tryptase beta-2,1009.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tryptase gamma,188.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,434.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor,522.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,5665.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,454.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,766.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,1321.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,589.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,955.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,693,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,300.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",538.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,2367.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,362,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1423.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,357.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,1029.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1335.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,14637.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,199.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,1011,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,2475.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,555.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,9781.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,786.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,1060.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,2668.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,1266.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,11636.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,8355,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,928.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,5936.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,792.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,1865.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,736.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,1085.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,364.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,2148.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,138.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,19703.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,17130.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,3401.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,375.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,5539.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,166,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,125639.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,326.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,8427,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",46449,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",6165.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,520.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,5760.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,632,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,1461.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,12812.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,9486.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,2321.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,293.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,8205.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,6202.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin,1424.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",3432.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,962.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1818.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,5282.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,2332.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,9775.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,8969.8,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,35102.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,2728.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,UMP-CMP kinase,5211.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,11132,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,1444.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,47578.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,14168.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vascular endothelial growth factor A,12899.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",733.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vascular endothelial growth factor C,1771.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vascular endothelial growth factor D,477.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,6442,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,7585.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,420.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,9956.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vitamin K-dependent protein C,1477.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vitamin K-dependent protein S,4546.9,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Vitronectin,35261.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,von Willebrand factor,15841.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,332.7,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",968,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7033.6,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,2399.4,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,1056.5,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Wnt inhibitory factor 1,3194.1,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,13543.3,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,1142.2,RFU
BF-1083,PDHC631ZTT,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,265.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,14-3-3 protein beta/alpha,17035.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,14-3-3 protein epsilon,1310.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,14-3-3 protein family,3694.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,14-3-3 protein sigma,650.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,14-3-3 protein theta,1184.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,14-3-3 protein zeta/delta,147961.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],2622.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",446.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,742.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,305.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,348.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1354.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",2794.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",964.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,992.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,40S ribosomal protein S3,497.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,40S ribosomal protein S3a,2730.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,40S ribosomal protein S7,928.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,40S ribosomal protein SA,4210.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",16986.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",7554.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,72 kDa type IV collagenase,8860.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Abelson tyrosine-protein kinase 2,1690.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,169,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,2665.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Activated Protein C,646.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Activin receptor type-1B,241.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Adapter molecule crk,11548,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Adenylate kinase isoenzyme 1,14943.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Adenylosuccinate lyase,4740.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Adhesion G protein-coupled receptor E2,661.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Adhesion G-protein coupled receptor G5,512.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Adiponectin,7974.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,273.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,3030,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,335.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,133.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,291.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,723.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,8601.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Adrenomedullin,2040.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",357.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Afamin,23450.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,2860.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Aggrecan core protein,612.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Agouti-related protein,1584.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,AH receptor-interacting protein,3895.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alanine aminotransferase 1,3420.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],3775.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Allograft inflammatory factor 1,3082.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",3717.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-1-antichymotrypsin,302048.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-1-antichymotrypsin complex,6775,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-1-antitrypsin,716.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-2-antiplasmin,1663,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-2-HS-glycoprotein,1055.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-2-macroglobulin,15652,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,676.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-enolase,34699.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,alpha-Fetoprotein,742.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-L-iduronidase,1045,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-soluble NSF attachment protein,5090.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Alpha-synuclein,8038.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Aminoacylase-1,2330.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Amphiregulin,1801.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Amphoterin-induced protein 2,2287.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),1837.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),3877.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Amyloid beta A4 protein,17070,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiogenin,3475.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiopoietin-1,733,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",2131.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiopoietin-2,222.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiopoietin-4,508.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiopoietin-related protein 3,304.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiopoietin-related protein 4,4312.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiostatin,17996.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiotensin-converting enzyme 2,528,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Angiotensinogen,6056.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ankyrin-2,551.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Annexin A1,5814.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Annexin A2,9438.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Annexin A5,1133,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Annexin A6,5015.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Anterior gradient protein 2 homolog,1135.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Antileukoproteinase,36253.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Antithrombin-III,118604.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein A-I,11856,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein B,7691,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein D,5200.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein E,46082.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein E (isoform E2),288163.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein E (isoform E3),250681.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein E (isoform E4),253269.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein L1,34698.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apolipoprotein M,14268.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Apoptosis regulator Bcl-2,1473,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Appetite-regulating hormone,1685.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Arginase-1,2331.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,359.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Artemin,462.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Arylsulfatase A,1196.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Arylsulfatase B,1561.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Asialoglycoprotein receptor 1,1643.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",15476.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,3868.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",2971.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",5701.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Atrial natriuretic factor,779.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,531,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Aurora kinase A,2098.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Aurora kinase B,654.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Azurocidin,239.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bactericidal permeability-increasing protein,750.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,551.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,475.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,96,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Basal Cell Adhesion Molecule,1621.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Basigin,385,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,B-cell lymphoma 6 protein,2340.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,B-cell receptor CD22,769.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bcl2-associated agonist of cell death,6711.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bcl-2-like protein 1,1101.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bcl-2-like protein 2,743.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bcl-2-related protein A1,935.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,BDNF/NT-3 growth factors receptor,1372.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Beta-2-microglobulin,2446.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,beta-adrenergic receptor kinase 1,6098.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Beta-Ala-His dipeptidase,5092.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Betacellulin,1161.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Beta-endorphin,1295.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,beta-nerve growth factor,1244.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,BH3-interacting domain death agonist,2431.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Biglycan,1795.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,BMP-binding endothelial regulator protein,382,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bone morphogenetic protein 10,1113.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bone morphogenetic protein 1,3031.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bone morphogenetic protein 6,15101.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bone morphogenetic protein 7,703.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,1159.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bone morphogenetic protein receptor type-2,903.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Bone sialoprotein 2,4180.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Brain-derived neurotrophic factor,538.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Brain natriuretic peptide 32,653.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Brain-specific serine protease 4,1405.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1292.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Brevican core protein,1386.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Brother of CDO,1509.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C3a anaphylatoxin,809.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C3a anaphylatoxin des Arginine,195090.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C5a anaphylatoxin,9156.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cadherin-12,529.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cadherin-15,3721.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cadherin-1,67856.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cadherin-2,3297.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cadherin-3,26166,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cadherin-5,22663,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cadherin-6,519.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcineurin,1482.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcineurin subunit B type 1,7478.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",733.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,307.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,7297.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1914.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,781.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,1727.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,6020,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calcium-dependent phospholipase A2,812,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calpain I,36740.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calpastatin,10130.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Calreticulin,2364.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,1808.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,cAMP-regulated phosphoprotein 19,1838.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",2732.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbohydrate sulfotransferase 15,8325.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbohydrate sulfotransferase 2,310.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbohydrate sulfotransferase 6,320.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase 1,11333.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase 13,2002.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase 2,594.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase 3,2810.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase 4,2452.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase 6,6083,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase 7,303.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase 9,2731.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carbonic anhydrase-related protein 10,600.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carboxypeptidase B2,13591.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Carboxypeptidase E,2161.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cardiotrophin-1,637,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,1332.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,7055.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Casein kinase II subunit alpha,347.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Caspase-10,4009.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Caspase-2,435.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Caspase-3,10971,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Catalase,11001.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin B,1281.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin D,476.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin E,545.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin F,3045,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin G,769.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin H,658.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin L2,1055.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin S,905.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cathepsin Z,6353.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,34322.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CCAAT/enhancer-binding protein beta,1369,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 1,2556.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 13,500.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 14,9211.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 15,6671.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 16,37862,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 17,2070.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 18,9610.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 19,455.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 20,1094.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 21,24942.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 22,811.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 23,3576.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 24,298.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 25,1741.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 26,1557.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 27,1113.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 2,745.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 28,6579.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 3,1226.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 3-like 1,2265.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 4-like,478.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 5,25069.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 7,820.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-C motif chemokine 8,178.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD109 antigen,5070.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD166 antigen,20394.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD177 antigen,4181.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD209 antigen,2351.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD226 antigen,850.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD27 antigen,6378.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD40 ligand,268.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD48 antigen,704,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD59 glycoprotein,2683,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD5 antigen-like,2699,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD63 antigen,459.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD70 antigen,347.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD83 antigen,600.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CD97 antigen,1714.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cell adhesion molecule 1,3352.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cell adhesion molecule 3,1730.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5226.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,1245.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cellular tumor antigen p53,1383.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cerebral dopamine neurotrophic factor,5154.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",6206,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",814.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",14208.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Chitinase-3-like protein 1,15347.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Chitotriosidase-1,2721.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Chloride intracellular channel protein 1,5309,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Choline/ethanolamine kinase,2576,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Chordin-like protein 1,2688.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Chorionic somatomammotropin hormone,3879,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Chromobox protein homolog 5,399.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Chromogranin-A,29742.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Chymase,413.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ciliary neurotrophic factor,170.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,12940.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ck-beta-8-1,81428,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Clusterin,1273.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,CMRF35-like molecule 6,5641.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coactosin-like protein,3840.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coagulation factor IX,13573.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coagulation factor IXab,9920.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coagulation Factor V,64816.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coagulation factor VII,699.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coagulation Factor X,5029.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coagulation factor Xa,4176.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coagulation Factor XI,1742.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cofilin-1,8469.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Coiled-coil domain-containing protein 80,1813.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Collagen alpha-1(VIII) chain,1248.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Collagen alpha-1(XXIII) chain,310.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Collagenase 3,978.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Collectin-11,8589.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Collectin-12,3490.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,COMM domain-containing protein 7,2073.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C1q subcomponent,47115.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C1r subcomponent,1758,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C2,2417.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C3,95478.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C3b,7767.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Complement C3b, inactivated",13896.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C3d fragment,10915.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C4,91669.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C4b,766.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C5,6928.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement C5b-C6 complex,508.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",5400.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement component C1q receptor,16687.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement component C6,96576.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement component C7,1767.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement component C8,2928.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement component C9,54063.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement decay-accelerating factor,21456.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement factor B,18606.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement factor D,1441.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement factor H,47649.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement factor H-related protein 5,813,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Complement factor I,44852.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Connective tissue-activating peptide III,15032,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Connective tissue growth factor,1197,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Contactin-1,258.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Contactin-2,956.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Contactin-4,5113.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Contactin-5,531.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Copine-1,3397.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Corticosteroid-binding globulin,663.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Corticotropin,551.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-reactive protein,23526.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Creatine kinase B-type,1640.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Creatine kinase M-type,305.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,186.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cryptic protein,2016.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-type lectin domain family 1 member B,12582.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-type lectin domain family 4 member K,165,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-type lectin domain family 4 member M,51198.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-type lectin domain family 7 member A,551.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-type mannose receptor 2,4497.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-X-C motif chemokine 10,1729.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-X-C motif chemokine 11,5401.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-X-C motif chemokine 13,3489.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-X-C motif chemokine 16,18772.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-X-C motif chemokine 5,423.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-X-C motif chemokine 6,560.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,C-X-C motif chemokine 9,656.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,532.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,260.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1327.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1404.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,1329.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cystatin-C,6150,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cystatin-D,6598.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cystatin-F,850.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cystatin-M,12695.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cystatin-S,428.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cystatin-SA,17852.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cystatin-SN,1040.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cysteine and glycine-rich protein 3,3171.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cysteine-rich secretory protein 3,795.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,3011.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytochrome c,1926.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytochrome P450 3A4,17604.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytokine receptor common subunit gamma,2493.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,417.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytokine receptor-like factor 2,1028.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytoplasmic protein NCK1,2127.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,241.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytoskeleton-associated protein 2,28910.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytosolic non-specific dipeptidase,1030,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,670.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,110.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,dCTP pyrophosphatase 1,10784,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,D-dimer,12301.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Death-associated protein kinase 2,2523.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Decorin,3065.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Delta-like protein 1,3605.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Delta-like protein 4,406.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dermatopontin,5802.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Desert hedgehog protein N-product,387.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Desmocollin-2,4953.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Desmocollin-3,331.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Desmoglein-1,2500.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Diablo homolog, mitochondrial",4740.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dickkopf-like protein 1,2753.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dickkopf-related protein 1,14352.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dickkopf-related protein 3,7417.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dickkopf-related protein 4,4907.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dipeptidyl peptidase 1,831.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dipeptidyl peptidase 2,6037.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Discoidin domain-containing receptor 2,3905.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,4260.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1111.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,DnaJ homolog subfamily B member 1,513.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,DNA repair protein RAD51 homolog 1,3069.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,DNA topoisomerase 1,448.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Down syndrome cell adhesion molecule,1333.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Drebrin-like protein,2729.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2447.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,397.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2431.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,1969.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,49884.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dual specificity protein phosphatase 3,2295.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2125.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dynactin subunit 2,1473.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",287.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Dynein light chain roadblock-type 1,3338.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,1157.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,2185.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,173.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,13661.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,1040.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Ectodysplasin-A, secreted form",1528.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1653.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1038.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,4855.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,7907.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1846.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Elafin,8765.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Elongation factor 1-beta,508.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Endoglin,2252.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,109862.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Endoplasmic reticulum resident protein 29,9512.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Endostatin,98397.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Endothelial cell-selective adhesion molecule,5812.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Endothelial cell-specific molecule 1,832.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,3833.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Endothelin-converting enzyme 1,16617.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Enteropeptidase,163.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Eotaxin,9347.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin-A2,1301.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin-A3,3093.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin-A4,2180.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin-A5,3911.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin-B1,2714.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin-B2,25579.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin-B3,816.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin type-A receptor 10,536.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin type-A receptor 1,16091.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin type-A receptor 2,5454.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin type-A receptor 3,162.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin type-A receptor 5,1251.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin type-B receptor 2,27180.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin type-B receptor 4,2705.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ephrin type-B receptor 6,2386.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Epidermal growth factor,417.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Epidermal growth factor receptor,26762,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,505.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Epidermal growth factor receptor variant III,4986.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Epiregulin,1614.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,327.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Erythropoietin,1483.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Erythropoietin receptor,266.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,E-selectin,20327.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,1518.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Estrogen receptor,592,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Eukaryotic initiation factor 4A-III,518.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,285,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,3698.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Eukaryotic translation initiation factor 4H,7019.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Eukaryotic translation initiation factor 5,1697.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,31728.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Extracellular matrix protein 1,12536.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],705.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,FACT complex subunit SSRP1,510.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Fatty acid-binding protein, epidermal",1398.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Fatty acid-binding protein, heart",43447.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Fatty acid-binding protein, liver",5555.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fc receptor-like protein 3,409.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ferritin,4549.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fetuin-B,4698.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibrinogen,150068.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibrinogen gamma chain,56150.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 10,185.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 1,161.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 12,205.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 16,1570.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 17,187.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 18,219.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 19,3865.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 20,307.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 23,5162.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 2,6370.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 4,166.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 5,603.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 6,258.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 7,1353.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 8 isoform A,258.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 8 isoform B,931.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor 9,467.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor receptor 1,880.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor receptor 2,335.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor receptor 3,3425,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibroblast growth factor receptor 4,2422.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibronectin,8139.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibronectin Fragment 3,1877.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fibronectin Fragment 4,63688.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ficolin-1,1813.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ficolin-2,1609.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ficolin-3,397.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,999.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Focal adhesion kinase 1,386.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Follicle stimulating hormone,4187.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Follistatin,715.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Follistatin-related protein 1,39835,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Follistatin-related protein 3,14642.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,14878.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fractalkine,5839.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Fructose-bisphosphate aldolase A,68953.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,G2/mitotic-specific cyclin-B1,772,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,490.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galectin-10,502.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galectin-2,436.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galectin-3,22767.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galectin-3-binding protein,1260.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galectin-4,479.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galectin-7,658.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galectin-8,551.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Galectin-9,7470,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Gamma-enolase,33240.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Gastrin-releasing peptide,673.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,GDNF family receptor alpha-1,1388.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,GDNF family receptor alpha-2,7115.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,GDNF family receptor alpha-3,840.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Gelsolin,967.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glia-derived nexin,1210.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glial cell line-derived neurotrophic factor,397.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glial fibrillary acidic protein,812.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glucagon,3621.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glucocorticoid receptor,86.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glucokinase regulatory protein,807.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glucose-6-phosphate isomerase,18582.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glutamate carboxypeptidase 2,656,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glutathione S-transferase A3,383.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glutathione S-transferase P,15953.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,80456.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",3465.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,10787.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,3230.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glypican-2,298.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glypican-3,528.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glypican-5,762.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Glypican-6,5123.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"gp41 C34 peptide, HIV",732.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Granulins,26610,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Granulocyte colony-stimulating factor,1795.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,760.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,325.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Granulysin,1281.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Granzyme A,1863.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Granzyme B,200.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Granzyme H,253.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,GRB2-related adapter protein 2,423,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Gremlin-1,319.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Gro-beta/gamma,543.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Group 10 secretory phospholipase A2,498.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Group IIE secretory phospholipase A2,294.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth arrest-specific protein 1,932.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth/differentiation factor 11,1819.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth/differentiation factor 11/8,596.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth/differentiation factor 15,1520.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth/differentiation factor 2,2208.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth/differentiation factor 5,1296.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth/differentiation factor 8,2878.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth/differentiation factor 9,951.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth factor receptor-bound protein 2,35527.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth hormone receptor,873.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Growth-regulated alpha protein,3197.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,GTPase KRas,1371,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,GTP-binding nuclear protein Ran,6568.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Haptoglobin,70247.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heat shock 70 kDa protein 1A,8167,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heat shock cognate 71 kDa protein,1671.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heat shock protein beta-1,12806.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,5606.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heat shock protein HSP 90-beta,34539.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heme oxygenase 2,318.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,HemK methyltransferase family member 2,2676.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hemoglobin,999.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hemojuvelin,1309.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hemopexin,1436,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2808.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heparin-binding EGF-like growth factor,253.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heparin cofactor 2,2627.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hepatitis A virus cellular receptor 2,17844.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hepatocyte growth factor,1510.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hepatocyte growth factor activator,3499.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hepatocyte growth factor-like protein,713,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hepatocyte growth factor receptor,8294.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,650.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hepcidin,2441,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,HERV-H LTR-associating protein 2,2199.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1183.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,322.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2525.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,2503.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hexokinase-1,3498.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hexokinase-2,668.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",349.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",605.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,258.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,High affinity nerve growth factor receptor,2804,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,High mobility group protein B1,4490,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histidine-rich glycoprotein,3533.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,1585.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone acetyltransferase KAT6A,1278.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,217.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone deacetylase 8,1895.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone H1.2,979.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone H2A type 3,630.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone H2A.z,1280,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone H2B type 2-E,12965.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone H3.1,1616.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,553.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Homeobox protein NANOG,122.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Homeodomain-interacting protein kinase 3,628.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hsp90 co-chaperone Cdc37,330.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Human Chorionic Gonadotropin,1878.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,1054.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,1263.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,ICOS ligand,2150.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Iduronate 2-sulfatase,4416.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Immunoglobulin A,3986.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Immunoglobulin alpha Fc receptor,280.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Immunoglobulin D,2443.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Immunoglobulin E,446.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Immunoglobulin G,254660.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Immunoglobulin M,4939.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,9251.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Importin subunit alpha-1,206.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Importin subunit beta-1,6964.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1409.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Inducible T-cell costimulator,601.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Inhibin beta A chain,3816.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,2210.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Inhibitor of growth protein 1,12861.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Inorganic pyrophosphatase,38897.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1577.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2319.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin,184.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-degrading enzyme,36744.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor 1 receptor,8680.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor-binding protein 1,1071.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor-binding protein 2,801.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor-binding protein 3,1613.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor-binding protein 4,5710.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor-binding protein 5,3273.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor-binding protein 6,2947,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor-binding protein 7,44040.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin-like growth factor I,1106,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Insulin receptor,10228.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Integrin alpha-I: beta-1 complex,1100.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,2587.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Integrin alpha-V: beta-5 complex,668.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,41032.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Intercellular adhesion molecule 1,6067.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Intercellular adhesion molecule 2,1581,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Intercellular adhesion molecule 3,593.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Intercellular adhesion molecule 5,856.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon alpha-10,496.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon alpha-2,139.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon alpha-7,388.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon alpha/beta receptor 1,2702.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon beta,769,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon gamma,932.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon gamma receptor 1,735.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon gamma receptor 2,505.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon lambda-1,259.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon lambda-2,135.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interferon regulatory factor 1,1206.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-10,155.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1461.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-10 receptor subunit beta,1344.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-11,225.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-12,311.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,582.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,868.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-13,1331.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,2452.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-15 receptor subunit alpha,1411,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-16,361.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-17A,395.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-17B,148.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-17D,192.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-17F,1023.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-17 receptor A,1448.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-17 receptor B,2858.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-17 receptor C,1050.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-17 receptor D,530.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-18-binding protein,11029.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-18 receptor 1,14471.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-18 receptor accessory protein,264.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-19,6489.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-1 alpha,586.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-1 beta,1964.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-1 Receptor accessory protein,34268.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-1 receptor antagonist protein,16105.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-1 receptor-like 1,11733.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-1 receptor-like 2,735.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-1 receptor type 1,13323.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-1 receptor type 2,16948.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-20,321.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-20 receptor subunit alpha,282.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-22,480.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-2,2577.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,692,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,939.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-23,949.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-23 receptor,1898.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-24,189.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-25,287.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-27,724.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-27 receptor subunit alpha,3106,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-2 receptor subunit alpha,880.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-3,1390.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-34,740.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-36 alpha,3925.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-36 beta,909.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-37,2239.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-3 receptor subunit alpha,832.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-4,389.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-4 receptor subunit alpha,295.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-5,377.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-5 receptor subunit alpha,2547.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-6,309.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-6 receptor subunit alpha,19065.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-6 receptor subunit beta,9541.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-7,226.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-7 receptor subunit alpha,391.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-8,875.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interleukin-9,393.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Interstitial collagenase,965.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Junctional adhesion molecule B,10689.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Junctional adhesion molecule C,4560.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Junctional adhesion molecule-like,903.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-11,1351,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-12,6234.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-13,953.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-14,8914.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-4,263.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-5,131,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-6,3100,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-7,677.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallikrein-8,2678.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kallistatin,39359.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kelch-like ECH-associated protein 1,903.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Keratin, type I cytoskeletal 18",1147.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1808.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,3645,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,1768.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,554.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kinesin-like protein KIF23,961.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kininogen-1,21250.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kin of IRRE-like protein 3,289.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kremen protein 2,2533.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kunitz-type protease inhibitor 1,4025.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kunitz-type protease inhibitor 2,763.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Kynureninase,885.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lactadherin,1192.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lactoperoxidase,730.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lactotransferrin,32660.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lamin-B1,568.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Laminin,2126.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1465.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Layilin,1940.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Legumain,2253,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leptin,51694.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leptin receptor,1358.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leucine carboxyl methyltransferase 1,2151.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,7655.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2162.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,105.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,187.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,759,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,34818.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,5024.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leukemia inhibitory factor receptor,6613.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,1913.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,6395.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leukocyte surface antigen CD47,640.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Leukotriene A-4 hydrolase,1201.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,278.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Limbic system-associated membrane protein,2119,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lipopolysaccharide-binding protein,101451.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lithostathine-1-alpha,541.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,L-lactate dehydrogenase B chain,870.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,3699.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,3919.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,2315.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,2276.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Low-density lipoprotein receptor,189.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,30029.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",2943.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,2222.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,5408.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,L-Selectin,4057.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lumican,2083.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Luteinizing hormone,2877.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,3289.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,551.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lymphocyte activation gene 3 protein,4056,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lymphocyte antigen 86,4464.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lymphotactin,337.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lymphotoxin alpha1:beta2,93.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lymphotoxin alpha2:beta1,1664.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lymphotoxin-alpha,950.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lysosomal protective protein,5173,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lysosome membrane protein 2,501.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Lysozyme C,113050.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Macrophage-capping protein,1992.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Macrophage colony-stimulating factor 1,1332.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,194.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Macrophage mannose receptor 1,18754.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Macrophage metalloelastase,743.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Macrophage migration inhibitory factor,996.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Macrophage scavenger receptor types I and II,753.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Macrophage-stimulating protein receptor,449.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",15580.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mammaglobin-B,8593.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mannan-binding lectin serine protease 1,5921.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mannose-binding protein C,20900.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,MAP kinase-activated protein kinase 2,6849.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,MAP kinase-activated protein kinase 3,1228.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,MAP kinase-activated protein kinase 5,741.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,14024.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Matrilin-2,10443.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Matrilin-3,458.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Matrilysin,2683.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,189.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Matrix metalloproteinase-14,4704.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Matrix metalloproteinase-16,620.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Matrix metalloproteinase-17,782.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Matrix metalloproteinase-9,19624.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,88810,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,403.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Melanoma-derived growth regulatory protein,3909.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Membrane frizzled-related protein,1475.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,914.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mesothelin,450.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Metalloproteinase inhibitor 1,73.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Metalloproteinase inhibitor 2,387.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Metalloproteinase inhibitor 3,1645.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Methionine aminopeptidase 1,1743.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Methionine aminopeptidase 2,24271.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Methyl-CpG-binding domain protein 4,327.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,MHC class I polypeptide-related sequence A,567.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,MHC class I polypeptide-related sequence B,975.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Microtubule-associated protein tau,329.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Midkine,15208.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitochondrial glutamate carrier 2,730.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,456.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase 11,833.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase 12,895.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase 13,1120.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase 14,1877.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase 1,6238,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase 3,23810.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase 8,1552.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase 9,1006.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,2136,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Moesin,2221.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mothers against decapentaplegic homolog 2,10493.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mothers against decapentaplegic homolog 3,12656.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Mucin-1,14391.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Muellerian-inhibiting factor,12183.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Myc proto-oncogene protein,1045.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Myeloblastin,3787.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Myeloid cell surface antigen CD33,5242.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Myeloperoxidase,12692.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Myoglobin,1674.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Myosin-binding protein C, slow-type",1630.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,N-acetyl-D-glucosamine kinase,575.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,2680.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,6853.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,8514.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NADPH--cytochrome P450 reductase,3223.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,3670.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,3309.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,287.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,447.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Natural killer cell receptor 2B4,206.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Netrin-1,530.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Netrin-4,576,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Netrin receptor UNC5C,6165.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Netrin receptor UNC5D,10010.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",11898,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neural cell adhesion molecule L1,442.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,18521.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neuregulin-1,249.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neuregulin-4,1114.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neurexin-1-beta,1144.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neurexin-3-beta,965.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neurexophilin-1,2966.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,2023.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neurogenic locus notch homolog protein 1,25191.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neurogenic locus notch homolog protein 2,2395.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neurogenic locus notch homolog protein 3,635.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Neuroligin-4, X-linked",686,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neuronal cell adhesion molecule,15418.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neuronal growth regulator 1,6260.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neuropilin-1,3022.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neurotrophin-3,226.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neurotrophin-4,187.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neutral ceramidase,3214.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neutrophil-activating peptide 2,5065.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neutrophil collagenase,3188.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neutrophil elastase,479.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,12411.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,684.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Nidogen-1,4181.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Nidogen-2,2056.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NKG2D ligand 1,434.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NKG2D ligand 2,448.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NKG2D ligand 3,865.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NKG2-D type II integral membrane protein,1130.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Noggin,1848.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Non-histone chromosomal protein HMG-14,646.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,3716.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NSFL1 cofactor p47,484.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NT-3 growth factor receptor,7454.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,N-terminal pro-BNP,16093.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,754.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Nucleoside diphosphate kinase A,587.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Nucleoside diphosphate kinase B,15281.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,NudC domain-containing protein 3,364.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,OCIA domain-containing protein 1,791.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Olfactomedin-4,154.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Oncostatin-M,2136.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,3982.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Osteocalcin,1070,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Osteomodulin,12168.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Osteopontin,10828.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,OX-2 membrane glycoprotein,3853.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,1266.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pancreatic hormone,3459.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pappalysin-1,19378.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Parathyroid hormone,2846.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Parathyroid hormone-related protein,783.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peptide YY,1792.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peptidoglycan recognition protein 1,508.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,116475.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,2767.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,4202.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,1096.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",17934.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Periostin,6067.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peroxiredoxin-1,1513,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",616.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peroxiredoxin-6,367.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,369.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Persephin,199.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3329,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pescadillo homolog,178.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,4884.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1136.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",1777.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Phosphoglucomutase-1,894.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Phosphoglycerate kinase 1,5242.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Phosphoglycerate mutase 1,387.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Phospholipase A2,1455.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Phospholipase A2, membrane associated",10405.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pigment epithelium-derived factor,64412.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,PIK3CA/PIK3R1,579,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,PILR alpha-associated neural protein,7124,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,762.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,286.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Placenta growth factor,715.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Plasma kallikrein,23414,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Plasma protease C1 inhibitor,9809.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Plasma serine protease inhibitor,105538.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Plasmin,607.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Plasminogen,3426.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Plasminogen activator inhibitor 1,342.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet-activating factor acetylhydrolase,663.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,4729,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet-derived growth factor C,558.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet-derived growth factor receptor alpha,72832.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet-derived growth factor receptor beta,8829.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet-derived growth factor subunit A,6477,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet-derived growth factor subunit B,17794.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet endothelial cell adhesion molecule,1083.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet factor 4,21078.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet glycoprotein 4,11667.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,995.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet glycoprotein VI,10026.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Platelet receptor Gi24,733.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pleiotrophin,2025.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Plexin-B2,5185.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Plexin-C1,775.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Polymeric immunoglobulin receptor,2602.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,PolyUbiquitin K48-linked,1486.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,PolyUbiquitin K63-linked,4309.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Prefoldin subunit 5,384.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Programmed cell death 1 ligand 1,5341.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Programmed cell death 1 ligand 2,5430.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Prokineticin-1,203.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Prolactin,1822.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Prolactin receptor,2237.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proliferating cell nuclear antigen,163.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proliferation-associated protein 2G4,1393.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Prolyl endopeptidase FAP,1245.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pro-opiomelanocortin,2824.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Properdin,116477.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,2658,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,772.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Prostaglandin G/H synthase 2,333.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Prostate-specific antigen,537.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proteasome activator complex subunit 1,1156.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proteasome activator complex subunit 3,531.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proteasome subunit alpha type-1,566.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proteasome subunit alpha type-2,630.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proteasome subunit alpha type-6,619.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein 4.1,7270,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein amnionless,115.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein deglycase DJ-1,1153.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein disulfide-isomerase,187.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein disulfide-isomerase A3,3283,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein E7_HPV16,723.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein E7_HPV18,3323.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein FAM107A,273.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein FAM107B,3164.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein FAM3B,1208.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein FAM3D,8457.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,1716.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein jagged-1,745.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein jagged-2,364.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein kinase C alpha type,48082.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),7252.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein kinase C delta type,4237.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein kinase C gamma type,559.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein kinase C iota type,1938.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein kinase C theta type,4769.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein kinase C zeta type,1293.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein lin-7 homolog B,379.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein NOV homolog,1099.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein Rev_HV2BE,136.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein S100-A12,795.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein S100-A4,1783.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein S100-A6,1972.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein S100-A7,554,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein S100-A9,5358.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein SET,518.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein-tyrosine kinase 6,283.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein Wnt-7a,309.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Protein Z-dependent protease inhibitor,6123.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Prothrombin,144397,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,912.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,40571.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Proto-oncogene vav,9715,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,P-selectin,16588.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pulmonary surfactant-associated protein D,3586.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pyridoxal kinase,341.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pyridoxal phosphate phosphatase,2234,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",2401.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Pyruvate kinase PKM,21885.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Quinone oxidoreductase-like protein 1,2025.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Rab GDP dissociation inhibitor beta,12584.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,4903.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,13596.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ras GTPase-activating protein 1,2325.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,25253.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,6219.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,3015.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,353,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,256.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,132.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Regenerating islet-derived protein 4,2588.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Relaxin receptor 1,1761.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Renin,2900.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Repulsive guidance molecule A,26980.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Resistin,1421.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Reticulon-4 receptor,2168.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Retinoblastoma-associated protein,1767,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Retinoic acid receptor responder protein 2,2720.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Retinol-binding protein 4,277.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,RGM domain family member B,2608.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ribonuclease H1,14494.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,659,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,151.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ribosome maturation protein SBDS,6759.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,RNA-binding protein 39,295.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Roundabout homolog 2,3167.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Roundabout homolog 3,387.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,R-spondin-2,275.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,R-spondin-3,2148.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,R-spondin-4,423,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Scavenger receptor class F member 1,9158.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Scavenger receptor class F member 2,542.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,8912.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sclerostin,26514,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Secreted and transmembrane protein 1,1593.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Secreted frizzled-related protein 1,3866.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Secreted frizzled-related protein 3,3303.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Secretin,296.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Seizure 6-like protein 2,790.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Semaphorin-3A,1242.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Semaphorin-3E,2595.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Semaphorin-5A,4749.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Semaphorin-6A,16026.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Semaphorin-6B,4529.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine protease 27,5927,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",4778.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase 16,2278.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase 17B,3780,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase Chk1,529.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase Chk2,514.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1039.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,1066.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,3606.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,564.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase pim-1,809.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase PLK1,160.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1723.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase TBK1,230.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serine/threonine-protein kinase WNK3,924.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serotransferrin,215487,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serum albumin,6706.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serum amyloid A-1 protein,812.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serum amyloid P-component,42092.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Serum paraoxonase/arylesterase 1,149.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sex hormone-binding globulin,3817,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,S-formylglutathione hydrolase,2463.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SH2 domain-containing protein 1A,4371.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SHC-transforming protein 1,13054.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,12524.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,152.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1031.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,361,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sialoadhesin,95.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,10663.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Signal transducer and activator of transcription 3,1399.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Signal transducer and activator of transcription 6,414.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SLAM family member 5,8822.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SLAM family member 6,615.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SLAM family member 7,53855.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SLIT and NTRK-like protein 1,1283.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SLIT and NTRK-like protein 5,2290.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,2447.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Small nuclear ribonucleoprotein F,5461.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Small ubiquitin-related modifier 3,3230.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Somatostatin-28,1330.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Somatotropin,360.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sonic hedgehog protein,1921.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sorting nexin-4,10733.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SPARC,10178.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SPARC-like protein 1,22291.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,4988,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",184.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,S-phase kinase-associated protein 1,3305.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sphingosine kinase 1,8890.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Sphingosine kinase 2,519.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Spondin-1,3458.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Stabilin-2,717.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Stanniocalcin-1,3428.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Stem cell growth factor-alpha,1847.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Stem Cell Growth Factor-beta,877.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Stress-induced-phosphoprotein 1,7012.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Stromal cell-derived factor 1,5650.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Stromelysin-1,8155.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Stromelysin-2,874.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,SUMO-conjugating enzyme UBC9,1538.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Superoxide dismutase [Cu-Zn],901.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",38842.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Synaptosomal-associated protein 25,44262.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Syntaxin-1A,1341.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,7636.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,TATA-box-binding protein,6850.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,T-cell surface glycoprotein CD4,332.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tenascin,25347,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,3049.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Testican-1,2744.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Testican-2,577.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,TGF-beta receptor type-2,1436.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thioredoxin domain-containing protein 12,4852.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thrombin,818.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thrombopoietin,308.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thrombopoietin Receptor,142.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thrombospondin-1,1418.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thrombospondin-2,14054.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thrombospondin-4,1038.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thymic stromal lymphopoietin,323.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Thymidine kinase, cytosolic",596.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thymidylate synthase,461.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thyroglobulin,294,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thyroid peroxidase,15636,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thyroid Stimulating Hormone,383.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Thyroxine-binding globulin,31373.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tissue Factor,1996.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tissue factor pathway inhibitor,78015.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tissue-type plasminogen activator,362.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,T-lymphocyte activation antigen CD80,662.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,T-lymphocyte activation antigen CD86,1316.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,3061.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Toll-like receptor 2,1540.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Toll-like receptor 4,538.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,5498.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transcription factor AP-1,9715.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,5294.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transforming growth factor beta-1,1161,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transforming growth factor beta-2,184.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transforming growth factor beta-3,387,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,33203.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transforming growth factor beta receptor type 3,53359.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transgelin-2,5224,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transketolase,34161.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Translationally-controlled tumor protein,12686.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Transmembrane glycoprotein NMB,6075.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Trefoil factor 1,24635.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Trefoil factor 2,16654.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Trefoil factor 3,17717,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Triosephosphate isomerase,5973,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tropomyosin alpha-1 chain,1262.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tropomyosin alpha-4 chain,87307.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tropomyosin beta chain,3111.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Troponin I, cardiac muscle",469.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Troponin I, fast skeletal muscle",19482.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Troponin T, cardiac muscle",3249.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Trypsin-1,10991.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Trypsin-2,5117.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Trypsin-3,431.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tryptase beta-2,4400.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tryptase gamma,288.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor-associated calcium signal transducer 2,534.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor,512.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,1113.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,573.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,1092,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,1512,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,828.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,766.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,676.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,337.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",782.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,2820.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,401.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,990.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,396.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,1263.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1158.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,15259.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,240.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,2294.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2187.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,658.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,9287.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,1720.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,1384.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,3735.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,2457.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,19668,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,11888.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,1069.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,6068.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,570.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,8641.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,1098.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,1048.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,327.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,614,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase ABL1,120.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase BTK,7644.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase CSK,6500.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase Fer,1672.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase Fgr,779.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase Fyn,6947.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase HCK,170,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase JAK2,129100.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase Lck,343.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase Lyn,7221.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",46196.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",11770.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,679.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase Tec,3022.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,843.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase Yes,956.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,12303.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,5715.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,3237.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,302.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,4207.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,7627.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin,1099.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",2105,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1439.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,9260.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,8371.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,958.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,4056.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin-fold modifier 1,5610.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,19567.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Ubiquitin-like protein ISG15,2840.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,UMP-CMP kinase,5334.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Urokinase plasminogen activator surface receptor,18545.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Urokinase-type plasminogen activator,1292,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,20612.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vascular cell adhesion protein 1,10092.4,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vascular endothelial growth factor A,11920.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",1594.6,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vascular endothelial growth factor C,1540.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vascular endothelial growth factor D,639.8,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vascular endothelial growth factor receptor 2,7606.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vascular endothelial growth factor receptor 3,9227.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vasoactive Intestinal Peptide,255,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vesicular integral-membrane protein VIP36,13182.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vitamin K-dependent protein C,1948.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vitamin K-dependent protein S,4654.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Vitronectin,34392.7,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,von Willebrand factor,16350.5,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,325.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",340.9,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",8429.2,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,3029.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,3664.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Wnt inhibitory factor 1,3367.1,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,Xaa-Pro aminopeptidase 1,5544,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,1833.3,RFU
BF-1106,PDGM907UXQ,M0,0,Plasma,X-ray repair cross-complementing protein 6,368.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,12045,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,14-3-3 protein epsilon,1109.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,14-3-3 protein family,3326.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,14-3-3 protein sigma,677.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,14-3-3 protein theta,1068.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,106661.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1518.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",429.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,585.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,290.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,328.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1243.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",2971.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",872.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,961.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,40S ribosomal protein S3,434.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,40S ribosomal protein S3a,2181.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,40S ribosomal protein S7,794.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,40S ribosomal protein SA,3248.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",11751.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",6298.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,72 kDa type IV collagenase,10841.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1862.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,200.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,2533.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Activated Protein C,663.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Activin receptor type-1B,231.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Adapter molecule crk,8477.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,10639.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Adenylosuccinate lyase,2298.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,840.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,543.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Adiponectin,6544.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,307.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2319.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,356.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,156.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,315.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,702.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,7439.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Adrenomedullin,2254.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",464.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Afamin,25500.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,1834.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Aggrecan core protein,556.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Agouti-related protein,1549.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,AH receptor-interacting protein,3261.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alanine aminotransferase 1,3249.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],3713.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Allograft inflammatory factor 1,3199.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",7098.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,264383.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,6148.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-1-antitrypsin,729.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-2-antiplasmin,1732.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1150.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-2-macroglobulin,12017.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,714.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-enolase,26477.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,alpha-Fetoprotein,630,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-L-iduronidase,772.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,3725.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Alpha-synuclein,5069,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Aminoacylase-1,2359.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Amphiregulin,1399.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Amphoterin-induced protein 2,1663.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),1577.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),3236.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Amyloid beta A4 protein,15544.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiogenin,2822.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiopoietin-1,452.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",2029,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiopoietin-2,236.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiopoietin-4,471.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiopoietin-related protein 3,365.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiopoietin-related protein 4,4644.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiostatin,15288.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,466.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Angiotensinogen,5712.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ankyrin-2,492.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Annexin A1,5891.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Annexin A2,8399.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Annexin A5,1006.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Annexin A6,2637.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,1005.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Antileukoproteinase,35310.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Antithrombin-III,113235.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein A-I,10782.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein B,5581.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein D,5812.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein E,50686,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),280605.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),249599.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),254619,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein L1,30803.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apolipoprotein M,12923.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,927.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Appetite-regulating hormone,1582.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Arginase-1,1971.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,246,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Artemin,456.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Arylsulfatase A,1254.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Arylsulfatase B,1534.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1616.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",5660.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,2312.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",1855.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",2661.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Atrial natriuretic factor,940.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,413.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Aurora kinase A,1569.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Aurora kinase B,720.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Azurocidin,227.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,778.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,417.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,514.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,107.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1523.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Basigin,390.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,1958.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,B-cell receptor CD22,758.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,4609.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bcl-2-like protein 1,1084.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bcl-2-like protein 2,737.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bcl-2-related protein A1,746.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,1116.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Beta-2-microglobulin,3030.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,4675.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,6258.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Betacellulin,1101.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Beta-endorphin,1106,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,beta-nerve growth factor,933.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,BH3-interacting domain death agonist,1936.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Biglycan,2023.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,376.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1369.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bone morphogenetic protein 1,2305.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bone morphogenetic protein 6,14843.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bone morphogenetic protein 7,681.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,1165.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,780.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Bone sialoprotein 2,7402.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,516.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Brain natriuretic peptide 32,575.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Brain-specific serine protease 4,1632.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1344,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Brevican core protein,1450.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Brother of CDO,2582.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C3a anaphylatoxin,490.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,196434.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C5a anaphylatoxin,16720.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cadherin-12,553.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cadherin-15,3683.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cadherin-1,78166.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cadherin-2,3054,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cadherin-3,31012.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cadherin-5,18588.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cadherin-6,557.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcineurin,1172.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcineurin subunit B type 1,8226.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",736.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,268.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,8660.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2129.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,731.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,1721.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,5631.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,745.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calpain I,24102.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calpastatin,8106.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Calreticulin,2406.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,1085.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,1142.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1764.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,7344.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,294,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,331.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase 1,10787.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase 13,1240.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase 2,492.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase 3,2509.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase 4,2826.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase 6,3731.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase 7,316,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase 9,2722,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,668,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carboxypeptidase B2,10971.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Carboxypeptidase E,1884.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cardiotrophin-1,666.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,4671.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,997.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Casein kinase II subunit alpha,322.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Caspase-10,4094,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Caspase-2,354.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Caspase-3,5232.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Catalase,9558,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin B,2087.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin D,526.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin E,575.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin F,2026.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin G,941,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin H,669.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin L2,884.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin S,1203.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cathepsin Z,8841.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,33818.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,981.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 1,2952,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 13,441.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 14,9726.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 15,5195.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 16,45910.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 17,869.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 18,11910.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 19,553.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 20,885,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 21,34310.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 2,1422.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 22,904.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 23,4090.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 24,307.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 25,2143.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 26,1209.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 27,1252.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 28,6021.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 3,1270.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,2328.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 4-like,612.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 5,11093.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 7,1039.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-C motif chemokine 8,216.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD109 antigen,4001.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD166 antigen,16029.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD177 antigen,2876.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD209 antigen,2414.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD226 antigen,777.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD27 antigen,6516.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD40 ligand,228.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD48 antigen,615.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD59 glycoprotein,2390.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD5 antigen-like,3443.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD63 antigen,434.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD70 antigen,299.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD83 antigen,500.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CD97 antigen,1961.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cell adhesion molecule 1,2519.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cell adhesion molecule 3,1496.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,7433.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,876.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cellular tumor antigen p53,1314.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,4872.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",6241,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",773.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",8358,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Chitinase-3-like protein 1,16712.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Chitotriosidase-1,2395.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,3420.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Choline/ethanolamine kinase,2828.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Chordin-like protein 1,2933.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,2689,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Chromobox protein homolog 5,431.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Chromogranin-A,32969.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Chymase,444.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ciliary neurotrophic factor,190.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,11919,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ck-beta-8-1,87468.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Clusterin,1270.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,CMRF35-like molecule 6,5591.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coactosin-like protein,2648.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coagulation factor IX,13531.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coagulation factor IXab,9749.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coagulation Factor V,82905.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coagulation factor VII,772.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coagulation Factor X,4497.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coagulation factor Xa,3657.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coagulation Factor XI,1602.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cofilin-1,7217.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,1563.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,1051,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,308.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Collagenase 3,864,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Collectin-11,9735.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Collectin-12,2248,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,COMM domain-containing protein 7,1714.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C1q subcomponent,43661.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C1r subcomponent,2741.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C2,2800.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C3,75095.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C3b,10435.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Complement C3b, inactivated",8793.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C3d fragment,12692.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C4,126309.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C4b,338.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C5,8361.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement C5b-C6 complex,621.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4863.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement component C1q receptor,13109,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement component C6,100931.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement component C7,1692.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement component C8,3311.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement component C9,77614.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement decay-accelerating factor,20674.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement factor B,24231,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement factor D,1486.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement factor H,50908.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement factor H-related protein 5,1066.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Complement factor I,44512.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Connective tissue-activating peptide III,6663.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Connective tissue growth factor,1069.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Contactin-1,197.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Contactin-2,837.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Contactin-4,4381.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Contactin-5,515.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Copine-1,1969.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Corticosteroid-binding globulin,638.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Corticotropin,451.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-reactive protein,130711.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Creatine kinase B-type,1215.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Creatine kinase M-type,369.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,219.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cryptic protein,1971.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,6999.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,183.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,50423.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,589,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-type mannose receptor 2,2919.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-X-C motif chemokine 10,4488.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-X-C motif chemokine 11,7543.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-X-C motif chemokine 13,1662.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-X-C motif chemokine 16,26618,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-X-C motif chemokine 5,441.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-X-C motif chemokine 6,583.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,C-X-C motif chemokine 9,1040.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,556.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,316.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1360,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1328.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,1071.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cystatin-C,4405.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cystatin-D,4114.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cystatin-F,840.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cystatin-M,11372.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cystatin-S,339,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cystatin-SA,17773.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cystatin-SN,1084.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,2449.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,668.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,4910.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytochrome c,1269.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytochrome P450 3A4,12150.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,1901.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,436.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,1017.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,1788.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,253.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,23443,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,1111.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,549.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,100.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,11161.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,D-dimer,13657.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Death-associated protein kinase 2,2116.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Decorin,3683,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Delta-like protein 1,3403.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Delta-like protein 4,457,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dermatopontin,7107,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Desert hedgehog protein N-product,324.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Desmocollin-2,4728.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Desmocollin-3,309.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Desmoglein-1,2743.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",4016,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dickkopf-like protein 1,2801.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dickkopf-related protein 1,10106.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dickkopf-related protein 3,9167.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dickkopf-related protein 4,4304.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,817.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,5763.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1846.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,3371.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1350.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,416.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,3052.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,DNA topoisomerase 1,429.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,1177.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Drebrin-like protein,3038.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2011.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,452.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2645.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,1718,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,62608,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,1379.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2139.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dynactin subunit 2,1877.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",293.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,2523.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,781.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,919.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,191.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,11319.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,791.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",1502.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1550.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1129.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,6322.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,10818.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1770.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Elafin,9136.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Elongation factor 1-beta,495.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Endoglin,1631.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,108279.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,10364,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Endostatin,103398.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,5995.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,1432.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,3605.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,15853.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Enteropeptidase,178.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Eotaxin,11493.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin-A2,1170.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin-A3,2378.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin-A4,2491.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin-A5,4070.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin-B1,2547,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin-B2,24976.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin-B3,959.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin type-A receptor 10,462.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin type-A receptor 1,16229,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin type-A receptor 2,4976.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin type-A receptor 3,148.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin type-A receptor 5,902.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin type-B receptor 2,23326.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin type-B receptor 4,2915.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ephrin type-B receptor 6,2351.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Epidermal growth factor,715.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Epidermal growth factor receptor,22483.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,476.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,4753.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Epiregulin,1209.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,276.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Erythropoietin,2054.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Erythropoietin receptor,263.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,E-selectin,23737.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,1602.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Estrogen receptor,632.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,439.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,310.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,2244,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,3542.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,1356.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,21375.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Extracellular matrix protein 1,12278,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],638.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,FACT complex subunit SSRP1,479.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",1755.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",56186.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",4897,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fc receptor-like protein 3,404.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ferritin,7725.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fetuin-B,6105.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibrinogen,168974.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibrinogen gamma chain,63576.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 10,173.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 1,181.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 12,209.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 16,1193.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 17,217.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 18,229.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 19,5196.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 20,314.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 23,4606.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 2,4657.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 4,166,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 5,567.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 6,235.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 7,1264.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,223.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,913.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor 9,449.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,763.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,286.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,3090.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,2082,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibronectin,12810.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibronectin Fragment 3,2136.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fibronectin Fragment 4,70572.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ficolin-1,2094,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ficolin-2,2248.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ficolin-3,206.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,850.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Focal adhesion kinase 1,348.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Follicle stimulating hormone,3734.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Follistatin,759.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Follistatin-related protein 1,34614.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Follistatin-related protein 3,14593.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,13829.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fractalkine,6278.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,60435.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,660,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,489.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galectin-10,531.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galectin-2,410.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galectin-3,24113.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galectin-3-binding protein,1393.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galectin-4,499.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galectin-7,671.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galectin-8,492.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Galectin-9,6563,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Gamma-enolase,19249.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Gastrin-releasing peptide,557.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,GDNF family receptor alpha-1,1213.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,GDNF family receptor alpha-2,7309.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,GDNF family receptor alpha-3,948.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Gelsolin,817.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glia-derived nexin,1170.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,381.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glial fibrillary acidic protein,658.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glucagon,3358.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glucocorticoid receptor,72.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glucokinase regulatory protein,789.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,14078.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,567.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glutathione S-transferase A3,348,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glutathione S-transferase P,14511.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,56956.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",2802.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,8607.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,2050.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glypican-2,309.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glypican-3,521.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glypican-5,738.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Glypican-6,2527,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",913,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Granulins,27916.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1739.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,681.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,291.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Granulysin,2074.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Granzyme A,2990,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Granzyme B,276,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Granzyme H,251.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,GRB2-related adapter protein 2,464.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Gremlin-1,369.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Gro-beta/gamma,471.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,474.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,299,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth arrest-specific protein 1,982.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth/differentiation factor 11,1594.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,542.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth/differentiation factor 15,1982.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth/differentiation factor 2,2425,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth/differentiation factor 5,926.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth/differentiation factor 8,2729.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth/differentiation factor 9,718,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,23979,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth hormone receptor,1156.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Growth-regulated alpha protein,2769,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,GTPase KRas,1260.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,3429.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Haptoglobin,61321.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,9849.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,1670.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heat shock protein beta-1,6488.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,4724.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,27074.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heme oxygenase 2,353.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,HemK methyltransferase family member 2,1969,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hemoglobin,893.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hemojuvelin,1044.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hemopexin,1609.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2711.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,262.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heparin cofactor 2,2752.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,18290.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hepatocyte growth factor,1405.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hepatocyte growth factor activator,3213.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,763,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,8576.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,701.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hepcidin,15712.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,1583.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1321.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,265.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2698.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,2440.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hexokinase-1,2994.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hexokinase-2,673.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",352.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",535.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,309.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,2543.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,High mobility group protein B1,4855.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histidine-rich glycoprotein,3875.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,1337,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1397.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,186.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone deacetylase 8,1950.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone H1.2,1328.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone H2A type 3,763.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone H2A.z,2279.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone H2B type 2-E,22131.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone H3.1,1801.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,396.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Homeobox protein NANOG,142.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,607.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,319.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,1618.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,1177.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,1110.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,ICOS ligand,1246.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Iduronate 2-sulfatase,3200,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Immunoglobulin A,3461.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,256.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Immunoglobulin D,2334.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Immunoglobulin E,320.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Immunoglobulin G,201099.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Immunoglobulin M,3856.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,7203.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Importin subunit alpha-1,216.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Importin subunit beta-1,4446.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1213.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Inducible T-cell costimulator,552.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Inhibin beta A chain,4021.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,1935.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Inhibitor of growth protein 1,10121.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Inorganic pyrophosphatase,23969.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1320.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,1992.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin,167.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-degrading enzyme,30844.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,9139.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,1378.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,729.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,2310.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,8955.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,2686.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,2474.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,52062.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin-like growth factor I,1397.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Insulin receptor,8703.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,1050.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,1456.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,678,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,45402.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,5042.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,1458,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,626.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,774.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon alpha-10,384.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon alpha-2,144.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon alpha-7,307.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,2244.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon beta,748.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon gamma,850.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon gamma receptor 1,606.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon gamma receptor 2,434.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon lambda-1,236.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon lambda-2,163.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interferon regulatory factor 1,1105.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-10,171.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1523.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,1352.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-11,247.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-12,286.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,619.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,787.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-13,1024.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,2475,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,1604.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-16,363.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-17A,361.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-17B,156.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-17D,222.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-17F,875.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-17 receptor A,1187,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-17 receptor B,2179.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-17 receptor C,960.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-17 receptor D,518.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-18-binding protein,17215.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-18 receptor 1,14765.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,264,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-19,5452.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-1 alpha,506.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-1 beta,2002.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,32873.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,16528.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,5824,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,791.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,10298.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,11533.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-20,327.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,256.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-2,2379.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-22,699.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,665.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,999.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-23,950.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-23 receptor,1720.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-24,201,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-25,326.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-27,774.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,2252.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,794.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-3,1397.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-34,789.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-36 alpha,1849.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-36 beta,796.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-37,2210.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,638.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-4,377.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,234.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-5,384.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,1852.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-6,434.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,19152,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,9153.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-7,212.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,328.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-8,1146.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interleukin-9,336.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Interstitial collagenase,836.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Junctional adhesion molecule B,12331.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Junctional adhesion molecule C,3939.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Junctional adhesion molecule-like,741.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-11,1345.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-12,6493.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-13,909.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-14,9664.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-4,293.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-5,153.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-6,3410.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-7,989.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallikrein-8,2809,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kallistatin,34146.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,498.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",941,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1812.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,2841.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,1425.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,499.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kinesin-like protein KIF23,736.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kininogen-1,26871.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,267.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kremen protein 2,2270.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,4663,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,948.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Kynureninase,937.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lactadherin,831.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lactoperoxidase,597.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lactotransferrin,25186.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lamin-B1,544.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Laminin,2366.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1498.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Layilin,2050.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Legumain,2641.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leptin,16271.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leptin receptor,1312.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,2058.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,9606.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2134.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,116.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,202.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,695.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,33875.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,4271.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,4325.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,1636.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,5516.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,635.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,1123.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,269.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Limbic system-associated membrane protein,1575.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,152910.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lithostathine-1-alpha,742.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,836.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,5296.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,3477.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,2021.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1866.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Low-density lipoprotein receptor,160,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,29448,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",2400.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,2100.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,3929.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,L-Selectin,3753.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lumican,1876,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Luteinizing hormone,2639.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,2596.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,536.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,4136.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lymphocyte antigen 86,4562,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lymphotactin,368.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,96.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,1703,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lymphotoxin-alpha,954.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lysosomal protective protein,3841.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lysosome membrane protein 2,445.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Lysozyme C,99796.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Macrophage-capping protein,1519.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1483.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,163.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Macrophage mannose receptor 1,18418.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Macrophage metalloelastase,806.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,999.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,772.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,524.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",12337.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mammaglobin-B,8610.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,5523.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mannose-binding protein C,17542.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,4551.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,810.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,542,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,14407.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Matrilin-2,9857.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Matrilin-3,526.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Matrilysin,2932.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,211.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Matrix metalloproteinase-14,4103.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Matrix metalloproteinase-16,705.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Matrix metalloproteinase-17,945.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Matrix metalloproteinase-9,15796.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,90108.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,441.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,4228.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Membrane frizzled-related protein,1404.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,880.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mesothelin,382.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,84.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,518.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,1153.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Methionine aminopeptidase 1,1533.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Methionine aminopeptidase 2,19576.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,319.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,490.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,983.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Microtubule-associated protein tau,262,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Midkine,15254.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,776.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,471.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,803.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,754.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,948.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,4074.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,1492.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,18830,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,1153.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,1003.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,1739.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Moesin,1652.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,8642.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,9328.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Mucin-1,12272.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Muellerian-inhibiting factor,12265.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Myc proto-oncogene protein,775,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Myeloblastin,5217.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,4459.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Myeloperoxidase,9920,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Myoglobin,1675.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",1876.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,682.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,2175.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,4598.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,7867.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,3077.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,3118.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,3133.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,316,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,491.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,164.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Netrin-1,555.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Netrin-4,522.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Netrin receptor UNC5C,6523.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Netrin receptor UNC5D,9213.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",11995.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,334.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,17450.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neuregulin-1,222,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neuregulin-4,940,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neurexin-1-beta,960.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neurexin-3-beta,839.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neurexophilin-1,3426,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1921.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,24443.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,1928.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,595.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",867.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,10584.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neuronal growth regulator 1,5734.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neuropilin-1,2755.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neurotrophin-3,226.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neurotrophin-4,209.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neutral ceramidase,3955.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,2051.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neutrophil collagenase,2470.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neutrophil elastase,454,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,14093.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,560.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Nidogen-1,6906.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Nidogen-2,3024.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NKG2D ligand 1,356,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NKG2D ligand 2,365.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NKG2D ligand 3,736.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,948.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Noggin,1361.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,805.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,4580,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NSFL1 cofactor p47,386.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NT-3 growth factor receptor,5713.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,N-terminal pro-BNP,15415.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,664.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,533.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,8099.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,NudC domain-containing protein 3,368.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,OCIA domain-containing protein 1,798.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Olfactomedin-4,158.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Oncostatin-M,2060.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,4138.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Osteocalcin,1020.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Osteomodulin,10832.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Osteopontin,12060.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,3369.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,1305.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pancreatic hormone,5386.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pappalysin-1,23055,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Parathyroid hormone,2654.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Parathyroid hormone-related protein,856.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peptide YY,1826.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,517.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,87033.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,3050.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,3239.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,703.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",8209.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Periostin,6606.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peroxiredoxin-1,1239.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",566,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peroxiredoxin-6,241,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,305,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Persephin,205.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3704.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pescadillo homolog,197.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,3991.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",860.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",1847.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Phosphoglucomutase-1,770.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,2635.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,339.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Phospholipase A2,1100.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",17178.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pigment epithelium-derived factor,65278.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,PIK3CA/PIK3R1,554.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,PILR alpha-associated neural protein,5790.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,508.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,314,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Placenta growth factor,589.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Plasma kallikrein,22913.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,8847.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Plasma serine protease inhibitor,110305.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Plasmin,656.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Plasminogen,2802.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,396.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,698.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,3540.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet-derived growth factor C,458.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,59783.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,7764.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,3566.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,10297.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,1057.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet factor 4,14670.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet glycoprotein 4,11571.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,895.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet glycoprotein VI,6926.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Platelet receptor Gi24,646.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pleiotrophin,1904,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Plexin-B2,4918.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Plexin-C1,620.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,2482.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,1555.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,3589.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Prefoldin subunit 5,382.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,4155.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,4175.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Prokineticin-1,195.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Prolactin,2601.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Prolactin receptor,2056.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,164.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,892.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,841.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pro-opiomelanocortin,2488.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Properdin,184156.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,2866.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,965.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,370.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Prostate-specific antigen,475.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,916.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,457.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,538.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,624.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,516.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein 4.1,5477.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein amnionless,126,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein deglycase DJ-1,1287.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein disulfide-isomerase,192.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,2937,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein E7_HPV16,855.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein E7_HPV18,3182.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein FAM107A,282.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein FAM107B,2903.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein FAM3B,1193,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein FAM3D,8483.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,1533.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein jagged-1,597.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein jagged-2,310.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein kinase C alpha type,30004.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),4364.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein kinase C delta type,3294.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein kinase C gamma type,526.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein kinase C iota type,1641.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein kinase C theta type,3706.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein kinase C zeta type,1043.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein lin-7 homolog B,378.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein NOV homolog,947.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein Rev_HV2BE,151.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein S100-A12,705.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein S100-A4,1407.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein S100-A6,1899,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein S100-A7,408.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein S100-A9,4464.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein SET,568.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,259.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein Wnt-7a,271.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,6630.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Prothrombin,143248.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,853.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,31575.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Proto-oncogene vav,7532.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,P-selectin,14248.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,3130.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pyridoxal kinase,289.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,1695.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1729.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Pyruvate kinase PKM,21985,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,2405,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,10670.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,3583.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,8574.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,1760.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,14468.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,4719.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,2145.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,383.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,266.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,151.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,3248,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Relaxin receptor 1,1612.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Renin,2309.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Repulsive guidance molecule A,22571.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Resistin,1255,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Reticulon-4 receptor,2200.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1489.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,4153.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Retinol-binding protein 4,258.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,RGM domain family member B,2978.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ribonuclease H1,12331.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,537.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,123.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,6950.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,RNA-binding protein 39,340.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Roundabout homolog 2,2467.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Roundabout homolog 3,397.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,R-spondin-2,296.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,R-spondin-3,2325.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,R-spondin-4,408,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Scavenger receptor class F member 1,7903.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Scavenger receptor class F member 2,403,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,7181.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sclerostin,29438,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,1936,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,3389.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,2935.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Secretin,247.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Seizure 6-like protein 2,631.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Semaphorin-3A,1196.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Semaphorin-3E,2326.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Semaphorin-5A,6125,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Semaphorin-6A,12370,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Semaphorin-6B,4531.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine protease 27,6161.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",4203.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,2202.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,3652.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,618.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,514.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,1154.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,1103.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,3510.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,584.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,758.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,185.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1622.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,240.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,824,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serotransferrin,219579,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serum albumin,8117,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serum amyloid A-1 protein,1414.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serum amyloid P-component,43306,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,155,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sex hormone-binding globulin,2533.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,S-formylglutathione hydrolase,1903.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,3490.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SHC-transforming protein 1,11030.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,13858.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,191.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1068.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,326.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sialoadhesin,96.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,7757.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,1301.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,404.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SLAM family member 5,7273.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SLAM family member 6,475.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SLAM family member 7,49941.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1237.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,2154.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,1431.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,3850.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,1916.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Somatostatin-28,1128.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Somatotropin,276.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sonic hedgehog protein,1835.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sorting nexin-4,6700.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SPARC,7052.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SPARC-like protein 1,12239.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,3885.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",174.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,3016.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sphingosine kinase 1,5668.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Sphingosine kinase 2,521.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Spondin-1,3246.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Stabilin-2,823.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Stanniocalcin-1,3242.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Stem cell growth factor-alpha,2681,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,1183,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,4864.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Stromal cell-derived factor 1,6245.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Stromelysin-1,5495.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Stromelysin-2,774.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,1069.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],832.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",32076.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,3776.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Syntaxin-1A,1142.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,9460,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,TATA-box-binding protein,6076.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,329.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tenascin,19835.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,2605.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Testican-1,2561.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Testican-2,548.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,TGF-beta receptor type-2,1290,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,4138.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thrombin,637.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thrombopoietin,399.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thrombopoietin Receptor,156.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thrombospondin-1,1110.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thrombospondin-2,34151.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thrombospondin-4,389.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,296.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",609.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thymidylate synthase,361.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thyroglobulin,324.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thyroid peroxidase,11846.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,477.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Thyroxine-binding globulin,30787.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tissue Factor,2274.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,76070.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tissue-type plasminogen activator,836.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,652.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,986.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,2127.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Toll-like receptor 2,1038.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Toll-like receptor 4,379.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4519.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transcription factor AP-1,4661.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,4607.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transforming growth factor beta-1,1290.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transforming growth factor beta-2,193.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transforming growth factor beta-3,497.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,32048.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,53990.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transgelin-2,3652.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transketolase,21796.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Translationally-controlled tumor protein,9034.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,5783.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Trefoil factor 1,20352.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Trefoil factor 2,14394.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Trefoil factor 3,18517.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Triosephosphate isomerase,3996,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,1093,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,52355.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tropomyosin beta chain,3009.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",431.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",17146.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",3981.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Trypsin-1,9514.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Trypsin-2,4570.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Trypsin-3,436.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tryptase beta-2,5860,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tryptase gamma,289.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,481.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor,582.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,1232.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,566.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,832,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,1897.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,718.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,874.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,690,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,280.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",622.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,2309.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,410.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1029.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,406.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,1029.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1117.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,14364.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,184.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,2382.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,1909.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,637.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,7845.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,1334.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,1338.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,3420.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,3090.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,26803.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,10549.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,1023.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,6740.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,668.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,6733.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,1007.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,1027.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,370.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,544.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,144.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,4946.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,4130.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,1846.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,542.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,5916.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,166.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,163743,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,315.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,4457.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",30112.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",12765.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,686.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,2413,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,759.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,988.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,14653.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,4156.6,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,2666.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,344.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,2270.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,7407.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin,1100.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",1889.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1119.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,2386.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,9122.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,808.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,2704,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,3301.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,14663.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,1944.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,UMP-CMP kinase,5307.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,17297,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,1724.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,14398.4,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,11860.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vascular endothelial growth factor A,14137.9,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",1378.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vascular endothelial growth factor C,1203.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vascular endothelial growth factor D,718.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,7264,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,10879.5,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,236.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,16482.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vitamin K-dependent protein C,1484.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vitamin K-dependent protein S,4225.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Vitronectin,36174.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,von Willebrand factor,23877.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,322.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",299.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",8311.2,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,3934.3,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,1612.1,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Wnt inhibitory factor 1,3175,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,3886.8,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,1390.7,RFU
BF-1106,PDGM907UXQ,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,324.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,14-3-3 protein beta/alpha,34084.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,14-3-3 protein epsilon,1227.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,14-3-3 protein family,9815.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,14-3-3 protein sigma,924.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,14-3-3 protein theta,1179.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,14-3-3 protein zeta/delta,188344.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1191.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",397.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,331.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,361.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,275.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,4186.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",6109.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",1295.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,2379.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,40S ribosomal protein S3,542.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,40S ribosomal protein S3a,608.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,40S ribosomal protein S7,1439.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,40S ribosomal protein SA,1677.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",37865.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",19770.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,72 kDa type IV collagenase,6049.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Abelson tyrosine-protein kinase 2,1564.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,215.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,2550.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Activated Protein C,698.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Activin receptor type-1B,225.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Adapter molecule crk,19807.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Adenylate kinase isoenzyme 1,25403.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Adenylosuccinate lyase,1433.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Adhesion G protein-coupled receptor E2,1058,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Adhesion G-protein coupled receptor G5,687.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Adiponectin,3983.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,1842.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,355.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,341.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,145.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,394.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,592.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,10128.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Adrenomedullin,1800.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",909.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Afamin,22271.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,6815.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Aggrecan core protein,629.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Agouti-related protein,2983.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,AH receptor-interacting protein,8692.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alanine aminotransferase 1,3114.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],7215.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Allograft inflammatory factor 1,2710.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",11907.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-1-antichymotrypsin,236877.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-1-antichymotrypsin complex,11846.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-1-antitrypsin,970,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-2-antiplasmin,1657.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-2-HS-glycoprotein,1939.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-2-macroglobulin,12368.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,2522.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-enolase,59946.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,alpha-Fetoprotein,835.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-L-iduronidase,1402.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-soluble NSF attachment protein,9019.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Alpha-synuclein,18089,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Aminoacylase-1,3832.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Amphiregulin,4079,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Amphoterin-induced protein 2,3669.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),305.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),5310.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Amyloid beta A4 protein,21657.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiogenin,4600.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiopoietin-1,705.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",2441,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiopoietin-2,177.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiopoietin-4,627.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiopoietin-related protein 3,431.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiopoietin-related protein 4,4364.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiostatin,14212.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiotensin-converting enzyme 2,524.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Angiotensinogen,5638.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ankyrin-2,385.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Annexin A1,7345.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Annexin A2,8333.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Annexin A5,826.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Annexin A6,11052.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Anterior gradient protein 2 homolog,676.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Antileukoproteinase,36006.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Antithrombin-III,106198.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein A-I,13961.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein B,4539.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein D,4280.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein E,33419.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein E (isoform E2),223835.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein E (isoform E3),174150.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein E (isoform E4),192099.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein L1,27289.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apolipoprotein M,9480.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Apoptosis regulator Bcl-2,1420.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Appetite-regulating hormone,1411.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Arginase-1,919.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,206,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Artemin,421.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Arylsulfatase A,1245.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Arylsulfatase B,1103.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Asialoglycoprotein receptor 1,2046.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",2964.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,6120.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",1342.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",10891,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Atrial natriuretic factor,1332.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,1799.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Aurora kinase A,1067.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Aurora kinase B,630.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Azurocidin,287.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bactericidal permeability-increasing protein,876.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,179.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,453.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,102,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Basal Cell Adhesion Molecule,1758.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Basigin,326.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,B-cell lymphoma 6 protein,1687.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,B-cell receptor CD22,797.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bcl2-associated agonist of cell death,13554.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bcl-2-like protein 1,1730.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bcl-2-like protein 2,892.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bcl-2-related protein A1,762.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,BDNF/NT-3 growth factors receptor,958.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Beta-2-microglobulin,5907.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,beta-adrenergic receptor kinase 1,13378.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Beta-Ala-His dipeptidase,2144.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Betacellulin,594,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Beta-endorphin,681.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,beta-nerve growth factor,628.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,BH3-interacting domain death agonist,2400.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Biglycan,2730.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,BMP-binding endothelial regulator protein,414.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bone morphogenetic protein 10,1741.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bone morphogenetic protein 1,1703.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bone morphogenetic protein 6,14554.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bone morphogenetic protein 7,868,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,859.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bone morphogenetic protein receptor type-2,401.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Bone sialoprotein 2,9724.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Brain-derived neurotrophic factor,1797.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Brain natriuretic peptide 32,782.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Brain-specific serine protease 4,2322.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1254.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Brevican core protein,1147.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Brother of CDO,1717.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C3a anaphylatoxin,570.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C3a anaphylatoxin des Arginine,145426.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C5a anaphylatoxin,12623.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cadherin-12,776.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cadherin-15,3730.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cadherin-1,57741.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cadherin-2,1924.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cadherin-3,22013.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cadherin-5,14215.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cadherin-6,369.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcineurin,3181,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcineurin subunit B type 1,6735.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",788.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,424.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,4078.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1841.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,1261.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,3156.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,9606.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calcium-dependent phospholipase A2,318.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calpain I,54888.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calpastatin,6476.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Calreticulin,2007,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,3400.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,cAMP-regulated phosphoprotein 19,5110.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1362.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbohydrate sulfotransferase 15,5205.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbohydrate sulfotransferase 2,324.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbohydrate sulfotransferase 6,258.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase 13,7711.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase 1,8019.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase 2,165.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase 3,3540.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase 4,2241.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase 6,10697.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase 7,270.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase 9,1301.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carbonic anhydrase-related protein 10,586.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carboxypeptidase B2,11976.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Carboxypeptidase E,1543,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cardiotrophin-1,611.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,14753.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,540.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Casein kinase II subunit alpha,581,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Caspase-10,3731.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Caspase-2,341.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Caspase-3,25925,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Catalase,9395.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin B,2148.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin D,1876.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin E,391.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin F,2562.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin G,921.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin H,1656.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin L2,912.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin S,769.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cathepsin Z,7493.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,26287.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CCAAT/enhancer-binding protein beta,1059.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 1,2292.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 13,420.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 14,10888.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 15,6608.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 16,32347.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 17,1936,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 18,13863.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 19,496.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 20,141.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 21,31924.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 22,1326.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 23,3466,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 2,4249.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 24,318.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 25,1836.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 26,952.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 27,1242.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 28,7378.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 3,1189.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 3-like 1,2688.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 4-like,694.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 5,32828.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 7,1000.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-C motif chemokine 8,217.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD109 antigen,4577.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD166 antigen,14607.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD177 antigen,520,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD209 antigen,993.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD226 antigen,921.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD27 antigen,6114.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD40 ligand,364.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD48 antigen,742.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD59 glycoprotein,2821,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD5 antigen-like,4319.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD63 antigen,376.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD70 antigen,188.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD83 antigen,351.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CD97 antigen,1569.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cell adhesion molecule 1,3674,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cell adhesion molecule 3,2043.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5460.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,1313.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cellular tumor antigen p53,748.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cerebral dopamine neurotrophic factor,5830.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",6392,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",834.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",50707.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Chitinase-3-like protein 1,34696.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Chitotriosidase-1,4597.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Chloride intracellular channel protein 1,9811.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Choline/ethanolamine kinase,2144.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Chordin-like protein 1,4275.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Chorionic somatomammotropin hormone,4359.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Chromobox protein homolog 5,398.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Chromogranin-A,41955.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Chymase,631.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ciliary neurotrophic factor,217.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,11286.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ck-beta-8-1,68488.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Clusterin,1283.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,CMRF35-like molecule 6,5239.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coactosin-like protein,2871,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coagulation factor IX,11029,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coagulation factor IXab,7826,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coagulation Factor V,53185.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coagulation factor VII,777.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coagulation Factor X,5428,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coagulation factor Xa,4452.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coagulation Factor XI,4071.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cofilin-1,13746,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Coiled-coil domain-containing protein 80,3679.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Collagen alpha-1(VIII) chain,1000.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Collagen alpha-1(XXIII) chain,561.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Collagenase 3,467,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Collectin-11,6918,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Collectin-12,2249.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,COMM domain-containing protein 7,2436,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C1q subcomponent,39063.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C1r subcomponent,2685.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C2,3034.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C3,67656.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C3b,15423.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Complement C3b, inactivated",10889.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C3d fragment,11380,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C4,110590.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C4b,701.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C5,7492.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement C5b-C6 complex,558.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",3631.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement component C1q receptor,11821.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement component C6,87294.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement component C7,1645.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement component C8,2388,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement component C9,86684.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement decay-accelerating factor,19910.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement factor B,26434.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement factor D,1704.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement factor H,53110.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement factor H-related protein 5,1364.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Complement factor I,40437.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Connective tissue-activating peptide III,37751.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Connective tissue growth factor,1889.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Contactin-1,291.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Contactin-2,997.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Contactin-4,2982.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Contactin-5,520,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Copine-1,6625.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Corticosteroid-binding globulin,555,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Corticotropin,381,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-reactive protein,56936.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Creatine kinase B-type,631.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Creatine kinase M-type,344.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,248.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cryptic protein,3465.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-type lectin domain family 1 member B,26873.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-type lectin domain family 4 member K,165.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-type lectin domain family 4 member M,34169.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-type lectin domain family 7 member A,668.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-type mannose receptor 2,3532.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-X-C motif chemokine 10,3250.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-X-C motif chemokine 11,5223.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-X-C motif chemokine 13,4875.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-X-C motif chemokine 16,12153.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-X-C motif chemokine 5,652.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-X-C motif chemokine 6,3297.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,C-X-C motif chemokine 9,1081.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,643.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,296.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1165.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1724.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,1088.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cystatin-C,5463.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cystatin-D,26821.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cystatin-F,1160.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cystatin-M,17033,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cystatin-S,156,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cystatin-SA,66110.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cystatin-SN,4950.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cysteine and glycine-rich protein 3,3124.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cysteine-rich secretory protein 3,242.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,2816.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytochrome c,1656.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytochrome P450 3A4,22900.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytokine receptor common subunit gamma,4459.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,582,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytokine receptor-like factor 2,1574,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytoplasmic protein NCK1,1319.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,279.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytoskeleton-associated protein 2,14612.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytosolic non-specific dipeptidase,1360.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,738.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,73.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,dCTP pyrophosphatase 1,14884.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,D-dimer,14439.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Death-associated protein kinase 2,2624.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Decorin,2934.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Delta-like protein 1,2612.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Delta-like protein 4,644.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dermatopontin,5333,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Desert hedgehog protein N-product,731,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Desmocollin-2,5149,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Desmocollin-3,283.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Desmoglein-1,3193.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Diablo homolog, mitochondrial",4263.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dickkopf-like protein 1,2325.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dickkopf-related protein 1,28962.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dickkopf-related protein 3,5254.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dickkopf-related protein 4,9210.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dipeptidyl peptidase 1,655.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dipeptidyl peptidase 2,1296.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Discoidin domain-containing receptor 2,1641.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,408.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,5068.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,DnaJ homolog subfamily B member 1,1013.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,DNA repair protein RAD51 homolog 1,2367.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,DNA topoisomerase 1,397.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Down syndrome cell adhesion molecule,1314.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Drebrin-like protein,4933.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",3224.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,451.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2566.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,2617.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,26449.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dual specificity protein phosphatase 3,6017,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2090.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dynactin subunit 2,1545.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",251.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Dynein light chain roadblock-type 1,11187,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,697.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,1544.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,214,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,1034.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,446.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Ectodysplasin-A, secreted form",1443.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1933.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1237.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3780,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,6501.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1977,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Elafin,28444,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Elongation factor 1-beta,789.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Endoglin,2184.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,99349.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Endoplasmic reticulum resident protein 29,12732,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Endostatin,91799.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Endothelial cell-selective adhesion molecule,6518.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Endothelial cell-specific molecule 1,1264.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,2729,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Endothelin-converting enzyme 1,15422.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Enteropeptidase,157,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Eotaxin,15894.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin-A2,1618.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin-A3,2055.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin-A4,3474.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin-A5,7622,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin-B1,2831.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin-B2,29241.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin-B3,2818.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin type-A receptor 10,325.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin type-A receptor 1,19900.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin type-A receptor 2,6779.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin type-A receptor 3,183.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin type-A receptor 5,1096.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin type-B receptor 2,21079.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin type-B receptor 4,2941.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ephrin type-B receptor 6,2185.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Epidermal growth factor,986.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Epidermal growth factor receptor,18291.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,841.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Epidermal growth factor receptor variant III,182.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Epiregulin,1004.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,331.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Erythropoietin,973.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Erythropoietin receptor,317.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,E-selectin,21866.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,1508,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Estrogen receptor,683.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Eukaryotic initiation factor 4A-III,445.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,264.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,9781.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Eukaryotic translation initiation factor 4H,19503.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Eukaryotic translation initiation factor 5,2000.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,50350.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Extracellular matrix protein 1,12126,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],562.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,FACT complex subunit SSRP1,406.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Fatty acid-binding protein, epidermal",13064.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Fatty acid-binding protein, heart",20480,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Fatty acid-binding protein, liver",11196.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fc receptor-like protein 3,364.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ferritin,48049.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fetuin-B,6056.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibrinogen,142060.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibrinogen gamma chain,64006.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 10,183.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 1,159.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 12,204.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 16,3276.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 17,190.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 18,201.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 19,20724.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 20,284.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 2,2111.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 23,744.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 4,205.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 5,447.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 6,603.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 7,2256.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 8 isoform A,434.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 8 isoform B,743.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor 9,381,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor receptor 1,951.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor receptor 2,192.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor receptor 3,735.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibroblast growth factor receptor 4,843.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibronectin,7121.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibronectin Fragment 3,1484.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fibronectin Fragment 4,40483.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ficolin-1,3522.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ficolin-2,1111.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ficolin-3,584.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,378.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Focal adhesion kinase 1,259.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Follicle stimulating hormone,1240.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Follistatin,958,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Follistatin-related protein 1,30220.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Follistatin-related protein 3,10711.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,22428.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fractalkine,3667.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Fructose-bisphosphate aldolase A,87739.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,G2/mitotic-specific cyclin-B1,312.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,471.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galectin-10,939.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galectin-2,569.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galectin-3,18563.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galectin-3-binding protein,931.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galectin-4,679.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galectin-7,608,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galectin-8,382.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Galectin-9,1985.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Gamma-enolase,41287.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Gastrin-releasing peptide,281.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,GDNF family receptor alpha-1,1286.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,GDNF family receptor alpha-2,5802,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,GDNF family receptor alpha-3,944.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Gelsolin,845.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glia-derived nexin,1276.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glial cell line-derived neurotrophic factor,304.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glial fibrillary acidic protein,457.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glucagon,2490.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glucocorticoid receptor,113.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glucokinase regulatory protein,800,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glucose-6-phosphate isomerase,36283.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glutamate carboxypeptidase 2,253.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glutathione S-transferase A3,200.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glutathione S-transferase P,9740,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,126168.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",3517.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,27676.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,6362.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glypican-2,144.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glypican-3,446.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glypican-5,828.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Glypican-6,1717,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"gp41 C34 peptide, HIV",786.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Granulins,25026.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Granulocyte colony-stimulating factor,1866.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,714.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,300.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Granulysin,1168.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Granzyme A,2392.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Granzyme B,160.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Granzyme H,602.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,GRB2-related adapter protein 2,423.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Gremlin-1,427.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Gro-beta/gamma,1049.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Group 10 secretory phospholipase A2,550.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Group IIE secretory phospholipase A2,226.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth arrest-specific protein 1,907.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth/differentiation factor 11,783.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth/differentiation factor 11/8,560.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth/differentiation factor 15,2082.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth/differentiation factor 2,1835.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth/differentiation factor 5,1234.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth/differentiation factor 8,2719.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth/differentiation factor 9,413,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth factor receptor-bound protein 2,75969.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth hormone receptor,655.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Growth-regulated alpha protein,8133.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,GTPase KRas,1046.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,GTP-binding nuclear protein Ran,6962.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Haptoglobin,54074.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heat shock 70 kDa protein 1A,7617.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heat shock cognate 71 kDa protein,1904.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heat shock protein beta-1,22670.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,13762.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heat shock protein HSP 90-beta,56018.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heme oxygenase 2,458.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,HemK methyltransferase family member 2,4346.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hemoglobin,958.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hemojuvelin,1041.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hemopexin,1914.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2130.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heparin-binding EGF-like growth factor,307.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heparin cofactor 2,3218.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hepatitis A virus cellular receptor 2,8821,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hepatocyte growth factor,1490.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hepatocyte growth factor activator,3383.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hepatocyte growth factor-like protein,3868,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hepatocyte growth factor receptor,7192.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,789.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hepcidin,45671.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,HERV-H LTR-associating protein 2,1126.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,2044,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,201.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2632.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3758.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hexokinase-1,1277,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hexokinase-2,890.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",516.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",460.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,273.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,High affinity nerve growth factor receptor,2977.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,High mobility group protein B1,6416,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histidine-rich glycoprotein,3267.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,2147.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone acetyltransferase KAT6A,1385.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,231.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone deacetylase 8,2771.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone H1.2,1455.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone H2A type 3,730.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone H2A.z,2609.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone H2B type 2-E,20203.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone H3.1,1994.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,276.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Homeobox protein NANOG,130.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Homeodomain-interacting protein kinase 3,355.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hsp90 co-chaperone Cdc37,2013.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Human Chorionic Gonadotropin,5829.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,1120.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,661.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,ICOS ligand,2162.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Iduronate 2-sulfatase,3412.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Immunoglobulin A,1549.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Immunoglobulin alpha Fc receptor,207.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Immunoglobulin D,1344,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Immunoglobulin E,115.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Immunoglobulin G,165665.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Immunoglobulin M,6268.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,5002.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Importin subunit alpha-1,273.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Importin subunit beta-1,24287.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1013.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Inducible T-cell costimulator,1776.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Inhibin beta A chain,6412.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,916.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Inhibitor of growth protein 1,52072.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Inorganic pyrophosphatase,34037,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1752.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2093,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin,161.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-degrading enzyme,2528.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor 1 receptor,7180.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor-binding protein 1,1973.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor-binding protein 2,1496,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor-binding protein 3,976.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor-binding protein 4,7280.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor-binding protein 5,2517.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor-binding protein 6,1362,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor-binding protein 7,44538.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin-like growth factor I,1120.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Insulin receptor,7666.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Integrin alpha-I: beta-1 complex,1127.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,12223.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Integrin alpha-V: beta-5 complex,516.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,36280.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Intercellular adhesion molecule 1,5238.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Intercellular adhesion molecule 2,1475.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Intercellular adhesion molecule 3,576.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Intercellular adhesion molecule 5,801.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon alpha-10,281,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon alpha-2,123.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon alpha-7,736.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon alpha/beta receptor 1,2103.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon beta,669.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon gamma,737,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon gamma receptor 1,562.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon gamma receptor 2,366.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon lambda-1,322,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon lambda-2,162.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interferon regulatory factor 1,1319.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-10,188,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1117.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-10 receptor subunit beta,1349.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-11,274.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-12,191.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,451.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,738.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-13,690.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,2674,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-15 receptor subunit alpha,1635.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-16,304.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-17A,282.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-17B,152.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-17D,208.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-17F,1511.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-17 receptor A,1044.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-17 receptor B,904.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-17 receptor C,1274.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-17 receptor D,402.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-18-binding protein,16748.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-18 receptor 1,11026.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-18 receptor accessory protein,269,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-19,3507.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-1 alpha,824,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-1 beta,2121.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-1 Receptor accessory protein,24751,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-1 receptor antagonist protein,4647.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-1 receptor-like 1,3468.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-1 receptor-like 2,942.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-1 receptor type 1,11142.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-1 receptor type 2,7381.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-20,338.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-20 receptor subunit alpha,276.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-22,1474.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-2,2390,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,651.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,3122,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-23,3885.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-23 receptor,2972,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-24,269,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-25,464.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-27,756.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-27 receptor subunit alpha,1291.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-2 receptor subunit alpha,888.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-3,1264.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-34,662.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-36 alpha,768.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-36 beta,394.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-37,1950.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-3 receptor subunit alpha,1373.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-4,458.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-4 receptor subunit alpha,151.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-5,1145,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-5 receptor subunit alpha,2185.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-6,476.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-6 receptor subunit alpha,17153.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-6 receptor subunit beta,6829,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-7,134.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-7 receptor subunit alpha,283.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-8,804.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interleukin-9,328,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Interstitial collagenase,2046.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Junctional adhesion molecule B,15552.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Junctional adhesion molecule C,8053.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Junctional adhesion molecule-like,383.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-11,1559.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-12,6165.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-13,1100.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-14,7576.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-4,296,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-5,221.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-6,3086.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-7,1030.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallikrein-8,4244.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kallistatin,38558.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kelch-like ECH-associated protein 1,418.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Keratin, type I cytoskeletal 18",995.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1376,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,200.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,363,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,334.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kinesin-like protein KIF23,1178.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kininogen-1,23181.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kin of IRRE-like protein 3,306.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kremen protein 2,4286.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kunitz-type protease inhibitor 1,5798,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kunitz-type protease inhibitor 2,1587,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Kynureninase,1345.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lactadherin,896.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lactoperoxidase,977.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lactotransferrin,33095.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lamin-B1,686.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Laminin,2322.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1450.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Layilin,2568.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Legumain,2339.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leptin,4403.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leptin receptor,2043.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leucine carboxyl methyltransferase 1,2561.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,6892.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,1843.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,91,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,170.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1083.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,23072.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,5527.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leukemia inhibitory factor receptor,3667.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,4160.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,10145.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leukocyte surface antigen CD47,954.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Leukotriene A-4 hydrolase,1295.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,210.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Limbic system-associated membrane protein,2016.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lipopolysaccharide-binding protein,104549.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lithostathine-1-alpha,1448.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,L-lactate dehydrogenase B chain,1406,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,8897.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,6486.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,7179.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1756.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Low-density lipoprotein receptor,111.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,26599.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",2814.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,2293.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,15289.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,L-Selectin,4295.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lumican,2061,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Luteinizing hormone,1037.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,2428.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,432.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lymphocyte activation gene 3 protein,14449.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lymphocyte antigen 86,4947.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lymphotactin,344.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lymphotoxin alpha1:beta2,127.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lymphotoxin alpha2:beta1,2170,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lymphotoxin-alpha,448.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lysosomal protective protein,6421.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lysosome membrane protein 2,329.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Lysozyme C,91447.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Macrophage-capping protein,1803.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Macrophage colony-stimulating factor 1,1400,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,218.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Macrophage mannose receptor 1,10132.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Macrophage metalloelastase,3614.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Macrophage migration inhibitory factor,1417.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Macrophage scavenger receptor types I and II,900.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Macrophage-stimulating protein receptor,496.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",23540,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mammaglobin-B,7909.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mannan-binding lectin serine protease 1,4682,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mannose-binding protein C,7818.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,MAP kinase-activated protein kinase 2,18239.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,MAP kinase-activated protein kinase 3,1897.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,MAP kinase-activated protein kinase 5,550.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,16323.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Matrilin-2,10324.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Matrilin-3,479.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Matrilysin,4281,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,214.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Matrix metalloproteinase-14,843.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Matrix metalloproteinase-16,641.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Matrix metalloproteinase-17,939.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Matrix metalloproteinase-9,8657.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,54331.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,322.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Melanoma-derived growth regulatory protein,5301.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Membrane frizzled-related protein,5797.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,890.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mesothelin,3301.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Metalloproteinase inhibitor 1,95,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Metalloproteinase inhibitor 2,451.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Metalloproteinase inhibitor 3,1573.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Methionine aminopeptidase 1,3210.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Methionine aminopeptidase 2,45479,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Methyl-CpG-binding domain protein 4,2193.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,MHC class I polypeptide-related sequence A,91.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,MHC class I polypeptide-related sequence B,1248.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Microtubule-associated protein tau,123.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Midkine,28837.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitochondrial glutamate carrier 2,1554.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,518.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase 1,14037,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase 11,871.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase 12,1178.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase 13,426.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase 14,3424.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase 3,44389.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase 8,2185.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase 9,870.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,1835.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Moesin,796.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mothers against decapentaplegic homolog 2,22953.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mothers against decapentaplegic homolog 3,18020.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Mucin-1,1135,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Muellerian-inhibiting factor,8360.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Myc proto-oncogene protein,443.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Myeloblastin,7778.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Myeloid cell surface antigen CD33,3289.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Myeloperoxidase,27134.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Myoglobin,2084.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Myosin-binding protein C, slow-type",1341.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,N-acetyl-D-glucosamine kinase,1056.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,2124.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,9201.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,5683.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NADPH--cytochrome P450 reductase,5281.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,59186.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,3940.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,300.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,388.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Natural killer cell receptor 2B4,330.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Netrin-1,633.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Netrin-4,639.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Netrin receptor UNC5C,7142,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Netrin receptor UNC5D,8508.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",10832.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neural cell adhesion molecule L1,331.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,10848.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neuregulin-1,149.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neuregulin-4,866.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neurexin-1-beta,1070,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neurexin-3-beta,1264.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neurexophilin-1,4533.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,4316.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neurogenic locus notch homolog protein 1,19993.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neurogenic locus notch homolog protein 2,1487.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neurogenic locus notch homolog protein 3,643,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Neuroligin-4, X-linked",616.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neuronal cell adhesion molecule,15815.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neuronal growth regulator 1,4981.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neuropilin-1,3744,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neurotrophin-3,171.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neurotrophin-4,167.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neutral ceramidase,3247.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neutrophil-activating peptide 2,10577.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neutrophil collagenase,2933.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neutrophil elastase,390,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,59221.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,768.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Nidogen-1,4330.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Nidogen-2,2106.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NKG2D ligand 1,336.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NKG2D ligand 2,349.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NKG2D ligand 3,882.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NKG2-D type II integral membrane protein,558,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Noggin,3442.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Non-histone chromosomal protein HMG-14,814.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,3773.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NSFL1 cofactor p47,975.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NT-3 growth factor receptor,7051.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,N-terminal pro-BNP,47600.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,387.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Nucleoside diphosphate kinase A,639.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Nucleoside diphosphate kinase B,47521,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,NudC domain-containing protein 3,610.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,OCIA domain-containing protein 1,873.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Olfactomedin-4,154.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Oncostatin-M,1885,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,2606,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Osteocalcin,1545.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Osteomodulin,10312.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Osteopontin,28925.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,OX-2 membrane glycoprotein,3344.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,1500.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pancreatic hormone,4678.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pappalysin-1,33763.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Parathyroid hormone,4124.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Parathyroid hormone-related protein,947.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peptide YY,2666.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peptidoglycan recognition protein 1,678.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,144839,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,15400.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,29011.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,2384.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",53667.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Periostin,4447.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peroxiredoxin-1,3676,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",465.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peroxiredoxin-6,797,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,177.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Persephin,270.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",2817.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pescadillo homolog,227.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,8645.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",777.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",1932.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Phosphoglucomutase-1,523.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Phosphoglycerate kinase 1,4199.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Phosphoglycerate mutase 1,5451,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Phospholipase A2,1233.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Phospholipase A2, membrane associated",7315.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pigment epithelium-derived factor,58159.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,PIK3CA/PIK3R1,703.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,PILR alpha-associated neural protein,7636,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,225.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,200.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Placenta growth factor,298.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Plasma kallikrein,17380.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Plasma protease C1 inhibitor,4408.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Plasma serine protease inhibitor,82765.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Plasmin,644.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Plasminogen,3387.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Plasminogen activator inhibitor 1,1028.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet-activating factor acetylhydrolase,815,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,10400.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet-derived growth factor C,329.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet-derived growth factor receptor alpha,1559.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet-derived growth factor receptor beta,6526.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet-derived growth factor subunit A,19825.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet-derived growth factor subunit B,49421,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet endothelial cell adhesion molecule,1107.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet factor 4,55506,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet glycoprotein 4,9464.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,1552.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet glycoprotein VI,21211.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Platelet receptor Gi24,503.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pleiotrophin,2781.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Plexin-B2,4383.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Plexin-C1,710.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Polymeric immunoglobulin receptor,3262.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,PolyUbiquitin K48-linked,1408.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,PolyUbiquitin K63-linked,4604.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Prefoldin subunit 5,391,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Programmed cell death 1 ligand 1,1064.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Programmed cell death 1 ligand 2,5212.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Prokineticin-1,172.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Prolactin,1411.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Prolactin receptor,1232.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proliferating cell nuclear antigen,147.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proliferation-associated protein 2G4,2935.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Prolyl endopeptidase FAP,747.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pro-opiomelanocortin,1759.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Properdin,105880.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,3291,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,1061.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Prostaglandin G/H synthase 2,715.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Prostate-specific antigen,16403.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proteasome activator complex subunit 1,1365,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proteasome activator complex subunit 3,238.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proteasome subunit alpha type-1,665.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proteasome subunit alpha type-2,625.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proteasome subunit alpha type-6,1052.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein 4.1,10219.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein amnionless,107,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein deglycase DJ-1,769.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein disulfide-isomerase,406.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein disulfide-isomerase A3,4996.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein E7_HPV16,462.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein E7_HPV18,1815,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein FAM107A,247.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein FAM107B,3152.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein FAM3B,1401.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein FAM3D,23865.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,412.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein jagged-1,590.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein jagged-2,304.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein kinase C alpha type,116049.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),16883.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein kinase C delta type,4158.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein kinase C gamma type,568.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein kinase C iota type,3102.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein kinase C theta type,3783.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein kinase C zeta type,954.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein lin-7 homolog B,418.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein NOV homolog,575.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein Rev_HV2BE,142.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein S100-A12,823,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein S100-A4,1478.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein S100-A6,2057.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein S100-A7,281.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein S100-A9,4301.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein SET,523.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein-tyrosine kinase 6,212.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein Wnt-7a,187.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Protein Z-dependent protease inhibitor,3494.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Prothrombin,120382.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,1123.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,68965.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Proto-oncogene vav,13265.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,P-selectin,19561.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pulmonary surfactant-associated protein D,5514.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pyridoxal kinase,522.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pyridoxal phosphate phosphatase,8819.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1550.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Pyruvate kinase PKM,80197.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Quinone oxidoreductase-like protein 1,1488.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Rab GDP dissociation inhibitor beta,25552.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,8590.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,23185.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ras GTPase-activating protein 1,1101.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,45461.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,11487,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,7057.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,429.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,248.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,137.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Regenerating islet-derived protein 4,2823.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Relaxin receptor 1,331.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Renin,2194.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Repulsive guidance molecule A,18074.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Resistin,2081.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Reticulon-4 receptor,2323.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Retinoblastoma-associated protein,1237.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Retinoic acid receptor responder protein 2,3897.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Retinol-binding protein 4,301.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,RGM domain family member B,3020.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ribonuclease H1,167.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,1188.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,1034.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ribosome maturation protein SBDS,36781.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,RNA-binding protein 39,432.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Roundabout homolog 2,2757.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Roundabout homolog 3,311.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,R-spondin-2,350.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,R-spondin-3,2419.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,R-spondin-4,530.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Scavenger receptor class F member 1,10221.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Scavenger receptor class F member 2,212.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2783.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sclerostin,21809,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Secreted and transmembrane protein 1,2079.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Secreted frizzled-related protein 1,7654.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Secreted frizzled-related protein 3,3332.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Secretin,208,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Seizure 6-like protein 2,7344.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Semaphorin-3A,1383.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Semaphorin-3E,1989.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Semaphorin-5A,7586.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Semaphorin-6A,15645.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Semaphorin-6B,5756.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine protease 27,5769.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",7252.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase 16,1804.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase 17B,4482.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase Chk1,542.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase Chk2,145.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1228.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,923.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,13698.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,746.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase pim-1,743.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase PLK1,156.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1387.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase TBK1,404.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serine/threonine-protein kinase WNK3,1438.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serotransferrin,161177.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serum albumin,6503,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serum amyloid A-1 protein,5357.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serum amyloid P-component,37745.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Serum paraoxonase/arylesterase 1,209.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sex hormone-binding globulin,2007,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,S-formylglutathione hydrolase,4792.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SH2 domain-containing protein 1A,5377.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SHC-transforming protein 1,20311.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,26186.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,268.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,896,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,12985.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sialoadhesin,137.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,18547.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Signal transducer and activator of transcription 3,2343.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Signal transducer and activator of transcription 6,546,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SLAM family member 5,14473,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SLAM family member 6,517.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SLAM family member 7,16616.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SLIT and NTRK-like protein 1,1333.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SLIT and NTRK-like protein 5,4595.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,11824,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Small nuclear ribonucleoprotein F,2370.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Small ubiquitin-related modifier 3,5132.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Somatostatin-28,1533.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Somatotropin,269.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sonic hedgehog protein,980.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sorting nexin-4,19396.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SPARC,15225,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SPARC-like protein 1,6545,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,4653.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",128.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,S-phase kinase-associated protein 1,4920.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sphingosine kinase 1,24418.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Sphingosine kinase 2,554.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Spondin-1,2612.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Stabilin-2,783.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Stanniocalcin-1,2259.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Stem cell growth factor-alpha,5270,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Stem Cell Growth Factor-beta,2168.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Stress-induced-phosphoprotein 1,11135.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Stromal cell-derived factor 1,5447.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Stromelysin-1,1473.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Stromelysin-2,1461.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,SUMO-conjugating enzyme UBC9,3049,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Superoxide dismutase [Cu-Zn],1218.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",30943.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Synaptosomal-associated protein 25,1369.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Syntaxin-1A,249.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,6296.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,TATA-box-binding protein,401.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,T-cell surface glycoprotein CD4,418,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tenascin,17261.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,1192.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Testican-1,2787.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Testican-2,444,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,TGF-beta receptor type-2,989,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thioredoxin domain-containing protein 12,2137.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thrombin,802.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thrombopoietin,193.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thrombopoietin Receptor,204.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thrombospondin-1,4607.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thrombospondin-2,18130,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thrombospondin-4,543.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thymic stromal lymphopoietin,444.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Thymidine kinase, cytosolic",512.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thymidylate synthase,373.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thyroglobulin,315.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thyroid peroxidase,1608.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thyroid Stimulating Hormone,740.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Thyroxine-binding globulin,40899.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tissue Factor,3488.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tissue factor pathway inhibitor,51752.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tissue-type plasminogen activator,2037.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,T-lymphocyte activation antigen CD80,573,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,T-lymphocyte activation antigen CD86,31432.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,4121.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Toll-like receptor 2,601.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Toll-like receptor 4,284.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4589.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transcription factor AP-1,7303.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,1694.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transforming growth factor beta-1,1485.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transforming growth factor beta-2,201.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transforming growth factor beta-3,420.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,35372.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transforming growth factor beta receptor type 3,32582.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transgelin-2,6996.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transketolase,60184.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Translationally-controlled tumor protein,29242.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Transmembrane glycoprotein NMB,4373,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Trefoil factor 1,4674.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Trefoil factor 2,25891.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Trefoil factor 3,24781.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Triosephosphate isomerase,13748.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tropomyosin alpha-1 chain,776.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tropomyosin alpha-4 chain,119955.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tropomyosin beta chain,2017.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Troponin I, cardiac muscle",1338.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Troponin I, fast skeletal muscle",9801,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Troponin T, cardiac muscle",4635.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Trypsin-1,9115.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Trypsin-2,3936.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Trypsin-3,378.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tryptase beta-2,4159.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tryptase gamma,239.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor-associated calcium signal transducer 2,446.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor,523.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,1100.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,425.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,775.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,1641.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,645.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,1509.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,641.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,277.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",949.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,2795.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,318.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1019.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,336.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,954.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1355.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,12928.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,139.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,1064,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2178.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,520.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,8720.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,936.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,1731.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,5215.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,3083.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,20653.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,9699.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,1106.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,5511,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,861.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,1984.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,741.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,1427.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,655.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,1368.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase ABL1,122.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase BTK,18782.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase CSK,16753.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase Fer,3284.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase Fgr,378,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase Fyn,6230.7,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase HCK,148.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase JAK2,101855,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase Lck,326.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase Lyn,9943.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",44207.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",10584.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,587.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase Tec,4967.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,817.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase Yes,1621.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,12118.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,10876.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,3152.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,282.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,13932.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,12468.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin,1737,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",3789.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,788.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,2016.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,8186.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,5526.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,8756.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin-fold modifier 1,12267.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,35457.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Ubiquitin-like protein ISG15,2711.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,UMP-CMP kinase,4518.4,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Urokinase plasminogen activator surface receptor,13865.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Urokinase-type plasminogen activator,1802.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,49879.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vascular cell adhesion protein 1,20868.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vascular endothelial growth factor A,12251.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",691.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vascular endothelial growth factor C,1669.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vascular endothelial growth factor D,775.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vascular endothelial growth factor receptor 2,6436.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vascular endothelial growth factor receptor 3,6998.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vasoactive Intestinal Peptide,363.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vesicular integral-membrane protein VIP36,9093.9,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vitamin K-dependent protein C,1468.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vitamin K-dependent protein S,4030.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Vitronectin,46260.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,von Willebrand factor,9074.5,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,279,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",997,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7510.1,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,4580.6,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,962,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Wnt inhibitory factor 1,3984.2,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,Xaa-Pro aminopeptidase 1,17478.8,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,904.3,RFU
BF-1133,PD_INVTG922XML,M0,0,Plasma,X-ray repair cross-complementing protein 6,314.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,17895.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,14-3-3 protein epsilon,926.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,14-3-3 protein family,3620.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,14-3-3 protein sigma,1030.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,14-3-3 protein theta,1151,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,143180.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1011.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",464.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,351.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,245.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,379.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1298.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",6596.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",1373.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,876.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,40S ribosomal protein S3,516.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,40S ribosomal protein S3a,618,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,40S ribosomal protein S7,1314.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,40S ribosomal protein SA,1429.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",7304.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",12846.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,72 kDa type IV collagenase,7472.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1807.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,227.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,3283.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Activated Protein C,808.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Activin receptor type-1B,252.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Adapter molecule crk,4296.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,27931.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Adenylosuccinate lyase,1189.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,1143.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,859.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Adiponectin,4675.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2219.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,349.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,357.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,175.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,453.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,693.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,9111.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Adrenomedullin,1688.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",1207.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Afamin,22259.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,2852.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Aggrecan core protein,468.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Agouti-related protein,2223.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,AH receptor-interacting protein,5703.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alanine aminotransferase 1,2750.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],6297.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Allograft inflammatory factor 1,2690.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",12421.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,292013.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,11684.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-1-antitrypsin,1062.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-2-antiplasmin,1537.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1846.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-2-macroglobulin,14290.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,2969.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-enolase,38507.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,alpha-Fetoprotein,812.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-L-iduronidase,1157.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,4504.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Alpha-synuclein,11122.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Aminoacylase-1,4229.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Amphiregulin,2806.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Amphoterin-induced protein 2,2798.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),335.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),2945.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Amyloid beta A4 protein,19063.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiogenin,4399.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiopoietin-1,715.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",2373.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiopoietin-2,173.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiopoietin-4,517.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiopoietin-related protein 3,513.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiopoietin-related protein 4,5512.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiostatin,16557.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,560.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Angiotensinogen,5350.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ankyrin-2,473,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Annexin A1,4659.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Annexin A2,4739.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Annexin A5,919.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Annexin A6,8631.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,837.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Antileukoproteinase,46946.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Antithrombin-III,122373.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein A-I,15332.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein B,5226.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein D,4833.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein E,37496.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),288510.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),231503.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),259487.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein L1,31569.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apolipoprotein M,11237.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,1299.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Appetite-regulating hormone,885.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Arginase-1,976.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,233.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Artemin,487.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Arylsulfatase A,1071.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Arylsulfatase B,897.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1210.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",2800.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,3270.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",1911,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",3643.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Atrial natriuretic factor,852.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,1951.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Aurora kinase A,1127.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Aurora kinase B,742.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Azurocidin,253.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,1770.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,223.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,574.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,106.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1734.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Basigin,373.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,1658.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,B-cell receptor CD22,822.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,8465.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bcl-2-like protein 1,1058.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bcl-2-like protein 2,850.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bcl-2-related protein A1,819.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,1074,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Beta-2-microglobulin,5490.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,5113.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,1934,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Betacellulin,562,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Beta-endorphin,903.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,beta-nerve growth factor,744.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,BH3-interacting domain death agonist,1503.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Biglycan,1337,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,492.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1443.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bone morphogenetic protein 1,1963.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bone morphogenetic protein 6,20220.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bone morphogenetic protein 7,601.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,964.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,446.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Bone sialoprotein 2,9974,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,1416.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Brain natriuretic peptide 32,632.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Brain-specific serine protease 4,2522.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1609.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Brevican core protein,1224.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Brother of CDO,1197.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C3a anaphylatoxin,594.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,165561.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C5a anaphylatoxin,14956.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cadherin-12,779.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cadherin-15,4872.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cadherin-1,75033.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cadherin-2,2242.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cadherin-3,23177.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cadherin-5,16221.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cadherin-6,408.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcineurin,1666.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcineurin subunit B type 1,7038.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",728.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,328.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,4169.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2373.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,728.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,1994,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,7361.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,286.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calpain I,33847.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calpastatin,6714,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Calreticulin,2207.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,670.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,2487.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1230.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,5842.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,279.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,298.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase 1,26268,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase 13,1193.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase 2,190,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase 3,5554.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase 4,2371.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase 6,13180.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase 7,316.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase 9,1665.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,677.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carboxypeptidase B2,12374.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Carboxypeptidase E,1853.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cardiotrophin-1,660.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,246.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,7420.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Casein kinase II subunit alpha,512.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Caspase-10,4074.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Caspase-2,376.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Caspase-3,4690.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Catalase,19737,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin B,2185.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin D,932.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin E,398.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin F,3333.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin G,1047,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin H,1343.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin L2,732.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin S,910,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cathepsin Z,7281,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,35350.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,1148.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 1,2784.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 13,444,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 14,12806.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 15,7724.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 16,41222.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 17,1312.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 18,14739.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 19,473.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 20,174.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 21,37019.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 22,1584.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 23,3639.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 24,344.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 25,2132.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 2,5335.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 26,1116.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 27,1132.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 28,9046.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 3,1344,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,3432.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 4-like,417.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 5,32236.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 7,729,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-C motif chemokine 8,226.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD109 antigen,2326.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD166 antigen,18000.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD177 antigen,635.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD209 antigen,1168.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD226 antigen,845.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD27 antigen,6420.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD40 ligand,282.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD48 antigen,911.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD59 glycoprotein,3758.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD5 antigen-like,3442.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD63 antigen,368.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD70 antigen,250.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD83 antigen,317.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CD97 antigen,1852.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cell adhesion molecule 1,1682,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cell adhesion molecule 3,1294.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5912.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,1312.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cellular tumor antigen p53,856.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,6979.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",5942.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",921.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",12415.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Chitinase-3-like protein 1,40198.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Chitotriosidase-1,5150.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,4050.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Choline/ethanolamine kinase,2538.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Chordin-like protein 1,4831.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,3419,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Chromobox protein homolog 5,446.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Chromogranin-A,62420.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Chymase,615.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ciliary neurotrophic factor,273.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,12682.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ck-beta-8-1,77922.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Clusterin,1253.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,CMRF35-like molecule 6,6770.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coactosin-like protein,1999.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coagulation factor IX,10649.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coagulation factor IXab,7575.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coagulation Factor V,65836.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coagulation factor VII,710.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coagulation Factor X,5863.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coagulation factor Xa,4821.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coagulation Factor XI,4103.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cofilin-1,7530.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,3979.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,1153.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,343.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Collagenase 3,579.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Collectin-11,9515.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Collectin-12,2454.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,COMM domain-containing protein 7,1535.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C1q subcomponent,44558,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C1r subcomponent,1531.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C2,2911.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C3,55732.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C3b,18877.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Complement C3b, inactivated",8247,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C3d fragment,9329,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C4,137785.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C4b,628.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C5,7034.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement C5b-C6 complex,472.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4091.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement component C1q receptor,15337.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement component C6,83602.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement component C7,1620.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement component C8,2657.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement component C9,94120.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement decay-accelerating factor,25857.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement factor B,27805.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement factor D,1697.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement factor H,55308.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement factor H-related protein 5,1220.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Complement factor I,46925.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Connective tissue-activating peptide III,18823.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Connective tissue growth factor,1397.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Contactin-1,276.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Contactin-2,1024.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Contactin-4,3477.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Contactin-5,536.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Copine-1,3269.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Corticosteroid-binding globulin,687.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Corticotropin,390.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-reactive protein,58251.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Creatine kinase B-type,794.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Creatine kinase M-type,552.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,466.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cryptic protein,2444.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,18227.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,193.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,45294.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,848.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-type mannose receptor 2,4227.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-X-C motif chemokine 10,2895.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-X-C motif chemokine 11,3647.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-X-C motif chemokine 13,6028.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-X-C motif chemokine 16,14604.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-X-C motif chemokine 5,637,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-X-C motif chemokine 6,2651.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,C-X-C motif chemokine 9,952.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,608.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,296.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1298.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1246.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,890,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cystatin-C,5702,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cystatin-D,31191.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cystatin-F,947.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cystatin-M,22131.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cystatin-S,174.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cystatin-SA,76963.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cystatin-SN,5536,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,2656.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,282.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,3180.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytochrome c,1330.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytochrome P450 3A4,13806.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,2940.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,733.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,1532.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,954,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,292.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,14343.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,1108.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,746.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,84.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,8232.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,D-dimer,14726.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Death-associated protein kinase 2,2204.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Decorin,2306.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Delta-like protein 1,3228.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Delta-like protein 4,441.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dermatopontin,6301.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Desert hedgehog protein N-product,538.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Desmocollin-2,6754.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Desmocollin-3,301.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Desmoglein-1,2514.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",5093.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dickkopf-like protein 1,2523.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dickkopf-related protein 1,23876,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dickkopf-related protein 3,5766.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dickkopf-related protein 4,8403.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,830.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,1343.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1935,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,465,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,3000.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,462.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,2584.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,DNA topoisomerase 1,573.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,1261.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Drebrin-like protein,2694.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",1767.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,426.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2745.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,2298.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,37797.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,1550.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2658.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dynactin subunit 2,1813.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",280.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,2092.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,720,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,895.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,188.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,1157.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,469.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",1413.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1676,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1300.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3770.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,6701.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1885.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Elafin,35773.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Elongation factor 1-beta,601.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Endoglin,1172.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,72714.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,13834.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Endostatin,117036.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,6631.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,1352.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,3275.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,19228.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Enteropeptidase,188.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Eotaxin,13406.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin-A2,2022,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin-A3,2936.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin-A4,3729.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin-A5,5202,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin-B1,3113.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin-B2,18587.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin-B3,3262.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin type-A receptor 10,397.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin type-A receptor 1,6618.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin type-A receptor 2,5688.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin type-A receptor 3,234.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin type-A receptor 5,666.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin type-B receptor 2,26317.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin type-B receptor 4,3102.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ephrin type-B receptor 6,2588.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Epidermal growth factor,847,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Epidermal growth factor receptor,22304.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,430.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,214.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Epiregulin,654.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,310.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Erythropoietin,668.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Erythropoietin receptor,355.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,E-selectin,27825.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,1876.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Estrogen receptor,872.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,444.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,246.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,1624.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,2899.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,1462.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,38213.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Extracellular matrix protein 1,11284.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],631,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,FACT complex subunit SSRP1,470.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",13778.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",26098.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",6133.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fc receptor-like protein 3,341.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ferritin,64752.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fetuin-B,5722.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibrinogen,187925,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibrinogen gamma chain,69728.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 10,223.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 1,193,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 12,226.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 16,2328.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 17,212.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 18,256.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 19,15869.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 20,287.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 2,1605.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 23,760.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 4,178.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 5,524.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 6,459.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 7,1789.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,375.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,853.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor 9,542.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,1001.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,209.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,862.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,981.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibronectin,5255.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibronectin Fragment 3,1404.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fibronectin Fragment 4,48080.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ficolin-1,2381.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ficolin-2,1265.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ficolin-3,1906.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,461.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Focal adhesion kinase 1,288.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Follicle stimulating hormone,1517,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Follistatin,897.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Follistatin-related protein 1,40035.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Follistatin-related protein 3,13199.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,38602.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fractalkine,4198.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,69616.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,436.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,473.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galectin-10,1127.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galectin-2,518.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galectin-3,26052,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galectin-3-binding protein,1051.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galectin-4,810.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galectin-7,552.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galectin-8,424.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Galectin-9,1836.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Gamma-enolase,12997.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Gastrin-releasing peptide,336.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,GDNF family receptor alpha-1,1442.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,GDNF family receptor alpha-2,7077.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,GDNF family receptor alpha-3,1117.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Gelsolin,793.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glia-derived nexin,1079.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,384.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glial fibrillary acidic protein,501.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glucagon,2372.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glucocorticoid receptor,114.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glucokinase regulatory protein,941.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,14318.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,259.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glutathione S-transferase A3,217.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glutathione S-transferase P,5326.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,89322.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",3387.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,11851.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,3236.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glypican-2,164.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glypican-3,550.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glypican-5,909.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Glypican-6,1664.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",974.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Granulins,30537.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1753.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,920,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,306.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Granulysin,1323.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Granzyme A,2619.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Granzyme B,169.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Granzyme H,687.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,GRB2-related adapter protein 2,483.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Gremlin-1,397,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Gro-beta/gamma,746.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,578.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,260.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth arrest-specific protein 1,1067.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,627.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth/differentiation factor 11,972.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth/differentiation factor 15,2200.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth/differentiation factor 2,2249.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth/differentiation factor 5,1724.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth/differentiation factor 8,4075.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth/differentiation factor 9,394.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,19912.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth hormone receptor,610.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Growth-regulated alpha protein,6489.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,GTPase KRas,1515.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,6349.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Haptoglobin,59530.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,8346.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,1772.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heat shock protein beta-1,11629.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,6421.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,40083.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heme oxygenase 2,446.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,HemK methyltransferase family member 2,2470,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hemoglobin,2186.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hemojuvelin,1051.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hemopexin,2081.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2561,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,297.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heparin cofactor 2,3364.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,10334.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hepatocyte growth factor,2227.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hepatocyte growth factor activator,3197.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,3700,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,7918.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,999,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hepcidin,64591.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,892.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1800.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,262.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2351.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,4157.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hexokinase-1,1639.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hexokinase-2,1014.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",596.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",575.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,280.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,3783.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,High mobility group protein B1,6689.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histidine-rich glycoprotein,3784.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,1649.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1517.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,255.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone deacetylase 8,2066.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone H1.2,2023.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone H2A type 3,841.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone H2A.z,2958.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone H2B type 2-E,20902.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone H3.1,2157.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,323.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Homeobox protein NANOG,151.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,388.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,1992,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,5698.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,1222.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,805.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,ICOS ligand,1402.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Iduronate 2-sulfatase,1613.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Immunoglobulin A,1546.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,221.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Immunoglobulin D,1490.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Immunoglobulin E,136.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Immunoglobulin G,195433.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Immunoglobulin M,6767.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,5825.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Importin subunit alpha-1,256,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Importin subunit beta-1,2516.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1247.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Inducible T-cell costimulator,1999.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Inhibin beta A chain,2821.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,602.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Inhibitor of growth protein 1,41719.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Inorganic pyrophosphatase,12905.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1473.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2125.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin,141.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-degrading enzyme,1417.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,9242.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,2169.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,1848.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,909,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,8399.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,2331.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,1290.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,49623,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin-like growth factor I,924.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Insulin receptor,6920.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,1344.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,15770.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,468.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,39522.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,6179.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,1897.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,629.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,929.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon alpha-10,362.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon alpha-2,150.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon alpha-7,689.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,1145,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon beta,693.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon gamma,594.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon gamma receptor 1,393.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon gamma receptor 2,411.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon lambda-1,289.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon lambda-2,172,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interferon regulatory factor 1,1543.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-10,239.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1316.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,1373.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-11,275.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-12,223.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,508,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,803.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-13,736.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,2924.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,1356.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-16,382.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-17A,314.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-17B,183.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-17D,224.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-17F,2324.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-17 receptor A,1285.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-17 receptor B,1029.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-17 receptor C,1427,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-17 receptor D,481.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-18-binding protein,21154,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-18 receptor 1,13668.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,311.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-19,4703,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-1 alpha,999.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-1 beta,3009.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,26798.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,4732.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,4115.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,1014.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,9218.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,8857.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-20,328.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,236.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-2,1131.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-22,1697.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,802.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,2178.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-23,1992.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-23 receptor,2902.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-24,221.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-25,504.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-27,731,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,1638,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,1001.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-3,1538.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-34,737.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-36 alpha,629.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-36 beta,429.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-37,2132.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,1062.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-4,513,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,184.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-5,1325.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,1483.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-6,336.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,17077,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,7992.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-7,159.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,327.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-8,990.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interleukin-9,236.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Interstitial collagenase,2083.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Junctional adhesion molecule B,17051.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Junctional adhesion molecule C,6622.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Junctional adhesion molecule-like,454.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-11,978.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-12,6054.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-13,1088.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-14,8108.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-4,324.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-5,285.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-6,3357.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-7,1258.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallikrein-8,2421.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kallistatin,37038.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,507.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",1002,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1442.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,293.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,392.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,400.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kinesin-like protein KIF23,938.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kininogen-1,23813.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,301.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kremen protein 2,2998.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,4878.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,1185.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Kynureninase,957.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lactadherin,935.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lactoperoxidase,781.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lactotransferrin,54136.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lamin-B1,668.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Laminin,2620.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1687.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Layilin,2303.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Legumain,2559,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leptin,4456.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leptin receptor,2326.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,2070.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,5582.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2012.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,114.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,204.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,906.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,28244.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,2577.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,5203.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,5360,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,12736.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,658.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,786.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,260.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Limbic system-associated membrane protein,2371.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,120511.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lithostathine-1-alpha,2584.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,994.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,10499.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,6616.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,8919.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1704.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Low-density lipoprotein receptor,141.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,30665.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",1457.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,1852.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,7347.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,L-Selectin,4125.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lumican,1929.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Luteinizing hormone,873.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,3079,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,382.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,11799.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lymphocyte antigen 86,4733.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lymphotactin,384,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,98.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,2553.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lymphotoxin-alpha,491.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lysosomal protective protein,5372.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lysosome membrane protein 2,403.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Lysozyme C,136501.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Macrophage-capping protein,1839.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1558.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,207.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Macrophage mannose receptor 1,12745.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Macrophage metalloelastase,4522.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,1216.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,1036.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,556.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",19972.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mammaglobin-B,7827.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,5043.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mannose-binding protein C,9627.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,7922.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,1072.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,585.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,16613.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Matrilin-2,10947.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Matrilin-3,506.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Matrilysin,5824.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,276.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Matrix metalloproteinase-14,890,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Matrix metalloproteinase-16,727.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Matrix metalloproteinase-17,1048.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Matrix metalloproteinase-9,30831.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,71608.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,381.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,5976.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Membrane frizzled-related protein,5864.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,970.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mesothelin,3850,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,92.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,480.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,1185.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Methionine aminopeptidase 1,1718.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Methionine aminopeptidase 2,27882.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,2605.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,117.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,973.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Microtubule-associated protein tau,149.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Midkine,33260.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,1636.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,577.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,864.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,731.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,491,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,1698.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,9114.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,22385.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,985.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,1027.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,1886.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Moesin,953.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,11699.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,13517.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Mucin-1,1195.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Muellerian-inhibiting factor,10127.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Myc proto-oncogene protein,547.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Myeloblastin,8654.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,4791,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Myeloperoxidase,30722.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Myoglobin,2085.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",1530.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,1051.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,1867.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,5866.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,5909.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,5888.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,61998.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,4021.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,329.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,437.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,201.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Netrin-1,629,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Netrin-4,719.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Netrin receptor UNC5C,8814,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Netrin receptor UNC5D,8743.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",13373.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,400.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,12864.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neuregulin-1,189,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neuregulin-4,1007.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neurexin-1-beta,962.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neurexin-3-beta,1565.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neurexophilin-1,3901.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1529.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,25148.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,1341.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,672.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",652.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,16106.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neuronal growth regulator 1,5892.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neuropilin-1,2547.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neurotrophin-3,181.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neurotrophin-4,190,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neutral ceramidase,3730,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,6198.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neutrophil collagenase,3938.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neutrophil elastase,495.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,83372.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,596.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Nidogen-1,4224.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Nidogen-2,1963.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NKG2D ligand 1,373.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NKG2D ligand 2,421.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NKG2D ligand 3,787.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,564.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Noggin,3076.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,1002.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,4187.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NSFL1 cofactor p47,238.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NT-3 growth factor receptor,3547.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,N-terminal pro-BNP,48479.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,420.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,599.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,15741.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,NudC domain-containing protein 3,361.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,OCIA domain-containing protein 1,901.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Olfactomedin-4,168.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Oncostatin-M,2071.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,2935,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Osteocalcin,1668.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Osteomodulin,10643.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Osteopontin,8003.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,2366.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,2488.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pancreatic hormone,3798.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pappalysin-1,42109.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Parathyroid hormone,6146.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Parathyroid hormone-related protein,856.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peptide YY,2359.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,859.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,134528,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,19560.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,12679.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,824.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",6995.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Periostin,5763.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peroxiredoxin-1,3951.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",449.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peroxiredoxin-6,459.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,210.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Persephin,267.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3443.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pescadillo homolog,235.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,7824.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",498,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",1736.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Phosphoglucomutase-1,629.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,1918.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,489.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Phospholipase A2,1034.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",8231.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pigment epithelium-derived factor,63235.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,PIK3CA/PIK3R1,435.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,PILR alpha-associated neural protein,8497.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,303.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,227.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Placenta growth factor,361.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Plasma kallikrein,18085,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,5143.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Plasma serine protease inhibitor,95443.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Plasmin,730.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Plasminogen,3613.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,649,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,788,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,9117,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet-derived growth factor C,443.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,992.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,3773.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,15526.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,29324.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,1314.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet factor 4,32095.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet glycoprotein 4,9692,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,1643.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet glycoprotein VI,13898.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Platelet receptor Gi24,478.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pleiotrophin,3178.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Plexin-B2,5420.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Plexin-C1,813.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,3389.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,2000.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,4913.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Prefoldin subunit 5,368.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,621.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,4307.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Prokineticin-1,207.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Prolactin,1352.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Prolactin receptor,1297.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,176.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,1908,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,804.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pro-opiomelanocortin,1869.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Properdin,89571.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,1433,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,968.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,773.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Prostate-specific antigen,7624.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,1202.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,239.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,740.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,470,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,809.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein 4.1,9856.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein amnionless,128.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein deglycase DJ-1,442.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein disulfide-isomerase,565.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,3045.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein E7_HPV16,510.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein E7_HPV18,2113.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein FAM107A,325.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein FAM107B,1654.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein FAM3B,1717.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein FAM3D,21740.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,294.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein jagged-1,717.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein jagged-2,365.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein kinase C alpha type,30465.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),7225.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein kinase C delta type,3406.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein kinase C gamma type,613,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein kinase C iota type,2508.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein kinase C theta type,2474.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein kinase C zeta type,844.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein lin-7 homolog B,387.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein NOV homolog,642,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein Rev_HV2BE,162.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein S100-A12,1122.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein S100-A4,1755.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein S100-A6,2908.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein S100-A7,262.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein S100-A9,6660.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein SET,466.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,264.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein Wnt-7a,236.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,4047.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Prothrombin,161646.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,1202.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,50659.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Proto-oncogene vav,9060.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,P-selectin,16203.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,6004.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pyridoxal kinase,314.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,8065.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1407.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Pyruvate kinase PKM,36683,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,1660.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,18047,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,3791.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,12314.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,789.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,23314.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,5475.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,4006,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,543.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,281.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,158.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,3742.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Relaxin receptor 1,393.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Renin,2327,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Repulsive guidance molecule A,21883.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Resistin,2252.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Reticulon-4 receptor,2751.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1516,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,3586.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Retinol-binding protein 4,305.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,RGM domain family member B,3414.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ribonuclease H1,191.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,496.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,1178,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,14175.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,RNA-binding protein 39,310.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Roundabout homolog 2,3625.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Roundabout homolog 3,370.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,R-spondin-2,435.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,R-spondin-3,2225.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,R-spondin-4,469.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Scavenger receptor class F member 1,11019.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Scavenger receptor class F member 2,242.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,3436.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sclerostin,43218.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,2880.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,4436,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,3553.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Secretin,186.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Seizure 6-like protein 2,7991.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Semaphorin-3A,1883.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Semaphorin-3E,2391.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Semaphorin-5A,7655,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Semaphorin-6A,9186.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Semaphorin-6B,3250.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine protease 27,7046.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",3981.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,2010.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,5484.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,553.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,161.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,1196.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,1148.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,9944.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,683.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,931.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,173.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1387,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,420.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,1028.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serotransferrin,238696.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serum albumin,7159.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serum amyloid A-1 protein,4919.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serum amyloid P-component,39555.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,230.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sex hormone-binding globulin,2146.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,S-formylglutathione hydrolase,2598,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,7171,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SHC-transforming protein 1,12072.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,33174.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,289.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1030.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,15200.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sialoadhesin,135.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,12161.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,1257.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,363.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SLAM family member 5,5894.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SLAM family member 6,475.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SLAM family member 7,21690.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1451.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,2254.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,9521.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,2302.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,3279.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Somatostatin-28,1591.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Somatotropin,288.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sonic hedgehog protein,1175.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sorting nexin-4,9448.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SPARC,13355.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SPARC-like protein 1,8503.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,5739.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",146.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,4318.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sphingosine kinase 1,9529.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Sphingosine kinase 2,623,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Spondin-1,2655.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Stabilin-2,757.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Stanniocalcin-1,2739.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Stem cell growth factor-alpha,4951.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,2091.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,7383.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Stromal cell-derived factor 1,5934.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Stromelysin-1,2127.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Stromelysin-2,729.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,1966.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],1120.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",39045.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,2147.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Syntaxin-1A,309.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,7573.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,TATA-box-binding protein,458,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,403,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tenascin,20863.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,998.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Testican-1,2212.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Testican-2,589.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,TGF-beta receptor type-2,1212,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,2515.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thrombin,528.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thrombopoietin,131.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thrombopoietin Receptor,171.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thrombospondin-1,3120.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thrombospondin-2,21085.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thrombospondin-4,535.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,420.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",627.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thymidylate synthase,485.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thyroglobulin,323.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thyroid peroxidase,1926.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,491.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Thyroxine-binding globulin,45280.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tissue Factor,2206.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,70129.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tissue-type plasminogen activator,2463,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,642.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,24991,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,1394.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Toll-like receptor 2,635.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Toll-like receptor 4,368.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,5396.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transcription factor AP-1,6908.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,1904,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transforming growth factor beta-1,1456.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transforming growth factor beta-2,226.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transforming growth factor beta-3,472.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,43881.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,41311,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transgelin-2,4340.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transketolase,39934.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Translationally-controlled tumor protein,14490.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,5346.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Trefoil factor 1,6433.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Trefoil factor 2,15561.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Trefoil factor 3,31484.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Triosephosphate isomerase,6782.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,883.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,69755.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tropomyosin beta chain,2126.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",1377.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",16008.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",7613,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Trypsin-1,10019.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Trypsin-2,4426.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Trypsin-3,439.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tryptase beta-2,5322.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tryptase gamma,245,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,511.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor,799.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,1467.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,532.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,656.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,1355.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,657.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,829.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,599.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,292.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",906.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,2284.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,339.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1141.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,385.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,1253.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1386.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,15320.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,144.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,1220.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,2067.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,634.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,10941.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,1009,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,2068.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,4795.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,3581.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,26858.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,12341.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,1390.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,6027.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,839.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,2475,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,953.3,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,1257,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,567.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,810.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,126.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,6787.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,6180.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,1785.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,343.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,4749.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,187,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,117119.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,356.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,4322.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",24877.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",11745,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,490,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,2677.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,990.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,994.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,12552.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,6375.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,2237.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,294.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,6385.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,9147.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin,1365.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",3113.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,901.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1303.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,9357.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,5705.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,5238.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,2289.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,18511.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,1368.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,UMP-CMP kinase,5760.4,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,14231.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,1768.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,27178.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,24293.9,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vascular endothelial growth factor A,13004.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",698.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vascular endothelial growth factor C,1355.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vascular endothelial growth factor D,878.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,7605.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,8463.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,350.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,10921,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vitamin K-dependent protein C,1546.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vitamin K-dependent protein S,4254.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Vitronectin,60125.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,von Willebrand factor,8962.2,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,396.6,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",1400.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7120.1,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,3675.7,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,1158.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Wnt inhibitory factor 1,4398.8,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,2394.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,1019.5,RFU
BF-1133,PD_INVTG922XML,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,231.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,14-3-3 protein beta/alpha,42469,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,14-3-3 protein epsilon,935.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,14-3-3 protein family,10049.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,14-3-3 protein sigma,624.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,14-3-3 protein theta,1350.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,14-3-3 protein zeta/delta,251194.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1336.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",505.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,321,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,326.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,312,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,2472.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",5327.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",541.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,4254,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,40S ribosomal protein S3,588.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,40S ribosomal protein S3a,600.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,40S ribosomal protein S7,1061.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,40S ribosomal protein SA,1510.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",25803.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",36718,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,72 kDa type IV collagenase,6986.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Abelson tyrosine-protein kinase 2,1488.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,156.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,2904,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Activated Protein C,797.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Activin receptor type-1B,237.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Adapter molecule crk,14536.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Adenylate kinase isoenzyme 1,55810.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Adenylosuccinate lyase,1604.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Adhesion G protein-coupled receptor E2,711.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Adhesion G-protein coupled receptor G5,625.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Adiponectin,4134.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2445.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,392.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,317.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,155.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,314.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,620.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,12004.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Adrenomedullin,1835.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",573.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Afamin,31360.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,7603.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Aggrecan core protein,533.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Agouti-related protein,1935.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,AH receptor-interacting protein,11105.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alanine aminotransferase 1,3782.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],3999.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Allograft inflammatory factor 1,3370.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",6238.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-1-antichymotrypsin,254789.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-1-antichymotrypsin complex,7093.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-1-antitrypsin,964.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-2-antiplasmin,1940,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-2-HS-glycoprotein,1853.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-2-macroglobulin,10690.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,714.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-enolase,87896.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,alpha-Fetoprotein,680.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-L-iduronidase,1273.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-soluble NSF attachment protein,14986.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Alpha-synuclein,14163.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Aminoacylase-1,2250.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Amphiregulin,4915.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Amphoterin-induced protein 2,2707.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),413.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),15042.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Amyloid beta A4 protein,44205.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiogenin,1983.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiopoietin-1,1262.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",1832.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiopoietin-2,115.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiopoietin-4,501.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiopoietin-related protein 3,377.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiopoietin-related protein 4,3793.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiostatin,18899.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiotensin-converting enzyme 2,565.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Angiotensinogen,4644.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ankyrin-2,455.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Annexin A1,10025,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Annexin A2,5096.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Annexin A5,920.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Annexin A6,16294.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Anterior gradient protein 2 homolog,750.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Antileukoproteinase,34051.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Antithrombin-III,134784.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein A-I,16811.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein B,6698.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein D,6221.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein E,29252.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein E (isoform E2),244281.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein E (isoform E3),180270.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein E (isoform E4),210547.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein L1,49818.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apolipoprotein M,18680.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Apoptosis regulator Bcl-2,1778.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Appetite-regulating hormone,1462.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Arginase-1,1442.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,205.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Artemin,571.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Arylsulfatase A,1358.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Arylsulfatase B,1153.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Asialoglycoprotein receptor 1,1133.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",2858.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,6870.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",2028.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",4235.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Atrial natriuretic factor,673.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,787.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Aurora kinase A,1007.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Aurora kinase B,760.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Azurocidin,335.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bactericidal permeability-increasing protein,1450,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,195.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,574.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,117.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Basal Cell Adhesion Molecule,1428.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Basigin,381.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,B-cell lymphoma 6 protein,2229.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,B-cell receptor CD22,908.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bcl2-associated agonist of cell death,16329.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bcl-2-like protein 1,1760.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bcl-2-like protein 2,696.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bcl-2-related protein A1,953,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,BDNF/NT-3 growth factors receptor,1187,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Beta-2-microglobulin,1343.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,beta-adrenergic receptor kinase 1,20242.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Beta-Ala-His dipeptidase,5582.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Betacellulin,584,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Beta-endorphin,1035.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,beta-nerve growth factor,801,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,BH3-interacting domain death agonist,3836.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Biglycan,2197,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,BMP-binding endothelial regulator protein,391.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bone morphogenetic protein 10,1103.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bone morphogenetic protein 1,3864.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bone morphogenetic protein 6,13999.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bone morphogenetic protein 7,607.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,1020.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bone morphogenetic protein receptor type-2,432.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Bone sialoprotein 2,3741.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Brain-derived neurotrophic factor,1985.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Brain natriuretic peptide 32,396.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Brain-specific serine protease 4,1987.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1291.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Brevican core protein,2187,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Brother of CDO,2019.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C3a anaphylatoxin,450.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C3a anaphylatoxin des Arginine,206240.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C5a anaphylatoxin,9264.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cadherin-12,786.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cadherin-15,3927.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cadherin-1,67358.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cadherin-2,2267.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cadherin-3,28002.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cadherin-5,10504.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cadherin-6,438.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcineurin,3402.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcineurin subunit B type 1,7790.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",820.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,533.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,6532.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2593.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,1983.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,5053.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,19397.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calcium-dependent phospholipase A2,336.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calpain I,83203.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calpastatin,5488.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Calreticulin,2095,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,1915.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,cAMP-regulated phosphoprotein 19,4665.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1075,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbohydrate sulfotransferase 15,4902.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbohydrate sulfotransferase 2,327.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbohydrate sulfotransferase 6,263.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase 13,4821.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase 1,35487.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase 2,185.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase 3,2495.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase 4,2253.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase 6,8886,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase 7,291.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase 9,802.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carbonic anhydrase-related protein 10,751.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carboxypeptidase B2,13413.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Carboxypeptidase E,1599.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cardiotrophin-1,713.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,16391.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,545.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Casein kinase II subunit alpha,523.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Caspase-10,43817,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Caspase-2,662.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Caspase-3,26302.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Catalase,21488.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin B,1418.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin D,582.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin E,338.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin F,2937,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin G,1342.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin H,912.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin L2,1593,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin S,991.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cathepsin Z,3885.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,32522,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CCAAT/enhancer-binding protein beta,915.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 1,2567.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 13,428.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 14,5094.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 15,2107.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 16,25272.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 17,5821.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 18,5417.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 19,392.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 20,118,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 21,28208,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 22,1848,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 23,1997.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 24,318,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 25,1114.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 26,1055.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 27,1239.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 28,11850.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 2,861.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 3,740.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 3-like 1,1586.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 4-like,614.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 5,94181,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 7,857.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-C motif chemokine 8,216.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD109 antigen,4525.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD166 antigen,17857,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD177 antigen,571.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD209 antigen,1617.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD226 antigen,740.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD27 antigen,7465.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD40 ligand,455.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD48 antigen,591,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD59 glycoprotein,1644.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD5 antigen-like,1838.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD63 antigen,422.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD70 antigen,242.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD83 antigen,397.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CD97 antigen,1935.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cell adhesion molecule 1,2380,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cell adhesion molecule 3,1651.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,7319.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,1219.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cellular tumor antigen p53,928.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cerebral dopamine neurotrophic factor,3430.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",8525.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1554.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",36613.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Chitinase-3-like protein 1,3123.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Chitotriosidase-1,2091.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Chloride intracellular channel protein 1,13735.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Choline/ethanolamine kinase,2347.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Chordin-like protein 1,2340.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Chorionic somatomammotropin hormone,4886.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Chromobox protein homolog 5,444.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Chromogranin-A,7816.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Chymase,593.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ciliary neurotrophic factor,199,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,6472.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ck-beta-8-1,47679.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Clusterin,1358.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,CMRF35-like molecule 6,2988.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coactosin-like protein,2651.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coagulation factor IX,10384.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coagulation factor IXab,7428.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coagulation Factor V,70525.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coagulation factor VII,797.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coagulation Factor X,6210.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coagulation factor Xa,5093.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coagulation Factor XI,1596.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cofilin-1,15966.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Coiled-coil domain-containing protein 80,1498.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Collagen alpha-1(VIII) chain,915.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Collagen alpha-1(XXIII) chain,392.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Collagenase 3,665.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Collectin-11,6822.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Collectin-12,2790.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,COMM domain-containing protein 7,4066.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C1q subcomponent,38172.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C1r subcomponent,1484.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C2,3224.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C3,82594.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C3b,11128.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Complement C3b, inactivated",8185.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C3d fragment,10648.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C4,139767.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C4b,89.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C5,7456.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement C5b-C6 complex,523.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4857.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement component C1q receptor,10189.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement component C6,106229.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement component C7,1582.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement component C8,2898.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement component C9,83650.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement decay-accelerating factor,13293.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement factor B,27646.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement factor D,1057.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement factor H,55511.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement factor H-related protein 5,1233.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Complement factor I,47656.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Connective tissue-activating peptide III,65956.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Connective tissue growth factor,2691,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Contactin-1,333.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Contactin-2,1019,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Contactin-4,4143,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Contactin-5,885.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Copine-1,8552.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Corticosteroid-binding globulin,698.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Corticotropin,360.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-reactive protein,53419.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Creatine kinase B-type,542,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Creatine kinase M-type,492.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,903.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cryptic protein,3151.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-type lectin domain family 1 member B,38991.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-type lectin domain family 4 member K,181.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-type lectin domain family 4 member M,52082.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-type lectin domain family 7 member A,715.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-type mannose receptor 2,3996.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-X-C motif chemokine 10,1227.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-X-C motif chemokine 11,2884.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-X-C motif chemokine 13,2499.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-X-C motif chemokine 16,10763.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-X-C motif chemokine 5,667.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-X-C motif chemokine 6,2945.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,C-X-C motif chemokine 9,390.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,772.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,288.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1399.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1948.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,821.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cystatin-C,2006.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cystatin-D,8100.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cystatin-F,1143.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cystatin-M,6523.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cystatin-S,176.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cystatin-SA,22988,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cystatin-SN,1338.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cysteine and glycine-rich protein 3,4723.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cysteine-rich secretory protein 3,263.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,2432.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytochrome c,3349.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytochrome P450 3A4,22822.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytokine receptor common subunit gamma,5215.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,427.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytokine receptor-like factor 2,1611.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytoplasmic protein NCK1,1678.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,294.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytoskeleton-associated protein 2,17972.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytosolic non-specific dipeptidase,1394.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,930.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,75.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,dCTP pyrophosphatase 1,10033.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,D-dimer,12832,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Death-associated protein kinase 2,4180.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Decorin,4152.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Delta-like protein 1,1529.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Delta-like protein 4,442.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dermatopontin,2946.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Desert hedgehog protein N-product,854.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Desmocollin-2,2362.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Desmocollin-3,294,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Desmoglein-1,2983,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Diablo homolog, mitochondrial",3910.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dickkopf-like protein 1,2767.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dickkopf-related protein 1,39938.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dickkopf-related protein 3,5486.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dickkopf-related protein 4,8239.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dipeptidyl peptidase 1,530.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dipeptidyl peptidase 2,1594.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Discoidin domain-containing receptor 2,1463.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,460.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1632.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,DnaJ homolog subfamily B member 1,1687.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,DNA repair protein RAD51 homolog 1,2560,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,DNA topoisomerase 1,598.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Down syndrome cell adhesion molecule,1253,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Drebrin-like protein,3783.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",3615.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,409,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1042.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,2988.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,48792,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dual specificity protein phosphatase 3,5020.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2134.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dynactin subunit 2,974.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",286.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Dynein light chain roadblock-type 1,5937,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,808.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,1693.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,210.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,1197.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,561,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Ectodysplasin-A, secreted form",1648.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1613.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1320.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,4961.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,8531.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1250.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Elafin,8893.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Elongation factor 1-beta,988.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Endoglin,2039.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,105520.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Endoplasmic reticulum resident protein 29,6655.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Endostatin,64680.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Endothelial cell-selective adhesion molecule,4060.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Endothelial cell-specific molecule 1,863.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,5787.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Endothelin-converting enzyme 1,16831.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Enteropeptidase,201.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Eotaxin,13563.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin-A2,1017.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin-A3,2372.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin-A4,1761.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin-A5,3314.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin-B1,1921.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin-B2,13901.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin-B3,732.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin type-A receptor 10,360.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin type-A receptor 1,8678,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin type-A receptor 2,2181,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin type-A receptor 3,199.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin type-A receptor 5,630,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin type-B receptor 2,17415.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin type-B receptor 4,5067,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ephrin type-B receptor 6,1384.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Epidermal growth factor,1585.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Epidermal growth factor receptor,28356.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,1063.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Epidermal growth factor receptor variant III,211.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Epiregulin,1104.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,416.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Erythropoietin,671.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Erythropoietin receptor,424.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,E-selectin,25641.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,1818.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Estrogen receptor,733.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Eukaryotic initiation factor 4A-III,681.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,264.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,10073.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Eukaryotic translation initiation factor 4H,18504.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Eukaryotic translation initiation factor 5,1776.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,67648.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Extracellular matrix protein 1,21001.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],644.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,FACT complex subunit SSRP1,407,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Fatty acid-binding protein, epidermal",854.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Fatty acid-binding protein, heart",15828.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Fatty acid-binding protein, liver",3964.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fc receptor-like protein 3,475.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ferritin,11338.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fetuin-B,6054.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibrinogen,167723.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibrinogen gamma chain,61968.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 10,193.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 1,187.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 12,190.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 16,4004.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 17,232.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 18,239.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 19,4161.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 20,372.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 2,1525,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 23,447,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 4,294.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 5,433.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 6,484.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 7,2540.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 8 isoform A,547.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 8 isoform B,764.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor 9,514.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor receptor 1,784,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor receptor 2,734.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor receptor 3,762.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibroblast growth factor receptor 4,634.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibronectin,19845.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibronectin Fragment 3,3345,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fibronectin Fragment 4,71094.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ficolin-1,1959.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ficolin-2,1346.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ficolin-3,309.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,545.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Focal adhesion kinase 1,269.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Follicle stimulating hormone,11354.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Follistatin,1000.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Follistatin-related protein 1,26704.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Follistatin-related protein 3,5148.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,5433.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fractalkine,3048.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Fructose-bisphosphate aldolase A,122749,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,G2/mitotic-specific cyclin-B1,402,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,409.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galectin-10,467.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galectin-2,354.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galectin-3,20754.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galectin-3-binding protein,1277.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galectin-4,670.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galectin-7,736.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galectin-8,503.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Galectin-9,1272.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Gamma-enolase,29479.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Gastrin-releasing peptide,294.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,GDNF family receptor alpha-1,1202.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,GDNF family receptor alpha-2,4513.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,GDNF family receptor alpha-3,725.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Gelsolin,779.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glia-derived nexin,1697.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glial cell line-derived neurotrophic factor,436.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glial fibrillary acidic protein,609.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glucagon,2463.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glucocorticoid receptor,89.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glucokinase regulatory protein,746.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glucose-6-phosphate isomerase,37455.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glutamate carboxypeptidase 2,399,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glutathione S-transferase A3,207.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glutathione S-transferase P,4646,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,226591,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1343.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,29706.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,5723,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glypican-2,140.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glypican-3,801.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glypican-5,855.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Glypican-6,1563.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"gp41 C34 peptide, HIV",533.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Granulins,21818,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Granulocyte colony-stimulating factor,1120.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,746.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,463,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Granulysin,3237.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Granzyme A,2537.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Granzyme B,168.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Granzyme H,229.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,GRB2-related adapter protein 2,552.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Gremlin-1,401.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Gro-beta/gamma,1394.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Group 10 secretory phospholipase A2,658.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Group IIE secretory phospholipase A2,296.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth arrest-specific protein 1,578.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth/differentiation factor 11,1445.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth/differentiation factor 11/8,811,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth/differentiation factor 15,1266.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth/differentiation factor 2,2766.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth/differentiation factor 5,1953.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth/differentiation factor 8,3615.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth/differentiation factor 9,377.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth factor receptor-bound protein 2,99056.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth hormone receptor,958.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Growth-regulated alpha protein,12898.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,GTPase KRas,1384.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,GTP-binding nuclear protein Ran,14578.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Haptoglobin,57956.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heat shock 70 kDa protein 1A,5634.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heat shock cognate 71 kDa protein,1842.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heat shock protein beta-1,9192.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,13617.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heat shock protein HSP 90-beta,70657.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heme oxygenase 2,399.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,HemK methyltransferase family member 2,5089.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hemoglobin,3803.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hemojuvelin,1042.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hemopexin,2752,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2167,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heparin-binding EGF-like growth factor,330.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heparin cofactor 2,3978.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hepatitis A virus cellular receptor 2,7735.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hepatocyte growth factor,1877.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hepatocyte growth factor activator,4306,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hepatocyte growth factor-like protein,3924.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hepatocyte growth factor receptor,7925.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,667.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hepcidin,20375,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,HERV-H LTR-associating protein 2,2040.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,2211.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,275.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,3782.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3611.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hexokinase-1,1286.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hexokinase-2,700.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",386.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",589.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,241.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,High affinity nerve growth factor receptor,2686,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,High mobility group protein B1,6717.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histidine-rich glycoprotein,5085,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,2288.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone acetyltransferase KAT6A,1441.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,395,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone deacetylase 8,2662.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone H1.2,898.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone H2A type 3,540.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone H2A.z,1041.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone H2B type 2-E,7033.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone H3.1,1447.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,548,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Homeobox protein NANOG,157.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Homeodomain-interacting protein kinase 3,727.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hsp90 co-chaperone Cdc37,548.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Human Chorionic Gonadotropin,6789.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,939.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,394.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,ICOS ligand,2079,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Iduronate 2-sulfatase,4368,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Immunoglobulin A,1435.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Immunoglobulin alpha Fc receptor,165.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Immunoglobulin D,133.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Immunoglobulin E,195.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Immunoglobulin G,155663.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Immunoglobulin M,2316.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,7280.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Importin subunit alpha-1,257.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Importin subunit beta-1,18684,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,665.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Inducible T-cell costimulator,636.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Inhibin beta A chain,3900,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,615.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Inhibitor of growth protein 1,38986.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Inorganic pyrophosphatase,50076.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1682.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2690.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin,111.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-degrading enzyme,2641.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor 1 receptor,7002.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor-binding protein 1,1991.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor-binding protein 2,928.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor-binding protein 3,2541.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor-binding protein 4,5709.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor-binding protein 5,1796.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor-binding protein 6,530.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor-binding protein 7,47832.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin-like growth factor I,1438.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Insulin receptor,7098.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Integrin alpha-I: beta-1 complex,2353.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,1795.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Integrin alpha-V: beta-5 complex,611.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,34211.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Intercellular adhesion molecule 1,4503.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Intercellular adhesion molecule 2,1666.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Intercellular adhesion molecule 3,618.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Intercellular adhesion molecule 5,1404,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon alpha-10,297.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon alpha-2,137.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon alpha-7,187.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon alpha/beta receptor 1,1856.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon beta,506,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon gamma,1006.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon gamma receptor 1,366.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon gamma receptor 2,561.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon lambda-1,363.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon lambda-2,153.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interferon regulatory factor 1,3700.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-10,171.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1435.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-10 receptor subunit beta,1094.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-11,276,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-12,268.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,443.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,918.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-13,713.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,1993.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-15 receptor subunit alpha,884.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-16,285.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-17A,347.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-17B,142.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-17D,215.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-17F,626.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-17 receptor A,599.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-17 receptor B,857.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-17 receptor C,810.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-17 receptor D,429,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-18-binding protein,10345.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-18 receptor 1,9195.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-18 receptor accessory protein,306.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-19,5661.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-1 alpha,526.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-1 beta,1765.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-1 Receptor accessory protein,30572.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-1 receptor antagonist protein,3665.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-1 receptor-like 1,2496.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-1 receptor-like 2,1472.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-1 receptor type 1,8824.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-1 receptor type 2,10547.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-20,346.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-20 receptor subunit alpha,290,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-2,1627.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-22,1328.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,735.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,2113,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-23,847.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-23 receptor,4227.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-24,254.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-25,268.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-27,582.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-27 receptor subunit alpha,1256.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-2 receptor subunit alpha,848.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-3,1460.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-34,781.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-36 alpha,537.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-36 beta,417.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-37,2387.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-3 receptor subunit alpha,1571.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-4,539.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-4 receptor subunit alpha,189.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-5,239.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-5 receptor subunit alpha,1045.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-6,526.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-6 receptor subunit alpha,14241.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-6 receptor subunit beta,7166.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-7,228.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-7 receptor subunit alpha,305.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-8,995.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interleukin-9,238.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Interstitial collagenase,1264.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Junctional adhesion molecule B,9040,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Junctional adhesion molecule C,8218.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Junctional adhesion molecule-like,433.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-11,1215,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-12,8253.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-13,1327.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-14,8683.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-4,306.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-5,164,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-6,3178.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-7,1014.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallikrein-8,3077.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kallistatin,37038.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kelch-like ECH-associated protein 1,485.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Keratin, type I cytoskeletal 18",931,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1624,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,218,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,398.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,355.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kinesin-like protein KIF23,1423.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kininogen-1,30430.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kin of IRRE-like protein 3,312.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kremen protein 2,5163.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kunitz-type protease inhibitor 1,5255.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kunitz-type protease inhibitor 2,902.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Kynureninase,956.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lactadherin,645.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lactoperoxidase,708.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lactotransferrin,46725.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lamin-B1,813.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Laminin,2287.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1011.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Layilin,1398.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Legumain,2796.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leptin,5464.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leptin receptor,1199.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leucine carboxyl methyltransferase 1,1940.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,7399.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2425.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,110.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,3778,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1251.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,17410.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,6431.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leukemia inhibitory factor receptor,4273.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,4214.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,11226.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leukocyte surface antigen CD47,976,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Leukotriene A-4 hydrolase,958,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,269.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Limbic system-associated membrane protein,2090.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lipopolysaccharide-binding protein,88996.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lithostathine-1-alpha,305.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,L-lactate dehydrogenase B chain,1781.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,4626.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,2108.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,1430.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1363.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Low-density lipoprotein receptor,172.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,35264.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",1998.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,2191.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,4163.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,L-Selectin,4746,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lumican,1528.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Luteinizing hormone,6040.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,1588.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,318.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lymphocyte activation gene 3 protein,6869.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lymphocyte antigen 86,4604.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lymphotactin,339.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lymphotoxin alpha1:beta2,123.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lymphotoxin alpha2:beta1,2358.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lymphotoxin-alpha,365.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lysosomal protective protein,7077.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lysosome membrane protein 2,370.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Lysozyme C,88424.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Macrophage-capping protein,785.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Macrophage colony-stimulating factor 1,1098.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,172.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Macrophage mannose receptor 1,7534.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Macrophage metalloelastase,2171.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Macrophage migration inhibitory factor,1774.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Macrophage scavenger receptor types I and II,819.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Macrophage-stimulating protein receptor,525.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",36043,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mammaglobin-B,9391.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mannan-binding lectin serine protease 1,4395.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mannose-binding protein C,17384.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,MAP kinase-activated protein kinase 2,13906.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,MAP kinase-activated protein kinase 3,1963.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,MAP kinase-activated protein kinase 5,548.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,32208,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Matrilin-2,6633.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Matrilin-3,518.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Matrilysin,2475.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,216.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Matrix metalloproteinase-14,4286.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Matrix metalloproteinase-16,542.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Matrix metalloproteinase-17,830,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Matrix metalloproteinase-9,33379.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,69947.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,622.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Melanoma-derived growth regulatory protein,2936.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Membrane frizzled-related protein,2037,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,963.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mesothelin,333.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Metalloproteinase inhibitor 1,64.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Metalloproteinase inhibitor 2,356.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Metalloproteinase inhibitor 3,3863.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Methionine aminopeptidase 1,6161.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Methionine aminopeptidase 2,53105.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Methyl-CpG-binding domain protein 4,408.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,MHC class I polypeptide-related sequence A,249.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,MHC class I polypeptide-related sequence B,799.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Microtubule-associated protein tau,136.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Midkine,32256.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitochondrial glutamate carrier 2,774.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,539.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase 11,506.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase 1,17464.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase 12,1577.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase 13,777.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase 14,4107.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase 3,60110.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase 8,2747,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase 9,1038,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,4960.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Moesin,3213.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mothers against decapentaplegic homolog 2,38117.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mothers against decapentaplegic homolog 3,25818.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Mucin-1,2181.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Muellerian-inhibiting factor,9455.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Myc proto-oncogene protein,390.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Myeloblastin,4839,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Myeloid cell surface antigen CD33,2904.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Myeloperoxidase,17885.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Myoglobin,898.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Myosin-binding protein C, slow-type",1879.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,N-acetyl-D-glucosamine kinase,1109.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,2541.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,6700.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,6167.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NADPH--cytochrome P450 reductase,3533.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,7236.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,1571.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,331.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,523.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Natural killer cell receptor 2B4,288.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Netrin-1,392.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Netrin-4,740.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Netrin receptor UNC5C,3055.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Netrin receptor UNC5D,6919,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",12513.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neural cell adhesion molecule L1,460.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,14524.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neuregulin-1,146.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neuregulin-4,648.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neurexin-1-beta,783.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neurexin-3-beta,882.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neurexophilin-1,8580.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,954.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neurogenic locus notch homolog protein 1,22211.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neurogenic locus notch homolog protein 2,778.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neurogenic locus notch homolog protein 3,575.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Neuroligin-4, X-linked",689,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neuronal cell adhesion molecule,18338.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neuronal growth regulator 1,4882.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neuropilin-1,2272.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neurotrophin-3,229,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neurotrophin-4,202,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neutral ceramidase,3405.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neutrophil-activating peptide 2,22406,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neutrophil collagenase,4471,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neutrophil elastase,347.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,15645.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,457.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Nidogen-1,4809.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Nidogen-2,2505.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NKG2D ligand 1,299.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NKG2D ligand 2,325.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NKG2D ligand 3,1115.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NKG2-D type II integral membrane protein,831.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Noggin,6535.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Non-histone chromosomal protein HMG-14,679.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,4000.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NSFL1 cofactor p47,1161.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NT-3 growth factor receptor,5761.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,N-terminal pro-BNP,1430.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,540.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Nucleoside diphosphate kinase A,956.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Nucleoside diphosphate kinase B,52359.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,NudC domain-containing protein 3,556,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,OCIA domain-containing protein 1,852.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Olfactomedin-4,161.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Oncostatin-M,2053.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,3106.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Osteocalcin,15240.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Osteomodulin,6330.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Osteopontin,7596.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,OX-2 membrane glycoprotein,2320.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,4409.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pancreatic hormone,1165.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pappalysin-1,11188.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Parathyroid hormone,3165.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Parathyroid hormone-related protein,824.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peptide YY,1502,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peptidoglycan recognition protein 1,829.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,195749,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,2527.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,42974.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,2083.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",36404.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Periostin,3751.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peroxiredoxin-1,3983,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",455.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peroxiredoxin-6,996.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,276,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Persephin,204.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3759.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pescadillo homolog,215,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,11632.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",2270.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2605.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Phosphoglucomutase-1,558.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Phosphoglycerate kinase 1,4850.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Phosphoglycerate mutase 1,2069.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Phospholipase A2,1029.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Phospholipase A2, membrane associated",2623.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pigment epithelium-derived factor,46482.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,PIK3CA/PIK3R1,858,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,PILR alpha-associated neural protein,4813.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,211.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,178.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Placenta growth factor,260.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Plasma kallikrein,22962.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Plasma protease C1 inhibitor,6279.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Plasma serine protease inhibitor,94026.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Plasmin,825.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Plasminogen,3916.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Plasminogen activator inhibitor 1,1709.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet-activating factor acetylhydrolase,973.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,8284.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet-derived growth factor C,1415.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet-derived growth factor receptor alpha,2744.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet-derived growth factor receptor beta,9180.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet-derived growth factor subunit A,33136.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet-derived growth factor subunit B,85609,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet endothelial cell adhesion molecule,974.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet factor 4,98085.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet glycoprotein 4,16052.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,1669.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet glycoprotein VI,26581.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Platelet receptor Gi24,513.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pleiotrophin,1257.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Plexin-B2,5146,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Plexin-C1,951.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Polymeric immunoglobulin receptor,11186,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,PolyUbiquitin K48-linked,2137,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,PolyUbiquitin K63-linked,3660.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Prefoldin subunit 5,393.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Programmed cell death 1 ligand 1,980,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Programmed cell death 1 ligand 2,4446.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Prokineticin-1,177.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Prolactin,582.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Prolactin receptor,997.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proliferating cell nuclear antigen,162.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proliferation-associated protein 2G4,4075.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Prolyl endopeptidase FAP,862.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pro-opiomelanocortin,495.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Properdin,154230.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,2767.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,708.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Prostaglandin G/H synthase 2,456.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Prostate-specific antigen,731.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proteasome activator complex subunit 1,1460.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proteasome activator complex subunit 3,1161.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proteasome subunit alpha type-1,649.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proteasome subunit alpha type-2,556.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proteasome subunit alpha type-6,1340.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein 4.1,21267,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein amnionless,128.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein deglycase DJ-1,451.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein disulfide-isomerase,242.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein disulfide-isomerase A3,5917.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein E7_HPV16,325.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein E7_HPV18,2038.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein FAM107A,283.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein FAM107B,2940.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein FAM3B,749.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein FAM3D,6029.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,516.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein jagged-1,497.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein jagged-2,302.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein kinase C alpha type,109251.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),17536.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein kinase C delta type,7593,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein kinase C gamma type,447.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein kinase C iota type,4794.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein kinase C theta type,7295.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein kinase C zeta type,763.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein lin-7 homolog B,465.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein NOV homolog,755.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein Rev_HV2BE,156,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein S100-A12,624.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein S100-A4,1541.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein S100-A6,4231.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein S100-A7,189.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein S100-A9,3430.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein SET,590.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein-tyrosine kinase 6,203,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein Wnt-7a,201.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Protein Z-dependent protease inhibitor,3648.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Prothrombin,179005.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,1306.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,142975.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Proto-oncogene vav,43501.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,P-selectin,26836.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pulmonary surfactant-associated protein D,5892.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pyridoxal kinase,414.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pyridoxal phosphate phosphatase,6152.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",2019.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Pyruvate kinase PKM,101044.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Quinone oxidoreductase-like protein 1,1256,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Rab GDP dissociation inhibitor beta,32919.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,12136.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,34224.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ras GTPase-activating protein 1,1243.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,60988,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,12620.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,4205,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,367,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,388.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,151.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Regenerating islet-derived protein 4,1620,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Relaxin receptor 1,383.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Renin,795.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Repulsive guidance molecule A,18831.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Resistin,1010.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Reticulon-4 receptor,1165.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Retinoblastoma-associated protein,1274.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Retinoic acid receptor responder protein 2,2696.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Retinol-binding protein 4,222,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,RGM domain family member B,1743.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ribonuclease H1,126.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,1840.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,296.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ribosome maturation protein SBDS,41922.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,RNA-binding protein 39,258.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Roundabout homolog 2,3784.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Roundabout homolog 3,310.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,R-spondin-2,419.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,R-spondin-3,1332.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,R-spondin-4,666.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Scavenger receptor class F member 1,11473.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Scavenger receptor class F member 2,542.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2234.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sclerostin,18799.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Secreted and transmembrane protein 1,1052.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Secreted frizzled-related protein 1,6268.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Secreted frizzled-related protein 3,3068.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Secretin,181.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Seizure 6-like protein 2,1697.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Semaphorin-3A,2139.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Semaphorin-3E,3335.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Semaphorin-5A,5428,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Semaphorin-6A,11083.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Semaphorin-6B,4523.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine protease 27,6338.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",6459.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase 16,2098.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase 17B,4728.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase Chk1,565.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase Chk2,180.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1214.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,1107.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,14575.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,585.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase pim-1,659,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase PLK1,165.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1343.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase TBK1,265,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serine/threonine-protein kinase WNK3,2567.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serotransferrin,236434.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serum albumin,6689.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serum amyloid A-1 protein,3813.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serum amyloid P-component,35691.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Serum paraoxonase/arylesterase 1,188.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sex hormone-binding globulin,5382.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,S-formylglutathione hydrolase,2708.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SH2 domain-containing protein 1A,3021.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SHC-transforming protein 1,32517.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,7959.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,223.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1546.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,17071.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sialoadhesin,723,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,20423.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Signal transducer and activator of transcription 3,3737.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Signal transducer and activator of transcription 6,677.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SLAM family member 5,9710.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SLAM family member 6,337.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SLAM family member 7,130721,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SLIT and NTRK-like protein 1,1446.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SLIT and NTRK-like protein 5,2178.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,8616.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Small nuclear ribonucleoprotein F,2880.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Small ubiquitin-related modifier 3,6000.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Somatostatin-28,1243.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Somatotropin,190.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sonic hedgehog protein,1464,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sorting nexin-4,23396.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SPARC,32019.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SPARC-like protein 1,8486.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,2750.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",145.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,S-phase kinase-associated protein 1,5656.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sphingosine kinase 1,35950.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Sphingosine kinase 2,622.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Spondin-1,1737.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Stabilin-2,816.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Stanniocalcin-1,1724.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Stem cell growth factor-alpha,2402.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Stem Cell Growth Factor-beta,1069.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Stress-induced-phosphoprotein 1,16129.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Stromal cell-derived factor 1,5822.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Stromelysin-1,1016.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Stromelysin-2,850.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,SUMO-conjugating enzyme UBC9,4080.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Superoxide dismutase [Cu-Zn],1449.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",47445.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Synaptosomal-associated protein 25,1310.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Syntaxin-1A,390,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,6653.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,TATA-box-binding protein,407.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,T-cell surface glycoprotein CD4,341.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tenascin,19422.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,556.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Testican-1,3273.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Testican-2,1084.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,TGF-beta receptor type-2,756.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thioredoxin domain-containing protein 12,1826.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thrombin,689.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thrombopoietin,360.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thrombopoietin Receptor,269.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thrombospondin-1,7619,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thrombospondin-2,7484.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thrombospondin-4,261.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thymic stromal lymphopoietin,450.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Thymidine kinase, cytosolic",484.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thymidylate synthase,376.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thyroglobulin,357.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thyroid peroxidase,2394.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thyroid Stimulating Hormone,477.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Thyroxine-binding globulin,43325.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tissue Factor,1270.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tissue factor pathway inhibitor,62379.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tissue-type plasminogen activator,222.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,T-lymphocyte activation antigen CD80,570.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,T-lymphocyte activation antigen CD86,1229.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,3120.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Toll-like receptor 2,669.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Toll-like receptor 4,291.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4664.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transcription factor AP-1,4008.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,1896.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transforming growth factor beta-1,1624.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transforming growth factor beta-2,541,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transforming growth factor beta-3,428.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,27288.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transforming growth factor beta receptor type 3,29116.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transgelin-2,7702.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transketolase,88540.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Translationally-controlled tumor protein,31511.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Transmembrane glycoprotein NMB,4701.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Trefoil factor 1,8910.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Trefoil factor 2,13184,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Trefoil factor 3,10022.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Triosephosphate isomerase,17566.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tropomyosin alpha-1 chain,832.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tropomyosin alpha-4 chain,189611,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tropomyosin beta chain,2402.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Troponin I, cardiac muscle",554.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Troponin I, fast skeletal muscle",3113.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Troponin T, cardiac muscle",2601.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Trypsin-1,8961.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Trypsin-2,3390.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Trypsin-3,339.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tryptase beta-2,1872.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tryptase gamma,201.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor-associated calcium signal transducer 2,403.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor,439.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,1594.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,468,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,810.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,2010.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,638.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,1038.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,704,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,267.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",435.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,2121.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,351.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1207.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,316.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,848.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1172.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,16561.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,144.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,1093.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2164,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,510.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,9696.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,682.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,688.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,1846.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,955.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,9439.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,7852.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,602.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,6825.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,460.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,1327.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,611.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,893.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,300.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,2190,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase ABL1,173.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase BTK,24881.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase CSK,22825.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase Fer,9307.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase Fgr,769.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase Fyn,24057.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase HCK,163.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase JAK2,112083.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase Lck,368.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase Lyn,25696.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",124323.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",7552.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,572.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase Tec,10819.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,573.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase Yes,1117.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,16917.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,10953.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,5692.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,309.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,9732.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,4947.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin,1632.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",5506.1,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1634.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,2079.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,8251.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,2339.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,13067.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin-fold modifier 1,11547.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,39008.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Ubiquitin-like protein ISG15,2357.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,UMP-CMP kinase,5305.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Urokinase plasminogen activator surface receptor,12185.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Urokinase-type plasminogen activator,1820.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,86337,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vascular cell adhesion protein 1,10474.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vascular endothelial growth factor A,9582.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",764.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vascular endothelial growth factor C,1705.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vascular endothelial growth factor D,431.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vascular endothelial growth factor receptor 2,7377.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vascular endothelial growth factor receptor 3,8877.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vasoactive Intestinal Peptide,416.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vesicular integral-membrane protein VIP36,9302.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vitamin K-dependent protein C,2032.5,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vitamin K-dependent protein S,4802,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Vitronectin,73071.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,von Willebrand factor,8024.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,309.6,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",797.3,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7928.7,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,4265.2,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,942.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Wnt inhibitory factor 1,3784.9,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,Xaa-Pro aminopeptidase 1,9471.4,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,777.8,RFU
BF-1136,PD_INVLC005HYQ,M0,0,Plasma,X-ray repair cross-complementing protein 6,294.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,32786.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,14-3-3 protein epsilon,1156.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,14-3-3 protein family,6895.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,14-3-3 protein sigma,620,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,14-3-3 protein theta,1227.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,262183.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1305.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",493.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,336.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,373.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,294.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,2721.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",5373.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",510.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,3053.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,40S ribosomal protein S3,396.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,40S ribosomal protein S3a,471.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,40S ribosomal protein S7,890,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,40S ribosomal protein SA,1746.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",40217.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",24726.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,72 kDa type IV collagenase,8483.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1379.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,137.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,2483.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Activated Protein C,664.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Activin receptor type-1B,231.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Adapter molecule crk,19144,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,27384.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Adenylosuccinate lyase,3918.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,968.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,619.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Adiponectin,4572.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,312.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2547.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,312.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,150,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,292.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,588.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,13146.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Adrenomedullin,1856.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",647.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Afamin,30773.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,5445.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Aggrecan core protein,551.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Agouti-related protein,2581.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,AH receptor-interacting protein,11026.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alanine aminotransferase 1,4035.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],3102.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Allograft inflammatory factor 1,3105.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",7536.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,298132.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,6830.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-1-antitrypsin,946.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-2-antiplasmin,1955.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1796.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-2-macroglobulin,12639.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,640.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-enolase,80000.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,alpha-Fetoprotein,697.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-L-iduronidase,1324.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,9055.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Alpha-synuclein,10132.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Aminoacylase-1,2879.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Amphiregulin,3342.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Amphoterin-induced protein 2,2998.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),359.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),13479.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Amyloid beta A4 protein,28030.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiogenin,2124.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiopoietin-1,770.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",1849.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiopoietin-2,125.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiopoietin-4,481.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiopoietin-related protein 3,336.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiopoietin-related protein 4,3089,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiostatin,17759.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,513.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Angiotensinogen,4340.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ankyrin-2,424.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Annexin A1,7369.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Annexin A2,5960.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Annexin A5,936.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Annexin A6,9322.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,727.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Antileukoproteinase,32123.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Antithrombin-III,147275.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein A-I,18069.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein B,6756.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein D,6506,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein E,28679,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),267731.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),190883.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),228825.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein L1,49703.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apolipoprotein M,20605.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,1466.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Appetite-regulating hormone,1778.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Arginase-1,1335.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,198.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Artemin,577.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Arylsulfatase A,1659.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Arylsulfatase B,1252.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1906.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",3340.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,6265.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",1895.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",5740.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Atrial natriuretic factor,628.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,653,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Aurora kinase A,951.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Aurora kinase B,776.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Azurocidin,264.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,486.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,179.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,532.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,108.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1783.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Basigin,371.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,2425.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,B-cell receptor CD22,840.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,12860,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bcl-2-like protein 1,1756.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bcl-2-like protein 2,708.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bcl-2-related protein A1,898.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,1232.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Beta-2-microglobulin,2259.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,17939.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,4878.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Betacellulin,489.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Beta-endorphin,1211.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,beta-nerve growth factor,849.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,BH3-interacting domain death agonist,3914.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Biglycan,4730.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,375.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1413.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bone morphogenetic protein 1,2668.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bone morphogenetic protein 6,17891.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bone morphogenetic protein 7,710.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,1300.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,442.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Bone sialoprotein 2,5412.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,1152.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Brain natriuretic peptide 32,382.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Brain-specific serine protease 4,2245.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1190.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Brevican core protein,2571.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Brother of CDO,2358.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C3a anaphylatoxin,459.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,224083.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C5a anaphylatoxin,10415.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cadherin-12,647.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cadherin-15,3682,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cadherin-1,64948.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cadherin-2,2446.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cadherin-3,27090.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cadherin-5,10784.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cadherin-6,448.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcineurin,2670.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcineurin subunit B type 1,7504.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",698.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,414.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,7291.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2439.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,1619.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,3634.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,13397,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,293.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calpain I,67180.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calpastatin,5344.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Calreticulin,2170,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,3623.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,3083.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1977.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,5266.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,321.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,243.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase 13,7189.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase 1,8553.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase 2,171,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase 3,1111.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase 4,2561.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase 6,9917.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase 7,306.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase 9,772.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,734,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carboxypeptidase B2,12921.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Carboxypeptidase E,1793.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cardiotrophin-1,710.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,12368.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,600.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Casein kinase II subunit alpha,478.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Caspase-10,46480.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Caspase-2,661.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Caspase-3,40668.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Catalase,7953.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin B,1236.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin D,675.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin E,338.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin F,2585.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin G,1468,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin H,1171.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin L2,1794.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin S,1455,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cathepsin Z,5349.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,34349.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,867.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 1,2677.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 13,359.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 14,3849.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 15,2713.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 16,23321.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 17,4979.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 18,4566.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 19,653.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 20,105.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 2,1009.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 21,29189.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 22,1778.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 23,2037.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 24,306.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 25,1742.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 26,927.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 27,1212.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 28,8725.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 3,714.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,1661,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 4-like,875.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 5,57318,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 7,2671.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-C motif chemokine 8,345.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD109 antigen,6733.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD166 antigen,18383,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD177 antigen,536,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD209 antigen,1783.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD226 antigen,760.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD27 antigen,7330.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD40 ligand,352.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD48 antigen,797.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD59 glycoprotein,1780,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD5 antigen-like,1817.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD63 antigen,393.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD70 antigen,222.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD83 antigen,470.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CD97 antigen,1925,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cell adhesion molecule 1,3166.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cell adhesion molecule 3,2202.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,7392.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,1262.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cellular tumor antigen p53,992,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,3498.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",7619.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1306.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",46376.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Chitinase-3-like protein 1,5506.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Chitotriosidase-1,2107.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,10222.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Choline/ethanolamine kinase,2152.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Chordin-like protein 1,2352,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,4372.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Chromobox protein homolog 5,430.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Chromogranin-A,11857.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Chymase,537.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ciliary neurotrophic factor,182.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,7626.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ck-beta-8-1,51453.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Clusterin,1386.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,CMRF35-like molecule 6,3700.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coactosin-like protein,3529.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coagulation factor IX,10690.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coagulation factor IXab,7857.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coagulation Factor V,81774,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coagulation factor VII,798.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coagulation Factor X,5821.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coagulation factor Xa,4981.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coagulation Factor XI,1455.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cofilin-1,11682.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,1631.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,1019.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,383.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Collagenase 3,662.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Collectin-11,6802.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Collectin-12,2949,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,COMM domain-containing protein 7,4925.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C1q subcomponent,42343.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C1r subcomponent,2493,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C2,2984.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C3,72853.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C3b,15381.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Complement C3b, inactivated",9533.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C3d fragment,12990.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C4,141283.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C4b,497.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C5,7201.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement C5b-C6 complex,522.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",5032.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement component C1q receptor,11820.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement component C6,125484.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement component C7,1565.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement component C8,3187.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement component C9,95858.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement decay-accelerating factor,14114.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement factor B,30773.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement factor D,1127.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement factor H,59455.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement factor H-related protein 5,1046.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Complement factor I,50185.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Connective tissue-activating peptide III,41821.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Connective tissue growth factor,2593.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Contactin-1,326.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Contactin-2,1212,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Contactin-4,4325.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Contactin-5,892.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Copine-1,6212.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Corticosteroid-binding globulin,553.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Corticotropin,320.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-reactive protein,73116.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Creatine kinase B-type,584.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Creatine kinase M-type,465,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,608,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cryptic protein,2964.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,28477.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,160.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,60669.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,575.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-type mannose receptor 2,4377.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-X-C motif chemokine 10,8335,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-X-C motif chemokine 11,6570.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-X-C motif chemokine 13,2829.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-X-C motif chemokine 16,15256.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-X-C motif chemokine 5,594.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-X-C motif chemokine 6,2084.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,C-X-C motif chemokine 9,724.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,666.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,297.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1454.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1895.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,778.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cystatin-C,2521.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cystatin-D,8519.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cystatin-F,907.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cystatin-M,7182.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cystatin-S,194.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cystatin-SA,27273.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cystatin-SN,1498.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,4158.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,256.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,2395.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytochrome c,2377.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytochrome P450 3A4,20039.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,4010.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,402.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,1459.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,1550.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,264.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,20566.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,1304.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,786.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,79,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,16166.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,D-dimer,13810.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Death-associated protein kinase 2,3711.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Decorin,4984.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Delta-like protein 1,2038.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Delta-like protein 4,583,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dermatopontin,3144.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Desert hedgehog protein N-product,670.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Desmocollin-2,2519.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Desmocollin-3,305.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Desmoglein-1,3191.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",4360,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dickkopf-like protein 1,2657.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dickkopf-related protein 1,29485.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dickkopf-related protein 3,7841.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dickkopf-related protein 4,6959.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,547.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,1617.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1489.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,442.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1756.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,1219.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,2807.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,DNA topoisomerase 1,471,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,1458.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Drebrin-like protein,3249.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2951.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,421.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1042.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,2884.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,56570.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,6245.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2000.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dynactin subunit 2,1040.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",270.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,3672.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,778.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,1528.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,197.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,1277.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,540.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",1820.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1709.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1249.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,6473.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,8507.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1341.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Elafin,10065.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Elongation factor 1-beta,823.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Endoglin,2996.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,149797.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,7100.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Endostatin,70631.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,3849,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,1407.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,5691.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,17648.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Enteropeptidase,178.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Eotaxin,14974.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin-A2,1170.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin-A3,2648.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin-A4,1816.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin-A5,4317.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin-B1,1778.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin-B2,20035.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin-B3,762.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin type-A receptor 10,360.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin type-A receptor 1,17799.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin type-A receptor 2,3573.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin type-A receptor 3,232,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin type-A receptor 5,885.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin type-B receptor 2,23914,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin type-B receptor 4,4766.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ephrin type-B receptor 6,1660.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Epidermal growth factor,940.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Epidermal growth factor receptor,30114.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,1108.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,177.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Epiregulin,1050.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,398,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Erythropoietin,1173.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Erythropoietin receptor,361.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,E-selectin,30352,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,1591,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Estrogen receptor,651.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,457.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,205.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,11128.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,26118.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,1562.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,58820.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Extracellular matrix protein 1,18923.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],694.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,FACT complex subunit SSRP1,385,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",870,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",14756.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",6200.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fc receptor-like protein 3,479.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ferritin,9821.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fetuin-B,6271.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibrinogen,182458.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibrinogen gamma chain,65320.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 10,170.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 1,181,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 12,189.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 16,2919.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 17,216.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 18,221,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 19,5257.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 20,359.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 2,1518,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 23,556.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 4,273.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 5,434,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 6,391.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 7,2181.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,422.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,711.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor 9,426.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,762.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,789.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,695.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,554.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibronectin,15395.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibronectin Fragment 3,2760,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fibronectin Fragment 4,75381.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ficolin-1,2351,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ficolin-2,1376.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ficolin-3,214,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,530.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Focal adhesion kinase 1,278.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Follicle stimulating hormone,11053.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Follistatin,889,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Follistatin-related protein 1,30900.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Follistatin-related protein 3,6484.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,3249.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fractalkine,4446.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,120909.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,359.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,442.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galectin-10,435,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galectin-2,356.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galectin-3,20671.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galectin-3-binding protein,1692.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galectin-4,578.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galectin-7,615.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galectin-8,510.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Galectin-9,1866.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Gamma-enolase,53903.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Gastrin-releasing peptide,267.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,GDNF family receptor alpha-1,1667.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,GDNF family receptor alpha-2,5063.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,GDNF family receptor alpha-3,663.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Gelsolin,813.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glia-derived nexin,1258.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,398.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glial fibrillary acidic protein,597.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glucagon,3172.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glucocorticoid receptor,84.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glucokinase regulatory protein,730.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,34862.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,363.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glutathione S-transferase A3,231.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glutathione S-transferase P,5936.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,192764.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",2889.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,26571.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,4640,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glypican-2,138.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glypican-3,886.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glypican-5,758.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Glypican-6,1498.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",581.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Granulins,33497.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1521.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,669.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,438.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Granulysin,3557.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Granzyme A,3188.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Granzyme B,241.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Granzyme H,226,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,GRB2-related adapter protein 2,529.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Gremlin-1,361,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Gro-beta/gamma,1047.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,624.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,274.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth arrest-specific protein 1,654.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth/differentiation factor 11,1387.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,860.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth/differentiation factor 15,1407.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth/differentiation factor 2,2801.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth/differentiation factor 5,1657.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth/differentiation factor 8,4390.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth/differentiation factor 9,346.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,108349.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth hormone receptor,958.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Growth-regulated alpha protein,10138.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,GTPase KRas,1261.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,11009.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Haptoglobin,64373.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,6498.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,1757.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heat shock protein beta-1,9914.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,10732.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,61755,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heme oxygenase 2,339.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,HemK methyltransferase family member 2,4189.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hemoglobin,1272.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hemojuvelin,1126.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hemopexin,2371.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2466.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,296.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heparin cofactor 2,3968.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,9319,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hepatocyte growth factor,1637.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hepatocyte growth factor activator,4094.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,3229.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,7873.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,578.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hepcidin,12298.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,2154.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1623.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,265.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,3618.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,2618.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hexokinase-1,1326.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hexokinase-2,505,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",370.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",633.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,228.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,2267.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,High mobility group protein B1,5408.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histidine-rich glycoprotein,5248.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,1884.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1399.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,328.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone deacetylase 8,2717.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone H1.2,821.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone H2A type 3,621.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone H2A.z,1317.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone H2B type 2-E,11897.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone H3.1,1622.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,616,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Homeobox protein NANOG,140.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,723.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,481.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,6837.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,1023.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,355.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,ICOS ligand,3506,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Iduronate 2-sulfatase,7295,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Immunoglobulin A,1461.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,162.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Immunoglobulin D,157,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Immunoglobulin E,205,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Immunoglobulin G,181402.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Immunoglobulin M,2280.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,7970.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Importin subunit alpha-1,297.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Importin subunit beta-1,23651.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,724.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Inducible T-cell costimulator,570.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Inhibin beta A chain,5540.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,744.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Inhibitor of growth protein 1,26282.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Inorganic pyrophosphatase,49961,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1611.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2412.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin,119.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-degrading enzyme,2151.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,8171.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,4715.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,1392.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,2837.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,6531.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,1896.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,582.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,57440.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin-like growth factor I,1510.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Insulin receptor,7976.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,1928,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,1619.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,680.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,35341.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,4942.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,1683.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,579.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,1451.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon alpha-10,302.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon alpha-2,145.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon alpha-7,321.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,2940.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon beta,563,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon gamma,1346.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon gamma receptor 1,492.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon gamma receptor 2,683,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon lambda-1,337.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon lambda-2,138.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interferon regulatory factor 1,3097.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-10,164,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1568.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,1137.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-11,247.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-12,269.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,407.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,895,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-13,664.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,2595.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,1136.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-16,293.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-17A,308.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-17B,131.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-17D,190.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-17F,617.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-17 receptor A,596.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-17 receptor B,848.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-17 receptor C,912.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-17 receptor D,428.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-18-binding protein,17354.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-18 receptor 1,12002.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,273.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-19,6472.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-1 alpha,471.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-1 beta,1610.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,32317.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,10940.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,3322.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,1596.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,11200.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,10224.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-20,332.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,275.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-22,1363.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-2,2425.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,655.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,3234.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-23,1382.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-23 receptor,4217.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-24,241.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-25,254,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-27,687.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,1442.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,785.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-3,1290.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-34,942.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-36 alpha,2430.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-36 beta,390.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-37,2528.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,1277.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-4,441.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,184,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-5,214.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,1077.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-6,485.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,14056,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,7789.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-7,218.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,285.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-8,957.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interleukin-9,230.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Interstitial collagenase,827.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Junctional adhesion molecule B,9118.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Junctional adhesion molecule C,6650.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Junctional adhesion molecule-like,405.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-11,1780.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-12,9712.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-13,1427.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-14,9035.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-4,275.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-5,145.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-6,3496.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-7,1042.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallikrein-8,5470.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kallistatin,36576.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,515.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",869.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1486.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,173.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,357.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,332.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kinesin-like protein KIF23,1065.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kininogen-1,27524.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,310.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kremen protein 2,4485.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,6483.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,771.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Kynureninase,989.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lactadherin,810.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lactoperoxidase,1025,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lactotransferrin,25271.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lamin-B1,711.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Laminin,2278.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1289.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Layilin,1554.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Legumain,3193,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leptin,7642.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leptin receptor,1204.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,1884.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,8624.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2457.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,108.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,3981.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1001.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,20592.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,9341.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,4474,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,4163.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,12607,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,800.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,1251.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,270.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Limbic system-associated membrane protein,2291.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,124806.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lithostathine-1-alpha,397.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,1355.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,5593.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,2335.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,1568.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1351.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Low-density lipoprotein receptor,226.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,35248,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",3075.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,2831.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,3382,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,L-Selectin,4758.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lumican,1651.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Luteinizing hormone,4776.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,1885.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,336.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,13192.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lymphocyte antigen 86,4458.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lymphotactin,318.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,177.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,3020.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lymphotoxin-alpha,319.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lysosomal protective protein,6628.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lysosome membrane protein 2,325,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Lysozyme C,108630.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Macrophage-capping protein,871.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1106.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,166.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Macrophage mannose receptor 1,7842.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Macrophage metalloelastase,2381.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,1307.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,768.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,499.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",25894.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mammaglobin-B,9797,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,5172.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mannose-binding protein C,18456,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,13789.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,1575.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,488.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,36325.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Matrilin-2,7835.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Matrilin-3,514.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Matrilysin,2096.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,196.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Matrix metalloproteinase-14,3846.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Matrix metalloproteinase-16,562.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Matrix metalloproteinase-17,830.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Matrix metalloproteinase-9,11687.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,69001.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,600.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,2933.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Membrane frizzled-related protein,1716,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,849.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mesothelin,283.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,72.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,387.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,1965.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Methionine aminopeptidase 1,4993.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Methionine aminopeptidase 2,45106.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,343.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,271,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,911.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Microtubule-associated protein tau,117,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Midkine,36362.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,766.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,487.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,12545.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,557.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,1494,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,774.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,3277.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,52641.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,2139.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,1168.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,4127,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Moesin,2664.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,29790.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,23410.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Mucin-1,2199.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Muellerian-inhibiting factor,10505.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Myc proto-oncogene protein,349.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Myeloblastin,7518.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,2806.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Myeloperoxidase,20029.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Myoglobin,1156,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",1064.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,992.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,4204.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,6642.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,5953.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,3795.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,7229.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,1820.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,285.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,593.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,296.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Netrin-1,394.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Netrin-4,828.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Netrin receptor UNC5C,3887.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Netrin receptor UNC5D,8671.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",12731.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,543.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,14292.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neuregulin-1,144.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neuregulin-4,657.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neurexin-1-beta,944.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neurexin-3-beta,1023.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neurexophilin-1,6064.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1375.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,24700.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,839,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,637.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",838,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,24355.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neuronal growth regulator 1,5238.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neuropilin-1,2686.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neurotrophin-3,207.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neurotrophin-4,202.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neutral ceramidase,3001.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,15131,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neutrophil collagenase,3737.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neutrophil elastase,339.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,16316.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,506.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Nidogen-1,4150.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Nidogen-2,2055.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NKG2D ligand 1,278,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NKG2D ligand 2,321.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NKG2D ligand 3,912.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,830.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Noggin,5654,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,666.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,3776.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NSFL1 cofactor p47,1419.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NT-3 growth factor receptor,7784.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,N-terminal pro-BNP,5303.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,439,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,727.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,53918.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,NudC domain-containing protein 3,552.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,OCIA domain-containing protein 1,846.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Olfactomedin-4,146.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Oncostatin-M,2191.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,2943.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Osteocalcin,16129.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Osteomodulin,7398.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Osteopontin,15968,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,2964.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,2523.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pancreatic hormone,1171.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pappalysin-1,12943.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Parathyroid hormone,3180.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Parathyroid hormone-related protein,856.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peptide YY,1302.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,543.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,192586.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,2347,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,32895.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,1907.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",47871.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Periostin,4076.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peroxiredoxin-1,2324.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",477.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peroxiredoxin-6,637.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,262.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Persephin,206.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3604.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pescadillo homolog,195.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,7263.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",2627.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2689.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Phosphoglucomutase-1,571.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,5564.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,7510.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Phospholipase A2,1019.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",2610.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pigment epithelium-derived factor,50413,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,PIK3CA/PIK3R1,943.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,PILR alpha-associated neural protein,5523.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,223.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,175.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Placenta growth factor,276.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Plasma kallikrein,20779,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,6417.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Plasma serine protease inhibitor,83406,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Plasmin,781.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Plasminogen,3631.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,923.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,875.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,7369.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet-derived growth factor C,1420,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,3960.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,12125.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,19415.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,45206.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,934.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet factor 4,37822.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet glycoprotein 4,17202.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,1521.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet glycoprotein VI,18273.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Platelet receptor Gi24,439,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pleiotrophin,1243.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Plexin-B2,6109.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Plexin-C1,981.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,14300.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,1309.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,4535.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Prefoldin subunit 5,478.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,1607.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,5205.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Prokineticin-1,154.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Prolactin,523.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Prolactin receptor,1023.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,147.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,2600.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,839.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pro-opiomelanocortin,600.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Properdin,182763.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,4764.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,994.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,392.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Prostate-specific antigen,497.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,1580.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,1081,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,549.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,671.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,1051.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein 4.1,9533.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein amnionless,118.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein deglycase DJ-1,473.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein disulfide-isomerase,273.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,4886.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein E7_HPV16,318.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein E7_HPV18,2053.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein FAM107A,258.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein FAM107B,4063.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein FAM3B,881.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein FAM3D,8329.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,615.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein jagged-1,540.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein jagged-2,278.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein kinase C alpha type,117775.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),14807.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein kinase C delta type,4768,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein kinase C gamma type,420.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein kinase C iota type,3439.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein kinase C theta type,6179,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein kinase C zeta type,689.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein lin-7 homolog B,432.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein NOV homolog,678.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein Rev_HV2BE,145.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein S100-A12,541.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein S100-A4,1392.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein S100-A6,2362.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein S100-A7,204.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein S100-A9,2228,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein SET,522.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,171.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein Wnt-7a,187.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,3930,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Prothrombin,192771.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,1350.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,127428.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Proto-oncogene vav,34133.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,P-selectin,21819.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,3637.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pyridoxal kinase,462.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,4378.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",2100.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Pyruvate kinase PKM,81276.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,1226.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,20839,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,9592.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,29702.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,1472.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,50969.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,13622.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,4462.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,347.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,362,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,141.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,1698.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Relaxin receptor 1,329.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Renin,736.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Repulsive guidance molecule A,22932.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Resistin,987.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Reticulon-4 receptor,1231.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1288.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,2785.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Retinol-binding protein 4,207.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,RGM domain family member B,1996.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ribonuclease H1,126.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,2315.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,226.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,31871.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,RNA-binding protein 39,264.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Roundabout homolog 2,4096.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Roundabout homolog 3,281.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,R-spondin-2,314,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,R-spondin-3,1438.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,R-spondin-4,655.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Scavenger receptor class F member 1,9894.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Scavenger receptor class F member 2,464,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2498.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sclerostin,16168.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,1588.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,6944.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,3290,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Secretin,174.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Seizure 6-like protein 2,1291.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Semaphorin-3A,1610.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Semaphorin-3E,3260.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Semaphorin-5A,6536.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Semaphorin-6A,16683.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Semaphorin-6B,7414.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine protease 27,6335.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",7287.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,2292.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,4371.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,527.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,173.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,1192.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,1112.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,17029.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,582.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,593.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,147.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1255.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,234.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,1592.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serotransferrin,266220.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serum albumin,6978.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serum amyloid A-1 protein,3260.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serum amyloid P-component,36745.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,169.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sex hormone-binding globulin,5761.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,S-formylglutathione hydrolase,3112.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,3577.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SHC-transforming protein 1,25767.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,13185.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,224.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1698.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,19547.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sialoadhesin,771.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,18035.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,2882.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,533.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SLAM family member 5,12916.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SLAM family member 6,390.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SLAM family member 7,145672.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1270.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,3001.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,9005.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,3054.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,4667.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Somatostatin-28,1282.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Somatotropin,178.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sonic hedgehog protein,1661.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sorting nexin-4,21574.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SPARC,22063,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SPARC-like protein 1,11041.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,3066.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",142.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,4515.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sphingosine kinase 1,28823.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Sphingosine kinase 2,602.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Spondin-1,1864,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Stabilin-2,804.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Stanniocalcin-1,2242.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Stem cell growth factor-alpha,2496.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,1149.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,11626,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Stromal cell-derived factor 1,5008.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Stromelysin-1,1386.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Stromelysin-2,1247.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,2934.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],1097.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",53269.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,1342.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Syntaxin-1A,374.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,6368,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,TATA-box-binding protein,413.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,335,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tenascin,22221.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,643.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Testican-1,3387.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Testican-2,1060.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,TGF-beta receptor type-2,718.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,1989,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thrombin,762.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thrombopoietin,423.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thrombopoietin Receptor,257.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thrombospondin-1,3665,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thrombospondin-2,10179.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thrombospondin-4,290.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,377.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",489.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thymidylate synthase,359.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thyroglobulin,338,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thyroid peroxidase,2513.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,643.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Thyroxine-binding globulin,45696.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tissue Factor,1520.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,63895.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tissue-type plasminogen activator,302.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,579.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,1685.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,6115.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Toll-like receptor 2,729.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Toll-like receptor 4,251.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,5098.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transcription factor AP-1,7583.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,1637.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transforming growth factor beta-1,1599.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transforming growth factor beta-2,513.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transforming growth factor beta-3,530.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,28834.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,35747.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transgelin-2,6365.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transketolase,66364.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Translationally-controlled tumor protein,23816.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,5307.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Trefoil factor 1,10019.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Trefoil factor 2,19573.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Trefoil factor 3,11073.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Triosephosphate isomerase,12321.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,843,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,189122.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tropomyosin beta chain,2590.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",574.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",3357.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",2310.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Trypsin-1,4905.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Trypsin-2,2217.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Trypsin-3,356.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tryptase beta-2,2284.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tryptase gamma,184.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,341,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor,482.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,2050.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,493.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,932.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,3239.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,544.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,1286.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,742.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,267.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",518.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,2353.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,341.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1110.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,269.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,736.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,979.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,19246.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,132.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,1053.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,2123.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,494.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,9146.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,858.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,768.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,2190.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,1182.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,14600.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,9498.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,545.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,7494.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,428.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,1617.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,686.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,1028.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,290.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,1842.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,146.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,18739.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,17354.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,6968.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,657,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,17964.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,158.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,129002.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,300,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,20402.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",114284.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",7504.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,652.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,8797.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,646.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,1151.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,17817.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,9747.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,4436.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,303.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,8904.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,7007.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin,1141.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",2698.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1429.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1889.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,7959.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,1712.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,7854.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,14172.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,39654.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,3661,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,UMP-CMP kinase,4708.8,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,16225,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,1979.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,59062.2,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,12481.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vascular endothelial growth factor A,11357.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",688.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vascular endothelial growth factor C,1574.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vascular endothelial growth factor D,457.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,7037.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,9561.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,357,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,10416.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vitamin K-dependent protein C,1930.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vitamin K-dependent protein S,4441.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Vitronectin,81684.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,von Willebrand factor,7743.6,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,282,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",706.4,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",8790.3,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,5041.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,983.5,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Wnt inhibitory factor 1,4362.9,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,13176.1,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,768.7,RFU
BF-1136,PD_INVLC005HYQ,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,312.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,14-3-3 protein beta/alpha,56116.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,14-3-3 protein epsilon,1551.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,14-3-3 protein family,12531.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,14-3-3 protein sigma,597.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,14-3-3 protein theta,1596.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,14-3-3 protein zeta/delta,293164,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1461.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",496.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,327.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,471.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,266.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,7227.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",5558.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",411.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,3959.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,40S ribosomal protein S3,575.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,40S ribosomal protein S3a,712.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,40S ribosomal protein S7,1266.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,40S ribosomal protein SA,1589.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",99530.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",30542.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,72 kDa type IV collagenase,7859.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Abelson tyrosine-protein kinase 2,1509.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,171.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,3130.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Activated Protein C,794.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Activin receptor type-1B,243,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Adapter molecule crk,33751.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Adenylate kinase isoenzyme 1,37879.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Adenylosuccinate lyase,1681.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Adhesion G protein-coupled receptor E2,625.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Adhesion G-protein coupled receptor G5,569.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Adiponectin,9028.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,3064.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,370.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,344.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,137.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,501.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,514.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,6681.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Adrenomedullin,2028.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",582.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Afamin,26983.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,9207.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Aggrecan core protein,633,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Agouti-related protein,2259.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,AH receptor-interacting protein,14751.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alanine aminotransferase 1,3711.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],6697,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Allograft inflammatory factor 1,3659.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",4474.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-1-antichymotrypsin,290046.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-1-antichymotrypsin complex,6613.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-1-antitrypsin,949.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-2-antiplasmin,1425.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-2-HS-glycoprotein,1473.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-2-macroglobulin,12770,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,820.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-enolase,92823.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,alpha-Fetoprotein,761.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-L-iduronidase,1818.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-soluble NSF attachment protein,15962.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Alpha-synuclein,19984.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Aminoacylase-1,2816.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Amphiregulin,5032.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Amphoterin-induced protein 2,3447.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),318.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),15896.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Amyloid beta A4 protein,34395.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiogenin,5929.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiopoietin-1,791.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",1733.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiopoietin-2,149.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiopoietin-4,650.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiopoietin-related protein 3,373.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiopoietin-related protein 4,4887.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiostatin,13440.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiotensin-converting enzyme 2,518.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Angiotensinogen,4350.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ankyrin-2,398.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Annexin A1,12944.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Annexin A2,11847.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Annexin A5,1056.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Annexin A6,18214.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Anterior gradient protein 2 homolog,738.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Antileukoproteinase,36541.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Antithrombin-III,121463.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein A-I,14607.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein B,10144.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein D,4688.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein E,43564.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein E (isoform E2),306887.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein E (isoform E3),261132.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein E (isoform E4),277508.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein L1,26019.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apolipoprotein M,15953.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Apoptosis regulator Bcl-2,1779.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Appetite-regulating hormone,1788.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Arginase-1,1089.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,242.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Artemin,413.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Arylsulfatase A,1605.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Arylsulfatase B,1184.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Asialoglycoprotein receptor 1,1426.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",3518.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,11765.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",2222.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",15553.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Atrial natriuretic factor,839.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,806.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Aurora kinase A,866.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Aurora kinase B,690.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Azurocidin,353.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bactericidal permeability-increasing protein,675.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,191.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,482.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,93.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Basal Cell Adhesion Molecule,1791,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Basigin,339,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,B-cell lymphoma 6 protein,1744.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,B-cell receptor CD22,900,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bcl2-associated agonist of cell death,19900.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bcl-2-like protein 1,2525.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bcl-2-like protein 2,742,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bcl-2-related protein A1,1038.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,BDNF/NT-3 growth factors receptor,1049,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Beta-2-microglobulin,1839.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,beta-adrenergic receptor kinase 1,24811,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Beta-Ala-His dipeptidase,3377.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Betacellulin,503.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Beta-endorphin,370.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,beta-nerve growth factor,303.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,BH3-interacting domain death agonist,3279.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Biglycan,6108.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,BMP-binding endothelial regulator protein,420.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bone morphogenetic protein 10,1145.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bone morphogenetic protein 1,3784.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bone morphogenetic protein 6,12949.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bone morphogenetic protein 7,819.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,771.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bone morphogenetic protein receptor type-2,400.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Bone sialoprotein 2,5928.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Brain-derived neurotrophic factor,1421.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Brain natriuretic peptide 32,474.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Brain-specific serine protease 4,1205.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1297.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Brevican core protein,2194.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Brother of CDO,2715,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C3a anaphylatoxin,441,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C3a anaphylatoxin des Arginine,188404,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C5a anaphylatoxin,4511.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cadherin-12,798.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cadherin-15,4011.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cadherin-1,99355.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cadherin-2,1605.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cadherin-3,25319.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cadherin-5,8390.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cadherin-6,415.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcineurin,4220.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcineurin subunit B type 1,6970.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",826.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,529.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,5988.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2079.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,2363.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,5910,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,19421.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calcium-dependent phospholipase A2,343.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calpain I,104925.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calpastatin,4873.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Calreticulin,1866.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,6524.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,cAMP-regulated phosphoprotein 19,5601.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1110.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbohydrate sulfotransferase 15,6946.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbohydrate sulfotransferase 2,421.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbohydrate sulfotransferase 6,250.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase 13,15555.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase 1,6558.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase 2,169.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase 3,1815.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase 4,2279.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase 6,4176.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase 7,282.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase 9,826.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carbonic anhydrase-related protein 10,619.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carboxypeptidase B2,10234.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Carboxypeptidase E,1792.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cardiotrophin-1,724.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,23142.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,974,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Casein kinase II subunit alpha,568,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Caspase-10,3284.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Caspase-2,320.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Caspase-3,60682.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Catalase,12271.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin B,1587.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin D,970.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin E,688.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin F,2242.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin G,723.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin H,830.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin L2,16317.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin S,963.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cathepsin Z,4124.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,33185.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CCAAT/enhancer-binding protein beta,937.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 1,2173.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 13,395.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 14,4850.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 15,4130,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 16,33404.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 17,5534.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 18,88972.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 19,447.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 20,108.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 21,30564.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 22,1451.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 23,3152.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 24,298.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 25,1369.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 2,558.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 26,1015.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 27,2118.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 28,19590.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 3,3836,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 3-like 1,9647.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 4-like,633.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 5,57399.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 7,1089.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-C motif chemokine 8,223.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD109 antigen,7098,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD166 antigen,14537.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD177 antigen,890.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD209 antigen,944.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD226 antigen,1082.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD27 antigen,6096.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD40 ligand,391.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD48 antigen,2580.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD59 glycoprotein,1365.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD5 antigen-like,432.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD63 antigen,441.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD70 antigen,231.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD83 antigen,266.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CD97 antigen,1657,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cell adhesion molecule 1,2634.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cell adhesion molecule 3,1955.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,8062,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,881,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cellular tumor antigen p53,942.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cerebral dopamine neurotrophic factor,4009.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",7746.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1342.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",71087.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Chitinase-3-like protein 1,15225.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Chitotriosidase-1,1363.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Chloride intracellular channel protein 1,12881.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Choline/ethanolamine kinase,2016.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Chordin-like protein 1,4587,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Chorionic somatomammotropin hormone,5916.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Chromobox protein homolog 5,395.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Chromogranin-A,5727,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Chymase,601.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ciliary neurotrophic factor,164.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,8105.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ck-beta-8-1,71158.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Clusterin,1301.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,CMRF35-like molecule 6,3353.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coactosin-like protein,4255.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coagulation factor IX,10192.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coagulation factor IXab,7273.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coagulation Factor V,68390.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coagulation factor VII,446.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coagulation Factor X,4542.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coagulation factor Xa,3838.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coagulation Factor XI,1779.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cofilin-1,19310.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Coiled-coil domain-containing protein 80,2803.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Collagen alpha-1(VIII) chain,578.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Collagen alpha-1(XXIII) chain,845.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Collagenase 3,644.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Collectin-11,9151.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Collectin-12,2893.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,COMM domain-containing protein 7,5240.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C1q subcomponent,31654.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C1r subcomponent,407.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C2,2843.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C3,66819.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C3b,15063.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Complement C3b, inactivated",9811.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C3d fragment,8904.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C4,78682.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C4b,70.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C5,6930.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement C5b-C6 complex,474.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4215.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement component C1q receptor,10048.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement component C6,95674.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement component C7,1351.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement component C8,2743,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement component C9,84707.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement decay-accelerating factor,15204.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement factor B,24025.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement factor D,1165.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement factor H,59771.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement factor H-related protein 5,1841.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Complement factor I,41386.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Connective tissue-activating peptide III,78167.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Connective tissue growth factor,2425.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Contactin-1,555.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Contactin-2,1797.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Contactin-4,5064,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Contactin-5,782.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Copine-1,5313.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Corticosteroid-binding globulin,541.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Corticotropin,352.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-reactive protein,10283.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Creatine kinase B-type,560.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Creatine kinase M-type,547.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,297.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cryptic protein,3024.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-type lectin domain family 1 member B,57831.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-type lectin domain family 4 member K,152.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-type lectin domain family 4 member M,45908.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-type lectin domain family 7 member A,719.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-type mannose receptor 2,3648.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-X-C motif chemokine 10,4775.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-X-C motif chemokine 11,4223.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-X-C motif chemokine 13,2505.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-X-C motif chemokine 16,13839,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-X-C motif chemokine 5,582.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-X-C motif chemokine 6,2332.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,C-X-C motif chemokine 9,642.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,730.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,280.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1233.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,2573.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,1123.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cystatin-C,2459.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cystatin-D,8465.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cystatin-F,633.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cystatin-M,8198.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cystatin-S,108.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cystatin-SA,30837.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cystatin-SN,1553.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cysteine and glycine-rich protein 3,5487,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cysteine-rich secretory protein 3,221.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,2860.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytochrome c,3359.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytochrome P450 3A4,33543,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytokine receptor common subunit gamma,5960.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,373.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytokine receptor-like factor 2,1486.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytoplasmic protein NCK1,1864.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,284.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytoskeleton-associated protein 2,20459.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytosolic non-specific dipeptidase,1724.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,719.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,63.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,dCTP pyrophosphatase 1,17300.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,D-dimer,13542.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Death-associated protein kinase 2,5340.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Decorin,4820.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Delta-like protein 1,1646,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Delta-like protein 4,548,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dermatopontin,4450.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Desert hedgehog protein N-product,883.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Desmocollin-2,2184.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Desmocollin-3,269.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Desmoglein-1,2775.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Diablo homolog, mitochondrial",5095.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dickkopf-like protein 1,2592.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dickkopf-related protein 1,62045.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dickkopf-related protein 3,4261.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dickkopf-related protein 4,17296.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dipeptidyl peptidase 1,504,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dipeptidyl peptidase 2,1349.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Discoidin domain-containing receptor 2,1552.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,496.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1639.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,DnaJ homolog subfamily B member 1,1919.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,DNA repair protein RAD51 homolog 1,2292.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,DNA topoisomerase 1,458.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Down syndrome cell adhesion molecule,1159.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Drebrin-like protein,4431.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",5572.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,470.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1891.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,3528.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,35387.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dual specificity protein phosphatase 3,10075.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,1919.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dynactin subunit 2,834.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",288.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Dynein light chain roadblock-type 1,11876.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,865.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,3589.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,279.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,1260.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,334.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Ectodysplasin-A, secreted form",2010.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1599.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1192.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3712.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2073.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1476.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Elafin,5126.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Elongation factor 1-beta,823,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Endoglin,2302.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,167499.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Endoplasmic reticulum resident protein 29,3560.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Endostatin,79070.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Endothelial cell-selective adhesion molecule,3560.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Endothelial cell-specific molecule 1,1317.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,3838.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Endothelin-converting enzyme 1,32425.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Enteropeptidase,160.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Eotaxin,15008.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin-A2,809.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin-A3,1992.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin-A4,1502,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin-A5,3833.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin-B1,2141.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin-B2,18382.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin-B3,851.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin type-A receptor 10,279.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin type-A receptor 1,11367.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin type-A receptor 2,2558.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin type-A receptor 3,109.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin type-A receptor 5,744.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin type-B receptor 2,17709.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin type-B receptor 4,2792.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ephrin type-B receptor 6,1345.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Epidermal growth factor,1358.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Epidermal growth factor receptor,23148.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,1683.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Epidermal growth factor receptor variant III,207.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Epiregulin,1305.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,414.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Erythropoietin,2682.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Erythropoietin receptor,357.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,E-selectin,28415,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,1633.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Estrogen receptor,618.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Eukaryotic initiation factor 4A-III,522.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,295.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,18651.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Eukaryotic translation initiation factor 4H,39774.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Eukaryotic translation initiation factor 5,2335.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,80971.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Extracellular matrix protein 1,15977.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],759.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,FACT complex subunit SSRP1,349.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Fatty acid-binding protein, epidermal",854.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Fatty acid-binding protein, heart",19243.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Fatty acid-binding protein, liver",5248.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fc receptor-like protein 3,488.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ferritin,18138.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fetuin-B,4144.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibrinogen,175232.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibrinogen gamma chain,62939.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 10,183.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 1,156.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 12,180.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 16,4277.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 17,171.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 18,224.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 19,9737.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 20,415.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 2,3148.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 23,597.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 4,244.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 5,381.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 6,510.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 7,3508.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 8 isoform A,544.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 8 isoform B,706.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor 9,404.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor receptor 1,878.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor receptor 2,190,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor receptor 3,685.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibroblast growth factor receptor 4,662.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibronectin,19573.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibronectin Fragment 3,3820.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fibronectin Fragment 4,81703,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ficolin-1,2476.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ficolin-2,994.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ficolin-3,186,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,358.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Focal adhesion kinase 1,231.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Follicle stimulating hormone,4669.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Follistatin,902.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Follistatin-related protein 1,27495.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Follistatin-related protein 3,5666.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,5145.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fractalkine,3295.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Fructose-bisphosphate aldolase A,128152.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,G2/mitotic-specific cyclin-B1,368.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,335,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galectin-10,532.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galectin-2,475,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galectin-3,16359.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galectin-3-binding protein,739.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galectin-4,620.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galectin-7,758.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galectin-8,378.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Galectin-9,1535.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Gamma-enolase,77049.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Gastrin-releasing peptide,267.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,GDNF family receptor alpha-1,1296,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,GDNF family receptor alpha-2,7372.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,GDNF family receptor alpha-3,787.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Gelsolin,1134.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glia-derived nexin,1910.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glial cell line-derived neurotrophic factor,250.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glial fibrillary acidic protein,454.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glucagon,1318.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glucocorticoid receptor,79.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glucokinase regulatory protein,396.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glucose-6-phosphate isomerase,60034.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glutamate carboxypeptidase 2,406.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glutathione S-transferase A3,127.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glutathione S-transferase P,14715.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,213686.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1856.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,36440.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,7831.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glypican-2,134.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glypican-3,1128.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glypican-5,1307.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Glypican-6,1633.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"gp41 C34 peptide, HIV",707.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Granulins,30338.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Granulocyte colony-stimulating factor,1544,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,859.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,283.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Granulysin,2293,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Granzyme A,2847.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Granzyme B,262.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Granzyme H,407.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,GRB2-related adapter protein 2,397.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Gremlin-1,446.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Gro-beta/gamma,1429.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Group 10 secretory phospholipase A2,555.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Group IIE secretory phospholipase A2,230.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth arrest-specific protein 1,616.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth/differentiation factor 11/8,843.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth/differentiation factor 11,942.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth/differentiation factor 15,956.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth/differentiation factor 2,3397.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth/differentiation factor 5,4153.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth/differentiation factor 8,4174.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth/differentiation factor 9,426.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth factor receptor-bound protein 2,130725.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth hormone receptor,871.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Growth-regulated alpha protein,13155.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,GTPase KRas,859.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,GTP-binding nuclear protein Ran,14699.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Haptoglobin,12104.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heat shock 70 kDa protein 1A,7149.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heat shock cognate 71 kDa protein,1843.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heat shock protein beta-1,20149.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,14981.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heat shock protein HSP 90-beta,73102.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heme oxygenase 2,435.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,HemK methyltransferase family member 2,5603.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hemoglobin,1491.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hemojuvelin,768.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hemopexin,1116.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2880.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heparin-binding EGF-like growth factor,297.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heparin cofactor 2,2538.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hepatitis A virus cellular receptor 2,6050.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hepatocyte growth factor,1534.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hepatocyte growth factor activator,4877.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hepatocyte growth factor-like protein,3597.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hepatocyte growth factor receptor,8970.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,637.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hepcidin,23838.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,HERV-H LTR-associating protein 2,1399.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1930.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,179.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,3523.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3501.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hexokinase-1,1273.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hexokinase-2,702.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",339.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",255.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,242.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,High affinity nerve growth factor receptor,2600.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,High mobility group protein B1,6489.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histidine-rich glycoprotein,3132.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,2768.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone acetyltransferase KAT6A,1554.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,311.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone deacetylase 8,3440,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone H1.2,1207,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone H2A type 3,595,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone H2A.z,1378.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone H2B type 2-E,11092.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone H3.1,1279.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,524.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Homeobox protein NANOG,109.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Homeodomain-interacting protein kinase 3,343.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hsp90 co-chaperone Cdc37,584.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Human Chorionic Gonadotropin,7806.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,941.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,400.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,ICOS ligand,1843.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Iduronate 2-sulfatase,13649.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Immunoglobulin A,604.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Immunoglobulin alpha Fc receptor,156,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Immunoglobulin D,208.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Immunoglobulin E,212,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Immunoglobulin G,278166.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Immunoglobulin M,657.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,8920.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Importin subunit alpha-1,280.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Importin subunit beta-1,46583.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,754.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Inducible T-cell costimulator,633.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Inhibin beta A chain,5956.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,868.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Inhibitor of growth protein 1,41185.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Inorganic pyrophosphatase,66471,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,3196.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,3283.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin,96.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-degrading enzyme,3851.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor 1 receptor,8593.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor-binding protein 1,2139,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor-binding protein 2,1227.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor-binding protein 3,2712.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor-binding protein 4,6131,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor-binding protein 5,2971.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor-binding protein 6,583.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor-binding protein 7,72342.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin-like growth factor I,1493.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Insulin receptor,12607,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Integrin alpha-I: beta-1 complex,2745.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,2270.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Integrin alpha-V: beta-5 complex,615.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,39779.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Intercellular adhesion molecule 1,4800.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Intercellular adhesion molecule 2,1402.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Intercellular adhesion molecule 3,598.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Intercellular adhesion molecule 5,1724.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon alpha-10,265.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon alpha-2,126.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon alpha-7,179.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon alpha/beta receptor 1,3742.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon beta,421.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon gamma,978.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon gamma receptor 1,463.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon gamma receptor 2,353.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon lambda-1,376.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon lambda-2,136,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interferon regulatory factor 1,1603,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-10,162.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1187.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-10 receptor subunit beta,1060.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-11,273.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-12,181,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,403.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,785.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-13,588.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,2104.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-15 receptor subunit alpha,944.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-16,277.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-17A,350.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-17B,134.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-17D,236.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-17F,422.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-17 receptor A,922.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-17 receptor B,2748.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-17 receptor C,635.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-17 receptor D,448.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-18-binding protein,7207.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-18 receptor 1,7835.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-18 receptor accessory protein,280.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-19,5510.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-1 alpha,560.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-1 beta,1663.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-1 Receptor accessory protein,30800.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-1 receptor antagonist protein,3653.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-1 receptor-like 1,3801.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-1 receptor-like 2,690.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-1 receptor type 1,11729.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-1 receptor type 2,6875.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-20,411.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-20 receptor subunit alpha,260.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-2,2486.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-22,764.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,776.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,2170.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-23,4015.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-23 receptor,3379,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-24,324.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-25,225,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-27,574.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-27 receptor subunit alpha,2308.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-2 receptor subunit alpha,957.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-3,1464.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-34,717.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-36 alpha,585.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-36 beta,400.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-37,1989.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-3 receptor subunit alpha,1657.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-4,497.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-4 receptor subunit alpha,158.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-5,209.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-5 receptor subunit alpha,4342.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-6,662.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-6 receptor subunit alpha,14892.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-6 receptor subunit beta,6830.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-7,146.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-7 receptor subunit alpha,234.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-8,3669.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interleukin-9,366.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Interstitial collagenase,2511.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Junctional adhesion molecule B,9395.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Junctional adhesion molecule C,8291,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Junctional adhesion molecule-like,460,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-11,1745.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-12,5868.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-13,1121.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-14,8293.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-4,250.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-5,128.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-6,2919.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-7,1482.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallikrein-8,3423.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kallistatin,54924.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kelch-like ECH-associated protein 1,441.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Keratin, type I cytoskeletal 18",975.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1673,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,198.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,391.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,279.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kinesin-like protein KIF23,1393.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kininogen-1,22360.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kin of IRRE-like protein 3,323.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kremen protein 2,4932.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kunitz-type protease inhibitor 1,5840.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kunitz-type protease inhibitor 2,992.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Kynureninase,1010.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lactadherin,823.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lactoperoxidase,1078.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lactotransferrin,100386.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lamin-B1,733.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Laminin,3472.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1689.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Layilin,1406.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Legumain,2681.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leptin,2217.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leptin receptor,1306.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leucine carboxyl methyltransferase 1,2389.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,6761.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2127.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,111.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,176.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1198.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,23401.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,8175.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leukemia inhibitory factor receptor,3938.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3977.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,9721.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leukocyte surface antigen CD47,1004.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Leukotriene A-4 hydrolase,1434,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,179.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Limbic system-associated membrane protein,1582.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lipopolysaccharide-binding protein,100885.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lithostathine-1-alpha,315,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,L-lactate dehydrogenase B chain,1935.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,1177.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,3123.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,2576.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1792.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Low-density lipoprotein receptor,113.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,35678.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",4340.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,2852.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,8608.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,L-Selectin,4058.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lumican,1331.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Luteinizing hormone,2695.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,1571.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,397.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lymphocyte activation gene 3 protein,14470.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lymphocyte antigen 86,4770.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lymphotactin,352.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lymphotoxin alpha1:beta2,140.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lymphotoxin alpha2:beta1,2190.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lymphotoxin-alpha,338.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lysosomal protective protein,5992.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lysosome membrane protein 2,322,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Lysozyme C,102722.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Macrophage-capping protein,862.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Macrophage colony-stimulating factor 1,1281.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,198.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Macrophage mannose receptor 1,7810.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Macrophage metalloelastase,1786.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Macrophage migration inhibitory factor,1760.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Macrophage scavenger receptor types I and II,799.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Macrophage-stimulating protein receptor,483.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",36443.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mammaglobin-B,8690.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mannan-binding lectin serine protease 1,4635.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mannose-binding protein C,7127.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,MAP kinase-activated protein kinase 2,24284.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,MAP kinase-activated protein kinase 3,2804.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,MAP kinase-activated protein kinase 5,564.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,16927.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Matrilin-2,11253.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Matrilin-3,492.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Matrilysin,2297.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,190.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Matrix metalloproteinase-14,915.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Matrix metalloproteinase-16,579,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Matrix metalloproteinase-17,802.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Matrix metalloproteinase-9,3007.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,74809.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,267.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Melanoma-derived growth regulatory protein,3714.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Membrane frizzled-related protein,2178.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,990.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mesothelin,335,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Metalloproteinase inhibitor 1,117.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Metalloproteinase inhibitor 2,470.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Metalloproteinase inhibitor 3,3331.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Methionine aminopeptidase 1,7626.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Methionine aminopeptidase 2,71233.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Methyl-CpG-binding domain protein 4,392.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,MHC class I polypeptide-related sequence A,468.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,MHC class I polypeptide-related sequence B,1745.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Microtubule-associated protein tau,129.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Midkine,52733.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitochondrial glutamate carrier 2,690.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,659.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase 11,462.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase 1,20203.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase 12,1864.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase 13,426,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase 14,4857.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase 3,72228.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase 8,2697.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase 9,931.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,4722,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Moesin,2599.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mothers against decapentaplegic homolog 2,40852.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mothers against decapentaplegic homolog 3,33979.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Mucin-1,1156.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Muellerian-inhibiting factor,7352.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Myc proto-oncogene protein,385.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Myeloblastin,1441.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Myeloid cell surface antigen CD33,4156.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Myeloperoxidase,17453.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Myoglobin,1151.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Myosin-binding protein C, slow-type",3832.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,N-acetyl-D-glucosamine kinase,1199.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,2704.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,3703.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,9353.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NADPH--cytochrome P450 reductase,3670.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,12639.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,1959,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,315.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,462.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Natural killer cell receptor 2B4,153.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Netrin-1,834.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Netrin-4,1626.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Netrin receptor UNC5C,3521.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Netrin receptor UNC5D,6635.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",11915.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neural cell adhesion molecule L1,398.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,11700,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neuregulin-1,135.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neuregulin-4,654.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neurexin-1-beta,702.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neurexin-3-beta,915.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neurexophilin-1,5658.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1246.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neurogenic locus notch homolog protein 1,20414.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neurogenic locus notch homolog protein 2,347.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neurogenic locus notch homolog protein 3,897.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Neuroligin-4, X-linked",795.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neuronal cell adhesion molecule,17271.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neuronal growth regulator 1,3509.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neuropilin-1,3634.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neurotrophin-3,370.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neurotrophin-4,180.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neutral ceramidase,3972.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neutrophil-activating peptide 2,24372.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neutrophil collagenase,3019.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neutrophil elastase,297.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,8589.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,912.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Nidogen-1,5375.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Nidogen-2,2896.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NKG2D ligand 1,313.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NKG2D ligand 2,232.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NKG2D ligand 3,962,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NKG2-D type II integral membrane protein,421.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Noggin,4936.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Non-histone chromosomal protein HMG-14,561.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,1366,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NSFL1 cofactor p47,2284.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NT-3 growth factor receptor,12130.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,N-terminal pro-BNP,13598.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,437.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Nucleoside diphosphate kinase A,839.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Nucleoside diphosphate kinase B,83341.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,NudC domain-containing protein 3,753.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,OCIA domain-containing protein 1,892,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Olfactomedin-4,146.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Oncostatin-M,1804.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,2821.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Osteocalcin,1234.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Osteomodulin,10774,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Osteopontin,10809.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,OX-2 membrane glycoprotein,4242.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,1405.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pancreatic hormone,1624.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pappalysin-1,9109.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Parathyroid hormone,2644.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Parathyroid hormone-related protein,1447.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peptide YY,1525.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peptidoglycan recognition protein 1,371.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,227929.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,2586.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,38144.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,4782,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",128767.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Periostin,6769.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peroxiredoxin-1,2941.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",441,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peroxiredoxin-6,1071.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,200.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Persephin,257.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3293.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pescadillo homolog,212,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,10213.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",928.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2354.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Phosphoglucomutase-1,506.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Phosphoglycerate kinase 1,9843.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Phosphoglycerate mutase 1,2929.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Phospholipase A2,1237.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Phospholipase A2, membrane associated",7385.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pigment epithelium-derived factor,50851.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,PIK3CA/PIK3R1,915.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,PILR alpha-associated neural protein,5907.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,182.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,149.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Placenta growth factor,277.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Plasma kallikrein,18975.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Plasma protease C1 inhibitor,9890.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Plasma serine protease inhibitor,105642.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Plasmin,709.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Plasminogen,3045,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Plasminogen activator inhibitor 1,1307.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet-activating factor acetylhydrolase,729.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,11233.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet-derived growth factor C,252,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet-derived growth factor receptor alpha,1742.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet-derived growth factor receptor beta,7983,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet-derived growth factor subunit A,27178.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet-derived growth factor subunit B,89642.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet endothelial cell adhesion molecule,974.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet factor 4,110956.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet glycoprotein 4,12836.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,1002.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet glycoprotein VI,25327.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Platelet receptor Gi24,569.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pleiotrophin,2845.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Plexin-B2,3975.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Plexin-C1,2231.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Polymeric immunoglobulin receptor,2783.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,PolyUbiquitin K48-linked,840.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,PolyUbiquitin K63-linked,4821.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Prefoldin subunit 5,503.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Programmed cell death 1 ligand 1,718.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Programmed cell death 1 ligand 2,5173,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Prokineticin-1,159.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Prolactin,596.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Prolactin receptor,1100.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proliferating cell nuclear antigen,157.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proliferation-associated protein 2G4,4246.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Prolyl endopeptidase FAP,878.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pro-opiomelanocortin,514.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Properdin,124267.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,3181.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,613.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Prostaglandin G/H synthase 2,464.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Prostate-specific antigen,531.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proteasome activator complex subunit 1,1524,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proteasome activator complex subunit 3,250.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proteasome subunit alpha type-1,631.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proteasome subunit alpha type-2,737.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proteasome subunit alpha type-6,1309.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein 4.1,17087.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein amnionless,105.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein deglycase DJ-1,497.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein disulfide-isomerase,183.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein disulfide-isomerase A3,7194.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein E7_HPV16,296.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein E7_HPV18,1847.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein FAM107A,251.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein FAM107B,3916.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein FAM3B,783.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein FAM3D,5389.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,251,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein jagged-1,607.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein jagged-2,255.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein kinase C alpha type,180845,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),26154.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein kinase C delta type,9859.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein kinase C gamma type,396.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein kinase C iota type,4606.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein kinase C theta type,7360.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein kinase C zeta type,980.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein lin-7 homolog B,464.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein NOV homolog,703.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein Rev_HV2BE,145.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein S100-A12,621.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein S100-A4,1807.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein S100-A6,3217.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein S100-A7,157.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein S100-A9,3164.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein SET,703.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein-tyrosine kinase 6,171.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein Wnt-7a,167,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Protein Z-dependent protease inhibitor,5549.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Prothrombin,178888.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,808.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,122936.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Proto-oncogene vav,38634.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,P-selectin,23577.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pulmonary surfactant-associated protein D,6060.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pyridoxal kinase,668.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pyridoxal phosphate phosphatase,6277.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",2865.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Pyruvate kinase PKM,111338.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Quinone oxidoreductase-like protein 1,1943.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Rab GDP dissociation inhibitor beta,31833,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,13588.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,40870.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ras GTPase-activating protein 1,1682.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,71467.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,18982.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,9117.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,343.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,287.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,131.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Regenerating islet-derived protein 4,2763.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Relaxin receptor 1,339.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Renin,935.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Repulsive guidance molecule A,17157.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Resistin,699,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Reticulon-4 receptor,882.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Retinoblastoma-associated protein,1256.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Retinoic acid receptor responder protein 2,3286.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Retinol-binding protein 4,234.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,RGM domain family member B,1714.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ribonuclease H1,136.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,2756.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,301,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ribosome maturation protein SBDS,45110.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,RNA-binding protein 39,364.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Roundabout homolog 2,3717.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Roundabout homolog 3,282.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,R-spondin-2,365.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,R-spondin-3,1681.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,R-spondin-4,492.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Scavenger receptor class F member 1,9568.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Scavenger receptor class F member 2,237,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2373.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sclerostin,18775.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Secreted and transmembrane protein 1,930.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Secreted frizzled-related protein 1,8239.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Secreted frizzled-related protein 3,3924.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Secretin,169.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Seizure 6-like protein 2,1783.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Semaphorin-3A,1512.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Semaphorin-3E,3510.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Semaphorin-5A,7565.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Semaphorin-6A,15747.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Semaphorin-6B,4888.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine protease 27,6020.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",10091.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase 16,1851.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase 17B,4544.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase Chk1,575.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase Chk2,133.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1379.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,923.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,24509.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,758.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase pim-1,2061.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase PLK1,142.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1372.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase TBK1,246.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serine/threonine-protein kinase WNK3,1885.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serotransferrin,245008.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serum albumin,7461,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serum amyloid A-1 protein,103.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serum amyloid P-component,2156.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Serum paraoxonase/arylesterase 1,177.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sex hormone-binding globulin,4029.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,S-formylglutathione hydrolase,8731.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SH2 domain-containing protein 1A,3439.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SHC-transforming protein 1,36483.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,8668.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,260.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1237,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,41037.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sialoadhesin,110.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,27049.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Signal transducer and activator of transcription 3,3535.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Signal transducer and activator of transcription 6,786.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SLAM family member 5,19360.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SLAM family member 6,434.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SLAM family member 7,264668,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SLIT and NTRK-like protein 1,1594.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SLIT and NTRK-like protein 5,4725.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,12972.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Small nuclear ribonucleoprotein F,3259.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Small ubiquitin-related modifier 3,7406.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Somatostatin-28,1483.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Somatotropin,174.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sonic hedgehog protein,1601.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sorting nexin-4,34429.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SPARC,28999.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SPARC-like protein 1,11337.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,3604.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",117.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,S-phase kinase-associated protein 1,5689,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sphingosine kinase 1,38554.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Sphingosine kinase 2,644.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Spondin-1,7374.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Stabilin-2,963,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Stanniocalcin-1,2660.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Stem cell growth factor-alpha,3492.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Stem Cell Growth Factor-beta,1415.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Stress-induced-phosphoprotein 1,16484.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Stromal cell-derived factor 1,6005.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Stromelysin-1,3330.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Stromelysin-2,941.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,SUMO-conjugating enzyme UBC9,4368.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Superoxide dismutase [Cu-Zn],1475.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",49308.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Synaptosomal-associated protein 25,1010.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Syntaxin-1A,242,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,7286.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,TATA-box-binding protein,393.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,T-cell surface glycoprotein CD4,347.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tenascin,19757.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,540.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Testican-1,3500.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Testican-2,1048.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,TGF-beta receptor type-2,685.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thioredoxin domain-containing protein 12,3801.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thrombin,1081.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thrombopoietin,396.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thrombopoietin Receptor,192.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thrombospondin-1,7762.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thrombospondin-2,23054.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thrombospondin-4,507.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thymic stromal lymphopoietin,442.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Thymidine kinase, cytosolic",469.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thymidylate synthase,295.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thyroglobulin,356,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thyroid peroxidase,1530.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thyroid Stimulating Hormone,1229.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Thyroxine-binding globulin,34981.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tissue Factor,1012.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tissue factor pathway inhibitor,60169.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tissue-type plasminogen activator,349.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,T-lymphocyte activation antigen CD80,535.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,T-lymphocyte activation antigen CD86,2491.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,20823.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Toll-like receptor 2,488,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Toll-like receptor 4,210.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,5568.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transcription factor AP-1,6546.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,1923.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transforming growth factor beta-1,1778.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transforming growth factor beta-2,225,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transforming growth factor beta-3,400.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,103096.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transforming growth factor beta receptor type 3,28825.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transgelin-2,10662.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transketolase,97424.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Translationally-controlled tumor protein,34360,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Transmembrane glycoprotein NMB,6785.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Trefoil factor 1,8694.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Trefoil factor 2,15983.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Trefoil factor 3,10623.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Triosephosphate isomerase,20443.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tropomyosin alpha-1 chain,827.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tropomyosin alpha-4 chain,228142.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tropomyosin beta chain,2080.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Troponin I, cardiac muscle",508.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Troponin I, fast skeletal muscle",6894.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Troponin T, cardiac muscle",3336.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Trypsin-1,6402.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Trypsin-2,1627.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Trypsin-3,353.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tryptase beta-2,5103.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tryptase gamma,163.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor-associated calcium signal transducer 2,328.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor,362.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,1625.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,442.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,1016.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,761.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,616.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,966.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,675.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,236.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",638.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,2839.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,304.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1272.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,310,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,930.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1290,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,15180.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,143.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,4998.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2429.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,422,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,80401.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,963.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,825.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,2062.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,744.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,7604.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,7310.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,769,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,5632.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,452.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,927.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,528.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,916.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,312.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,1787.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase ABL1,118.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase BTK,30979.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase CSK,25374.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase Fer,9509.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase Fgr,812.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase Fyn,24723.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase HCK,150.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase JAK2,116738.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase Lck,351.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase Lyn,28291.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",125339,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",6150,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,556.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase Tec,9808.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,507.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase Yes,1837.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,12009.6,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,19765.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,3764.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,298.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,20528.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,11208.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin,1883.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",4049.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1553,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,2446.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,2619.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,2461.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,12523.7,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin-fold modifier 1,24753.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,53633.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Ubiquitin-like protein ISG15,4824.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,UMP-CMP kinase,4585.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Urokinase plasminogen activator surface receptor,13432.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Urokinase-type plasminogen activator,2225.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,91459.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vascular cell adhesion protein 1,8006.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vascular endothelial growth factor A,12775.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",639,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vascular endothelial growth factor C,1948.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vascular endothelial growth factor D,494.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vascular endothelial growth factor receptor 2,5628.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vascular endothelial growth factor receptor 3,7507.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vasoactive Intestinal Peptide,417,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vesicular integral-membrane protein VIP36,8822.4,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vitamin K-dependent protein C,1336.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vitamin K-dependent protein S,3858.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Vitronectin,65116.5,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,von Willebrand factor,7181.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,275.2,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",552.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",8666.3,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,3926.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,1012.1,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Wnt inhibitory factor 1,4868.8,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,Xaa-Pro aminopeptidase 1,31914.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,809.9,RFU
BF-1138,PD_INVBD420RV2,M0,0,Plasma,X-ray repair cross-complementing protein 6,312.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,70415.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,14-3-3 protein epsilon,1369.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,14-3-3 protein family,14029.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,14-3-3 protein sigma,549.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,14-3-3 protein theta,1546.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,326677.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1490.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",472.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,334.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,524.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,253,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,7696.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",5589.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",402.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,4265.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,40S ribosomal protein S3,735.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,40S ribosomal protein S3a,760.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,40S ribosomal protein S7,1436.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,40S ribosomal protein SA,1665.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",124824,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",36458,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,72 kDa type IV collagenase,7512.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1425.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,165.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,3126.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Activated Protein C,820,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Activin receptor type-1B,259,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Adapter molecule crk,34678.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,40652.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Adenylosuccinate lyase,2988.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,715,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,606.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Adiponectin,10441.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2982.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,430.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,395.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,143.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,515.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,484.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,6554.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Adrenomedullin,2007.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",485.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Afamin,25759.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,10153.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Aggrecan core protein,641.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Agouti-related protein,2464.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,AH receptor-interacting protein,17331.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alanine aminotransferase 1,4243.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],6733.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Allograft inflammatory factor 1,3505.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",4764.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,277201.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,5954.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-1-antitrypsin,969.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-2-antiplasmin,1807.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1454.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-2-macroglobulin,14240.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,766.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-enolase,115110.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,alpha-Fetoprotein,803.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-L-iduronidase,1796.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,17675.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Alpha-synuclein,21926.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Aminoacylase-1,3111.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Amphiregulin,6319.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Amphoterin-induced protein 2,3415.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),337.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),17329.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Amyloid beta A4 protein,41447.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiogenin,6124.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiopoietin-1,824.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",1750.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiopoietin-2,154.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiopoietin-4,720.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiopoietin-related protein 3,416,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiopoietin-related protein 4,5542.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiostatin,14479.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,594.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Angiotensinogen,4593.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ankyrin-2,400.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Annexin A1,13032.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Annexin A2,12880,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Annexin A5,992.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Annexin A6,20992.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,668.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Antileukoproteinase,42646.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Antithrombin-III,123537.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein A-I,14722.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein B,11655.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein D,3675.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein E,42745,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),304501.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),241689.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),303566,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein L1,26164.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apolipoprotein M,14564.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,1995,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Appetite-regulating hormone,1886.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Arginase-1,931.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,257.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Artemin,431,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Arylsulfatase A,1775.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Arylsulfatase B,1010.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1348.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",3689.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,12629.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",1892.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",18346.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Atrial natriuretic factor,843.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,931.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Aurora kinase A,757.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Aurora kinase B,609.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Azurocidin,419.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,691.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,195.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,460.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,92.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1713.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Basigin,297.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,1574.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,B-cell receptor CD22,884.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,24157.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bcl-2-like protein 1,2542.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bcl-2-like protein 2,717.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bcl-2-related protein A1,1037.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,1041,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Beta-2-microglobulin,1743.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,28675.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,4300.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Betacellulin,463.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Beta-endorphin,344.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,beta-nerve growth factor,306.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,BH3-interacting domain death agonist,3432,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Biglycan,5535.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,399.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1024.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bone morphogenetic protein 1,4350.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bone morphogenetic protein 6,12972.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bone morphogenetic protein 7,910.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,643.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,387.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Bone sialoprotein 2,5843.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,1561.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Brain natriuretic peptide 32,440.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Brain-specific serine protease 4,1102.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1277.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Brevican core protein,2037.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Brother of CDO,2538,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C3a anaphylatoxin,1913.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,238944.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C5a anaphylatoxin,4896.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cadherin-1,114680.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cadherin-12,968.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cadherin-15,3807.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cadherin-2,1596,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cadherin-3,24290.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cadherin-5,8303.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cadherin-6,354.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcineurin,4494.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcineurin subunit B type 1,6152.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",932.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,622.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,6184.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1963.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,2698.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,6954.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,22233.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,373.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calpain I,128658.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calpastatin,5126.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Calreticulin,1759.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,6060.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,6563.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1103.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,6623.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,367.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,228.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase 13,14756.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase 1,5960.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase 2,164.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase 3,1798.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase 4,1803.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase 6,4223.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase 7,306.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase 9,834.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,567.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carboxypeptidase B2,10913.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Carboxypeptidase E,1557.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cardiotrophin-1,755.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,25848.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,991.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Casein kinase II subunit alpha,619.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Caspase-10,3506.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Caspase-2,337.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Caspase-3,70244.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Catalase,12036.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin B,1523.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin D,1128.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin E,668.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin F,2203.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin G,738.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin H,793.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin L2,17317.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin S,949.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cathepsin Z,3820.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,35680.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,811.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 1,1850.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 13,434.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 14,4967.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 15,3960.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 16,28914.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 17,5141.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 18,78159.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 19,456.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 20,132.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 21,32382.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 22,1509.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 23,2969.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 24,275.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 25,1929.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 2,681,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 26,936.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 27,2122.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 28,23760.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 3,3993.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,9362.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 4-like,642.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 5,80019.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 7,1148,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-C motif chemokine 8,231.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD109 antigen,6477.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD166 antigen,14640.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD177 antigen,815.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD209 antigen,836.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD226 antigen,1031,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD27 antigen,5740.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD40 ligand,477.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD48 antigen,2564.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD59 glycoprotein,1318.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD5 antigen-like,468,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD63 antigen,373.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD70 antigen,222.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD83 antigen,302.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CD97 antigen,1407,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cell adhesion molecule 1,2492.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cell adhesion molecule 3,1642.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,8700.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,845.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cellular tumor antigen p53,770.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,3899.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",6909.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1323.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",85669.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Chitinase-3-like protein 1,14217.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Chitotriosidase-1,1210,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,13752.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Choline/ethanolamine kinase,2000.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Chordin-like protein 1,4280.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,6664.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Chromobox protein homolog 5,362.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Chromogranin-A,5297.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Chymase,667,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ciliary neurotrophic factor,173.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,7806.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ck-beta-8-1,70196.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Clusterin,1003.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,CMRF35-like molecule 6,3463.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coactosin-like protein,4270.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coagulation factor IX,10212.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coagulation factor IXab,7536.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coagulation Factor V,66771.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coagulation factor VII,547.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coagulation Factor X,5205.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coagulation factor Xa,3965,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coagulation Factor XI,1901.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cofilin-1,19755.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,2688.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,493.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,843.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Collagenase 3,682.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Collectin-11,9653.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Collectin-12,2879.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,COMM domain-containing protein 7,5025.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C1q subcomponent,33140.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C1r subcomponent,366.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C2,2856,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C3,133295.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C3b,19703.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Complement C3b, inactivated",13647.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C3d fragment,11689.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C4,85571.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C4b,87.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C5,6331.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement C5b-C6 complex,464.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4113.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement component C1q receptor,10211.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement component C6,88757.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement component C7,1247.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement component C8,2215.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement component C9,87891.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement decay-accelerating factor,16221.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement factor B,23695,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement factor D,911.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement factor H,57322.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement factor H-related protein 5,1726.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Complement factor I,40252.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Connective tissue-activating peptide III,68491.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Connective tissue growth factor,2802.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Contactin-1,785.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Contactin-2,1658,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Contactin-4,4845.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Contactin-5,775.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Copine-1,5886,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Corticosteroid-binding globulin,592.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Corticotropin,353,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-reactive protein,10004.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Creatine kinase B-type,490.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Creatine kinase M-type,481.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,345.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cryptic protein,3391,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,60126.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,160,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,46320.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,748.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-type mannose receptor 2,3749.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-X-C motif chemokine 10,6297.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-X-C motif chemokine 11,4454.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-X-C motif chemokine 13,2992.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-X-C motif chemokine 16,14547.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-X-C motif chemokine 5,612.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-X-C motif chemokine 6,2689,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,C-X-C motif chemokine 9,663.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,824.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,285.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1029.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,2660.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,1305.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cystatin-C,2447.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cystatin-D,9511.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cystatin-F,643.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cystatin-M,8014.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cystatin-S,100.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cystatin-SA,33741.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cystatin-SN,1641.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,5744.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,229.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,2977.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytochrome c,3776.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytochrome P450 3A4,36803.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,7212.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,338.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,1684.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,2031.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,294.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,19764.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,1571.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,860,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,66,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,16257.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,D-dimer,12092.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Death-associated protein kinase 2,5520.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Decorin,4995.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Delta-like protein 1,1548.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Delta-like protein 4,560.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dermatopontin,4738.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Desert hedgehog protein N-product,1084.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Desmocollin-2,1899,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Desmocollin-3,269.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Desmoglein-1,2472.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",4800.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dickkopf-like protein 1,2272.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dickkopf-related protein 1,76588.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dickkopf-related protein 3,3651.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dickkopf-related protein 4,19191.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,481.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,1239.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1560.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,501.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1464.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,1999.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,1872,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,DNA topoisomerase 1,476.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,1012.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Drebrin-like protein,5144.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",5697.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,472.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1927.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,4295.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,41692.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,10141.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,1763.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dynactin subunit 2,853.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",304.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,9765.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,816,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,3548.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,278.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,1059.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,331,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",1885.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1490.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1107.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,3550.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2579.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1311.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Elafin,4961.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Elongation factor 1-beta,1025.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Endoglin,2164.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,196588.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,3822.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Endostatin,85537,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,3499.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,1098.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,4615.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,35736,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Enteropeptidase,180.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Eotaxin,16330.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin-A2,713.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin-A3,1554.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin-A4,1523.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin-A5,3498.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin-B1,2137.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin-B2,16754,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin-B3,856.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin type-A receptor 10,303.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin type-A receptor 1,9278.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin type-A receptor 2,2319.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin type-A receptor 3,108.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin type-A receptor 5,688.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin type-B receptor 2,17856.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin type-B receptor 4,2595.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ephrin type-B receptor 6,1227.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Epidermal growth factor,1153.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Epidermal growth factor receptor,23374.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,1627.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,206.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Epiregulin,1309.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,393.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Erythropoietin,2217.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Erythropoietin receptor,392.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,E-selectin,28263.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,1380.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Estrogen receptor,704.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,539.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,330,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,18694.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,41843.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,2463.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,98762.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Extracellular matrix protein 1,16283.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],1760.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,FACT complex subunit SSRP1,386.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",913.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",16128.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",4524,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fc receptor-like protein 3,495.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ferritin,16907.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fetuin-B,4232.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibrinogen,186683.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibrinogen gamma chain,58392.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 10,189.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 1,156.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 12,182.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 16,5200.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 17,179.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 18,231.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 19,13413.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 20,434.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 23,700.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 2,3923.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 4,253.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 5,385.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 6,630.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 7,3890.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,692.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,658.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor 9,464.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,1268.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,176.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,650.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,680.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibronectin,24434.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibronectin Fragment 3,4575.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fibronectin Fragment 4,97198.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ficolin-1,2160.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ficolin-2,886.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ficolin-3,280.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,317.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Focal adhesion kinase 1,249.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Follicle stimulating hormone,4240.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Follistatin,973,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Follistatin-related protein 1,29456.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Follistatin-related protein 3,5475.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,3885.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fractalkine,2710.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,153688.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,373,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,356.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galectin-10,432.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galectin-2,463.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galectin-3,17766.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galectin-3-binding protein,858.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galectin-4,668.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galectin-7,747.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galectin-8,394.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Galectin-9,1354.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Gamma-enolase,85378.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Gastrin-releasing peptide,261.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,GDNF family receptor alpha-1,1245.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,GDNF family receptor alpha-2,6978.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,GDNF family receptor alpha-3,755.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Gelsolin,1082.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glia-derived nexin,1866.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,239.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glial fibrillary acidic protein,427.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glucagon,2174.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glucocorticoid receptor,79.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glucokinase regulatory protein,385.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,67465.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,487.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glutathione S-transferase A3,107.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glutathione S-transferase P,13984.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,243957.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1718.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,43223.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,9125,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glypican-2,142.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glypican-3,1139.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glypican-5,1210.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Glypican-6,1731.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",743.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Granulins,29475.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1489.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,808.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,280.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Granulysin,2158.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Granzyme A,3022.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Granzyme B,323.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Granzyme H,399.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,GRB2-related adapter protein 2,376.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Gremlin-1,466.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Gro-beta/gamma,1604.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,535.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,237.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth arrest-specific protein 1,572.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth/differentiation factor 11,782.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,865.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth/differentiation factor 15,977.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth/differentiation factor 2,3974.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth/differentiation factor 5,3932.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth/differentiation factor 8,3936,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth/differentiation factor 9,530.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,178980.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth hormone receptor,842.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Growth-regulated alpha protein,15122.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,GTPase KRas,858.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,17245.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Haptoglobin,13660.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,6856.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,1931.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heat shock protein beta-1,18772.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,16803.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,93106.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heme oxygenase 2,492.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,HemK methyltransferase family member 2,6269.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hemoglobin,1174.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hemojuvelin,806.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hemopexin,1291,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2777.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,336.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heparin cofactor 2,3168.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,6246.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hepatocyte growth factor,1640.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hepatocyte growth factor activator,4906.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,3768,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,9149.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,722.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hepcidin,21850.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,1353.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,2101.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,161.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,3342.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3949.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hexokinase-1,1011.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hexokinase-2,779.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",346,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",246.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,234.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,2793.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,High mobility group protein B1,7385,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histidine-rich glycoprotein,2961.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,2986.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1237.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,372,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone deacetylase 8,3255.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone H1.2,2014.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone H2A type 3,494.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone H2A.z,1174.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone H2B type 2-E,9276.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone H3.1,1213.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,428.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Homeobox protein NANOG,120.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,342.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,707.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,7237.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,975.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,365.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,ICOS ligand,1613,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Iduronate 2-sulfatase,11888.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Immunoglobulin A,883.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,145.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Immunoglobulin D,187.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Immunoglobulin E,222.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Immunoglobulin G,292913.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Immunoglobulin M,924.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,8403.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Importin subunit alpha-1,271.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Importin subunit beta-1,41643.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,756,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Inducible T-cell costimulator,661.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Inhibin beta A chain,5822,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,799.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Inhibitor of growth protein 1,52197.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Inorganic pyrophosphatase,75759.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,3536.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,3330.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin,89,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-degrading enzyme,3829.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,8432.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,3616.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,1154.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,2619.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,6098,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,3005.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,620.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,78061.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin-like growth factor I,1358.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Insulin receptor,11973.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,2909.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,2404.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,559,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,39467,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,4827.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,1479.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,546.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,1732.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon alpha-10,268.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon alpha-2,166.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon alpha-7,159.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,3502.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon beta,402.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon gamma,917.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon gamma receptor 1,438.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon gamma receptor 2,367.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon lambda-1,454.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon lambda-2,129.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interferon regulatory factor 1,1561.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-10,166.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1057.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,1024.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-11,313.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-12,201,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,399.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,836.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-13,559.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,2099.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,901.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-16,273.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-17A,326.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-17B,143,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-17D,206.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-17F,417.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-17 receptor A,916.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-17 receptor B,2607.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-17 receptor C,655.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-17 receptor D,416,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-18-binding protein,6740.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-18 receptor 1,7844,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,283.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-19,5413.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-1 alpha,585.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-1 beta,1863.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,29051.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,3860.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,3694,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,706.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,11177.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,6919.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-20,388.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,266.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-2,2402,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-22,765.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,753.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,1966.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-23,3356.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-23 receptor,3739,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-24,326.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-25,250.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-27,549.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,2362.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,947.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-3,1365.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-34,598.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-36 alpha,646,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-36 beta,382.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-37,1700.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,2018.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-4,550,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,157.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-5,206.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,3949,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-6,664.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,14636.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,7099.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-7,147.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,244.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-8,4059.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interleukin-9,373.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Interstitial collagenase,3078.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Junctional adhesion molecule B,9186,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Junctional adhesion molecule C,9999.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Junctional adhesion molecule-like,400.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-11,1474,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-12,5213.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-13,1105.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-14,7053.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-4,310.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-5,128,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-6,2526.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-7,1468.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallikrein-8,2680,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kallistatin,56488.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,433,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",1053.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,1874,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,206.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,401.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,281.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kinesin-like protein KIF23,1756.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kininogen-1,29519.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,337.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kremen protein 2,5545.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,4927.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,1141,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Kynureninase,1007.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lactadherin,809.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lactoperoxidase,1041.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lactotransferrin,106154.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lamin-B1,802.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Laminin,4017.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1584.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Layilin,1253.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Legumain,2671.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leptin,2640,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leptin receptor,1149.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,2428.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,6682,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,1937.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,94.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,168.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1387.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,23423.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,7859.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,3912.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3982.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,9277.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,1164.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,1364.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,177,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Limbic system-associated membrane protein,1527.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,90749,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lithostathine-1-alpha,743.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,2509.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,1011.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,2840.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,2462.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1552.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Low-density lipoprotein receptor,106.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,40798.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",3876.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,2649.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,9218.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,L-Selectin,3743.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lumican,1517.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Luteinizing hormone,2924.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,1379.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,373.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,14953.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lymphocyte antigen 86,4760.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lymphotactin,364.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,129.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,1982.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lymphotoxin-alpha,348.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lysosomal protective protein,6175.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lysosome membrane protein 2,337.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Lysozyme C,114111.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Macrophage-capping protein,815.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1251.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,232.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Macrophage mannose receptor 1,7043.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Macrophage metalloelastase,1745.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,1859,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,803.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,404.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",38804,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mammaglobin-B,9489.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,4534.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mannose-binding protein C,7107.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,29879.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,3187.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,607.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,14893.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Matrilin-2,10583.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Matrilin-3,424.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Matrilysin,2480.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,191.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Matrix metalloproteinase-14,591,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Matrix metalloproteinase-16,565.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Matrix metalloproteinase-17,740.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Matrix metalloproteinase-9,3204.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,91685.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,312.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,3444.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Membrane frizzled-related protein,2415.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,969.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mesothelin,406.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,142.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,641.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,4065.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Methionine aminopeptidase 1,7284.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Methionine aminopeptidase 2,85813.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,464.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,466.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,1719.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Microtubule-associated protein tau,137.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Midkine,60268.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,683.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,669,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,441.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,1975,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,23957.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,436.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,5209.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,92554.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,3195.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,923,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,4794.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Moesin,2233.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,50979,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,41091,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Mucin-1,973.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Muellerian-inhibiting factor,7168,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Myc proto-oncogene protein,380.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Myeloblastin,1380.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,4063.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Myeloperoxidase,17256.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Myoglobin,1021.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",5448.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,1335.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,3052.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,3400.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,10615.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,3317.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,13882.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,1801.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,328.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,478.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,173.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Netrin-1,831.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Netrin-4,1637.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Netrin receptor UNC5C,3216.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Netrin receptor UNC5D,5880.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",11695.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,382.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,11856,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neuregulin-1,160.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neuregulin-4,591.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neurexin-1-beta,578.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neurexin-3-beta,783.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neurexophilin-1,5445.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1246.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,20191.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,355.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,1681.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",782.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,13651.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neuronal growth regulator 1,3313.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neuropilin-1,3379.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neurotrophin-3,394.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neurotrophin-4,167.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neutral ceramidase,4163.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,23624.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neutrophil collagenase,3192.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neutrophil elastase,335.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,9728,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,1079.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Nidogen-1,5630.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Nidogen-2,2905.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NKG2D ligand 1,308.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NKG2D ligand 2,240,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NKG2D ligand 3,1180.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,449.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Noggin,5150.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,588.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,1418.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NSFL1 cofactor p47,2081.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NT-3 growth factor receptor,11880.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,N-terminal pro-BNP,11868.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,432.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,864.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,100380.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,NudC domain-containing protein 3,732.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,OCIA domain-containing protein 1,900.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Olfactomedin-4,147.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Oncostatin-M,1513.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,2392.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Osteocalcin,1218.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Osteomodulin,9913.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Osteopontin,8312.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,3940.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,1371.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pancreatic hormone,2025.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pappalysin-1,7971.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Parathyroid hormone,2470.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Parathyroid hormone-related protein,1546.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peptide YY,1871.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,363.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,277314.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,2511.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,48891.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,5071.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",138922.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Periostin,7346.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peroxiredoxin-1,3726.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",437.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peroxiredoxin-6,1644.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,176.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Persephin,244.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3494.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pescadillo homolog,227.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,10925.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",974.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2323.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Phosphoglucomutase-1,495.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,7086,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,4112.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Phospholipase A2,1084.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",7505.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pigment epithelium-derived factor,55518.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,PIK3CA/PIK3R1,967.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,PILR alpha-associated neural protein,4775.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,188.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,143.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Placenta growth factor,266.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Plasma kallikrein,20552.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,9669.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Plasma serine protease inhibitor,115287.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Plasmin,650,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Plasminogen,3010.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,1528.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,713,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,12877.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet-derived growth factor C,234,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,1634.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,7838.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,32116.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,112904.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,969.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet factor 4,138262.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet glycoprotein 4,13675.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,914.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet glycoprotein VI,29746.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Platelet receptor Gi24,497.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pleiotrophin,2809.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Plexin-B2,3837.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Plexin-C1,2200.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,3321.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,857.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,5052.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Prefoldin subunit 5,473.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,677.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,5333,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Prokineticin-1,169,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Prolactin,514.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Prolactin receptor,927.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,166.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,4399.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,816.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pro-opiomelanocortin,543.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Properdin,119841.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,2963.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,945.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,488.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Prostate-specific antigen,586.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,1890.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,263.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,679.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,762.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,1639.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein 4.1,18230.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein amnionless,109.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein deglycase DJ-1,481.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein disulfide-isomerase,183.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,7571.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein E7_HPV16,292.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein E7_HPV18,1492.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein FAM107A,251.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein FAM107B,3903.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein FAM3B,807.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein FAM3D,5217.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,280.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein jagged-1,576.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein jagged-2,228.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein kinase C alpha type,221486.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),32712.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein kinase C delta type,8669,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein kinase C gamma type,407.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein kinase C iota type,5452.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein kinase C theta type,8745.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein kinase C zeta type,1009.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein lin-7 homolog B,475.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein NOV homolog,696.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein Rev_HV2BE,143.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein S100-A12,531.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein S100-A4,1706.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein S100-A6,3262.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein S100-A7,151.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein S100-A9,3190.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein SET,723.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,189.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein Wnt-7a,172.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,5508.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Prothrombin,190817.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,748.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,171977.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Proto-oncogene vav,43127.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,P-selectin,26863.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,7322.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pyridoxal kinase,693.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,7799.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",2705.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Pyruvate kinase PKM,133633.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,1897,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,35784.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,14537.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,45695.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,1842.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,81940.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,19658,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,9687.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,354.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,290,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,141.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,2761.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Relaxin receptor 1,333.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Renin,902.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Repulsive guidance molecule A,17222,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Resistin,643.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Reticulon-4 receptor,826.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1088.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,3873.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Retinol-binding protein 4,220.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,RGM domain family member B,1575.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ribonuclease H1,151.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,2950.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,362.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,55359.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,RNA-binding protein 39,391.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Roundabout homolog 2,3736.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Roundabout homolog 3,293.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,R-spondin-2,409.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,R-spondin-3,1597.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,R-spondin-4,484.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Scavenger receptor class F member 1,10312.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Scavenger receptor class F member 2,215,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2383,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sclerostin,19326.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,851.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,8967.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,3485.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Secretin,185.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Seizure 6-like protein 2,2204.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Semaphorin-3A,1773.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Semaphorin-3E,3595.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Semaphorin-5A,7213,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Semaphorin-6A,15937.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Semaphorin-6B,5031.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine protease 27,5458.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",10361.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,1732.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,4517.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,477.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,141.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,1254.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,860.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,28939.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,697,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,2769.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,137.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1373.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,275,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,2053.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serotransferrin,270568,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serum albumin,7392.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serum amyloid A-1 protein,96.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serum amyloid P-component,2740.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,189.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sex hormone-binding globulin,4273.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,S-formylglutathione hydrolase,8173.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,3042.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SHC-transforming protein 1,42148.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,8519.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,280.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1211.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,41265.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sialoadhesin,96.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,29378.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,4088.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,771.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SLAM family member 5,19349.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SLAM family member 6,385.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SLAM family member 7,300168.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1517.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,4407.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,13076.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,3426.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,7901.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Somatostatin-28,1541.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Somatotropin,184.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sonic hedgehog protein,1802.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sorting nexin-4,40077.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SPARC,35622.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SPARC-like protein 1,10183.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,3492.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",129.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,6460.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sphingosine kinase 1,47375.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Sphingosine kinase 2,616,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Spondin-1,7510.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Stabilin-2,790.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Stanniocalcin-1,2402.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Stem cell growth factor-alpha,3524.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,1446.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,18329.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Stromal cell-derived factor 1,6113.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Stromelysin-1,3740.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Stromelysin-2,746.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,4694,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],1704,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",48731.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,890.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Syntaxin-1A,268,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,7235.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,TATA-box-binding protein,400.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,343.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tenascin,20673.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,501.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Testican-1,4182.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Testican-2,1013.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,TGF-beta receptor type-2,687.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,3938.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thrombin,1065.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thrombopoietin,358.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thrombopoietin Receptor,182.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thrombospondin-1,8738,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thrombospondin-2,22094.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thrombospondin-4,829.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,517.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",430,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thymidylate synthase,277.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thyroglobulin,326.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thyroid peroxidase,1451.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,1279.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Thyroxine-binding globulin,34411.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tissue Factor,964.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,67287.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tissue-type plasminogen activator,355.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,476.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,2392.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,18872.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Toll-like receptor 2,496,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Toll-like receptor 4,198.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,5567.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transcription factor AP-1,4207.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,1828.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transforming growth factor beta-1,1870.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transforming growth factor beta-2,241.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transforming growth factor beta-3,411.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,125836.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,28733.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transgelin-2,11007.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transketolase,117763.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Translationally-controlled tumor protein,39683.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,6550.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Trefoil factor 1,6862,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Trefoil factor 2,14409.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Trefoil factor 3,10098.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Triosephosphate isomerase,22107.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,782.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,263145.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tropomyosin beta chain,1650,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",533.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",6363.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",3077,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Trypsin-1,6020.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Trypsin-2,1644.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Trypsin-3,340.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tryptase beta-2,4565,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tryptase gamma,157.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,385.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor,383.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,1470.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,386.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,925.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,746.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,630.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,1047.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,614.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,261.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",579.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,2787.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,343.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1111.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,328.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,772.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1231.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,12794.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,141,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,5259.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,2428.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,433.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,89513.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,880.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,765.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,2145.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,740.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,7300.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,7015,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,775.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,4701.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,450.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,877.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,554.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,829.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,310.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,1771.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,115.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,36597.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,29365.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,11267.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,839.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,27641.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,144.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,131128.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,329.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,30956.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",153201.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",6214.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,522.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,11045.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,493.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,1788,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,9527.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,23685.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,3883,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,267.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,25196.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,9876.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin,1644.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",4743.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1433.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,2559.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,2418.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,3006.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,14635.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,25175.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,63608.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,4950.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,UMP-CMP kinase,4642.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,13307.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,2115.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,98755.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,7306.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vascular endothelial growth factor A,13167.9,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",666.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vascular endothelial growth factor C,2239,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vascular endothelial growth factor D,427.6,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,5385.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,7574.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,479.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,8430,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vitamin K-dependent protein C,1426.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vitamin K-dependent protein S,3870.7,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Vitronectin,67579.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,von Willebrand factor,10553.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,296.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",555.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",8336.8,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,3862.4,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,970.1,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Wnt inhibitory factor 1,4562.3,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,32833.5,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,825.2,RFU
BF-1138,PD_INVBD420RV2,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,323.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,14-3-3 protein beta/alpha,27920,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,14-3-3 protein epsilon,1100.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,14-3-3 protein family,4541.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,14-3-3 protein sigma,607.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,14-3-3 protein theta,1154.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,14-3-3 protein zeta/delta,244098.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1314.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",437,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,533.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,327.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,448.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1732.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",5744.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",6064.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,1893.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,40S ribosomal protein S3,521.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,40S ribosomal protein S3a,688.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,40S ribosomal protein S7,958.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,40S ribosomal protein SA,1704.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",20164.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",16268.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,72 kDa type IV collagenase,7394.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Abelson tyrosine-protein kinase 2,1515.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,177.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,2309.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Activated Protein C,641.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Activin receptor type-1B,236.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Adapter molecule crk,13373.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Adenylate kinase isoenzyme 1,36873.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Adenylosuccinate lyase,4620.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Adhesion G protein-coupled receptor E2,664.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Adhesion G-protein coupled receptor G5,555.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Adiponectin,5632.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,4281.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,400.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,370.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,169.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,363,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,637.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,14918.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Adrenomedullin,2212.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",466.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Afamin,25589.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,5123.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Aggrecan core protein,546.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Agouti-related protein,2294.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,AH receptor-interacting protein,6806.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alanine aminotransferase 1,5069.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],4596.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Allograft inflammatory factor 1,2410.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",7640.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-1-antichymotrypsin,324169.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-1-antichymotrypsin complex,7404,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-1-antitrypsin,829.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-2-antiplasmin,2140.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-2-HS-glycoprotein,1750.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-2-macroglobulin,13139.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,614.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-enolase,55908.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,alpha-Fetoprotein,689.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-L-iduronidase,1431.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-soluble NSF attachment protein,9327.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Alpha-synuclein,14880.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Aminoacylase-1,3714.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Amphiregulin,3159.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Amphoterin-induced protein 2,3114.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),746.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),6499.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Amyloid beta A4 protein,19354.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiogenin,4585.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiopoietin-1,499.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",2231.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiopoietin-2,160.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiopoietin-4,508.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiopoietin-related protein 3,410.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiopoietin-related protein 4,4309.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiostatin,17239.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiotensin-converting enzyme 2,508.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Angiotensinogen,5061.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ankyrin-2,443.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Annexin A1,8057.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Annexin A2,8465.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Annexin A5,1092.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Annexin A6,5326.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Anterior gradient protein 2 homolog,983.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Antileukoproteinase,35196.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Antithrombin-III,149320.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein A-I,15118.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein B,20896.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein D,2426.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein E,35356.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein E (isoform E2),314458.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein E (isoform E3),230908.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein E (isoform E4),287155.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein L1,38851.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apolipoprotein M,14662.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Apoptosis regulator Bcl-2,1289.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Appetite-regulating hormone,1116.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Arginase-1,1174.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,310.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Artemin,518.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Arylsulfatase A,1264.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Arylsulfatase B,2028.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Asialoglycoprotein receptor 1,1349.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",3079.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,4936.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",2184.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",7436.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Atrial natriuretic factor,634.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,527.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Aurora kinase A,1494.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Aurora kinase B,582,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Azurocidin,262.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bactericidal permeability-increasing protein,614,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,383.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,457.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,103.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Basal Cell Adhesion Molecule,1711.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Basigin,351.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,B-cell lymphoma 6 protein,1596.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,B-cell receptor CD22,722,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bcl2-associated agonist of cell death,11201.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bcl-2-like protein 1,1029.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bcl-2-like protein 2,552.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bcl-2-related protein A1,852.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,BDNF/NT-3 growth factors receptor,1074,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Beta-2-microglobulin,2741.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,beta-adrenergic receptor kinase 1,10825.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Beta-Ala-His dipeptidase,6046.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Betacellulin,486.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Beta-endorphin,1761.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,beta-nerve growth factor,556,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,BH3-interacting domain death agonist,2303.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Biglycan,2532.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,BMP-binding endothelial regulator protein,393.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bone morphogenetic protein 10,1239.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bone morphogenetic protein 1,2862.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bone morphogenetic protein 6,21769,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bone morphogenetic protein 7,743.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,1125,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bone morphogenetic protein receptor type-2,917.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Bone sialoprotein 2,6633.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Brain-derived neurotrophic factor,879.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Brain natriuretic peptide 32,444.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Brain-specific serine protease 4,2286,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1412.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Brevican core protein,1968.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Brother of CDO,1390.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C3a anaphylatoxin,922.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C3a anaphylatoxin des Arginine,174751.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C5a anaphylatoxin,7740.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cadherin-12,703.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cadherin-15,3838.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cadherin-1,86712.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cadherin-2,2113.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cadherin-3,23399.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cadherin-5,14603,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cadherin-6,440.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcineurin,2244.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcineurin subunit B type 1,5038.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",708.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,372,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,6481.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1976.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,1381.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,3481.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,12552,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calcium-dependent phospholipase A2,316.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calpain I,56420.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calpastatin,6268.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Calreticulin,2341.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,1814.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,cAMP-regulated phosphoprotein 19,2919.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1696.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbohydrate sulfotransferase 15,5184.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbohydrate sulfotransferase 2,274.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbohydrate sulfotransferase 6,261.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase 1,28612.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase 13,3837.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase 2,280.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase 3,3347.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase 4,1217.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase 6,5743,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase 7,306.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase 9,1286.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carbonic anhydrase-related protein 10,567.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carboxypeptidase B2,13614.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Carboxypeptidase E,1909.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cardiotrophin-1,612.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,10256.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,417.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Casein kinase II subunit alpha,448.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Caspase-10,3830.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Caspase-2,452.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Caspase-3,17501,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Catalase,22149.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin B,1838.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin D,740.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin E,527.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin F,2305.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin G,759.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin H,834,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin L2,891.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin S,1063.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cathepsin Z,6601.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,28273.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CCAAT/enhancer-binding protein beta,853.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 1,2147.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 13,393.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 14,9178.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 15,5222,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 16,38665.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 17,1084.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 18,8418.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 19,503.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 20,121.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 21,32592.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 22,1377.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 23,3357,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 24,377.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 25,1683.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 26,927.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 27,1218.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 2,876,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 28,8036.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 3,832.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 3-like 1,1635.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 4-like,673.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 5,30481.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 7,561.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-C motif chemokine 8,201.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD109 antigen,3824.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD166 antigen,18695.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD177 antigen,355.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD209 antigen,1315.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD226 antigen,3058.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD27 antigen,5046.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD40 ligand,304.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD48 antigen,926.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD59 glycoprotein,2123.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD5 antigen-like,3488.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD63 antigen,346.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD70 antigen,269.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD83 antigen,402.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CD97 antigen,1145.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cell adhesion molecule 1,2362.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cell adhesion molecule 3,2831,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,4964.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,1431.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cellular tumor antigen p53,831.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cerebral dopamine neurotrophic factor,4068.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",4185.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1083.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",27404.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Chitinase-3-like protein 1,13159,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Chitotriosidase-1,1780.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Chloride intracellular channel protein 1,6086.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Choline/ethanolamine kinase,2481.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Chordin-like protein 1,2998.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Chorionic somatomammotropin hormone,3065.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Chromobox protein homolog 5,365.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Chromogranin-A,9198.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Chymase,447.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ciliary neurotrophic factor,208.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,10742.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ck-beta-8-1,86418.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Clusterin,884.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,CMRF35-like molecule 6,5736.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coactosin-like protein,2745.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coagulation factor IX,11701.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coagulation factor IXab,8485.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coagulation Factor V,72695.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coagulation factor VII,486.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coagulation Factor X,4115.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coagulation factor Xa,3375,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coagulation Factor XI,1657.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cofilin-1,11079.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Coiled-coil domain-containing protein 80,2170.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Collagen alpha-1(VIII) chain,1426.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Collagen alpha-1(XXIII) chain,371.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Collagenase 3,1434.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Collectin-11,10505.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Collectin-12,2471,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,COMM domain-containing protein 7,2571.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C1q subcomponent,44145.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C1r subcomponent,1086.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C2,2919.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C3,66001.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C3b,20908.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Complement C3b, inactivated",6428.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C3d fragment,7827.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C4,147044.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C4b,164.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C5,6174.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement C5b-C6 complex,412.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4183.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement component C1q receptor,13010.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement component C6,32506.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement component C7,1021.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement component C8,1875.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement component C9,89452,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement decay-accelerating factor,14953.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement factor B,27312.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement factor D,804.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement factor H,58661.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement factor H-related protein 5,961.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Complement factor I,44527,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Connective tissue-activating peptide III,20456.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Connective tissue growth factor,1505.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Contactin-1,285.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Contactin-2,1139.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Contactin-4,4079.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Contactin-5,573.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Copine-1,5154.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Corticosteroid-binding globulin,581.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Corticotropin,421.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-reactive protein,108054.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Creatine kinase B-type,726.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Creatine kinase M-type,551.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,270.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cryptic protein,2610.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-type lectin domain family 1 member B,15304.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-type lectin domain family 4 member K,178.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-type lectin domain family 4 member M,55331.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-type lectin domain family 7 member A,706.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-type mannose receptor 2,3615.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-X-C motif chemokine 10,3637.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-X-C motif chemokine 11,7250.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-X-C motif chemokine 13,4752.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-X-C motif chemokine 16,12535.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-X-C motif chemokine 5,446,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-X-C motif chemokine 6,2253,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,C-X-C motif chemokine 9,674.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,663.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,315,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,811.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1274.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,825.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cystatin-C,3234.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cystatin-D,11146.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cystatin-F,868.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cystatin-M,6535,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cystatin-S,155.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cystatin-SA,32962.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cystatin-SN,1649.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cysteine and glycine-rich protein 3,4649.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cysteine-rich secretory protein 3,325.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,2844,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytochrome c,1876,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytochrome P450 3A4,20126.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytokine receptor common subunit gamma,3326.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,441.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytokine receptor-like factor 2,1157.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytoplasmic protein NCK1,1828.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,278.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytoskeleton-associated protein 2,11937.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytosolic non-specific dipeptidase,1066.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,1006.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,223.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,dCTP pyrophosphatase 1,13457.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,D-dimer,14158.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Death-associated protein kinase 2,2955,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Decorin,3970.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Delta-like protein 1,2265.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Delta-like protein 4,450.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dermatopontin,6540.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Desert hedgehog protein N-product,603.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Desmocollin-2,3501.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Desmocollin-3,590.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Desmoglein-1,1898.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Diablo homolog, mitochondrial",4981.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dickkopf-like protein 1,2161.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dickkopf-related protein 1,34204.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dickkopf-related protein 3,6086.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dickkopf-related protein 4,7393.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dipeptidyl peptidase 1,487,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dipeptidyl peptidase 2,1217.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Discoidin domain-containing receptor 2,1386.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,410.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1405.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,DnaJ homolog subfamily B member 1,843.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,DNA repair protein RAD51 homolog 1,1449.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,DNA topoisomerase 1,523.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Down syndrome cell adhesion molecule,1518.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Drebrin-like protein,3322.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2936,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,426.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1321.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,1867.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,28355.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dual specificity protein phosphatase 3,3660.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,1849.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dynactin subunit 2,1440.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",291.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Dynein light chain roadblock-type 1,2323.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,2718.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,1237.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,203,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,950.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,565.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Ectodysplasin-A, secreted form",1859,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1294.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,946.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,4561,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,7421.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1636,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Elafin,10291.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Elongation factor 1-beta,612,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Endoglin,1976.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,127940.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Endoplasmic reticulum resident protein 29,7957.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Endostatin,103160.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Endothelial cell-selective adhesion molecule,4469.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Endothelial cell-specific molecule 1,1718.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,2959.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Endothelin-converting enzyme 1,20041.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Enteropeptidase,171.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Eotaxin,13365.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin-A2,1293.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin-A3,2398.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin-A4,2195.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin-A5,5021.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin-B1,2012.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin-B2,20764.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin-B3,817.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin type-A receptor 10,401.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin type-A receptor 1,8604.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin type-A receptor 2,3955.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin type-A receptor 3,143.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin type-A receptor 5,794.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin type-B receptor 2,24959.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin type-B receptor 4,2650.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ephrin type-B receptor 6,1796.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Epidermal growth factor,837.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Epidermal growth factor receptor,30019.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,681.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Epidermal growth factor receptor variant III,463.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Epiregulin,1864.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,357.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Erythropoietin,988.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Erythropoietin receptor,383.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,E-selectin,30916.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,1635.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Estrogen receptor,774.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Eukaryotic initiation factor 4A-III,508.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,217.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,6207,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Eukaryotic translation initiation factor 4H,9167.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Eukaryotic translation initiation factor 5,1836.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,54507.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Extracellular matrix protein 1,18850.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],892.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,FACT complex subunit SSRP1,654,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Fatty acid-binding protein, epidermal",749.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Fatty acid-binding protein, heart",57848.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Fatty acid-binding protein, liver",5521,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fc receptor-like protein 3,373,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ferritin,12524.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fetuin-B,6013.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibrinogen,167540.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibrinogen gamma chain,63192.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 10,199.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 1,190.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 12,197.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 16,2686.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 17,245.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 18,245.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 19,6203.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 20,373.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 2,1365.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 23,644.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 4,187.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 5,475.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 6,372.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 7,2018.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 8 isoform A,378.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 8 isoform B,634.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor 9,485.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor receptor 1,831.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor receptor 2,420.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor receptor 3,764,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibroblast growth factor receptor 4,785.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibronectin,7389.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibronectin Fragment 3,1665.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fibronectin Fragment 4,62178.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ficolin-1,2336,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ficolin-2,935.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ficolin-3,213.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,378.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Focal adhesion kinase 1,280.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Follicle stimulating hormone,9076.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Follistatin,851.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Follistatin-related protein 1,34703.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Follistatin-related protein 3,9780.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,2445.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fractalkine,2563.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Fructose-bisphosphate aldolase A,98651.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,G2/mitotic-specific cyclin-B1,396.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,397.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galectin-10,686.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galectin-2,464.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galectin-3,23952.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galectin-3-binding protein,1165.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galectin-4,573,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galectin-7,597.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galectin-8,472,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Galectin-9,1771.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Gamma-enolase,42074.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Gastrin-releasing peptide,368.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,GDNF family receptor alpha-1,1365.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,GDNF family receptor alpha-2,3946.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,GDNF family receptor alpha-3,750.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Gelsolin,845.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glia-derived nexin,853,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glial cell line-derived neurotrophic factor,464.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glial fibrillary acidic protein,505.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glucagon,3724.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glucocorticoid receptor,107.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glucokinase regulatory protein,423.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glucose-6-phosphate isomerase,25772.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glutamate carboxypeptidase 2,314.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glutathione S-transferase A3,326.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glutathione S-transferase P,7606.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,110318.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",2695.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,15752.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,3616.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glypican-2,189,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glypican-3,603.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glypican-5,1158.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Glypican-6,1916.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"gp41 C34 peptide, HIV",753.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Granulins,27664.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Granulocyte colony-stimulating factor,2082.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,14328.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,837.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Granulysin,3292.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Granzyme A,4682.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Granzyme B,189.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Granzyme H,206.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,GRB2-related adapter protein 2,418.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Gremlin-1,411.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Gro-beta/gamma,649.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Group 10 secretory phospholipase A2,750.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Group IIE secretory phospholipase A2,255.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth arrest-specific protein 1,728,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth/differentiation factor 11,797.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth/differentiation factor 11/8,779,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth/differentiation factor 15,1577,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth/differentiation factor 2,2299.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth/differentiation factor 5,1508.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth/differentiation factor 8,4273.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth/differentiation factor 9,1019.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth factor receptor-bound protein 2,63834.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth hormone receptor,1726.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Growth-regulated alpha protein,6281,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,GTPase KRas,1418.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,GTP-binding nuclear protein Ran,10307,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Haptoglobin,26369.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heat shock 70 kDa protein 1A,8196.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heat shock cognate 71 kDa protein,1913,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heat shock protein beta-1,12015.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,8747.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heat shock protein HSP 90-beta,53784,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heme oxygenase 2,376.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,HemK methyltransferase family member 2,3021,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hemoglobin,3209.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hemojuvelin,865.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hemopexin,2555.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2685.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heparin-binding EGF-like growth factor,464,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heparin cofactor 2,3249.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hepatitis A virus cellular receptor 2,13972.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hepatocyte growth factor,1894.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hepatocyte growth factor activator,1534.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hepatocyte growth factor-like protein,3312.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hepatocyte growth factor receptor,9368.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,767.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hepcidin,16254.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,HERV-H LTR-associating protein 2,37142.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1209.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,353.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,1715.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3134,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hexokinase-1,976.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hexokinase-2,678.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",330.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",418.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,241.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,High affinity nerve growth factor receptor,47791.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,High mobility group protein B1,5296.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histidine-rich glycoprotein,3361.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,1962.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone acetyltransferase KAT6A,1338.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,252,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone deacetylase 8,1774.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone H1.2,1214.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone H2A type 3,524.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone H2A.z,1619.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone H2B type 2-E,14844,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone H3.1,1715.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,571.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Homeobox protein NANOG,176.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Homeodomain-interacting protein kinase 3,355.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hsp90 co-chaperone Cdc37,460.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Human Chorionic Gonadotropin,14034.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,1066.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,384.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,ICOS ligand,1929.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Iduronate 2-sulfatase,2853.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Immunoglobulin A,7021.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Immunoglobulin alpha Fc receptor,181.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Immunoglobulin D,1086.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Immunoglobulin E,532.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Immunoglobulin G,215507.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Immunoglobulin M,2861.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,6785.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Importin subunit alpha-1,304,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Importin subunit beta-1,11694.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,5953.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Inducible T-cell costimulator,605,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Inhibin beta A chain,5234.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,895.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Inhibitor of growth protein 1,24166.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Inorganic pyrophosphatase,44235.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,2592.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2873.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin,142.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-degrading enzyme,2797.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor 1 receptor,7452.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor-binding protein 1,280.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor-binding protein 2,981.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor-binding protein 3,1364.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor-binding protein 4,5601.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor-binding protein 5,1438.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor-binding protein 6,752.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor-binding protein 7,68760,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin-like growth factor I,673.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Insulin receptor,12710.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Integrin alpha-I: beta-1 complex,2032.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,2020.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Integrin alpha-V: beta-5 complex,672.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,40806.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Intercellular adhesion molecule 1,4630.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Intercellular adhesion molecule 2,2022.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Intercellular adhesion molecule 3,510.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Intercellular adhesion molecule 5,1221.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon alpha-10,425.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon alpha-2,122.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon alpha-7,248.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon alpha/beta receptor 1,1938.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon beta,1192.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon gamma,1018,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon gamma receptor 1,479.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon gamma receptor 2,405.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon lambda-1,312,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon lambda-2,348.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interferon regulatory factor 1,1570.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-10,288.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1153.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-10 receptor subunit beta,941.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-11,265.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-12,399.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,450.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,819.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-13,813.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,2970.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-15 receptor subunit alpha,1266.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-16,314.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-17A,579.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-17B,281.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-17D,211.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-17F,749,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-17 receptor A,650.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-17 receptor B,1227.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-17 receptor C,849.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-17 receptor D,392.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-18-binding protein,13503.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-18 receptor 1,11889.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-18 receptor accessory protein,310,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-19,6344.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-1 alpha,534.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-1 beta,17544.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-1 Receptor accessory protein,31100.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-1 receptor antagonist protein,7812.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-1 receptor-like 1,4319.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-1 receptor-like 2,861.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-1 receptor type 1,7661.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-1 receptor type 2,12122.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-20,377.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-20 receptor subunit alpha,308.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-2,2300.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-22,889.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,693.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,2491.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-23,1867.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-23 receptor,4081,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-24,201.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-25,300.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-27,617.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-27 receptor subunit alpha,1565.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-2 receptor subunit alpha,993,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-3,1281.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-34,458.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-36 alpha,1300.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-36 beta,419.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-37,1539.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-3 receptor subunit alpha,1155.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-4,522.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-4 receptor subunit alpha,341.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-5,268.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-5 receptor subunit alpha,1943.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-6,424.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-6 receptor subunit alpha,26453.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-6 receptor subunit beta,6358.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-7,143.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-7 receptor subunit alpha,280.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-8,759.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interleukin-9,403.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Interstitial collagenase,708.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Junctional adhesion molecule B,8863,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Junctional adhesion molecule C,6092.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Junctional adhesion molecule-like,696.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-11,1238.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-12,2754.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-13,929.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-14,4622.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-4,261.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-5,169.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-6,1916.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-7,1099.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallikrein-8,2522.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kallistatin,36666.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kelch-like ECH-associated protein 1,482.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Keratin, type I cytoskeletal 18",957.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,2852.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,345.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,440.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,658.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kinesin-like protein KIF23,1086.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kininogen-1,31404.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kin of IRRE-like protein 3,329.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kremen protein 2,3017.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kunitz-type protease inhibitor 1,4239.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kunitz-type protease inhibitor 2,1287.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Kynureninase,731.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lactadherin,906.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lactoperoxidase,1306.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lactotransferrin,65855.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lamin-B1,657.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Laminin,2133.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1341,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Layilin,1695.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Legumain,2386.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leptin,21020.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leptin receptor,2456.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leucine carboxyl methyltransferase 1,1527.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,6966.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,1696,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,115,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,199.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,969,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,24434.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,8247.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leukemia inhibitory factor receptor,4410.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,4720,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,12829.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leukocyte surface antigen CD47,742.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Leukotriene A-4 hydrolase,669.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,210.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Limbic system-associated membrane protein,1950.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lipopolysaccharide-binding protein,107801.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lithostathine-1-alpha,574.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,L-lactate dehydrogenase B chain,1356.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,4146.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,2529.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,1537.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1757,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Low-density lipoprotein receptor,149,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,43398.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",2049.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,2489,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,2525.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,L-Selectin,5760.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lumican,1470.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Luteinizing hormone,4128.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,938.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,368.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lymphocyte activation gene 3 protein,13651.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lymphocyte antigen 86,6008.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lymphotactin,324.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lymphotoxin alpha1:beta2,146.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lymphotoxin alpha2:beta1,2601.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lymphotoxin-alpha,411.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lysosomal protective protein,5012.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lysosome membrane protein 2,508.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Lysozyme C,153942.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Macrophage-capping protein,1041.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Macrophage colony-stimulating factor 1,1319.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,216.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Macrophage mannose receptor 1,11951.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Macrophage metalloelastase,1107.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Macrophage migration inhibitory factor,1089.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Macrophage scavenger receptor types I and II,1085,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Macrophage-stimulating protein receptor,376.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",24132.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mammaglobin-B,8373.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mannan-binding lectin serine protease 1,4266.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mannose-binding protein C,15586.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,MAP kinase-activated protein kinase 2,10129.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,MAP kinase-activated protein kinase 3,1323.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,MAP kinase-activated protein kinase 5,909.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,11683,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Matrilin-2,11754,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Matrilin-3,389.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Matrilysin,3076.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,235.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Matrix metalloproteinase-14,695.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Matrix metalloproteinase-16,607,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Matrix metalloproteinase-17,743.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Matrix metalloproteinase-9,31895.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,110070.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,330.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Melanoma-derived growth regulatory protein,3408.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Membrane frizzled-related protein,1714.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,859.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mesothelin,281.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Metalloproteinase inhibitor 1,81,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Metalloproteinase inhibitor 2,415.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Metalloproteinase inhibitor 3,1060.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Methionine aminopeptidase 1,2774.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Methionine aminopeptidase 2,38294,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Methyl-CpG-binding domain protein 4,352.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,MHC class I polypeptide-related sequence A,118.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,MHC class I polypeptide-related sequence B,1275.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Microtubule-associated protein tau,237.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Midkine,25686.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitochondrial glutamate carrier 2,758.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,562.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase 1,10105.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase 11,1993.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase 12,1115.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase 13,1622.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase 14,2477.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase 3,35885.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase 8,1294.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase 9,1184.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,2994.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Moesin,1541.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mothers against decapentaplegic homolog 2,15351.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mothers against decapentaplegic homolog 3,18944,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Mucin-1,905.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Muellerian-inhibiting factor,10709.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Myc proto-oncogene protein,760.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Myeloblastin,7213,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Myeloid cell surface antigen CD33,4358.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Myeloperoxidase,21050,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Myoglobin,1300,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Myosin-binding protein C, slow-type",2874.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,N-acetyl-D-glucosamine kinase,854.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,2933.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,6828.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,6827.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NADPH--cytochrome P450 reductase,2310.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,4744,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,2826.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,312.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,584.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Natural killer cell receptor 2B4,178.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Netrin-1,423,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Netrin-4,721,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Netrin receptor UNC5C,4433.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Netrin receptor UNC5D,6749.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",12537.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neural cell adhesion molecule L1,425.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,12516.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neuregulin-1,214.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neuregulin-4,4713.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neurexin-1-beta,812.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neurexin-3-beta,1015.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neurexophilin-1,2766.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1228,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neurogenic locus notch homolog protein 1,24908.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neurogenic locus notch homolog protein 2,1115,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neurogenic locus notch homolog protein 3,872.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Neuroligin-4, X-linked",658.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neuronal cell adhesion molecule,22838.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neuronal growth regulator 1,4987.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neuropilin-1,2567.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neurotrophin-3,262.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neurotrophin-4,264.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neutral ceramidase,3376.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neutrophil-activating peptide 2,7125.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neutrophil collagenase,4243.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neutrophil elastase,399.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,34924.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,618.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Nidogen-1,3592.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Nidogen-2,1915.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NKG2D ligand 1,557,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NKG2D ligand 2,377.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NKG2D ligand 3,773,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NKG2-D type II integral membrane protein,740.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Noggin,2999.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Non-histone chromosomal protein HMG-14,486.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,1634.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NSFL1 cofactor p47,711.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NT-3 growth factor receptor,6229.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,N-terminal pro-BNP,5226.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,862.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Nucleoside diphosphate kinase A,681,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Nucleoside diphosphate kinase B,37086.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,NudC domain-containing protein 3,404.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,OCIA domain-containing protein 1,823.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Olfactomedin-4,173.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Oncostatin-M,1319.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,2348,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Osteocalcin,1382.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Osteomodulin,8668.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Osteopontin,6966.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,OX-2 membrane glycoprotein,2796.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,2548.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pancreatic hormone,4676.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pappalysin-1,22184.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Parathyroid hormone,2695.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Parathyroid hormone-related protein,1009.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peptide YY,2060.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peptidoglycan recognition protein 1,834.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,193910.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,28520.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,17489.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,1375.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23903.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Periostin,6542.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peroxiredoxin-1,2781.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",509.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peroxiredoxin-6,823.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,234.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Persephin,225.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3429.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pescadillo homolog,216.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,7669.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",930.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",1313.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Phosphoglucomutase-1,680.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Phosphoglycerate kinase 1,3462.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Phosphoglycerate mutase 1,403.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Phospholipase A2,858.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Phospholipase A2, membrane associated",3650.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pigment epithelium-derived factor,70283.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,PIK3CA/PIK3R1,664.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,PILR alpha-associated neural protein,6674.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,393.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,266.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Placenta growth factor,652.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Plasma kallikrein,20526.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Plasma protease C1 inhibitor,9350.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Plasma serine protease inhibitor,115236.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Plasmin,641,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Plasminogen,3296.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Plasminogen activator inhibitor 1,876.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet-activating factor acetylhydrolase,779.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,7380.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet-derived growth factor C,409.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet-derived growth factor receptor alpha,1459.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet-derived growth factor receptor beta,10003.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet-derived growth factor subunit A,11301.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet-derived growth factor subunit B,29164.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet endothelial cell adhesion molecule,823.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet factor 4,28813.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet glycoprotein 4,18066.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,1792.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet glycoprotein VI,14003.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Platelet receptor Gi24,466.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pleiotrophin,1531.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Plexin-B2,5053.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Plexin-C1,575.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Polymeric immunoglobulin receptor,1692.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,PolyUbiquitin K48-linked,1618.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,PolyUbiquitin K63-linked,4600.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Prefoldin subunit 5,360.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Programmed cell death 1 ligand 1,863,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Programmed cell death 1 ligand 2,4630.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Prokineticin-1,206.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Prolactin,458.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Prolactin receptor,1124.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proliferating cell nuclear antigen,174,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proliferation-associated protein 2G4,2385.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Prolyl endopeptidase FAP,635.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pro-opiomelanocortin,643,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Properdin,122171.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,2917.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,702,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Prostaglandin G/H synthase 2,418.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Prostate-specific antigen,554,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proteasome activator complex subunit 1,1375.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proteasome activator complex subunit 3,437.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proteasome subunit alpha type-1,596.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proteasome subunit alpha type-2,577.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proteasome subunit alpha type-6,880.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein 4.1,16739.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein amnionless,138.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein deglycase DJ-1,423.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein disulfide-isomerase,209,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein disulfide-isomerase A3,3954.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein E7_HPV16,425.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein E7_HPV18,1354.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein FAM107A,278.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein FAM107B,2787.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein FAM3B,1094.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein FAM3D,10023.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,1510.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein jagged-1,610,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein jagged-2,310.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein kinase C alpha type,74764.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),9999.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein kinase C delta type,4241.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein kinase C gamma type,524.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein kinase C iota type,3224.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein kinase C theta type,3389,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein kinase C zeta type,686.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein lin-7 homolog B,603.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein NOV homolog,742.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein Rev_HV2BE,159.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein S100-A12,637.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein S100-A4,1801.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein S100-A6,3344.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein S100-A7,336.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein S100-A9,4894.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein SET,487.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein-tyrosine kinase 6,255.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein Wnt-7a,281.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Protein Z-dependent protease inhibitor,2281.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Prothrombin,199756.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,983.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,84067.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Proto-oncogene vav,17740.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,P-selectin,23515.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pulmonary surfactant-associated protein D,6090.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pyridoxal kinase,334.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pyridoxal phosphate phosphatase,3968.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1956.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Pyruvate kinase PKM,53215.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Quinone oxidoreductase-like protein 1,1736.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Rab GDP dissociation inhibitor beta,22559,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,5977.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,19067.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ras GTPase-activating protein 1,1194.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,43196.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,9719.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,3555.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,378.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,346,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,179.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Regenerating islet-derived protein 4,2083.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Relaxin receptor 1,418.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Renin,2097,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Repulsive guidance molecule A,21050.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Resistin,1780.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Reticulon-4 receptor,1423,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Retinoblastoma-associated protein,1494.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Retinoic acid receptor responder protein 2,3451.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Retinol-binding protein 4,213.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,RGM domain family member B,2591.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ribonuclease H1,232.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,998.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,230.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ribosome maturation protein SBDS,13994.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,RNA-binding protein 39,281.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Roundabout homolog 2,3248.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Roundabout homolog 3,332.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,R-spondin-2,403.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,R-spondin-3,1984.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,R-spondin-4,402.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Scavenger receptor class F member 1,8763.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Scavenger receptor class F member 2,298.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,3530.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sclerostin,24540.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Secreted and transmembrane protein 1,1750.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Secreted frizzled-related protein 1,6282.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Secreted frizzled-related protein 3,2940.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Secretin,275.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Seizure 6-like protein 2,1311,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Semaphorin-3A,1879,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Semaphorin-3E,3111.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Semaphorin-5A,7255.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Semaphorin-6A,16472.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Semaphorin-6B,5270,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine protease 27,7537,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",5168.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase 16,1454.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase 17B,3593.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase Chk1,871.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase Chk2,183.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1005.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,971.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,12784.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,492.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase pim-1,741.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase PLK1,169,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1183.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase TBK1,257.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serine/threonine-protein kinase WNK3,2014.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serotransferrin,297969.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serum albumin,10409.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serum amyloid A-1 protein,799.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serum amyloid P-component,28617.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Serum paraoxonase/arylesterase 1,166.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sex hormone-binding globulin,5388.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,S-formylglutathione hydrolase,4057.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SH2 domain-containing protein 1A,3507.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SHC-transforming protein 1,20177.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,17680.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,316.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1689.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,257.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sialoadhesin,114.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,15169.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Signal transducer and activator of transcription 3,1883.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Signal transducer and activator of transcription 6,454,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SLAM family member 5,11825.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SLAM family member 6,588.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SLAM family member 7,90177.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SLIT and NTRK-like protein 1,1380.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SLIT and NTRK-like protein 5,2678.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,4741.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Small nuclear ribonucleoprotein F,2770.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Small ubiquitin-related modifier 3,4061.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Somatostatin-28,1561.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Somatotropin,316.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sonic hedgehog protein,1260.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sorting nexin-4,14865,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SPARC,16544.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SPARC-like protein 1,15249,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,3195.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",142.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,S-phase kinase-associated protein 1,4307.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sphingosine kinase 1,14632.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Sphingosine kinase 2,465,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Spondin-1,2151.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Stabilin-2,567.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Stanniocalcin-1,1940.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Stem cell growth factor-alpha,2147.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Stem Cell Growth Factor-beta,909.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Stress-induced-phosphoprotein 1,9644.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Stromal cell-derived factor 1,5728.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Stromelysin-1,3185.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Stromelysin-2,962.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,SUMO-conjugating enzyme UBC9,2400.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Superoxide dismutase [Cu-Zn],1133.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",32086.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Synaptosomal-associated protein 25,1147.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Syntaxin-1A,300.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,5109.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,TATA-box-binding protein,442.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,T-cell surface glycoprotein CD4,377.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tenascin,15347.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,2968.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Testican-1,3252.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Testican-2,841.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,TGF-beta receptor type-2,1225.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thioredoxin domain-containing protein 12,4169.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thrombin,1435,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thrombopoietin,196.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thrombopoietin Receptor,208.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thrombospondin-1,2478,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thrombospondin-2,15162.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thrombospondin-4,486.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thymic stromal lymphopoietin,375.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Thymidine kinase, cytosolic",445.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thymidylate synthase,425.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thyroglobulin,331.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thyroid peroxidase,1418,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thyroid Stimulating Hormone,403.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Thyroxine-binding globulin,54386.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tissue Factor,1651.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tissue factor pathway inhibitor,65443.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tissue-type plasminogen activator,607,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,T-lymphocyte activation antigen CD80,545.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,T-lymphocyte activation antigen CD86,1054.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,4070.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Toll-like receptor 2,513.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Toll-like receptor 4,295.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4542.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transcription factor AP-1,3180.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,1548,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transforming growth factor beta-1,1150.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transforming growth factor beta-2,204.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transforming growth factor beta-3,501.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,46211.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transforming growth factor beta receptor type 3,41357.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transgelin-2,6440.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transketolase,54636.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Translationally-controlled tumor protein,18163.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Transmembrane glycoprotein NMB,4033.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Trefoil factor 1,2834.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Trefoil factor 2,11950.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Trefoil factor 3,17561.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Triosephosphate isomerase,9416.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tropomyosin alpha-1 chain,875.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tropomyosin alpha-4 chain,151044.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tropomyosin beta chain,1163.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Troponin I, cardiac muscle",735.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Troponin I, fast skeletal muscle",11853,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Troponin T, cardiac muscle",3416.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Trypsin-1,9993,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Trypsin-2,3926.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Trypsin-3,694.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tryptase beta-2,1458.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tryptase gamma,208.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor-associated calcium signal transducer 2,361.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor,688,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,1321.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,364.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,833.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,1574.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,629.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,899.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,581.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,268.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",902.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,2686.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,441.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1231.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,322.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,2338.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1207.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,8007,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,148.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,993.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2277.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,547.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,11456.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,728.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,984.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,3229.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,1591.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,16701.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,10842.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,887.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,3624,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,594.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,2025.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,758.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,966.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,369.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,1703,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase ABL1,126.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase BTK,14260.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase CSK,11178.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase Fer,3582.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase Fgr,661,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase Fyn,12928.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase HCK,181.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase JAK2,160481.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase Lck,308.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase Lyn,11097.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",69235.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",7330.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,484.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase Tec,4894.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,756.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase Yes,971,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,6128.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,12684.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,2140.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,334.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,11977.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,6812.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin,1188.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",3456.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1349.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1854.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,4269.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,1540.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,7521.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin-fold modifier 1,8270.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,28628.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Ubiquitin-like protein ISG15,2962.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,UMP-CMP kinase,4854.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Urokinase plasminogen activator surface receptor,14922.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Urokinase-type plasminogen activator,1801.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,43475.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vascular cell adhesion protein 1,15973.3,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vascular endothelial growth factor A,13648.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",708.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vascular endothelial growth factor C,1334.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vascular endothelial growth factor D,518.4,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vascular endothelial growth factor receptor 2,6795.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vascular endothelial growth factor receptor 3,7714.1,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vasoactive Intestinal Peptide,361.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vesicular integral-membrane protein VIP36,12452.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vitamin K-dependent protein C,1511.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vitamin K-dependent protein S,3814.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Vitronectin,77139.2,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,von Willebrand factor,5975.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,353.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",997.7,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",11898.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,3023.9,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,990.5,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Wnt inhibitory factor 1,4935.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,Xaa-Pro aminopeptidase 1,8092.8,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,784.6,RFU
BF-1153,PD_INVGL974GBA,M0,0,Plasma,X-ray repair cross-complementing protein 6,269,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,15254.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,14-3-3 protein epsilon,1271.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,14-3-3 protein family,2871.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,14-3-3 protein sigma,624.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,14-3-3 protein theta,958.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,127957.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1141.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",434.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,526.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,321.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,438.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1035.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",5334.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",6087.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,768.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,40S ribosomal protein S3,410.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,40S ribosomal protein S3a,672.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,40S ribosomal protein S7,920.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,40S ribosomal protein SA,1775.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",9443.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",7672.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,72 kDa type IV collagenase,8432.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1658.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,196.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,2437.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Activated Protein C,615.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Activin receptor type-1B,239.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Adapter molecule crk,11104.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,33005.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Adenylosuccinate lyase,5147.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,672.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,563.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Adiponectin,5929,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,4274.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,387.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,381.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,175.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,389.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,671,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,17034,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Adrenomedullin,2495.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",499.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Afamin,29225.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,2812.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Aggrecan core protein,569.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Agouti-related protein,2541.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,AH receptor-interacting protein,4031.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alanine aminotransferase 1,3736.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],3830.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Allograft inflammatory factor 1,2185.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",7214.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,260754.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,9421.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-1-antitrypsin,851.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-2-antiplasmin,2442.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1824.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-2-macroglobulin,11163.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,635.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-enolase,32369.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,alpha-Fetoprotein,662.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-L-iduronidase,1638,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,6187.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Alpha-synuclein,14276.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Aminoacylase-1,2967.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Amphiregulin,2313.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Amphoterin-induced protein 2,3141.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),825.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),2821.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Amyloid beta A4 protein,17523.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiogenin,4661.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiopoietin-1,483.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",2496,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiopoietin-2,180.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiopoietin-4,469.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiopoietin-related protein 3,450.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiopoietin-related protein 4,5206.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiostatin,18483.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,507.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Angiotensinogen,6251.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ankyrin-2,446.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Annexin A1,7684.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Annexin A2,9508.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Annexin A5,1150.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Annexin A6,4550.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,997.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Antileukoproteinase,34942.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Antithrombin-III,126298.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein A-I,15877.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein B,17170.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein D,2545.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein E,45580.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),295298.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),241939.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),256157.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein L1,34714.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apolipoprotein M,14576.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,1128,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Appetite-regulating hormone,1289.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Arginase-1,1232.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,298.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Artemin,537.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Arylsulfatase A,1359.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Arylsulfatase B,2506.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1493.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",3473.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,2654.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",1935.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",4956.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Atrial natriuretic factor,757,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,405.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Aurora kinase A,1579.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Aurora kinase B,612.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Azurocidin,226.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,568.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,416.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,463.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,109.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1725.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Basigin,358.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,1546.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,B-cell receptor CD22,685.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,6948.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bcl-2-like protein 1,948.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bcl-2-like protein 2,563,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bcl-2-related protein A1,774.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,1184.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Beta-2-microglobulin,2697.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,5705.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,6019,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Betacellulin,458.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Beta-endorphin,1817,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,beta-nerve growth factor,596.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,BH3-interacting domain death agonist,2200.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Biglycan,3007.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,405.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1352.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bone morphogenetic protein 1,3358.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bone morphogenetic protein 6,24418.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bone morphogenetic protein 7,773.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,1417.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,938.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Bone sialoprotein 2,6275.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,881.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Brain natriuretic peptide 32,464.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Brain-specific serine protease 4,2325.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1497.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Brevican core protein,2201.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Brother of CDO,1668.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C3a anaphylatoxin,988,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,185427.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C5a anaphylatoxin,5231.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cadherin-12,662.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cadherin-15,4005.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cadherin-1,80022.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cadherin-2,2300.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cadherin-3,26190.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cadherin-5,16154.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cadherin-6,467.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcineurin,1210,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcineurin subunit B type 1,5339.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",674.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,283.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,6400.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1999.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,798.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,1685.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,5178.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,314,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calpain I,35937.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calpastatin,6692.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Calreticulin,2375.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,1298.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,1560.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1692.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,6243.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,289.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,306.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase 1,31221.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase 13,2154.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase 2,295.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase 3,2685.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase 4,1501.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase 6,5925,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase 7,345.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase 9,1835.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,666.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carboxypeptidase B2,14463,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Carboxypeptidase E,2011.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cardiotrophin-1,598.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,330.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,7127.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Casein kinase II subunit alpha,370.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Caspase-10,3717.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Caspase-2,473,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Caspase-3,9069.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Catalase,21450.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin B,2038.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin D,984.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin E,588.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin F,2727.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin G,860.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin H,1001.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin L2,1204.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin S,1116.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cathepsin Z,6531.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,28497.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,793.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 1,2300.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 13,417.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 14,10357.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 15,5035.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 16,40020.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 17,799.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 18,8503.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 19,495.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 20,137.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 21,33782.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 22,1608.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 23,3522.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 24,417.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 25,1532.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 26,887.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 27,1345,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 28,7529,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 2,899.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 3,889.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,1659.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 4-like,771.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 5,20528.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 7,470.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-C motif chemokine 8,206.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD109 antigen,4699.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD166 antigen,19257.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD177 antigen,334.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD209 antigen,1227.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD226 antigen,3046.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD27 antigen,5194.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD40 ligand,252.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD48 antigen,833.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD59 glycoprotein,2182.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD5 antigen-like,4163.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD63 antigen,331.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD70 antigen,293.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD83 antigen,464.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CD97 antigen,1290.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cell adhesion molecule 1,3097.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cell adhesion molecule 3,3040.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,6107.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,1614.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cellular tumor antigen p53,712.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,4320.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",3996.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",806.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",14955.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Chitinase-3-like protein 1,19688.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Chitotriosidase-1,1865.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,3094,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Choline/ethanolamine kinase,2165.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Chordin-like protein 1,3444.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,2214.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Chromobox protein homolog 5,400.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Chromogranin-A,8450,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Chymase,464.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ciliary neurotrophic factor,212.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,11087.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ck-beta-8-1,85831.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Clusterin,801,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,CMRF35-like molecule 6,5417.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coactosin-like protein,2633.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coagulation factor IX,11650.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coagulation factor IXab,8318.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coagulation Factor V,65578.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coagulation factor VII,603.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coagulation Factor X,4503.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coagulation factor Xa,3481.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coagulation Factor XI,1813.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cofilin-1,8299.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,2551,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,1528.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,323.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Collagenase 3,1626.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Collectin-11,10375.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Collectin-12,2708.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,COMM domain-containing protein 7,1983.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C1q subcomponent,44590.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C1r subcomponent,2149.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C2,2969.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C3,62044.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C3b,16189.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Complement C3b, inactivated",6350.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C3d fragment,8131.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C4,131948,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C4b,175.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C5,6323.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement C5b-C6 complex,479.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",3962.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement component C1q receptor,13480.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement component C6,35438.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement component C7,1186.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement component C8,2146.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement component C9,68825.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement decay-accelerating factor,15734.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement factor B,23408.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement factor D,926.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement factor H,55392.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement factor H-related protein 5,993.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Complement factor I,40764.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Connective tissue-activating peptide III,14026.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Connective tissue growth factor,1300.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Contactin-1,344.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Contactin-2,1447.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Contactin-4,4410.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Contactin-5,636.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Copine-1,2876.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Corticosteroid-binding globulin,600.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Corticotropin,449.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-reactive protein,69230.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Creatine kinase B-type,795.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Creatine kinase M-type,553.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,258,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cryptic protein,2426.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,10254,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,188.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,49784.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,793.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-type mannose receptor 2,3903.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-X-C motif chemokine 10,3009.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-X-C motif chemokine 11,4709.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-X-C motif chemokine 13,3973.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-X-C motif chemokine 16,12008.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-X-C motif chemokine 5,423.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-X-C motif chemokine 6,1976.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,C-X-C motif chemokine 9,717.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,687.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,354.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,887.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1035.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,813.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cystatin-C,3310,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cystatin-D,10682.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cystatin-F,1040.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cystatin-M,7294.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cystatin-S,180,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cystatin-SA,33779.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cystatin-SN,1732.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,2725.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,349.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,3040.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytochrome c,1725.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytochrome P450 3A4,11846,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,2331.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,443.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,1039.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,1544.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,277.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,12448.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,887.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,928.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,247.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,15988.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,D-dimer,13742.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Death-associated protein kinase 2,2302.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Decorin,4322,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Delta-like protein 1,2124,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Delta-like protein 4,450.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dermatopontin,6869.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Desert hedgehog protein N-product,465.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Desmocollin-2,3596.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Desmocollin-3,608.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Desmoglein-1,2017.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",5263.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dickkopf-like protein 1,2175.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dickkopf-related protein 1,29189.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dickkopf-related protein 3,6556.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dickkopf-related protein 4,8575.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,516.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,1165.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1606,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,412.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1425.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,536.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,1650.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,DNA topoisomerase 1,565.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,1741.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Drebrin-like protein,2951.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2363.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,461.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1252,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,1706.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,26015.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,1897.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,1960.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dynactin subunit 2,1385.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",308.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,1561.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,2530.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,729.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,200.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,945.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,628.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",2170.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1329.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1014.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,5024,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,9976.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1834.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Elafin,13092.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Elongation factor 1-beta,565.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Endoglin,2344.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,99255.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,7700.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Endostatin,95778.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,4558.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,1647,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,3041.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,18398.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Enteropeptidase,179.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Eotaxin,14450.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin-A2,1327.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin-A3,2762.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin-A4,2488.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin-A5,5627.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin-B1,1912.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin-B2,22172.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin-B3,974,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin type-A receptor 10,463.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin type-A receptor 1,11920.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin type-A receptor 2,4187.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin type-A receptor 3,152.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin type-A receptor 5,893.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin type-B receptor 2,23350.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin type-B receptor 4,2647.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ephrin type-B receptor 6,1953.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Epidermal growth factor,821.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Epidermal growth factor receptor,28835,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,494.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,499.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Epiregulin,2002.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,332.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Erythropoietin,1070.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Erythropoietin receptor,330.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,E-selectin,32509,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,1780.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Estrogen receptor,727.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,478.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,231.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,3141,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,4452.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,1717.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,38018.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Extracellular matrix protein 1,20200.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],1219,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,FACT complex subunit SSRP1,745.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",860.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",64512,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",8980.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fc receptor-like protein 3,386.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ferritin,10875.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fetuin-B,6665.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibrinogen,143673.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibrinogen gamma chain,57758.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 10,193.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 1,210,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 12,222.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 16,1861.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 17,277.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 18,244.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 19,9913.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 20,351.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 2,1203.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 23,602.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 4,177.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 5,526.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 6,302.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 7,1707.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,301.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,625.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor 9,470.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,975.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,433.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,778.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,797.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibronectin,10159.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibronectin Fragment 3,1917.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fibronectin Fragment 4,62713.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ficolin-1,2556.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ficolin-2,1005.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ficolin-3,216.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,384.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Focal adhesion kinase 1,294.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Follicle stimulating hormone,9704.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Follistatin,843.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Follistatin-related protein 1,34986,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Follistatin-related protein 3,10436.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,2820.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fractalkine,3047.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,66125.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,403.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,450.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galectin-10,706.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galectin-2,518.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galectin-3,25849,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galectin-3-binding protein,1145.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galectin-4,513.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galectin-7,561.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galectin-8,498.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Galectin-9,1822.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Gamma-enolase,36539.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Gastrin-releasing peptide,370.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,GDNF family receptor alpha-1,1358.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,GDNF family receptor alpha-2,4377.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,GDNF family receptor alpha-3,835.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Gelsolin,914.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glia-derived nexin,885.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,519.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glial fibrillary acidic protein,495.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glucagon,2469.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glucocorticoid receptor,111.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glucokinase regulatory protein,428.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,18449.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,322.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glutathione S-transferase A3,386.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glutathione S-transferase P,6436.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,60585.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",3080.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,9399.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,1994.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glypican-2,195.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glypican-3,672.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glypican-5,1283.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Glypican-6,2174.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",916.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Granulins,27139.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,2262.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,7168.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,907.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Granulysin,3723.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Granzyme A,5012.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Granzyme B,201.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Granzyme H,216.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,GRB2-related adapter protein 2,436.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Gremlin-1,444.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Gro-beta/gamma,383.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,592.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,257.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth arrest-specific protein 1,770.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth/differentiation factor 11,871.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,915.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth/differentiation factor 15,1675,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth/differentiation factor 2,2413.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth/differentiation factor 5,1046.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth/differentiation factor 8,5487.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth/differentiation factor 9,1063.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,29202.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth hormone receptor,2045.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Growth-regulated alpha protein,3897.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,GTPase KRas,1391.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,6550.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Haptoglobin,24057.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,8665.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,1674.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heat shock protein beta-1,6411.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,5445.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,31360.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heme oxygenase 2,387.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,HemK methyltransferase family member 2,1877.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hemoglobin,3853.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hemojuvelin,969.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hemopexin,2321.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2765.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,479.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heparin cofactor 2,3631.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,14357.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hepatocyte growth factor,1978.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hepatocyte growth factor activator,1720.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,3782.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,10000.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,769.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hepcidin,12424,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,43070.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,1247.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,360.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,1660.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3419.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hexokinase-1,974.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hexokinase-2,760.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",358.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",467.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,276.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,51085.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,High mobility group protein B1,5673.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histidine-rich glycoprotein,3268.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,1856.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1497.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,222.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone deacetylase 8,1741.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone H1.2,1944.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone H2A type 3,571.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone H2A.z,2295.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone H2B type 2-E,22095.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone H3.1,1970,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,553.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Homeobox protein NANOG,187.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,358.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,413.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,14787.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,1021.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,362.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,ICOS ligand,1294.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Iduronate 2-sulfatase,3563.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Immunoglobulin A,7120.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,198.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Immunoglobulin D,1176.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Immunoglobulin E,525,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Immunoglobulin G,176101,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Immunoglobulin M,3384.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,7589.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Importin subunit alpha-1,327.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Importin subunit beta-1,8276.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,5927.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Inducible T-cell costimulator,606.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Inhibin beta A chain,6018.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,968.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Inhibitor of growth protein 1,11026.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Inorganic pyrophosphatase,35586.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,2014,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2567.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin,166,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-degrading enzyme,3024.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,8436.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,1275.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,1113.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,1481.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,6580.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,1872.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,853.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,73036.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin-like growth factor I,691.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Insulin receptor,14557,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,1022.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,1738.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,816.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,33992,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,4642,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,2344.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,530.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,1384.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon alpha-10,415.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon alpha-2,137.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon alpha-7,258.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,2434.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon beta,1347.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon gamma,1203,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon gamma receptor 1,556.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon gamma receptor 2,418.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon lambda-1,278.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon lambda-2,369.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interferon regulatory factor 1,1371.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-10,310.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1133.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,1005.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-11,274.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-12,436.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,467.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,897.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-13,816.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,3190.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,1403.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-16,342.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-17A,633.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-17B,313.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-17D,228.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-17F,709.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-17 receptor A,657.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-17 receptor B,1328.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-17 receptor C,871.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-17 receptor D,445.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-18-binding protein,15416.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-18 receptor 1,11726.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,285.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-19,6397.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-1 alpha,530.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-1 beta,20696.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,34646.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,6241.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,4751.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,869.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,8521.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,12575.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-20,396.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,350.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-2,2592.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-22,854.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,662.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,2852.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-23,1864.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-23 receptor,3834.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-24,192.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-25,344.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-27,639.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,1588,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,955.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-3,1239.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-34,510.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-36 alpha,731.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-36 beta,428.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-37,1596.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,927.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-4,489.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,348.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-5,263.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,2368.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-6,351.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,33039.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,7528.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-7,150.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,297.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-8,781.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interleukin-9,392.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Interstitial collagenase,677.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Junctional adhesion molecule B,8916.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Junctional adhesion molecule C,4442.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Junctional adhesion molecule-like,702.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-11,1331.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-12,3261.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-13,996,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-14,5231,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-4,294.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-5,179.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-6,2108.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-7,1438.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallikrein-8,3146.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kallistatin,40849,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,463.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",922.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,2670.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,368.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,437.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,766.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kinesin-like protein KIF23,968.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kininogen-1,33043.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,321.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kremen protein 2,2511.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,5214.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,1156.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Kynureninase,733.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lactadherin,1064.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lactoperoxidase,1235,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lactotransferrin,58827.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lamin-B1,634.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Laminin,2425.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1460.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Layilin,1906.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Legumain,2625.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leptin,26651.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leptin receptor,2499.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,1718.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,8057.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,1558.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,113.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,213.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,870.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,26001.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,8914.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,4700.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,5015.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,12888.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,693.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,851.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,224.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Limbic system-associated membrane protein,2087.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,101211.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lithostathine-1-alpha,730.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,1213.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,4119.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,2885,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,1665.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1805.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Low-density lipoprotein receptor,155.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,36766.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",2304.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,2993.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,1906.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,L-Selectin,6080.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lumican,1811.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Luteinizing hormone,3934.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,948.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,419.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,11070.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lymphocyte antigen 86,5499.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lymphotactin,374.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,156.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,2595.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lymphotoxin-alpha,456.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lysosomal protective protein,6546.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lysosome membrane protein 2,543.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Lysozyme C,136871.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Macrophage-capping protein,1358.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1484.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,254.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Macrophage mannose receptor 1,10289.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Macrophage metalloelastase,1300.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,892.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,1205.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,411.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",18855.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mammaglobin-B,7588.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,4886.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mannose-binding protein C,12703.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,5642.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,814.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,957.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,15393.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Matrilin-2,13733.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Matrilin-3,436.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Matrilysin,3284.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,241.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Matrix metalloproteinase-14,691.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Matrix metalloproteinase-16,704.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Matrix metalloproteinase-17,825.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Matrix metalloproteinase-9,24624.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,93342.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,347.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,3918.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Membrane frizzled-related protein,1569.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,885,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mesothelin,250.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,88.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,512.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,1009.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Methionine aminopeptidase 1,1161.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Methionine aminopeptidase 2,23685.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,337,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,134,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,1385.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Microtubule-associated protein tau,248.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Midkine,20890.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,804.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,555.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,2217.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,858.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,1721,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,1579.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,5304.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,21196.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,761.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,1168.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,1604.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Moesin,1010.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,7519.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,10448.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Mucin-1,948.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Muellerian-inhibiting factor,11222.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Myc proto-oncogene protein,787.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Myeloblastin,6952.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,4694.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Myeloperoxidase,21183.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Myoglobin,1492.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",2124.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,766.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,3235.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,9086.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,7152.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,2043.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,4931.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,3214,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,318.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,597.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,171.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Netrin-1,496.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Netrin-4,803.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Netrin receptor UNC5C,4776.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Netrin receptor UNC5D,7372.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",13044.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,496.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,14272.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neuregulin-1,218.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neuregulin-4,4951.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neurexin-1-beta,948.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neurexin-3-beta,1121.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neurexophilin-1,3889.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1288.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,25308.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,1221.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,1131.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",706.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,28324.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neuronal growth regulator 1,5720.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neuropilin-1,3134.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neurotrophin-3,271.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neurotrophin-4,284.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neutral ceramidase,3921.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,4780,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neutrophil collagenase,4029.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neutrophil elastase,407.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,26866.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,657.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Nidogen-1,3997.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Nidogen-2,2115.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NKG2D ligand 1,576.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NKG2D ligand 2,372.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NKG2D ligand 3,621.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,813.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Noggin,3019.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,640.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,2040,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NSFL1 cofactor p47,558.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NT-3 growth factor receptor,7241.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,N-terminal pro-BNP,10302.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,962.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,474.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,18576.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,NudC domain-containing protein 3,361.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,OCIA domain-containing protein 1,807.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Olfactomedin-4,195.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Oncostatin-M,1387.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,2359.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Osteocalcin,1237.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Osteomodulin,9938.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Osteopontin,9120.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,3279.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,2695.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pancreatic hormone,4231.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pappalysin-1,19884.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Parathyroid hormone,2979.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Parathyroid hormone-related protein,1050.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peptide YY,1857.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,843.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,111750.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,37585.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,7927.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,1023,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",10051.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Periostin,7437.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peroxiredoxin-1,2276.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",536.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peroxiredoxin-6,885.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,234.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Persephin,227.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3230.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pescadillo homolog,228.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,6624.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",958.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",1284.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Phosphoglucomutase-1,726.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,2683.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,382.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Phospholipase A2,1088.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",3920.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pigment epithelium-derived factor,62983,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,PIK3CA/PIK3R1,607.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,PILR alpha-associated neural protein,8003.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,375.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,261.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Placenta growth factor,671.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Plasma kallikrein,22047.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,9628.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Plasma serine protease inhibitor,109626.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Plasmin,686,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Plasminogen,3278.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,1249.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,877.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,5373.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet-derived growth factor C,434.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,1662,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,12037.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,9023.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,19256,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,872.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet factor 4,22090.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet glycoprotein 4,18326.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,1969.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet glycoprotein VI,9969.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Platelet receptor Gi24,432.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pleiotrophin,1690.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Plexin-B2,4801.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Plexin-C1,633.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,1849.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,1749.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,4663.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Prefoldin subunit 5,360.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,928.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,4305.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Prokineticin-1,207.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Prolactin,520.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Prolactin receptor,1173.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,172.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,1826.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,726.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pro-opiomelanocortin,834.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Properdin,115798.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,3110.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,857.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,459.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Prostate-specific antigen,558.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,1105.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,481.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,527.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,673.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,719.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein 4.1,12992.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein amnionless,131.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein deglycase DJ-1,636.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein disulfide-isomerase,231.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,2830.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein E7_HPV16,642.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein E7_HPV18,1430.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein FAM107A,273.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein FAM107B,2671.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein FAM3B,871.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein FAM3D,10387.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,2570.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein jagged-1,679.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein jagged-2,328,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein kinase C alpha type,33710.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),4141.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein kinase C delta type,2994.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein kinase C gamma type,534.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein kinase C iota type,2125.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein kinase C theta type,1948,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein kinase C zeta type,730.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein lin-7 homolog B,656.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein NOV homolog,739.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein Rev_HV2BE,179.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein S100-A12,638.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein S100-A4,1878.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein S100-A6,2852.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein S100-A7,348.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein S100-A9,5191.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein SET,544.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,274.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein Wnt-7a,291.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,2489.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Prothrombin,163654.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,1073.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,34037.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Proto-oncogene vav,6812.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,P-selectin,24185.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,6783,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pyridoxal kinase,358.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,2567.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",1836.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Pyruvate kinase PKM,24954.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,2184.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,18594.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,3986.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,11855.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,988.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,23944.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,6446.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,2599.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,385.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,380.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,179.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,2375.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Relaxin receptor 1,424,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Renin,1451.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Repulsive guidance molecule A,21822.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Resistin,1763.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Reticulon-4 receptor,1517.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1515.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,3537.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Retinol-binding protein 4,223.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,RGM domain family member B,2764.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ribonuclease H1,225,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,663.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,165.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,7485.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,RNA-binding protein 39,326.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Roundabout homolog 2,3282.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Roundabout homolog 3,369.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,R-spondin-2,378.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,R-spondin-3,2320.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,R-spondin-4,407.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Scavenger receptor class F member 1,7310.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Scavenger receptor class F member 2,301.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,3672.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sclerostin,25763.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,1386.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,6330.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,3013.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Secretin,279.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Seizure 6-like protein 2,1021.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Semaphorin-3A,1587.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Semaphorin-3E,3193.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Semaphorin-5A,7453.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Semaphorin-6A,17635.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Semaphorin-6B,4955.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine protease 27,7708.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",4418.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,1485.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,3640.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,696.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,189.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,972.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,1083.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,8617.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,523.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,747.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,193.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1136.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,254.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,1239.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serotransferrin,238401.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serum albumin,9957.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serum amyloid A-1 protein,758.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serum amyloid P-component,26792.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,173.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sex hormone-binding globulin,5197.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,S-formylglutathione hydrolase,4864.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,5071.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SHC-transforming protein 1,10448,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,16342,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,318.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1746,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,265.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sialoadhesin,105.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,6758.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,979.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,354.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SLAM family member 5,13537.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SLAM family member 6,605.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SLAM family member 7,78933.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1308.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,3135.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,2766.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,2768.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,2473.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Somatostatin-28,1421.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Somatotropin,339.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sonic hedgehog protein,1283.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sorting nexin-4,7115.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SPARC,13837,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SPARC-like protein 1,13668,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,3213.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",150.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,4068.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sphingosine kinase 1,6601.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Sphingosine kinase 2,421.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Spondin-1,2707,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Stabilin-2,606.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Stanniocalcin-1,1754.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Stem cell growth factor-alpha,2345.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,1003.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,6241.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Stromal cell-derived factor 1,5989.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Stromelysin-1,1201.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Stromelysin-2,986.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,1591.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],1080.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",33813.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,1058.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Syntaxin-1A,296.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,6892.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,TATA-box-binding protein,494.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,362.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tenascin,17856.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,3174.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Testican-1,2541.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Testican-2,855.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,TGF-beta receptor type-2,1180.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,3438.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thrombin,1599.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thrombopoietin,188.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thrombopoietin Receptor,205,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thrombospondin-1,2319.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thrombospondin-2,17364.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thrombospondin-4,599.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,317.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",471.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thymidylate synthase,413.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thyroglobulin,329,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thyroid peroxidase,1427.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,561.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Thyroxine-binding globulin,48787.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tissue Factor,1859.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,59639.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tissue-type plasminogen activator,606,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,558.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,1100.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,4412.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Toll-like receptor 2,531,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Toll-like receptor 4,305.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4895.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transcription factor AP-1,5407.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,1633.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transforming growth factor beta-1,1133,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transforming growth factor beta-2,204.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transforming growth factor beta-3,507.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,47024.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,44804.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transgelin-2,4743.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transketolase,35046,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Translationally-controlled tumor protein,10184.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,4563.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Trefoil factor 1,3638,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Trefoil factor 2,12825.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Trefoil factor 3,17716.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Triosephosphate isomerase,6498.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,887.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,60613.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tropomyosin beta chain,1295.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",736.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",9375.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",3290.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Trypsin-1,9943.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Trypsin-2,4736.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Trypsin-3,763.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tryptase beta-2,1513.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tryptase gamma,223.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,345.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor,680.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,1393.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,384.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,906.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,1798,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,561.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,1003.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,615.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,255.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",900.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,2985.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,458.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1258.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,335.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,2447.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1318.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,8719.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,141.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,1067.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,2305.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,511.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,12114.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,758.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,1011.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,3729.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,1606.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,15626.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,11394.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,910.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,4373.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,635.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,2426,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,848.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,1042.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,383.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,1276.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,146.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,6838,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,5346.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,1211.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,462,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,5305.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,186.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,153302.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,308,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,4455.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",27956.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",7849.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,545.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,2425.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,861.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,885,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,7441,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,1500.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,7238.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,362.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,5516.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,8328.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin,1449.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",3027.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,1190.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1441,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,4675.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,1131.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,5067.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,5972.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,18528.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,2420.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,UMP-CMP kinase,5028.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,14448,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,2114.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,19950.4,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,16916.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vascular endothelial growth factor A,12715.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",682.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vascular endothelial growth factor C,1134.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vascular endothelial growth factor D,556.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,7449.1,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,7754.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,318.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,10508,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vitamin K-dependent protein C,1535.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vitamin K-dependent protein S,3944.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Vitronectin,73261.7,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,von Willebrand factor,5918.3,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,356.6,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",1014.5,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",14038,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,4352,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,953.8,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Wnt inhibitory factor 1,5501.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,7079.9,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,782.2,RFU
BF-1153,PD_INVGL974GBA,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,265.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,14-3-3 protein beta/alpha,81204,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,14-3-3 protein epsilon,1026.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,14-3-3 protein family,27624.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,14-3-3 protein sigma,1040,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,14-3-3 protein theta,2763.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,14-3-3 protein zeta/delta,225087.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],2599.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",522.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,2'-5'-oligoadenylate synthase 1,514,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,26S proteasome non-ATPase regulatory subunit 7,457.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,252,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,5443.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",6321.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",434.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,3-phosphoinositide-dependent protein kinase 1,3503.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,40S ribosomal protein S3,5399.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,40S ribosomal protein S3a,3379,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,40S ribosomal protein S7,9673.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,40S ribosomal protein SA,1630.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"60 kDa heat shock protein, mitochondrial",43831.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",67495.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,72 kDa type IV collagenase,5694.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Abelson tyrosine-protein kinase 2,1859.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,247.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,10675.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Activated Protein C,872.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Activin receptor type-1B,1316.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Adapter molecule crk,28240.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Adenylate kinase isoenzyme 1,82185.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Adenylosuccinate lyase,1646.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Adhesion G protein-coupled receptor E2,772.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Adhesion G-protein coupled receptor G5,722.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Adiponectin,8382.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2230,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,308.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,704.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,142.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,339.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,521.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,6768.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Adrenomedullin,2966.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Advanced glycosylation end product-specific receptor, soluble",398,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Afamin,29141.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Aflatoxin B1 aldehyde reductase member 2,21983.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Aggrecan core protein,605.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Agouti-related protein,1562.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,AH receptor-interacting protein,18821.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alanine aminotransferase 1,4995.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alcohol dehydrogenase [NADP(+)],14843.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Allograft inflammatory factor 1,7024.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Alpha-(1,3)-fucosyltransferase 5",4720.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-1-antichymotrypsin,227102.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-1-antichymotrypsin complex,17298.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-1-antitrypsin,2134,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-2-antiplasmin,2142.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-2-HS-glycoprotein,1927.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-2-macroglobulin,8672,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,alpha-2-macroglobulin receptor-associated protein,1249.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-enolase,136046.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,alpha-Fetoprotein,1208.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-L-iduronidase,1164.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-soluble NSF attachment protein,29275.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Alpha-synuclein,20249.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Aminoacylase-1,3030.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Amphiregulin,10919.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Amphoterin-induced protein 2,2075.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,AMP Kinase (alpha1beta1gamma1),412,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,AMP Kinase (alpha2beta2gamma1),13729.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Amyloid beta A4 protein,55319.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiogenin,3547.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiopoietin-1,1740.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Angiopoietin-1 receptor, soluble",1752.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiopoietin-2,131.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiopoietin-4,706.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiopoietin-related protein 3,479.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiopoietin-related protein 4,4946.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiostatin,15129.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiotensin-converting enzyme 2,807.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Angiotensinogen,5281,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ankyrin-2,499.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Annexin A1,52091.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Annexin A2,38480.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Annexin A5,1079,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Annexin A6,16021.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Anterior gradient protein 2 homolog,900.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Antileukoproteinase,16238.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Antithrombin-III,121747.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein A-I,17283.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein B,8946.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein D,3242.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein E,46556.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein E (isoform E2),259695.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein E (isoform E3),226513.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein E (isoform E4),228911.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein L1,37163.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apolipoprotein M,10542.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Apoptosis regulator Bcl-2,2860.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Appetite-regulating hormone,1255,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Arginase-1,1146.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Aromatic-L-amino-acid decarboxylase,284.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Artemin,673.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Arylsulfatase A,1826.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Arylsulfatase B,1192.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Asialoglycoprotein receptor 1,1158.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Aspartate aminotransferase, cytoplasmic",3529.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,ATP-dependent RNA helicase DDX19B,9904.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"ATP synthase subunit beta, mitochondrial",3754.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"ATP synthase subunit O, mitochondrial",4726.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Atrial natriuretic factor,851.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,AT-rich interactive domain-containing protein 3A,1285.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Aurora kinase A,779.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Aurora kinase B,584.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Azurocidin,702.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bactericidal permeability-increasing protein,9974.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Baculoviral IAP repeat-containing protein 3,215.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Baculoviral IAP repeat-containing protein 5,474.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,88.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Basal Cell Adhesion Molecule,1203.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Basigin,613.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,B-cell lymphoma 6 protein,11165.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,B-cell receptor CD22,904.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bcl2-associated agonist of cell death,29696.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bcl-2-like protein 1,2599.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bcl-2-like protein 2,793.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bcl-2-related protein A1,1442,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,BDNF/NT-3 growth factors receptor,963.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Beta-2-microglobulin,1556.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,beta-adrenergic receptor kinase 1,34541.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Beta-Ala-His dipeptidase,7052.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Betacellulin,966.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Beta-endorphin,763.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,beta-nerve growth factor,326.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,BH3-interacting domain death agonist,3956.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Biglycan,2353.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,BMP-binding endothelial regulator protein,464,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bone morphogenetic protein 10,1069.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bone morphogenetic protein 1,2648.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bone morphogenetic protein 6,11562.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bone morphogenetic protein 7,567.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bone morphogenetic protein receptor type-1A,746,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bone morphogenetic protein receptor type-2,465.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Bone sialoprotein 2,3321.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Brain-derived neurotrophic factor,1527,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Brain natriuretic peptide 32,477.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Brain-specific serine protease 4,951.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Breast cancer anti-estrogen resistance protein 3,1442.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Brevican core protein,1472.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Brother of CDO,1063.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C3a anaphylatoxin,328.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C3a anaphylatoxin des Arginine,140287.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C5a anaphylatoxin,3169.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cadherin-12,1612.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cadherin-1,47510.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cadherin-15,4756.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cadherin-2,1675.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cadherin-3,18377.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cadherin-5,9588.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cadherin-6,497.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcineurin,7496.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcineurin subunit B type 1,12207.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",1433.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,1245.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1,5702.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,1786.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,2245.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,6145.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,17701.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calcium-dependent phospholipase A2,480,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calpain I,127914,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calpastatin,8048.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Calreticulin,2002.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,3688.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,cAMP-regulated phosphoprotein 19,10643.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1534.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbohydrate sulfotransferase 15,4146,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbohydrate sulfotransferase 2,514.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbohydrate sulfotransferase 6,282.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase 13,14347.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase 1,31470.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase 2,234.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase 3,2994.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase 4,1321.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase 6,4832.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase 7,302.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase 9,1478.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carbonic anhydrase-related protein 10,516.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carboxypeptidase B2,13630.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Carboxypeptidase E,1387.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cardiotrophin-1,667.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,28970.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,798.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Casein kinase II subunit alpha,889.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Caspase-10,4461.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Caspase-2,1409.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Caspase-3,50491.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Catalase,27654.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin B,1343.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin D,1022.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin E,467.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin F,1920.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin G,1785.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin H,534.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin L2,1140.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin S,987.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cathepsin Z,5613.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cation-independent mannose-6-phosphate receptor,27824,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CCAAT/enhancer-binding protein beta,1374.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 1,1690.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 13,2467.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 14,3156.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 15,3140.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 16,14077.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 17,5818.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 18,6564.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 19,313.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 20,343.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 21,15735.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 22,1612.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 23,1934,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 24,355,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 25,1116.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 26,1638,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 27,1204.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 2,766.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 28,27403.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 3,828.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 3-like 1,1226.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 4-like,617.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 5,105649.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 7,683.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-C motif chemokine 8,190.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD109 antigen,4100.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD166 antigen,12082.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD177 antigen,489.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD209 antigen,1064.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD226 antigen,1045.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD27 antigen,6831.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD40 ligand,748.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD48 antigen,550.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD59 glycoprotein,1235.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD5 antigen-like,2178,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD63 antigen,736.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD70 antigen,205.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD83 antigen,296.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CD97 antigen,1337.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cell adhesion molecule 1,1765.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cell adhesion molecule 3,1431.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,5898.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cell surface glycoprotein CD200 receptor 1,844.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cellular tumor antigen p53,1148.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cerebral dopamine neurotrophic factor,2894.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",12494.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1460,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",80746.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Chitinase-3-like protein 1,6924.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Chitotriosidase-1,1215.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Chloride intracellular channel protein 1,28172,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Choline/ethanolamine kinase,2740.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Chordin-like protein 1,2613.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Chorionic somatomammotropin hormone,5048.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Chromobox protein homolog 5,375.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Chromogranin-A,5477.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Chymase,4558.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ciliary neurotrophic factor,155.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ciliary neurotrophic factor receptor subunit alpha,4950.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ck-beta-8-1,31494,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Clusterin,1440.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,CMRF35-like molecule 6,2220.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coactosin-like protein,3317.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coagulation factor IX,9751.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coagulation factor IXab,6793.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coagulation Factor V,46189.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coagulation factor VII,580.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coagulation Factor X,5604.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coagulation factor Xa,4797.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coagulation Factor XI,1729.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cofilin-1,13981.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Coiled-coil domain-containing protein 80,2287.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Collagen alpha-1(VIII) chain,696.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Collagen alpha-1(XXIII) chain,565,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Collagenase 3,657.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Collectin-11,3702.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Collectin-12,2929.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,COMM domain-containing protein 7,4446.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C1q subcomponent,27770,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C1r subcomponent,1448.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C2,2778.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C3,49500.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C3b,8880.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Complement C3b, inactivated",6652.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C3d fragment,7914.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C4,114981.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C4b,102.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C5,6424.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement C5b-C6 complex,489.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",5440.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement component C1q receptor,7733.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement component C6,61944,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement component C7,992.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement component C8,1671.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement component C9,60826.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement decay-accelerating factor,12971.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement factor B,18955.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement factor D,882.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement factor H,49589.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement factor H-related protein 5,2159.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Complement factor I,31921.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Connective tissue-activating peptide III,164072.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Connective tissue growth factor,3474.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Contactin-1,426.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Contactin-2,1073.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Contactin-4,3953,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Contactin-5,541.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Copine-1,20109.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Corticosteroid-binding globulin,750.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Corticotropin,459.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-reactive protein,8767.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Creatine kinase B-type,471.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Creatine kinase M-type,772.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,557.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cryptic protein,6262,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-type lectin domain family 1 member B,39903.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-type lectin domain family 4 member K,161.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-type lectin domain family 4 member M,36816.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-type lectin domain family 7 member A,1166.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-type mannose receptor 2,3021.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-X-C motif chemokine 10,1745.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-X-C motif chemokine 11,7350.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-X-C motif chemokine 13,1740.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-X-C motif chemokine 16,8835.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-X-C motif chemokine 5,964.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-X-C motif chemokine 6,2410.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,C-X-C motif chemokine 9,468.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,1074.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,273.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,856.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,3344.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cyclin-dependent kinase inhibitor 1B,4856.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cystatin-C,1926.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cystatin-D,2266.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cystatin-F,865.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cystatin-M,3385.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cystatin-S,139,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cystatin-SA,4455.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cystatin-SN,444.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cysteine and glycine-rich protein 3,4759,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cysteine-rich secretory protein 3,507.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cysteine-rich with EGF-like domain protein 1,1795.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytochrome c,3763.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytochrome P450 3A4,50067.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytokine receptor common subunit gamma,12117.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,399.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytokine receptor-like factor 2,2627.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytoplasmic protein NCK1,2052.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytoplasmic tyrosine-protein kinase BMX,362.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytoskeleton-associated protein 2,10041.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytosolic non-specific dipeptidase,2098.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytotoxic and regulatory T-cell molecule,1348.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Cytotoxic T-lymphocyte protein 4,56,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,dCTP pyrophosphatase 1,11827.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,D-dimer,12744.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Death-associated protein kinase 2,4255.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Decorin,4155.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Delta-like protein 1,1811.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Delta-like protein 4,525.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dermatopontin,3202.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Desert hedgehog protein N-product,1965.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Desmocollin-2,1579.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Desmocollin-3,254.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Desmoglein-1,2293.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Diablo homolog, mitochondrial",3400.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dickkopf-like protein 1,4615.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dickkopf-related protein 1,46455.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dickkopf-related protein 3,4134.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dickkopf-related protein 4,15325.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dipeptidyl peptidase 1,432.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dipeptidyl peptidase 2,1974.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Discoidin domain-containing receptor 2,1663.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,507.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1074.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,DnaJ homolog subfamily B member 1,2011.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,DNA repair protein RAD51 homolog 1,1435.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,DNA topoisomerase 1,8782.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Down syndrome cell adhesion molecule,820.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Drebrin-like protein,9998.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",6482,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,586,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,2020.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,5413.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,28961.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dual specificity protein phosphatase 3,13930.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,2203.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dynactin subunit 2,1118.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Dynein light chain 1, cytoplasmic",575.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Dynein light chain roadblock-type 1,12102.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,E3 SUMO-protein ligase PIAS4,1119.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,E3 ubiquitin-protein ligase CHIP,2794.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,E3 ubiquitin-protein ligase Mdm2,220.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,E3 ubiquitin-protein ligase RNF43,1108.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,E3 ubiquitin-protein ligase ZNRF3,337.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Ectodysplasin-A, secreted form",1407.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1355.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1274.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,5478.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,1870.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,2046.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Elafin,4281,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Elongation factor 1-beta,2166.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Endoglin,1258.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Endoplasmic reticulum aminopeptidase 1,68432.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Endoplasmic reticulum resident protein 29,5016.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Endostatin,47757,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Endothelial cell-selective adhesion molecule,6243.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Endothelial cell-specific molecule 1,936.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Endothelial monocyte-activating polypeptide 2,4290.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Endothelin-converting enzyme 1,13174.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Enteropeptidase,170.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Eotaxin,6120.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin-A2,700,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin-A3,1866.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin-A4,1062.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin-A5,2168.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin-B1,3040.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin-B2,8399.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin-B3,1055.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin type-A receptor 10,378.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin type-A receptor 1,5780.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin type-A receptor 2,2026.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin type-A receptor 3,99.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin type-A receptor 5,574.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin type-B receptor 2,11302.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin type-B receptor 4,7555.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ephrin type-B receptor 6,1300.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Epidermal growth factor,2664.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Epidermal growth factor receptor,20751.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Epidermal growth factor receptor substrate 15-like 1,1194.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Epidermal growth factor receptor variant III,227.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Epiregulin,1749.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Epithelial discoidin domain-containing receptor 1,330.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Erythropoietin,795.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Erythropoietin receptor,478.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,E-selectin,19939.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Estradiol 17-beta-dehydrogenase 1,6053.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Estrogen receptor,1035.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Eukaryotic initiation factor 4A-III,2087.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,451.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Eukaryotic translation initiation factor 4 gamma 2,16539.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Eukaryotic translation initiation factor 4H,31430.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Eukaryotic translation initiation factor 5,2582.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Eukaryotic translation initiation factor 5A-1,62305.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Extracellular matrix protein 1,17763.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Extracellular superoxide dismutase [Cu-Zn],4978.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,FACT complex subunit SSRP1,3315.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Fatty acid-binding protein, epidermal",727.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Fatty acid-binding protein, heart",10235.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Fatty acid-binding protein, liver",4155.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fc receptor-like protein 3,360.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ferritin,8960.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fetuin-B,5318.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibrinogen,139619.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibrinogen gamma chain,55609.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 10,211.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 1,123.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 12,338.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 16,8617.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 17,202.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 18,201.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 19,14190.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 20,416.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 23,380.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 2,5415.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 4,303.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 5,546.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 6,975.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 7,4680,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 8 isoform A,1060,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 8 isoform B,698.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor 9,448.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor receptor 1,961.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor receptor 2,186.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor receptor 3,749.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibroblast growth factor receptor 4,996.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibronectin,11224.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibronectin Fragment 3,2226,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fibronectin Fragment 4,44291.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ficolin-1,1854.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ficolin-2,1631.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ficolin-3,9001.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fms-related tyrosine kinase 3 ligand,381.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Focal adhesion kinase 1,373.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Follicle stimulating hormone,4271.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Follistatin,1344.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Follistatin-related protein 1,26733.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Follistatin-related protein 3,4307.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Formimidoyltransferase-cyclodeaminase,3073.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fractalkine,2182.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Fructose-bisphosphate aldolase A,141403.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,G2/mitotic-specific cyclin-B1,429.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galactoside 3(4)-L-fucosyltransferase,422.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galectin-10,621.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galectin-2,696.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galectin-3,18964.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galectin-3-binding protein,837.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galectin-4,831.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galectin-7,1249.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galectin-8,348.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Galectin-9,1170.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Gamma-enolase,52548.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Gastrin-releasing peptide,298.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,GDNF family receptor alpha-1,610.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,GDNF family receptor alpha-2,4608.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,GDNF family receptor alpha-3,938,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Gelsolin,890.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glia-derived nexin,3588.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glial cell line-derived neurotrophic factor,339.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glial fibrillary acidic protein,498.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glucagon,1600.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glucocorticoid receptor,186.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glucokinase regulatory protein,1319,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glucose-6-phosphate isomerase,65744.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glutamate carboxypeptidase 2,362,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glutathione S-transferase A3,204,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glutathione S-transferase P,8319.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,243046.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",968.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glycogen synthase kinase-3 alpha/beta,47243,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,11539.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glypican-2,207.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glypican-3,800.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glypican-5,981,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Glypican-6,2299.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"gp41 C34 peptide, HIV",511.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Granulins,19718.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Granulocyte colony-stimulating factor,1221.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Granulocyte colony-stimulating factor receptor,813.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Granulocyte-macrophage colony-stimulating factor,276.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Granulysin,2332.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Granzyme A,2553.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Granzyme B,1046.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Granzyme H,241.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,GRB2-related adapter protein 2,421.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Gremlin-1,639.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Gro-beta/gamma,3525.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Group 10 secretory phospholipase A2,587.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Group IIE secretory phospholipase A2,247.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth arrest-specific protein 1,557.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth/differentiation factor 11,611.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth/differentiation factor 11/8,1023,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth/differentiation factor 15,1222.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth/differentiation factor 2,4552.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth/differentiation factor 5,1412.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth/differentiation factor 8,3203,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth/differentiation factor 9,721.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth factor receptor-bound protein 2,90762.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth hormone receptor,922.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Growth-regulated alpha protein,4924.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,GTPase KRas,960.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,GTP-binding nuclear protein Ran,21991.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Haptoglobin,21042.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heat shock 70 kDa protein 1A,4700.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heat shock cognate 71 kDa protein,4572.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heat shock protein beta-1,18278.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heat shock protein HSP 90-alpha/beta,34686.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heat shock protein HSP 90-beta,96449.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heme oxygenase 2,715.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,HemK methyltransferase family member 2,10106.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hemoglobin,3749.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hemojuvelin,1122.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hemopexin,852,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,1443.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heparin-binding EGF-like growth factor,518,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heparin cofactor 2,3332.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hepatitis A virus cellular receptor 2,5911.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hepatocyte growth factor,1125.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hepatocyte growth factor activator,3664,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hepatocyte growth factor-like protein,3085.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hepatocyte growth factor receptor,8770.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hepatoma-derived growth factor-related protein 2,2240.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hepcidin,10597.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,HERV-H LTR-associating protein 2,1984,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,12601,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein K,166.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heterogeneous nuclear ribonucleoprotein Q,4224.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,49800.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hexokinase-1,1210.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hexokinase-2,5418.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",428.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",285.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,High affinity immunoglobulin gamma Fc receptor I,369.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,High affinity nerve growth factor receptor,4337.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,High mobility group protein B1,50811.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histidine-rich glycoprotein,3235.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histidine triad nucleotide-binding protein 1,3807.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone acetyltransferase KAT6A,1495.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone acetyltransferase type B catalytic subunit,642.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone deacetylase 8,4440.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone H1.2,47100.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone H2A type 3,4345.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone H2A.z,9016.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone H2B type 2-E,46934,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone H3.1,3222.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Histone-lysine N-methyltransferase EHMT2,781,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Homeobox protein NANOG,166.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Homeodomain-interacting protein kinase 3,345,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hsp90 co-chaperone Cdc37,1100.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Human Chorionic Gonadotropin,3387.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hyaluronan and proteoglycan link protein 1,1026.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Hypoxia-inducible factor 1-alpha,424.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,ICOS ligand,8837.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Iduronate 2-sulfatase,5535.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Immunoglobulin A,4083.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Immunoglobulin alpha Fc receptor,190.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Immunoglobulin D,2807,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Immunoglobulin E,1324,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Immunoglobulin G,167858.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Immunoglobulin M,4521,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,5584.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Importin subunit alpha-1,226.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Importin subunit beta-1,26255.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,1262.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Inducible T-cell costimulator,1672,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Inhibin beta A chain,4520.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,565.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Inhibitor of growth protein 1,53112.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Inorganic pyrophosphatase,58956.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 1,4239.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Inosine-5'-monophosphate dehydrogenase 2,5002.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin,112.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-degrading enzyme,5141.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor 1 receptor,4895.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor-binding protein 1,1076.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor-binding protein 2,1211.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor-binding protein 3,1667.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor-binding protein 4,4519.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor-binding protein 5,2087.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor-binding protein 6,567.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor-binding protein 7,42471.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin-like growth factor I,1686.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Insulin receptor,5535.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Integrin alpha-I: beta-1 complex,1921.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Integrin alpha-IIb: beta-3 complex,1971.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Integrin alpha-V: beta-5 complex,749.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,33699.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Intercellular adhesion molecule 1,4419.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Intercellular adhesion molecule 2,4332.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Intercellular adhesion molecule 3,731.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Intercellular adhesion molecule 5,697.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon alpha-10,232.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon alpha-2,223.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon alpha-7,172.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon alpha/beta receptor 1,1596,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon beta,548.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon gamma,663.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon gamma receptor 1,292.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon gamma receptor 2,399,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon lambda-1,627.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon lambda-2,176.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interferon regulatory factor 1,2391.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-10,261.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-10 receptor subunit alpha,1124.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-10 receptor subunit beta,1027.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-11,411,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-12,239.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-12 receptor subunit beta-1,428.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-12 receptor subunit beta-2,921.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-13,664.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-13 receptor subunit alpha-1,1716.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-15 receptor subunit alpha,1348,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-16,735.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-17A,366,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-17B,189.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-17D,305.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-17F,389.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-17 receptor A,901.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-17 receptor B,710.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-17 receptor C,773.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-17 receptor D,409.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-18-binding protein,5145.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-18 receptor 1,4964,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-18 receptor accessory protein,329.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-19,4366.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-1 alpha,794.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-1 beta,3221.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-1 Receptor accessory protein,43697.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-1 receptor antagonist protein,2626.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-1 receptor-like 1,6035.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-1 receptor-like 2,826.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-1 receptor type 1,7265.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-1 receptor type 2,8497.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-20,310.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-20 receptor subunit alpha,294.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-2,1652.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-22,1119.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-22 receptor subunit alpha-1,1092.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-22 receptor subunit alpha-2,1501.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-23,1141.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-23 receptor,4853.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-24,275.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-25,223.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-27,564.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-27 receptor subunit alpha,921.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-2 receptor subunit alpha,1090.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-3,1335.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-34,443.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-36 alpha,514.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-36 beta,425.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-37,1452.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-3 receptor subunit alpha,3286.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-4,657.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-4 receptor subunit alpha,141.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-5,226.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-5 receptor subunit alpha,1466.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-6,470.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-6 receptor subunit alpha,12991.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-6 receptor subunit beta,6452.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-7,146.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-7 receptor subunit alpha,286.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-8,860.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interleukin-9,227,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Interstitial collagenase,2540.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Junctional adhesion molecule B,9793.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Junctional adhesion molecule C,14703.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Junctional adhesion molecule-like,538.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-11,1526.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-12,3850,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-13,1156.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-14,9746.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-4,338.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-5,119.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-6,1999.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-7,886.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallikrein-8,2562.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kallistatin,37543,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kelch-like ECH-associated protein 1,498.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Keratin, type I cytoskeletal 18",1526.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Killer cell immunoglobulin-like receptor 2DL4,5257,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DL2,322.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Killer cell immunoglobulin-like receptor 3DS1,503.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Killer cell lectin-like receptor subfamily F member 1,341.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kinesin-like protein KIF23,3176.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kininogen-1,30073.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kin of IRRE-like protein 3,327.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kremen protein 2,7935.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kunitz-type protease inhibitor 1,3638.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kunitz-type protease inhibitor 2,1542.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Kynureninase,1653.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lactadherin,503,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lactoperoxidase,794.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lactotransferrin,46831.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lamin-B1,1023.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Laminin,3763.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Latent-transforming growth factor beta-binding protein 4,1435.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Layilin,1197.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Legumain,5562.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leptin,2496.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leptin receptor,1066.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leucine carboxyl methyltransferase 1,3073.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,4257.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,2918.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,87.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,153.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT1,2071.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT2,10990.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leucine-rich repeat transmembrane protein FLRT3,3598.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leukemia inhibitory factor receptor,2712,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,2335.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,4961.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leukocyte surface antigen CD47,1960.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Leukotriene A-4 hydrolase,969.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,183.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Limbic system-associated membrane protein,1257.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lipopolysaccharide-binding protein,52838,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lithostathine-1-alpha,483.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,L-lactate dehydrogenase B chain,3778.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Low affinity immunoglobulin epsilon Fc receptor,2366.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,4018,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,3115.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1075.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Low-density lipoprotein receptor,105.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Low-density lipoprotein receptor-related protein 1B,44828,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",2153.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Low-density lipoprotein receptor-related protein 8,1880.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Low molecular weight phosphotyrosine protein phosphatase,9754.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,L-Selectin,4017.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lumican,1842.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Luteinizing hormone,3674.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ly6/PLAUR domain-containing protein 3,1196.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,422.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lymphocyte activation gene 3 protein,2570,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lymphocyte antigen 86,7995.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lymphotactin,378.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lymphotoxin alpha1:beta2,108.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lymphotoxin alpha2:beta1,1759.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lymphotoxin-alpha,677,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lysosomal protective protein,13793.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lysosome membrane protein 2,476.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Lysozyme C,73719,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Macrophage-capping protein,1353.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Macrophage colony-stimulating factor 1,1546.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Macrophage colony-stimulating factor 1 receptor,191.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Macrophage mannose receptor 1,7494.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Macrophage metalloelastase,1417,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Macrophage migration inhibitory factor,3216.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Macrophage scavenger receptor types I and II,1025,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Macrophage-stimulating protein receptor,525.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Malate dehydrogenase, cytoplasmic",68964.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mammaglobin-B,13548.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mannan-binding lectin serine protease 1,4057.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mannose-binding protein C,10327.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,MAP kinase-activated protein kinase 2,33510.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,MAP kinase-activated protein kinase 3,5890.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,MAP kinase-activated protein kinase 5,848.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mast/stem cell growth factor receptor Kit,11931.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Matrilin-2,7485.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Matrilin-3,460.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Matrilysin,1676.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Matrix extracellular phosphoglycoprotein,224,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Matrix metalloproteinase-14,780.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Matrix metalloproteinase-16,1981.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Matrix metalloproteinase-17,884.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Matrix metalloproteinase-9,6686.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mediator of RNA polymerase II transcription subunit 1,47496.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Megakaryocyte-associated tyrosine-protein kinase,453,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Melanoma-derived growth regulatory protein,1659.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Membrane frizzled-related protein,3738,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Membrane metallo-endopeptidase-like 1,1172.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mesothelin,601.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Metalloproteinase inhibitor 1,92.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Metalloproteinase inhibitor 2,429.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Metalloproteinase inhibitor 3,6603.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Methionine aminopeptidase 1,8048.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Methionine aminopeptidase 2,79642,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Methyl-CpG-binding domain protein 4,599.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,MHC class I polypeptide-related sequence A,214.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,MHC class I polypeptide-related sequence B,5780.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Microtubule-associated protein tau,170.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Midkine,31391.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitochondrial glutamate carrier 2,782.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,635,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase 11,474.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase 12,1854.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase 1,28306.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase 13,1517,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase 14,9220.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase 3,78492.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase 8,6495.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase 9,650.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,3800,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Moesin,1306.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mothers against decapentaplegic homolog 2,53532.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mothers against decapentaplegic homolog 3,31619.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Mucin-1,809.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Muellerian-inhibiting factor,7299.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Myc proto-oncogene protein,461.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Myeloblastin,6792.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Myeloid cell surface antigen CD33,2027.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Myeloperoxidase,22407.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Myoglobin,777.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Myosin-binding protein C, slow-type",2056.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,N-acetyl-D-glucosamine kinase,2517.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,N-acetylglucosamine-6-sulfatase,5028.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,N-acylethanolamine-hydrolyzing acid amidase,12344.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NAD-dependent protein deacetylase sirtuin-2,18020.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NADPH--cytochrome P450 reductase,2701.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Nascent polypeptide-associated complex subunit alpha,11664,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Natural cytotoxicity triggering receptor 1,1985.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Natural cytotoxicity triggering receptor 2,285.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Natural cytotoxicity triggering receptor 3,435.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Natural killer cell receptor 2B4,226.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Netrin-1,399.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Netrin-4,842.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Netrin receptor UNC5C,2845.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Netrin receptor UNC5D,3103.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",9736.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neural cell adhesion molecule L1,545.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neural cell adhesion molecule L1-like protein,12128.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neuregulin-1,132.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neuregulin-4,535.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neurexin-1-beta,589.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neurexin-3-beta,651.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neurexophilin-1,5301.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1334.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neurogenic locus notch homolog protein 1,17099.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neurogenic locus notch homolog protein 2,434.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neurogenic locus notch homolog protein 3,719.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Neuroligin-4, X-linked",469.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neuronal cell adhesion molecule,11782.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neuronal growth regulator 1,4030.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neuropilin-1,2626,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neurotrophin-3,165.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neurotrophin-4,173.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neutral ceramidase,6134.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neutrophil-activating peptide 2,47518,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neutrophil collagenase,6097.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neutrophil elastase,500.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Neutrophil gelatinase-associated lipocalin,7577.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Nicotinamide phosphoribosyltransferase,653.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Nidogen-1,5872.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Nidogen-2,3517.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NKG2D ligand 1,367,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NKG2D ligand 2,453.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NKG2D ligand 3,1734.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NKG2-D type II integral membrane protein,766.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Noggin,3596.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Non-histone chromosomal protein HMG-14,5757.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Non-receptor tyrosine-protein kinase TYK2,7217.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NSFL1 cofactor p47,1629.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NT-3 growth factor receptor,5792.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,N-terminal pro-BNP,2516.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Nuclear receptor subfamily 1 group D member 1,592.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Nucleoside diphosphate kinase A,1290.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Nucleoside diphosphate kinase B,61981.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,NudC domain-containing protein 3,685.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,OCIA domain-containing protein 1,1022.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Olfactomedin-4,182.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Oncostatin-M,1400.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Opioid-binding protein/cell adhesion molecule,4462.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Osteocalcin,1712.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Osteomodulin,7037.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Osteopontin,6471.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,OX-2 membrane glycoprotein,2373.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Oxidized low-density lipoprotein receptor 1,3878.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pancreatic hormone,1332.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pappalysin-1,10723.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Parathyroid hormone,2655.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Parathyroid hormone-related protein,713.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peptide YY,1337.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peptidoglycan recognition protein 1,464.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase A,214034.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase B,4015.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase D,38149.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peptidyl-prolyl cis-trans isomerase E,5649.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",59813.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Periostin,2824,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peroxiredoxin-1,9042.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Peroxiredoxin-5, mitochondrial",409.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peroxiredoxin-6,2665.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Peroxisomal targeting signal 1 receptor,507.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Persephin,208.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",4325.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pescadillo homolog,847.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Phosphatidylethanolamine-binding protein 1,24459.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1062.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2211.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Phosphoglucomutase-1,433.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Phosphoglycerate kinase 1,10426.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Phosphoglycerate mutase 1,1186.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Phospholipase A2,565.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Phospholipase A2, membrane associated",2009.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pigment epithelium-derived factor,34376.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,PIK3CA/PIK3R1,1534.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,PILR alpha-associated neural protein,2969.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,204.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,212.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Placenta growth factor,249.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Plasma kallikrein,22630.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Plasma protease C1 inhibitor,6069.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Plasma serine protease inhibitor,66212,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Plasmin,716.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Plasminogen,3851.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Plasminogen activator inhibitor 1,4344.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet-activating factor acetylhydrolase,1107.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,14458,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet-derived growth factor C,259.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet-derived growth factor receptor alpha,2434.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet-derived growth factor receptor beta,4995.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet-derived growth factor subunit A,34947.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet-derived growth factor subunit B,102602.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet endothelial cell adhesion molecule,960.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet factor 4,185257.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet glycoprotein 4,12348.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet glycoprotein Ib alpha chain,1502.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet glycoprotein VI,52043.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Platelet receptor Gi24,1132.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pleiotrophin,1886.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Plexin-B2,3922.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Plexin-C1,688.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Polymeric immunoglobulin receptor,2671.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,PolyUbiquitin K48-linked,2203.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,PolyUbiquitin K63-linked,3460.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Prefoldin subunit 5,475.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Programmed cell death 1 ligand 1,605.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Programmed cell death 1 ligand 2,5910.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Prokineticin-1,401.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Prolactin,1349.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Prolactin receptor,966.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proliferating cell nuclear antigen,173,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proliferation-associated protein 2G4,9276.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Prolyl endopeptidase FAP,907.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pro-opiomelanocortin,697.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Properdin,91118.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 7,1923.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proprotein convertase subtilisin/kexin type 9,623.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Prostaglandin G/H synthase 2,3186.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Prostate-specific antigen,1019.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proteasome activator complex subunit 1,4470.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proteasome activator complex subunit 3,309.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proteasome subunit alpha type-1,815.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proteasome subunit alpha type-2,1119.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proteasome subunit alpha type-6,2429.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein 4.1,30369.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein amnionless,109.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein deglycase DJ-1,554.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein disulfide-isomerase,199.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein disulfide-isomerase A3,11142.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein E7_HPV16,478.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein E7_HPV18,1486.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein FAM107A,220,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein FAM107B,2082.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein FAM3B,750.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein FAM3D,6372.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein-glutamine gamma-glutamyltransferase E,5179.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein jagged-1,511.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein jagged-2,309.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein kinase C alpha type,115402.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein kinase C beta type (splice variant beta-II),46428.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein kinase C delta type,9898,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein kinase C gamma type,515,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein kinase C iota type,8042.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein kinase C theta type,9475.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein kinase C zeta type,2695.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein lin-7 homolog B,492.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein NOV homolog,729.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein Rev_HV2BE,132.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein S100-A12,1153.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein S100-A4,2344.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein S100-A6,8375,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein S100-A7,158,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein S100-A9,17161.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein SET,785.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein-tyrosine kinase 6,212.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein Wnt-7a,175.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Protein Z-dependent protease inhibitor,3879.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Prothrombin,149707.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,1114.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proto-oncogene tyrosine-protein kinase Src,85542.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Proto-oncogene vav,43110.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,P-selectin,37090,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pulmonary surfactant-associated protein D,137124.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pyridoxal kinase,869.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pyridoxal phosphate phosphatase,13096.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",3290.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Pyruvate kinase PKM,141366.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Quinone oxidoreductase-like protein 1,2573.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Rab GDP dissociation inhibitor beta,61014.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,25304.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,RAC-beta serine/threonine-protein kinase,52642,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ras GTPase-activating protein 1,1595.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 1,95787.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ras-related C3 botulinum toxin substrate 3,18576,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Receptor-type tyrosine-protein kinase FLT3,14103.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-2,380.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-3,278.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Receptor tyrosine-protein kinase erbB-4,121.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Regenerating islet-derived protein 4,1327.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Relaxin receptor 1,408.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Renin,438.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Repulsive guidance molecule A,16873.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Resistin,809.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Reticulon-4 receptor,667,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Retinoblastoma-associated protein,1158.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Retinoic acid receptor responder protein 2,2511.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Retinol-binding protein 4,268.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,RGM domain family member B,1540.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ribonuclease H1,477,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ribosomal protein S6 kinase alpha-3,3232.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ribosomal protein S6 kinase alpha-5,545,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ribosome maturation protein SBDS,69364.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,RNA-binding protein 39,1881.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Roundabout homolog 2,2723.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Roundabout homolog 3,375.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,R-spondin-2,783.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,R-spondin-3,1631.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,R-spondin-4,293.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Scavenger receptor class F member 1,12784.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Scavenger receptor class F member 2,273.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2035,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sclerostin,11506,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Secreted and transmembrane protein 1,1715.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Secreted frizzled-related protein 1,4924.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Secreted frizzled-related protein 3,2271.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Secretin,207.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Seizure 6-like protein 2,3859.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Semaphorin-3A,1854.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Semaphorin-3E,1595.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Semaphorin-5A,4298.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Semaphorin-6A,9906.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Semaphorin-6B,2975.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine protease 27,5738,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Serine protease HTRA2, mitochondrial",8245.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase 16,1359.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase 17B,19914.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase Chk1,710.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase Chk2,211.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase MRCK beta,1484.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase PAK 3,855.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase PAK 6,27783.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase PAK 7,704.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase pim-1,880.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase PLK1,186.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase receptor R3,1740.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase TBK1,367.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serine/threonine-protein kinase WNK3,3140.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serotransferrin,192140.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serum albumin,8553.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serum amyloid A-1 protein,1311.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serum amyloid P-component,23458.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Serum paraoxonase/arylesterase 1,309.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sex hormone-binding globulin,7274,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,S-formylglutathione hydrolase,5707.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SH2 domain-containing protein 1A,5405.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SHC-transforming protein 1,31686.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sialic acid-binding Ig-like lectin 14,12664.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sialic acid-binding Ig-like lectin 6,183,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sialic acid-binding Ig-like lectin 7,1049.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sialic acid-binding Ig-like lectin 9,201.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sialoadhesin,103.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Signal transducer and activator of transcription 1-alpha/beta,31919.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Signal transducer and activator of transcription 3,8472.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Signal transducer and activator of transcription 6,1479.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SLAM family member 5,11115,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SLAM family member 6,355.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SLAM family member 7,23850.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SLIT and NTRK-like protein 1,1709.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SLIT and NTRK-like protein 5,1512.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,11868.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Small nuclear ribonucleoprotein F,3157.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Small ubiquitin-related modifier 3,13447.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Somatostatin-28,1641.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Somatotropin,225.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sonic hedgehog protein,875.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sorting nexin-4,36556,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SPARC,55814.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SPARC-like protein 1,12351.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SPARC-related modular calcium-binding protein 1,2593.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Spectrin alpha chain, non-erythrocytic 1",149.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,S-phase kinase-associated protein 1,10582.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sphingosine kinase 1,34963.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Sphingosine kinase 2,517.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Spondin-1,1598.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Stabilin-2,691,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Stanniocalcin-1,1587.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Stem cell growth factor-alpha,1719.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Stem Cell Growth Factor-beta,679.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Stress-induced-phosphoprotein 1,27676,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Stromal cell-derived factor 1,6796.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Stromelysin-1,679.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Stromelysin-2,659.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,SUMO-conjugating enzyme UBC9,13323.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Superoxide dismutase [Cu-Zn],3024.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Superoxide dismutase [Mn], mitochondrial",31770.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Synaptosomal-associated protein 25,897.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Syntaxin-1A,480.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tartrate-resistant acid phosphatase type 5,6572.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,TATA-box-binding protein,1803.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,T-cell surface glycoprotein CD4,386.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tenascin,16371.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Teratocarcinoma-derived growth factor 1,341,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Testican-1,6866.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Testican-2,629.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,TGF-beta receptor type-2,844,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thioredoxin domain-containing protein 12,2594.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thrombin,1043,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thrombopoietin,255.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thrombopoietin Receptor,210.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thrombospondin-1,21400.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thrombospondin-2,6494.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thrombospondin-4,558.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thymic stromal lymphopoietin,713.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Thymidine kinase, cytosolic",553.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thymidylate synthase,235.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thyroglobulin,300.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thyroid peroxidase,1477.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thyroid Stimulating Hormone,409.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Thyroxine-binding globulin,36400.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tissue Factor,901.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tissue factor pathway inhibitor,55776.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tissue-type plasminogen activator,416.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,T-lymphocyte activation antigen CD80,433.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,T-lymphocyte activation antigen CD86,701,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,T-lymphocyte surface antigen Ly-9,2423.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Toll-like receptor 2,451.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Toll-like receptor 4,269.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,4730.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transcription factor AP-1,3526.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transcription factor IIIB 90 kDa subunit,2849.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transforming growth factor beta-1,1903.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transforming growth factor beta-2,246,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transforming growth factor beta-3,433.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transforming growth factor-beta-induced protein ig-h3,18150.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transforming growth factor beta receptor type 3,22985.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transgelin-2,18862.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transketolase,135245.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Translationally-controlled tumor protein,58812.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Transmembrane glycoprotein NMB,3953.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Trefoil factor 1,3908.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Trefoil factor 2,6690.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Trefoil factor 3,7893.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Triosephosphate isomerase,43830.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tropomyosin alpha-1 chain,845.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tropomyosin alpha-4 chain,176083.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tropomyosin beta chain,1152.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Troponin I, cardiac muscle",383.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Troponin I, fast skeletal muscle",5529.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Troponin T, cardiac muscle",3962.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Trypsin-1,3291.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Trypsin-2,984,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Trypsin-3,289.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tryptase beta-2,2982.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tryptase gamma,181.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor-associated calcium signal transducer 2,527,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor,382.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor-inducible gene 6 protein,829.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 11,319.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 12,906.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 13B,1392.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 14,856.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 15,878.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 18,645,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 4,291.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",376.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 8,2031,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor ligand superfamily member 9,333.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10A,1288.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10B,412.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 10D,755.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11A,1942.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 11B,7434.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 12A,161,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13B,948.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 13C,2948.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 14,449.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 17,6103.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 18,567.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19,602.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 19L,1309,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1A,944.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 1B,7190.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 21,5858,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 27,776.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 3,3322.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 4,870.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6,1121.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 6B,505.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 8,1061.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member 9,282.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tumor necrosis factor receptor superfamily member EDAR,4310.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase ABL1,149.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase BTK,55900,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase CSK,53800.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase Fer,8452.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase Fgr,1805.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase Fyn,10652,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase HCK,140.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase JAK2,91624.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase Lck,758,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase Lyn,16220,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Tyrosine-protein kinase Lyn, isoform B",64402.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",5759.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase receptor TYRO3,472.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase Tec,10651.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,467.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase Yes,2712.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein kinase ZAP-70,10837.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 11,26321.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 1,5012,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 2,316.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type 6,33172.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,4309.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Ubiquitin+1, truncated mutation for UbB",14806.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin,4156.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,931.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,4334.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 G2,3483.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 L3,4903.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin-conjugating enzyme E2 N,29919.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin-fold modifier 1,21148.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,47537.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Ubiquitin-like protein ISG15,5726,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,UMP-CMP kinase,5069.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Urokinase plasminogen activator surface receptor,6870.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Urokinase-type plasminogen activator,1351.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,95161.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vascular cell adhesion protein 1,6798.8,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vascular endothelial growth factor A,8057,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"Vascular endothelial growth factor A, isoform 121",711.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vascular endothelial growth factor C,2973.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vascular endothelial growth factor D,403.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vascular endothelial growth factor receptor 2,6570.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vascular endothelial growth factor receptor 3,7309.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vasoactive Intestinal Peptide,703.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vesicular integral-membrane protein VIP36,10351.5,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vitamin K-dependent protein C,1969,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vitamin K-dependent protein S,4776.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Vitronectin,45457.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,von Willebrand factor,5135.3,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,VPS10 domain-containing receptor SorCS2,226.7,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",327.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",4327.1,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,WNT1-inducible-signaling pathway protein 1,7734.9,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,WNT1-inducible-signaling pathway protein 3,994,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Wnt inhibitory factor 1,2967.6,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,Xaa-Pro aminopeptidase 1,29864.4,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,935.2,RFU
BF-1200,PDYG564WLA,M0,0,Plasma,X-ray repair cross-complementing protein 6,1797,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,14-3-3 protein beta/alpha,25130.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,14-3-3 protein epsilon,1013.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,14-3-3 protein family,7542,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,14-3-3 protein sigma,677.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,14-3-3 protein theta,1326,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,14-3-3 protein zeta/delta,196151.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1379,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",434.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,2'-5'-oligoadenylate synthase 1,317,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,26S proteasome non-ATPase regulatory subunit 7,361.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,3-hydroxy-3-methylglutaryl-coenzyme A reductase,268.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,3-hydroxyacyl-CoA dehydrogenase type-2,1651.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"3-hydroxyanthranilate 3,4-dioxygenase",3242.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",503.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,3-phosphoinositide-dependent protein kinase 1,1196.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,40S ribosomal protein S3,526.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,40S ribosomal protein S3a,865.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,40S ribosomal protein S7,1203,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,40S ribosomal protein SA,1600.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"60 kDa heat shock protein, mitochondrial",20375.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"6-phosphogluconate dehydrogenase, decarboxylating",22381.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,72 kDa type IV collagenase,8595.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Abelson tyrosine-protein kinase 2,1426,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Acidic leucine-rich nuclear phosphoprotein 32 family member B,196.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Acid sphingomyelinase-like phosphodiesterase 3a,4725.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Activated Protein C,905.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Activin receptor type-1B,248.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Adapter molecule crk,16357.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Adenylate kinase isoenzyme 1,37661.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Adenylosuccinate lyase,983.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Adhesion G protein-coupled receptor E2,972.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Adhesion G-protein coupled receptor G5,646.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Adiponectin,8494.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 13,2935.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 1,421.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 15,293.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 4,151.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,A disintegrin and metalloproteinase with thrombospondin motifs 5,366.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,623.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,10352.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Adrenomedullin,1771,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Advanced glycosylation end product-specific receptor, soluble",694.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Afamin,31657.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Aflatoxin B1 aldehyde reductase member 2,8151.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Aggrecan core protein,580.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Agouti-related protein,2782.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,AH receptor-interacting protein,8106.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alanine aminotransferase 1,2776.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alcohol dehydrogenase [NADP(+)],6179.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Allograft inflammatory factor 1,2667.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Alpha-(1,3)-fucosyltransferase 5",8730.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin,231183,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-1-antichymotrypsin complex,7023,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-1-antitrypsin,1297.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-2-antiplasmin,2197.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-2-HS-glycoprotein,1853.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-2-macroglobulin,11624.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,alpha-2-macroglobulin receptor-associated protein,659.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-enolase,72912.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,alpha-Fetoprotein,1148.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-L-iduronidase,1122.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-soluble NSF attachment protein,10537.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Alpha-synuclein,17746.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Aminoacylase-1,3905.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Amphiregulin,4553,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Amphoterin-induced protein 2,2891.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,AMP Kinase (alpha1beta1gamma1),366.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,AMP Kinase (alpha2beta2gamma1),5211.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Amyloid beta A4 protein,47691.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiogenin,3753.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiopoietin-1,1383.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Angiopoietin-1 receptor, soluble",2163,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiopoietin-2,146,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiopoietin-4,534.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiopoietin-related protein 3,398.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiopoietin-related protein 4,3989.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiostatin,18052.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiotensin-converting enzyme 2,622.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Angiotensinogen,5878.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ankyrin-2,515.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Annexin A1,17018.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Annexin A2,9785.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Annexin A5,918.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Annexin A6,21285.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Anterior gradient protein 2 homolog,707.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Antileukoproteinase,26634.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Antithrombin-III,126939.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein A-I,19943.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein B,26106.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein D,3596.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein E,58711.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein E (isoform E2),249275.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein E (isoform E3),244038.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein E (isoform E4),236668.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein L1,39253.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apolipoprotein M,15763.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Apoptosis regulator Bcl-2,1539.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Appetite-regulating hormone,1495.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Arginase-1,1057.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Aromatic-L-amino-acid decarboxylase,306.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Artemin,945.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Arylsulfatase A,1739.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Arylsulfatase B,1309.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Asialoglycoprotein receptor 1,1440.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Aspartate aminotransferase, cytoplasmic",2996.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,ATP-dependent RNA helicase DDX19B,5532.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"ATP synthase subunit beta, mitochondrial",1245.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"ATP synthase subunit O, mitochondrial",2952.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Atrial natriuretic factor,811.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,AT-rich interactive domain-containing protein 3A,603.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Aurora kinase A,798.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Aurora kinase B,631.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Azurocidin,336.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bactericidal permeability-increasing protein,2055.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 3,192.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 5,473.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Baculoviral IAP repeat-containing protein 7 Isoform beta,96.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Basal Cell Adhesion Molecule,1726.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Basigin,372.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,B-cell lymphoma 6 protein,18310.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,B-cell receptor CD22,777.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bcl2-associated agonist of cell death,13396.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bcl-2-like protein 1,1787.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bcl-2-like protein 2,677.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bcl-2-related protein A1,973.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,BDNF/NT-3 growth factors receptor,1164.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Beta-2-microglobulin,1691.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,beta-adrenergic receptor kinase 1,15550.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Beta-Ala-His dipeptidase,7735.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Betacellulin,659.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Beta-endorphin,1325.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,beta-nerve growth factor,439.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,BH3-interacting domain death agonist,1867.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Biglycan,3032.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,BMP-binding endothelial regulator protein,429.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bone morphogenetic protein 10,1190.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bone morphogenetic protein 1,3190.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bone morphogenetic protein 6,19084,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bone morphogenetic protein 7,582.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-1A,975.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bone morphogenetic protein receptor type-2,452.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Bone sialoprotein 2,4707.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Brain-derived neurotrophic factor,1517,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Brain natriuretic peptide 32,413.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Brain-specific serine protease 4,1975.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Breast cancer anti-estrogen resistance protein 3,1187.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Brevican core protein,1818.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Brother of CDO,1784.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C3a anaphylatoxin,734.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C3a anaphylatoxin des Arginine,130835.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C5a anaphylatoxin,5955.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cadherin-12,861.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cadherin-15,3290.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cadherin-1,68922.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cadherin-2,1816.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cadherin-3,22919.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cadherin-5,12986.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cadherin-6,440.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcineurin,2696.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcineurin subunit B type 1,6004.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",820.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase kinase 1,481.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1,4616.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type 1D,2083.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit alpha,714.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit beta,1624.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcium/calmodulin-dependent protein kinase type II subunit delta,4557.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calcium-dependent phospholipase A2,338,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calpain I,73486.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calpastatin,7622,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Calreticulin,1936.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,cAMP-dependent protein kinase catalytic subunit alpha,2949.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,cAMP-regulated phosphoprotein 19,5277.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1210.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 15,6352.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 2,261.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbohydrate sulfotransferase 6,269.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase 1,16587.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase 13,7898,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase 2,266.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase 3,1933.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase 4,1695.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase 6,6436.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase 7,332.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase 9,1560.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carbonic anhydrase-related protein 10,661.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carboxypeptidase B2,15107,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Carboxypeptidase E,1784.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cardiotrophin-1,615.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Casein kinase II 2-alpha':2-beta heterotetramer,387.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Casein kinase II 2-alpha:2-beta heterotetramer,9347.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Casein kinase II subunit alpha,476.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Caspase-10,3282.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Caspase-2,2063.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Caspase-3,31329.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Catalase,13320.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin B,1171.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin D,1777.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin E,442.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin F,2552.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin G,1056.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin H,766.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin L2,2341.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin S,1262.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cathepsin Z,7358.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cation-independent mannose-6-phosphate receptor,34629.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CCAAT/enhancer-binding protein beta,736,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 1,2313.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 13,448.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 14,4705.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 15,4368.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 16,20253.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 17,4309.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 18,7507.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 19,439.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 20,130,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 21,23435.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 22,1454.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 23,2335.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 24,398.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 25,2129.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 26,870.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 27,1521.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 28,27118.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 2,891.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 3,863,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 3-like 1,1489.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 4-like,640.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 5,109071.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 7,742.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-C motif chemokine 8,211.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD109 antigen,6525.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD166 antigen,16169.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD177 antigen,517.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD209 antigen,1321.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD226 antigen,826,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD27 antigen,6564.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD40 ligand,454.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD48 antigen,560.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD59 glycoprotein,1420.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD5 antigen-like,2118.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD63 antigen,358.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD70 antigen,217,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD83 antigen,350.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CD97 antigen,1516.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cell adhesion molecule 1,2839.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cell adhesion molecule 3,1388.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cell adhesion molecule-related/down-regulated by oncogenes,8101.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cell surface glycoprotein CD200 receptor 1,1036.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cellular tumor antigen p53,780,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cerebral dopamine neurotrophic factor,3728.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"cGMP-dependent 3',5'-cyclic phosphodiesterase",5636.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",1018.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"cGMP-specific 3',5'-cyclic phosphodiesterase",48391,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Chitinase-3-like protein 1,11147,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Chitotriosidase-1,781.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Chloride intracellular channel protein 1,10583.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Choline/ethanolamine kinase,2000.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Chordin-like protein 1,3832,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Chorionic somatomammotropin hormone,2351.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Chromobox protein homolog 5,418.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Chromogranin-A,9208.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Chymase,604.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ciliary neurotrophic factor,185.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ciliary neurotrophic factor receptor subunit alpha,7631.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ck-beta-8-1,52762.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Clusterin,1313.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,CMRF35-like molecule 6,2756.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coactosin-like protein,2896.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coagulation factor IX,10530.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coagulation factor IXab,7115.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coagulation Factor V,65411.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coagulation factor VII,538.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coagulation Factor X,6110.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coagulation factor Xa,4904.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coagulation Factor XI,1861.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cofilin-1,11222.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Coiled-coil domain-containing protein 80,3114.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Collagen alpha-1(VIII) chain,940.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Collagen alpha-1(XXIII) chain,324.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Collagenase 3,994.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Collectin-11,6225.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Collectin-12,4884.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,COMM domain-containing protein 7,2584.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C1q subcomponent,33547.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C1r subcomponent,2020.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C2,2795,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C3,57576.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C3b,9380.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Complement C3b, inactivated",6133,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C3d fragment,6143.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C4,116911.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C4b,101.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C5,7087.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement C5b-C6 complex,559,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Complement component 1 Q subcomponent-binding protein, mitochondrial",4590.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement component C1q receptor,10550.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement component C6,73605.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement component C7,981.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement component C8,2560.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement component C9,64656.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement decay-accelerating factor,16084.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement factor B,20205,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement factor D,999.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement factor H,51703.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement factor H-related protein 5,1566.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Complement factor I,35522.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Connective tissue-activating peptide III,81844,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Connective tissue growth factor,2034.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Contactin-1,364.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Contactin-2,1406.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Contactin-4,5418.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Contactin-5,647,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Copine-1,6979.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Corticosteroid-binding globulin,598.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Corticotropin,420.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-reactive protein,9081,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Creatine kinase B-type,721.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Creatine kinase M-type,743.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Creatine kinase M-type:Creatine kinase B-type heterodimer,428.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cryptic protein,2808,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-type lectin domain family 1 member B,28983.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-type lectin domain family 4 member K,184.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-type lectin domain family 4 member M,33514.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-type lectin domain family 7 member A,670.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-type mannose receptor 2,4005.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-X-C motif chemokine 10,2850.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-X-C motif chemokine 11,6122.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-X-C motif chemokine 13,2358.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-X-C motif chemokine 16,13511.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-X-C motif chemokine 5,557.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-X-C motif chemokine 6,1816,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,C-X-C motif chemokine 9,646.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,722.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cyclin-dependent kinase 2:Cyclin-A2 complex,314.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,1064.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cyclin-dependent kinase 8:Cyclin-C complex,1901.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cyclin-dependent kinase inhibitor 1B,1166.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cystatin-C,2294.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cystatin-D,4271.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cystatin-F,749.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cystatin-M,5015.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cystatin-S,135.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cystatin-SA,8062.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cystatin-SN,499.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cysteine and glycine-rich protein 3,3079,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cysteine-rich secretory protein 3,229.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cysteine-rich with EGF-like domain protein 1,2270.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytochrome c,5043.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytochrome P450 3A4,28107.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytokine receptor common subunit gamma,4833.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,444.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytokine receptor-like factor 2,1469.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytoplasmic protein NCK1,1187.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytoplasmic tyrosine-protein kinase BMX,288.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytoskeleton-associated protein 2,10882.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytosolic non-specific dipeptidase,1358.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytotoxic and regulatory T-cell molecule,751,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Cytotoxic T-lymphocyte protein 4,69.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,dCTP pyrophosphatase 1,13315.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,D-dimer,12890.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Death-associated protein kinase 2,2194.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Decorin,4231.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Delta-like protein 1,2088.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Delta-like protein 4,512.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dermatopontin,4298.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Desert hedgehog protein N-product,1028.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Desmocollin-2,2692.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Desmocollin-3,281,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Desmoglein-1,2488.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Diablo homolog, mitochondrial",4083,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dickkopf-like protein 1,2239.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dickkopf-related protein 1,52077.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dickkopf-related protein 3,5037.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dickkopf-related protein 4,18352.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dipeptidyl peptidase 1,554.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dipeptidyl peptidase 2,1372.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Discoidin domain-containing receptor 2,1454.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 12,464,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Disintegrin and metalloproteinase domain-containing protein 9,1527.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,DnaJ homolog subfamily B member 1,732.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,DNA repair protein RAD51 homolog 1,1978.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,DNA topoisomerase 1,685.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Down syndrome cell adhesion molecule,1023.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Drebrin-like protein,4367.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",2959.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 1,425.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 2,1735.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 3,2462.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dual specificity mitogen-activated protein kinase kinase 4,37219.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dual specificity protein phosphatase 3,6825.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dual specificity tyrosine-phosphorylation-regulated kinase 3,1761.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dynactin subunit 2,873.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Dynein light chain 1, cytoplasmic",281.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Dynein light chain roadblock-type 1,5329.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,E3 SUMO-protein ligase PIAS4,585.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase CHIP,1196.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase Mdm2,183,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase RNF43,1281.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,E3 ubiquitin-protein ligase ZNRF3,344.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Ectodysplasin-A, secreted form",2127.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 1,1477.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 3,1086.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ectonucleoside triphosphate diphosphohydrolase 5,5509,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,4088.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,EGF-containing fibulin-like extracellular matrix protein 1,1529.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Elafin,6400.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Elongation factor 1-beta,927.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Endoglin,1980.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Endoplasmic reticulum aminopeptidase 1,95568.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Endoplasmic reticulum resident protein 29,5004.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Endostatin,62610.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Endothelial cell-selective adhesion molecule,4759.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Endothelial cell-specific molecule 1,1139.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Endothelial monocyte-activating polypeptide 2,2609.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Endothelin-converting enzyme 1,17765,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Enteropeptidase,181.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Eotaxin,10974.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin-A2,838,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin-A3,2304.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin-A4,1775.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin-A5,3817.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin-B1,1741.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin-B2,15384.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin-B3,939.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin type-A receptor 10,433.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin type-A receptor 1,11175.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin type-A receptor 2,3314.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin type-A receptor 3,131.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin type-A receptor 5,651.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin type-B receptor 2,19536.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin type-B receptor 4,2983.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ephrin type-B receptor 6,1454.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Epidermal growth factor,1468.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Epidermal growth factor receptor,27465.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Epidermal growth factor receptor substrate 15-like 1,619.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Epidermal growth factor receptor variant III,174.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Epiregulin,1108.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Epithelial discoidin domain-containing receptor 1,313.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Erythropoietin,1415.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Erythropoietin receptor,351.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,E-selectin,29202.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Estradiol 17-beta-dehydrogenase 1,2017.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Estrogen receptor,683.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Eukaryotic initiation factor 4A-III,482.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4E-binding protein 2,368.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4 gamma 2,6531.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 4H,13430.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5,1380.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Eukaryotic translation initiation factor 5A-1,54434.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Extracellular matrix protein 1,19336.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Extracellular superoxide dismutase [Cu-Zn],5340,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,FACT complex subunit SSRP1,441.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Fatty acid-binding protein, epidermal",704.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Fatty acid-binding protein, heart",12678.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Fatty acid-binding protein, liver",9419.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fc receptor-like protein 3,389.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ferritin,8050.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fetuin-B,6591.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibrinogen,145752.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibrinogen gamma chain,58978.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 10,196.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 1,166.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 12,196.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 16,3752.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 17,209.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 18,261.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 19,16059.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 20,438.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 23,495.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 2,4770.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 4,220.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 5,525.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 6,487.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 7,2472.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform A,508.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 8 isoform B,672.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor 9,518.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor receptor 1,1020.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor receptor 2,201,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor receptor 3,744.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibroblast growth factor receptor 4,706.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibronectin,9808.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibronectin Fragment 3,2055.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fibronectin Fragment 4,56104.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ficolin-1,1935.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ficolin-2,1641.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ficolin-3,10673.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fms-related tyrosine kinase 3 ligand,405.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Focal adhesion kinase 1,274.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Follicle stimulating hormone,5639.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Follistatin,879.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Follistatin-related protein 1,32874.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Follistatin-related protein 3,6227.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Formimidoyltransferase-cyclodeaminase,4071.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fractalkine,3817.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Fructose-bisphosphate aldolase A,94947.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,G2/mitotic-specific cyclin-B1,436.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galactoside 3(4)-L-fucosyltransferase,620.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galectin-10,703,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galectin-2,764.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galectin-3,20311.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galectin-3-binding protein,1081.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galectin-4,615.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galectin-7,799.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galectin-8,399.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Galectin-9,1231.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Gamma-enolase,41184.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Gastrin-releasing peptide,323,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,GDNF family receptor alpha-1,1107.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,GDNF family receptor alpha-2,5243.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,GDNF family receptor alpha-3,768.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Gelsolin,842.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glia-derived nexin,1909.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glial cell line-derived neurotrophic factor,377.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glial fibrillary acidic protein,463.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glucagon,2177,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glucocorticoid receptor,96.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glucokinase regulatory protein,1750.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glucose-6-phosphate isomerase,37945.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glutamate carboxypeptidase 2,420.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glutathione S-transferase A3,259.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glutathione S-transferase P,7457.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glyceraldehyde-3-phosphate dehydrogenase,133434.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",1196.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glycogen synthase kinase-3 alpha/beta,26519.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glycylpeptide N-tetradecanoyltransferase 1,5428.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glypican-2,160.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glypican-3,1327.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glypican-5,1080.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Glypican-6,1597.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"gp41 C34 peptide, HIV",614.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Granulins,25077.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor,1422.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Granulocyte colony-stimulating factor receptor,724.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Granulocyte-macrophage colony-stimulating factor,230.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Granulysin,1068.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Granzyme A,2780.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Granzyme B,220.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Granzyme H,241.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,GRB2-related adapter protein 2,425,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Gremlin-1,431.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Gro-beta/gamma,1745.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Group 10 secretory phospholipase A2,656.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Group IIE secretory phospholipase A2,260.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth arrest-specific protein 1,674.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth/differentiation factor 11,655.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth/differentiation factor 11/8,731.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth/differentiation factor 15,1314.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth/differentiation factor 2,6325.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth/differentiation factor 5,1204.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth/differentiation factor 8,3763,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth/differentiation factor 9,496.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth factor receptor-bound protein 2,63077.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth hormone receptor,1178.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Growth-regulated alpha protein,3660.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,GTPase KRas,1176.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,GTP-binding nuclear protein Ran,11335.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Haptoglobin,26048.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heat shock 70 kDa protein 1A,7657.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heat shock cognate 71 kDa protein,1871.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heat shock protein beta-1,12245.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heat shock protein HSP 90-alpha/beta,12977,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heat shock protein HSP 90-beta,54768.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heme oxygenase 2,424.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,HemK methyltransferase family member 2,3943.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hemoglobin,1774.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hemojuvelin,1405.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hemopexin,828.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heparan-sulfate 6-O-sulfotransferase 1,2037.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heparin-binding EGF-like growth factor,401.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heparin cofactor 2,3696,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hepatitis A virus cellular receptor 2,7679.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hepatocyte growth factor,1184.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hepatocyte growth factor activator,3646.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hepatocyte growth factor-like protein,3396.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hepatocyte growth factor receptor,11692.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hepatoma-derived growth factor-related protein 2,653.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hepcidin,5848.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,HERV-H LTR-associating protein 2,1776.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein A/B,2090.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein K,197.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoprotein Q,2344,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Heterogeneous nuclear ribonucleoproteins A2/B1,3987.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hexokinase-1,953.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hexokinase-2,870.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",375.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",334.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,High affinity immunoglobulin gamma Fc receptor I,265.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,High affinity nerve growth factor receptor,3236.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,High mobility group protein B1,9549.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histidine-rich glycoprotein,3142,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histidine triad nucleotide-binding protein 1,2062.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone acetyltransferase KAT6A,1226.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone acetyltransferase type B catalytic subunit,330.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone deacetylase 8,2727.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone H1.2,6450.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone H2A type 3,738.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone H2A.z,2049.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone H2B type 2-E,20712.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone H3.1,1443.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Histone-lysine N-methyltransferase EHMT2,954.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Homeobox protein NANOG,198.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Homeodomain-interacting protein kinase 3,338.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hsp90 co-chaperone Cdc37,825.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Human Chorionic Gonadotropin,5386.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hyaluronan and proteoglycan link protein 1,1498.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Hypoxia-inducible factor 1-alpha,437.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,ICOS ligand,1628.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Iduronate 2-sulfatase,6862.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Immunoglobulin A,4194.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Immunoglobulin alpha Fc receptor,171.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Immunoglobulin D,3647.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Immunoglobulin E,1805.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Immunoglobulin G,186917.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Immunoglobulin M,4752.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Immunoglobulin superfamily containing leucine-rich repeat protein 2,9984.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Importin subunit alpha-1,245.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Importin subunit beta-1,13219.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Induced myeloid leukemia cell differentiation protein Mcl-1,758.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Inducible T-cell costimulator,632.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Inhibin beta A chain,7417.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Inhibin beta A chain:Inhibin beta B chain heterodimer,859.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Inhibitor of growth protein 1,28706.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Inorganic pyrophosphatase,38017.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 1,1628,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Inosine-5'-monophosphate dehydrogenase 2,2336.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin,146.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-degrading enzyme,4157.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor 1 receptor,8468.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 1,2495.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 2,1108.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 3,1794.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 4,5449.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 5,2272,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 6,598.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor-binding protein 7,63613.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin-like growth factor I,1087.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Insulin receptor,9742.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Integrin alpha-I: beta-1 complex,838.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Integrin alpha-IIb: beta-3 complex,1379.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Integrin alpha-V: beta-5 complex,860.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Inter-alpha-trypsin inhibitor heavy chain H4,36904.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Intercellular adhesion molecule 1,5420.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Intercellular adhesion molecule 2,1420.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Intercellular adhesion molecule 3,538.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Intercellular adhesion molecule 5,880.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon alpha-10,275.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon alpha-2,255,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon alpha-7,188.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon alpha/beta receptor 1,2211.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon beta,470.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon gamma,788.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon gamma receptor 1,395.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon gamma receptor 2,432.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon lambda-1,364.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon lambda-2,157.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interferon regulatory factor 1,1532,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-10,354.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-10 receptor subunit alpha,1175.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-10 receptor subunit beta,1036.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-11,292.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-12,243.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-1,467.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-12 receptor subunit beta-2,912.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-13,550.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-13 receptor subunit alpha-1,2507.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-15 receptor subunit alpha,989.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-16,268,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-17A,315.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-17B,156.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-17D,249.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-17F,482.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-17 receptor A,999,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-17 receptor B,818.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-17 receptor C,1014.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-17 receptor D,491.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-18-binding protein,7567.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-18 receptor 1,8387.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-18 receptor accessory protein,287.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-19,5737.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-1 alpha,940.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-1 beta,2668.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-1 Receptor accessory protein,57418.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-1 receptor antagonist protein,2273.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-1 receptor-like 1,8408.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-1 receptor-like 2,804.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-1 receptor type 1,12227.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-1 receptor type 2,11586,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-20,319.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-20 receptor subunit alpha,266.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-2,2002.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-22,1000.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-1,684.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-22 receptor subunit alpha-2,2881.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-23,1717.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-23 receptor,3359.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-24,202,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-25,275.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-27,575.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-27 receptor subunit alpha,1105.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-2 receptor subunit alpha,784.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-3,1162.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-34,611.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-36 alpha,544.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-36 beta,457.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-37,1757.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-3 receptor subunit alpha,1583.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-4,481.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-4 receptor subunit alpha,178.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-5,306.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-5 receptor subunit alpha,2333.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-6,320.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-6 receptor subunit alpha,17129.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-6 receptor subunit beta,8822,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-7,173.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-7 receptor subunit alpha,340.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-8,986.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interleukin-9,232.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Interstitial collagenase,1877.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Junctional adhesion molecule B,9431.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Junctional adhesion molecule C,7477.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Junctional adhesion molecule-like,473.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-11,2000.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-12,6463.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-13,1306.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-14,6301.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-4,307.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-5,147.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-6,2490.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-7,1930.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallikrein-8,6063.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kallistatin,42823.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kelch-like ECH-associated protein 1,476.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Keratin, type I cytoskeletal 18",1078.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 2DL4,2089.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DL2,316.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Killer cell immunoglobulin-like receptor 3DS1,403.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Killer cell lectin-like receptor subfamily F member 1,306.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kinesin-like protein KIF23,1424.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kininogen-1,31497.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kin of IRRE-like protein 3,339.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kremen protein 2,4349.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 1,6679.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kunitz-type protease inhibitor 2,1494.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Kynureninase,1045.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lactadherin,1254.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lactoperoxidase,1253.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lactotransferrin,27607.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lamin-B1,688.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Laminin,3896.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Latent-transforming growth factor beta-binding protein 4,1880.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Layilin,1550,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Legumain,3928.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leptin,3229.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leptin receptor,1239.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leucine carboxyl methyltransferase 1,1950,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leucine-rich repeats and immunoglobulin-like domains protein 3,8239.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leucine-rich repeat serine/threonine-protein kinase 2,1918.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 1,103.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane neuronal protein 3,189.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT1,1115.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT2,19444.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leucine-rich repeat transmembrane protein FLRT3,5742.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leukemia inhibitory factor receptor,4572.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 1,3053.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leukocyte immunoglobulin-like receptor subfamily B member 2,6674.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leukocyte surface antigen CD47,1040.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Leukotriene A-4 hydrolase,982.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ligand-dependent nuclear receptor corepressor-like protein,198.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Limbic system-associated membrane protein,1652.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lipopolysaccharide-binding protein,68122.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lithostathine-1-alpha,562.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,L-lactate dehydrogenase B chain,1587.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Low affinity immunoglobulin epsilon Fc receptor,3516.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-a,5034.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor II-b,3794.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Low affinity immunoglobulin gamma Fc region receptor III-B,1087.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Low-density lipoprotein receptor,118.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 1B,52293.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Low-density lipoprotein receptor-related protein 1, soluble",3056.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Low-density lipoprotein receptor-related protein 8,2623.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Low molecular weight phosphotyrosine protein phosphatase,3854.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,L-Selectin,4176.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lumican,2013,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Luteinizing hormone,3064.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ly6/PLAUR domain-containing protein 3,1500.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lymphatic vessel endothelial hyaluronic acid receptor 1,342.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lymphocyte activation gene 3 protein,5743.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lymphocyte antigen 86,4824.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lymphotactin,349.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lymphotoxin alpha1:beta2,139.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lymphotoxin alpha2:beta1,2441.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lymphotoxin-alpha,424.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lysosomal protective protein,13387.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lysosome membrane protein 2,534.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Lysozyme C,87076.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Macrophage-capping protein,1257.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1,1335.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Macrophage colony-stimulating factor 1 receptor,173.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Macrophage mannose receptor 1,10528.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Macrophage metalloelastase,2757.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Macrophage migration inhibitory factor,1329,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Macrophage scavenger receptor types I and II,848.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Macrophage-stimulating protein receptor,438.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Malate dehydrogenase, cytoplasmic",32078.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mammaglobin-B,9947.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mannan-binding lectin serine protease 1,5015.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mannose-binding protein C,13621.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 2,19622.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 3,2090.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,MAP kinase-activated protein kinase 5,645.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mast/stem cell growth factor receptor Kit,16811.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Matrilin-2,11774.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Matrilin-3,472.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Matrilysin,2278.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Matrix extracellular phosphoglycoprotein,210.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Matrix metalloproteinase-14,1027.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Matrix metalloproteinase-16,1720.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Matrix metalloproteinase-17,739.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Matrix metalloproteinase-9,7397.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mediator of RNA polymerase II transcription subunit 1,59621.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Megakaryocyte-associated tyrosine-protein kinase,351.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Melanoma-derived growth regulatory protein,2451.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Membrane frizzled-related protein,2048.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Membrane metallo-endopeptidase-like 1,980.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mesothelin,368.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Metalloproteinase inhibitor 1,82.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Metalloproteinase inhibitor 2,462.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Metalloproteinase inhibitor 3,4092.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Methionine aminopeptidase 1,3035.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Methionine aminopeptidase 2,42261.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Methyl-CpG-binding domain protein 4,425.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence A,323,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,MHC class I polypeptide-related sequence B,9117,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Microtubule-associated protein tau,157.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Midkine,37810.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitochondrial glutamate carrier 2,749.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitochondrial import inner membrane translocase subunit TIM14,515.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 1,11955.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 11,590.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 12,1100,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 13,469.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 14,3725.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 3,44712.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 8,2223.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase 9,1021.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,1357.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Moesin,835.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 2,24849.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mothers against decapentaplegic homolog 3,21019,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Mucin-1,1021.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Muellerian-inhibiting factor,8799.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Myc proto-oncogene protein,438.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Myeloblastin,3511.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Myeloid cell surface antigen CD33,3266.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Myeloperoxidase,14739.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Myoglobin,1209,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Myosin-binding protein C, slow-type",2279,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,N-acetyl-D-glucosamine kinase,989.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,N-acetylglucosamine-6-sulfatase,2991.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,N-acylethanolamine-hydrolyzing acid amidase,16905.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NAD-dependent protein deacetylase sirtuin-2,6039.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NADPH--cytochrome P450 reductase,2981.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Nascent polypeptide-associated complex subunit alpha,6746.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 1,2105.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 2,306.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Natural cytotoxicity triggering receptor 3,429.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Natural killer cell receptor 2B4,191,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Netrin-1,573.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Netrin-4,811.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Netrin receptor UNC5C,4173.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Netrin receptor UNC5D,6085.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Neural cell adhesion molecule 1, 120 kDa isoform",12436.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neural cell adhesion molecule L1,673.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neural cell adhesion molecule L1-like protein,15294.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neuregulin-1,157.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neuregulin-4,640.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neurexin-1-beta,832.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neurexin-3-beta,892.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neurexophilin-1,6482.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neuroblastoma suppressor of tumorigenicity 1,1615.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 1,22277.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 2,640,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neurogenic locus notch homolog protein 3,707.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Neuroligin-4, X-linked",564.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neuronal cell adhesion molecule,17934.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neuronal growth regulator 1,5335.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neuropilin-1,2687.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neurotrophin-3,199.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neurotrophin-4,201,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neutral ceramidase,9897.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neutrophil-activating peptide 2,24909.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neutrophil collagenase,2238.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neutrophil elastase,401.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Neutrophil gelatinase-associated lipocalin,7671.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Nicotinamide phosphoribosyltransferase,610.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Nidogen-1,5523.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Nidogen-2,2693.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NKG2D ligand 1,322.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NKG2D ligand 2,568.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NKG2D ligand 3,915.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NKG2-D type II integral membrane protein,607.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Noggin,3823,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Non-histone chromosomal protein HMG-14,641.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Non-receptor tyrosine-protein kinase TYK2,1534.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NSFL1 cofactor p47,768.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NT-3 growth factor receptor,8962,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,N-terminal pro-BNP,2239,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Nuclear receptor subfamily 1 group D member 1,602.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Nucleoside diphosphate kinase A,622.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Nucleoside diphosphate kinase B,46526.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,NudC domain-containing protein 3,466.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,OCIA domain-containing protein 1,771.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Olfactomedin-4,177.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Oncostatin-M,1576.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Opioid-binding protein/cell adhesion molecule,2383.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Osteocalcin,917.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Osteomodulin,10515.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Osteopontin,9981.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,OX-2 membrane glycoprotein,2831.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Oxidized low-density lipoprotein receptor 1,1880.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pancreatic hormone,1497.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pappalysin-1,15009.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Parathyroid hormone,3041.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Parathyroid hormone-related protein,1012.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peptide YY,1934,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peptidoglycan recognition protein 1,335.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase A,144942.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase B,3284.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase D,15812,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peptidyl-prolyl cis-trans isomerase E,2419.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",26094.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Periostin,5127,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peroxiredoxin-1,2809,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Peroxiredoxin-5, mitochondrial",450.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peroxiredoxin-6,856.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Peroxisomal targeting signal 1 receptor,721.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Persephin,225.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Persulfide dioxygenase ETHE1, mitochondrial",3695,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pescadillo homolog,347.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Phosphatidylethanolamine-binding protein 1,8882.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",731.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",1875,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Phosphoglucomutase-1,475.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Phosphoglycerate kinase 1,4418,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Phosphoglycerate mutase 1,2242.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Phospholipase A2,662.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Phospholipase A2, membrane associated",3215.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pigment epithelium-derived factor,38432.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,PIK3CA/PIK3R1,788.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,PILR alpha-associated neural protein,4367.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 27,277.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pituitary adenylate cyclase-activating polypeptide 38,252.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Placenta growth factor,289.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Plasma kallikrein,24548.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Plasma protease C1 inhibitor,8556.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Plasma serine protease inhibitor,85729.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Plasmin,696.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Plasminogen,3948.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Plasminogen activator inhibitor 1,2728.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase,884.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet-activating factor acetylhydrolase IB subunit beta,8717,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet-derived growth factor C,303.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet-derived growth factor receptor alpha,3762.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet-derived growth factor receptor beta,7610.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet-derived growth factor subunit A,32806.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet-derived growth factor subunit B,109437.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet endothelial cell adhesion molecule,945.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet factor 4,140198.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet glycoprotein 4,14810.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet glycoprotein Ib alpha chain,1418,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet glycoprotein VI,23322.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Platelet receptor Gi24,556,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pleiotrophin,2392.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Plexin-B2,5091.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Plexin-C1,847.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Polymeric immunoglobulin receptor,3896.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,PolyUbiquitin K48-linked,1246,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,PolyUbiquitin K63-linked,4391,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Prefoldin subunit 5,385.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Programmed cell death 1 ligand 1,722.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Programmed cell death 1 ligand 2,4217.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Prokineticin-1,173.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Prolactin,4544.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Prolactin receptor,1048.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proliferating cell nuclear antigen,167.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proliferation-associated protein 2G4,3285.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Prolyl endopeptidase FAP,1123.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pro-opiomelanocortin,1206.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Properdin,89339.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 7,3111,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proprotein convertase subtilisin/kexin type 9,818.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Prostaglandin G/H synthase 2,578.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Prostate-specific antigen,596.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proteasome activator complex subunit 1,1411.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proteasome activator complex subunit 3,272.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proteasome subunit alpha type-1,595.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proteasome subunit alpha type-2,626,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proteasome subunit alpha type-6,1174.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein 4.1,10305.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein amnionless,127.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein deglycase DJ-1,631.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein disulfide-isomerase,272.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein disulfide-isomerase A3,4327.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein E7_HPV16,471.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein E7_HPV18,1647.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein FAM107A,249.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein FAM107B,2552.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein FAM3B,1064,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein FAM3D,11796.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein-glutamine gamma-glutamyltransferase E,9401,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein jagged-1,623.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein jagged-2,292.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein kinase C alpha type,101817.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein kinase C beta type (splice variant beta-II),20409,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein kinase C delta type,4408.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein kinase C gamma type,456.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein kinase C iota type,3629.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein kinase C theta type,3648.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein kinase C zeta type,900.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein lin-7 homolog B,404.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein NOV homolog,624.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein Rev_HV2BE,134.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein S100-A12,537.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein S100-A4,1537.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein S100-A6,3170.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein S100-A7,209.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein S100-A9,5626.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein SET,629.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein-tyrosine kinase 6,208.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein Wnt-7a,197.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Protein Z-dependent protease inhibitor,4710,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Prothrombin,139902,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase receptor Ret,1469,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proto-oncogene tyrosine-protein kinase Src,70324.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Proto-oncogene vav,14103.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,P-selectin,27402.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pulmonary surfactant-associated protein D,11540.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pyridoxal kinase,648.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pyridoxal phosphate phosphatase,5307.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",3925,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Pyruvate kinase PKM,79614.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Quinone oxidoreductase-like protein 1,2858.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Rab GDP dissociation inhibitor beta,27983.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,RAC-alpha/beta/gamma serine/threonine-protein kinase,10451,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,RAC-beta serine/threonine-protein kinase,28632.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ras GTPase-activating protein 1,1068.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 1,48371.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ras-related C3 botulinum toxin substrate 3,11744.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Receptor-type tyrosine-protein kinase FLT3,6331.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-2,363.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-3,328.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Receptor tyrosine-protein kinase erbB-4,148.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Regenerating islet-derived protein 4,1549.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Relaxin receptor 1,376.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Renin,624.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Repulsive guidance molecule A,17117.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Resistin,678.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Reticulon-4 receptor,940.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Retinoblastoma-associated protein,1061.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Retinoic acid receptor responder protein 2,2547.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Retinol-binding protein 4,245.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,RGM domain family member B,2071.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ribonuclease H1,153.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-3,1446.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ribosomal protein S6 kinase alpha-5,256.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ribosome maturation protein SBDS,39410.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,RNA-binding protein 39,393.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Roundabout homolog 2,3390.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Roundabout homolog 3,362.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,R-spondin-2,430.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,R-spondin-3,2156.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,R-spondin-4,344.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Scavenger receptor class F member 1,7460,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Scavenger receptor class F member 2,275.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Scavenger receptor cysteine-rich type 1 protein M130,2966,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sclerostin,20322.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Secreted and transmembrane protein 1,1725.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Secreted frizzled-related protein 1,8078.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Secreted frizzled-related protein 3,2748.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Secretin,213.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Seizure 6-like protein 2,1705.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Semaphorin-3A,1784.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Semaphorin-3E,2324.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Semaphorin-5A,7345.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Semaphorin-6A,16399.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Semaphorin-6B,4484.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine protease 27,4793.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Serine protease HTRA2, mitochondrial",6261.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase 16,1688.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase 17B,4019.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk1,719.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase Chk2,168.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase MRCK beta,981.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 3,973.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 6,17220.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase PAK 7,583,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase pim-1,850.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase PLK1,185.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase receptor R3,1278.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase TBK1,279.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serine/threonine-protein kinase WNK3,998.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serotransferrin,191390.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serum albumin,8499.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serum amyloid A-1 protein,1911.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serum amyloid P-component,27211.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Serum paraoxonase/arylesterase 1,174.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sex hormone-binding globulin,6960.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,S-formylglutathione hydrolase,3791.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SH2 domain-containing protein 1A,5286.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SHC-transforming protein 1,14563.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 14,15791.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 6,207.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 7,1417.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sialic acid-binding Ig-like lectin 9,269.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sialoadhesin,103.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Signal transducer and activator of transcription 1-alpha/beta,15939.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Signal transducer and activator of transcription 3,2697,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Signal transducer and activator of transcription 6,546.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SLAM family member 5,9038,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SLAM family member 6,444.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SLAM family member 7,43776.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SLIT and NTRK-like protein 1,1290.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SLIT and NTRK-like protein 5,2711.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,5784.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Small nuclear ribonucleoprotein F,2762.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Small ubiquitin-related modifier 3,4727.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Somatostatin-28,1332.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Somatotropin,240.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sonic hedgehog protein,1279.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sorting nexin-4,20028.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SPARC,42320.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SPARC-like protein 1,19355.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SPARC-related modular calcium-binding protein 1,2897.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Spectrin alpha chain, non-erythrocytic 1",164.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,S-phase kinase-associated protein 1,5764.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sphingosine kinase 1,17435.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Sphingosine kinase 2,518.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Spondin-1,2350.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Stabilin-2,685.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Stanniocalcin-1,2185.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Stem cell growth factor-alpha,1635.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Stem Cell Growth Factor-beta,713.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Stress-induced-phosphoprotein 1,10086.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Stromal cell-derived factor 1,6383.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Stromelysin-1,719.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Stromelysin-2,797.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,SUMO-conjugating enzyme UBC9,3983.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Superoxide dismutase [Cu-Zn],1483.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Superoxide dismutase [Mn], mitochondrial",36343.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Synaptosomal-associated protein 25,947.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Syntaxin-1A,275.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tartrate-resistant acid phosphatase type 5,9009.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,TATA-box-binding protein,462.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,T-cell surface glycoprotein CD4,348.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tenascin,25550.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Teratocarcinoma-derived growth factor 1,448.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Testican-1,2945.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Testican-2,813.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,TGF-beta receptor type-2,825,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thioredoxin domain-containing protein 12,2586.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thrombin,1513.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thrombopoietin,242.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thrombopoietin Receptor,184.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thrombospondin-1,12902.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thrombospondin-2,14028.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thrombospondin-4,583.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thymic stromal lymphopoietin,440.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Thymidine kinase, cytosolic",422,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thymidylate synthase,287.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thyroglobulin,330.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thyroid peroxidase,1510.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thyroid Stimulating Hormone,896,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Thyroxine-binding globulin,39219.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tissue Factor,1199.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tissue factor pathway inhibitor,66298.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tissue-type plasminogen activator,411.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD80,524.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,T-lymphocyte activation antigen CD86,1024.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,T-lymphocyte surface antigen Ly-9,3841,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Toll-like receptor 2,478.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Toll-like receptor 4,246.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Toll-like receptor 4:Lymphocyte antigen 96 complex,5500.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transcription factor AP-1,4785.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transcription factor IIIB 90 kDa subunit,1851.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transforming growth factor beta-1,1520.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transforming growth factor beta-2,212.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transforming growth factor beta-3,519.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transforming growth factor-beta-induced protein ig-h3,25445.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transforming growth factor beta receptor type 3,32372.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transgelin-2,7906.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transketolase,75937,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Translationally-controlled tumor protein,25865,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Transmembrane glycoprotein NMB,5457,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Trefoil factor 1,5236.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Trefoil factor 2,10986,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Trefoil factor 3,10970.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Triosephosphate isomerase,17302.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tropomyosin alpha-1 chain,819.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tropomyosin alpha-4 chain,129113.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tropomyosin beta chain,1758.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Troponin I, cardiac muscle",500.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Troponin I, fast skeletal muscle",8822.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Troponin T, cardiac muscle",3049.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Trypsin-1,7953.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Trypsin-2,1849.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Trypsin-3,370.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tryptase beta-2,3742.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tryptase gamma,212.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor-associated calcium signal transducer 2,400.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor,443.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor-inducible gene 6 protein,1362.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 11,417.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 12,1061.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 13B,1220.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 14,766.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 15,933.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 18,705.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 4,271.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Tumor necrosis factor ligand superfamily member 6, soluble form",460.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 8,2877.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor ligand superfamily member 9,387.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10A,1221.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10B,358,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 10D,706.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11A,1315.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 11B,11736.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 12A,170.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13B,948.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 13C,2552.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 14,477.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 17,7757.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 18,700.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19,833.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 19L,1913,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1A,1122.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 1B,8807.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 21,7685.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 27,711,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 3,5399.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 4,1145.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6,1467.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 6B,566.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 8,1003.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member 9,331.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tumor necrosis factor receptor superfamily member EDAR,1977.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase ABL1,142.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase BTK,21599.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase CSK,19593.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase Fer,3179.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase Fgr,663.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase Fyn,3036.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase HCK,176.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase JAK2,120432.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase Lck,395.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase Lyn,7172.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Tyrosine-protein kinase Lyn, isoform B",37561.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Tyrosine-protein kinase receptor Tie-1, soluble",7792.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase receptor TYRO3,690.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase Tec,4552.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase transmembrane receptor ROR1,604,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase Yes,1241.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein kinase ZAP-70,11402.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 11,13206.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 1,2102.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 2,302.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type 6,15696,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Tyrosine-protein phosphatase non-receptor type substrate 1,6453.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin,1826.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Ubiquitin+1, truncated mutation for UbB",3843.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase 25,706.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin carboxyl-terminal hydrolase isozyme L1,2165.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 G2,2886.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 L3,2119.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin-conjugating enzyme E2 N,10551.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin-fold modifier 1,10911.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin-fold modifier-conjugating enzyme 1,38123.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Ubiquitin-like protein ISG15,2867,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,UMP-CMP kinase,3820.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Urokinase plasminogen activator surface receptor,11111.3,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Urokinase-type plasminogen activator,2443.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vacuolar protein sorting-associated protein VTA1 homolog,43336.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vascular cell adhesion protein 1,9144.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vascular endothelial growth factor A,11424.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"Vascular endothelial growth factor A, isoform 121",716.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vascular endothelial growth factor C,1706.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vascular endothelial growth factor D,526.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 2,8083.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vascular endothelial growth factor receptor 3,9803.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vasoactive Intestinal Peptide,378.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vesicular integral-membrane protein VIP36,9338.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vitamin K-dependent protein C,1611.2,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vitamin K-dependent protein S,4733.5,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Vitronectin,55942.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,von Willebrand factor,5788.1,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,VPS10 domain-containing receptor SorCS2,257.4,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1",513.9,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7738,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 1,3913.7,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,WNT1-inducible-signaling pathway protein 3,779.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Wnt inhibitory factor 1,4706.6,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,Xaa-Pro aminopeptidase 1,18038.8,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,X-linked interleukin-1 receptor accessory protein-like 2,855,RFU
BF-1200,PDYG564WLA,M0_5,0.5,Plasma,X-ray repair cross-complementing protein 6,309.1,RFU
